STUDYID|DOMAIN|USUBJID|MISEQ|MITESTCD|MITEST|MITSTDTL|MICAT|MIORRES|MIORRESU|MISTRESC|MISTRESN|MISTRESU|MIRESCAT|MISPEC|MISPCCND|MILOC|MILAT|MIDIR|MIMETHOD|MILOBXFL|MIBLFL|MIEVAL|VISITNUM|TAETORD|EPOCH|MIDTC|MIDY
e|MI|35f5401f-575a-44dc-9141-8084716a5b70|1|PAX3FKHR|PAX3-FKHR Fusion Protein|GLEASON PRIMARY SCORE|[?]|[?]|%|[?]|1|gpELISA unit/mL|BENIGN|BUFFY COAT|THAWED|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|IPSILATERAL|DORSAL|NON-CONTACT SPECULAR MICROSCOPY|||CLINICAL RESEARCH COORDINATOR|1|5|TREATMENT|2020-11-16|37
e|MI|8a863a88-67d8-4e50-bafa-c3146591f046|1|MSNGMTRX|Mesangial Matrix|PERCENT POSITIVE CELL|[?]|[?]|umol/dL|[?]|1|U/m2/min|MALIGNANT|URINE|CLOTTED|URETHRA|CONTRALATERAL|OCCIPITAL|ELLA|||ADJUDICATION COMMITTEE|1|6|WASHOUT|2021-01-19|31
e|MI|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|GLOMLTIS|Glomerulitis|ALLRED TOTAL SCORE|[?]|[?]|cg|[?]|1|g|MALIGNANT|BUFFY COAT|CONTAMINATED|CARDIOVASCULAR SYSTEM|LEFT|INNER|HIGH RESOLUTION MELT ANALYSIS||Y|CLINICAL RESEARCH ASSOCIATE|1|7|TREATMENT|2020-10-24|92
e|MI|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|ABNCE|Abnormal Cells|BAUERMEISTER SCORE|[?]|[?]|INHALATION|[?]|1|DNA copies/ug|BENIGN|CIRCULATING TUMOR CELL|HEMOLYZED|FINGERNAIL|IPSILATERAL|VOLAR|WHOLE EXOME SEQUENCING|||INTERVIEWER|1|5|SCREENING|2021-03-11|91
e|MI|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|EPITHINT|Epithelial Integrity|GLEASON PRIMARY SCORE|[?]|[?]|10^9/g|[?]|1|nkat/L|BENIGN|VITREOUS HUMOR|REFRIGERATED|CELIAC ARTERY|UNILATERAL|VENTROLATERAL|QUANTITATIVE ULTRASOUND|||PROXY|1|1|FOLLOW-UP|2020-09-29|98
e|MI|0389257f-50de-4a05-8f2a-69c068374337|1|STRMCECE|Stromal Cells/Total Cells|RECEPTOR OVERALL STATUS|[?]|[?]|IU/kg/h|[?]|1|kHz|MALIGNANT|LYMPH|DRIED|GREAT TROCHANTER|UNILATERAL|TIP|DISK DIFFUSION|||NON-HEALTH CARE PROFESSIONAL|1|7|WASHOUT|2021-01-02|96
e|MI|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|ROS1|ROS1 Protein|GLEASON PRIMARY SCORE|[?]|[?]|DAgU/mL|[?]|1|ukat/L|BENIGN|STRIATED MUSCLE TISSUE|LIPEMIC|SOFT TISSUE|LEFT|LOWER MEDIAL|THIN SMEAR|||CLINICAL STUDY SPONSOR|1|1|TREATMENT|2021-03-08|93
e|MI|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|CORBIOMN|Number of Malignant Biopsy Cores|ISHAK FIBROSIS SCORE|[?]|[?]|10^9 CFU/g|[?]|1|DNA copies/ug|BENIGN|DIALYSIS FLUID, PERITONEAL|CLOTTED|AORTOPULMONARY WINDOW LYMPH NODE|UNILATERAL|LOWER|IMPULSE OSCILLOMETRY|||INTERVIEWER|1|4|FOLLOW-UP|2021-03-19|97
e|MI|ad402b62-0625-431b-9bd7-ffd6124610f3|1|CANCLLTY|Cancer Cellularity|EUROPEAN CONSENSUS SCORE|[?]|[?]|HOMEOPATHIC DILUTION|[?]|1|umol/mg/min|BENIGN|LYSATE|LIPEMIC|AORTIC VALVE ANNULUS|BILATERAL|CENTRAL|DARK FIELD MICROSCOPY||Y|VENDOR|1|4|TREATMENT|2020-12-02|78
e|MI|d76b0f55-541c-491d-9162-4c133c9509f1|1|MSH6|MutS Homolog 6|EUROPEAN CONSENSUS SCORE|[?]|[?]|ng/mol|[?]|1|IU/day|MALIGNANT|PERITONEAL FLUID|REFRIGERATED|CORPUS CALLOSUM, BODY|RIGHT|ANTEROTEMPORAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||CLINICAL RESEARCH ASSOCIATE|1|5|TREATMENT|2020-05-30|16
e|MI|146059d8-5652-41cd-b484-c6e5d8ea540f|1|GZMB|Granzyme B|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|EID 50/dose|[?]|1|ppm|MALIGNANT|CIRCULATING TUMOR CELL|THAWED|HEART, LEFT ATRIAL APPENDAGE|LEFT|PROXIMAL|BIOPSY||Y|SPOUSE|1|5|TREATMENT|2020-10-19|64
e|MI|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|MMRPINTP|Mismatch Repair Proteins Interpretation|METAVIR FIBROSIS SCORE|[?]|[?]|Joule|[?]|1|STRIP|BENIGN|HAIR|THAWED|VULVOVAGINAL REGION|LATERAL|ANTEROLATERAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||STUDY SUBJECT|1|1|TREATMENT|2020-11-29|35
e|MI|129dc836-068a-463e-b789-a0d05c60605d|1|S100A7|S100 Calcium Binding Protein A7|EUROPEAN CONSENSUS SCORE|[?]|[?]|Siemens|[?]|1|uV|BENIGN|ARTERIAL CORD BLOOD|NON-HEMOLYZED|CANINE TOOTH|RIGHT|ROSTRAL|PET/CT SCAN|||PARENT|1|7|SCREENING|2020-07-15|19
e|MI|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|MITOFIG|Mitotic Figure|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mph|[?]|1|umol/L|BENIGN|CAPILLARY PLASMA|CONTAMINATED|HIP JOINT|BILATERAL|ROSTRAL|FREEZING POINT DEPRESSION|Y||PARENT|1|5|SCREENING|2020-12-31|64
e|MI|b91c4469-b3be-467f-8512-b73cf561e168|1|TRCETMCE|Transitional Cells/Tumor Cells|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|nmol/day|[?]|1|OI50|MALIGNANT|BUFFY COAT|LIPEMIC|CRANIAL NERVE|LATERAL|TIP|CELLULOSE TAPE||Y|CLINICAL RESEARCH COORDINATOR|1|3|TREATMENT|2020-08-02|86
e|MI|3637e1e0-8c0c-45cc-b139-e812a589f940|1|CRYPABSC|Crypt Abscess|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|log10 PFU/mL|[?]|1|BOWL|MALIGNANT|LOCHIA|AGGLUTINATED|RETINAL ARTERY|UNILATERAL|SURFACE|DIFFUSION TENSOR MRI|Y||SPOUSE|1|5|WASHOUT|2020-11-16|88
e|MI|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|10^3/hpf|[?]|1|10^6/Ejaculate U|MALIGNANT|ABSCESS FLUID|NON-HEMOLYZED|SKIN FOLD|IPSILATERAL|FACIAL|DNA MICROARRAY|||GUARDIAN|1|1|TREATMENT|2020-11-30|13
e|MI|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|HGFR|Hepatocyte Growth Factor Receptor|METAVIR FIBROSIS SCORE|[?]|[?]|pkat/L|[?]|1|nL|MALIGNANT|ABSCESS FLUID|THAWED|INTERPHALANGEAL JOINT 2 OF THE HAND|BILATERAL|VENTROLATERAL|IMMUNOFLUORESCENT STAIN|||INTERVIEWER|1|3|WASHOUT|2021-01-11|46
e|MI|f1327e16-08c6-4ef0-852e-13c095a94c00|1|GLOMLTIS|Glomerulitis|CHALKLEY SCORE|[?]|[?]|umol/dL|[?]|1|mol/L|MALIGNANT|BLOOD|CONTAMINATED|RAMUS INTERMEDIUS ARTERY|IPSILATERAL|DEEP|ELECTROCHEMILUMINESCENCE||Y|NON-HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-06-11|26
e|MI|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|CELLDIFF|Cellular Differentiation|KNODELL FIBROSIS SCORE|[?]|[?]|mL/min/1.73m2|[?]|1|Ci/ug|MALIGNANT|SMEGMA|CALCIFIED|INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|FRONTAL|CONTRAST ENHANCED PET SCAN||Y|INDEPENDENT ASSESSOR|1|3|TREATMENT|2021-02-27|53
e|MI|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|EGFR|Epidermal Growth Factor Receptor|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^7 CFU/mL|[?]|1|10^9 CFU/mL|BENIGN|PLATELET RICH PLASMA|THAWED|LENS|IPSILATERAL|SUBCORTICAL|INDIA INK STAIN|||CLINICAL RESEARCH ASSOCIATE|1|7|TREATMENT|2021-01-18|51
e|MI|854a9218-995e-47f4-87ab-e58d20f56d19|1|PNLINV|Perineural Invasion|GLEASON TOTAL SUM|[?]|[?]|ug/kg|[?]|1|g/U|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|TOE|RIGHT|LATERAL|TRIPLE-PHASE SPIRAL CT SCAN|Y||CLINICAL RESEARCH COORDINATOR|1|2|FOLLOW-UP|2021-01-08|56
e|MI|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|CRYPABSC|Crypt Abscess|METAVIR FIBROSIS SCORE|[?]|[?]|SFC/10^6 PBMC|[?]|1|log10 PFU|MALIGNANT|ARTERIAL BLOOD|LIPEMIC|EYE BULGE|LEFT|INFERIOR|APPLANATION TONOMETRY|Y||GUARDIAN|1|7|FOLLOW-UP|2020-06-14|3
e|MI|08944dcd-a62d-4932-bb15-a8f15cc73229|1|ICAM1|Intercellular Adhesion Molecule 1|BAUERMEISTER SCORE|[?]|[?]|DRINK|[?]|1|Roentgen|MALIGNANT|EXPIRED AIR|REFRIGERATED|FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL|OCCIPITAL|COLORIMETRY||Y|FRIEND|1|5|TREATMENT|2021-03-03|80
e|MI|1d7df560-695a-41fe-9226-4cc206b05f48|1|BD2|Beta-defensin 2|KNODELL FIBROSIS SCORE|[?]|[?]|10^4/L|[?]|1|mg2/dL2|BENIGN|ERYTHROCYTES|LIPEMIC|TIBIALIS ANTERIOR MUSCLE|BILATERAL|CRANIAL|PUPILLOMETRY|||VENDOR|1|5|SCREENING|2021-03-08|99
e|MI|12c802a8-862c-45a4-b12c-a6f920772534|1|BLDVESD|Blood Vessel Density|METAVIR FIBROSIS SCORE|[?]|[?]|mL/cage/wk|[?]|1|10^4/hpf|BENIGN|DERMAL TISSUE|THAWED|DISTAL LAD ARTERY|CONTRALATERAL|UPPER|NEXT GENERATION SEQUENCING|||SIGNIFICANT OTHER|1|4|WASHOUT|2020-08-08|62
e|MI|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|GZMB|Granzyme B|BAUERMEISTER SCORE|[?]|[?]|PIXEL|[?]|1|mL/h|BENIGN|ARTERIAL BLOOD|SOLIDIFIED|ISCHIAL TUBEROSITY|UNILATERAL|UPPER|LANDOLT RING||Y|SIBLING|1|1|SCREENING|2020-12-28|45
e|MI|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|MSH6|MutS Homolog 6|CHALKLEY SCORE|[?]|[?]|g/kg|[?]|1|mg/mol|MALIGNANT|EXUDATE|FROZEN|BRACHIALIS MUSCLE|UNILATERAL|PERIPHERAL|SNP ARRAY||Y|CLINICAL RESEARCH ASSOCIATE|1|7|FOLLOW-UP|2020-10-02|57
e|MI|96114171-59a0-4543-b3ec-c7796ae8ee92|1|MSNGMTRX|Mesangial Matrix|STAINING INTENSITY|[?]|[?]|GBq/ug|[?]|1|cm H2O|BENIGN|BREAST MILK|FRESH|ACROMIOCLAVICULAR JOINT|RIGHT|INNER|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y||PARENT|1|3|FOLLOW-UP|2020-11-28|14
e|MI|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|CD3|CD3|METAVIR FIBROSIS SCORE|[?]|[?]|DISK|[?]|1|ng|MALIGNANT|MECONIUM|NON-HEMOLYZED|ANKLE MORTISE|UNILATERAL|FACIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|||INDEPENDENT ASSESSOR|1|5|SCREENING|2020-08-21|16
e|MI|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|TISABNUM|Number of Abnormal Tissue Samples|SCHEUER FIBROSIS SCORE|[?]|[?]|DNA copies/mL|[?]|1|/wk|BENIGN|SWABBED MATERIAL|CONCENTRATED|TIBIOTARSAL JOINT|UNILATERAL|SUBCORTICAL|IMMUNORADIOMETRIC ASSAY|||GUARDIAN|1|4|FOLLOW-UP|2020-11-26|50
e|MI|cc562042-9641-460d-862e-d6923dd4207d|1|EGFR|Epidermal Growth Factor Receptor|PERCENT POSITIVE CELL|[?]|[?]|Ci/L|[?]|1|/sec|BENIGN|VENOUS PLASMA|PARAFFIN-EMBEDDED|FACIAL BONE|LATERAL|SUPERFICIAL|DYNAMOMETRY||Y|CHILD|1|1|SCREENING|2020-05-28|11
e|MI|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|BD2|Beta-defensin 2|METAVIR FIBROSIS SCORE|[?]|[?]|mEq/ug|[?]|1|g/kg|MALIGNANT|LYMPH|HEMOLYZED|STERNEBRA|CONTRALATERAL|PERIVENTRICULAR|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y|NON-HEALTH CARE PROFESSIONAL|1|3|FOLLOW-UP|2020-10-19|91
e|MI|d90f2824-692e-403f-b1ca-5b6462c93a75|1|ARTLRHYT|Arteriolar Hyaline Thickening|ISHAK FIBROSIS SCORE|[?]|[?]|USP U|[?]|1|RNA copies/mL|BENIGN|TRANSUDATE|FRESH|METACARPOPHALANGEAL JOINT 2|UNILATERAL|ANTERIOR|PHASE CONTRAST MICROSCOPY|||CLINICAL RESEARCH ASSOCIATE|1|4|FOLLOW-UP|2020-09-19|76
e|MI|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|ALK|ALK Protein|ISUP GLEASON GRADE GROUP|[?]|[?]|Henry|[?]|1|BISCUIT|MALIGNANT|CAPILLARY BLOOD|CALCIFIED|ETHMOID SINUS|LATERAL|LATERAL|MAPH|||SIBLING|1|5|FOLLOW-UP|2020-06-02|18
e|MI|6aa37bb3-85aa-427f-9e56-a776257f1548|1|PROGESTR|Progesterone Receptor|SCHEUER FIBROSIS SCORE|[?]|[?]|DROP|[?]|1|cmH2O*s2/mL|BENIGN|AQUEOUS HUMOR|LIPEMIC|APPENDIX|LATERAL|BASAL|FLOW CYTOMETRY||Y|SPOUSE|1|5|FOLLOW-UP|2020-12-06|32
e|MI|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|LCN2|Lipocalin-2|ISUP GLEASON GRADE GROUP|[?]|[?]|Frames/s|[?]|1|Roentgen|BENIGN|ALVEOLAR AIR|UNEXPECTED ODOR|MANDIBLE|CONTRALATERAL|VENTRAL|PHOTOMETRIC CLOT DETECTION|||SIBLING|1|2|SCREENING|2020-08-08|92
e|MI|940d4614-b41a-44d3-b878-6e19ee22f24b|1|PAP|Prostatic Acid Phosphatase|METMAB SCORE|[?]|[?]|ppb|[?]|1|10^6/Ejaculate U|MALIGNANT|MUSCLE TISSUE|CONCENTRATED|LEFT MAIN CORONARY ARTERY BIFURCATION|UNILATERAL|PERIVENTRICULAR|ATOMIC ABSORPTION SPECTROMETRY|||FAMILY MEMBER|1|5|FOLLOW-UP|2020-07-30|34
e|MI|e2edd4f0-926b-4514-bf3f-7449f248343f|1|PNLINV|Perineural Invasion|TUMOR PROPORTION SCORE|[?]|[?]|U/kg/h|[?]|1|mL/h|BENIGN|PLATELET POOR PLASMA|AUTOLYZED|SUBMANDIBULAR GLAND|RIGHT|VENTRAL|CYSTOSCOPY|||ADJUDICATOR|1|5|WASHOUT|2021-01-24|94
e|MI|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|PTEN|Phosphatase and Tensin Homolog|H SCORE TOTAL SCORE|[?]|[?]|10^9 organisms/mg|[?]|1|PFU/dose|MALIGNANT|SEMINAL FLUID|FROZEN|NOSTRIL|IPSILATERAL|LOWER EXTENSOR SURFACE|MULTIPLEXED BEAD BASED IMMUNOASSAY|||NON-HEALTH CARE PROFESSIONAL|1|7|SCREENING|2020-08-31|74
e|MI|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|MLH1|MutL Homolog 1|GLEASON SECONDARY SCORE|[?]|[?]|Mile|[?]|1|GBq/g|BENIGN|ATHEROSCLEROTIC PLAQUE|LIPEMIC|COLON|CONTRALATERAL|DORSAL|ETDRS EYE CHART||Y|NON-HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-09-20|79
e|MI|ba33de14-b676-4389-a863-a7fa3edb8543|1|IENFDEN|Intraepidermal Nerve Fiber Density|GLEASON SECONDARY SCORE|[?]|[?]|SFC/10^6 PBMC|[?]|1|CAN|BENIGN|SPUTUM|SOLIDIFIED|TRACHEOBRONCHIAL TREE|LATERAL|FACIAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y|CLINICAL RESEARCH ASSOCIATE|1|1|SCREENING|2021-01-01|69
e|MI|24801f05-79be-433d-8124-85580bc14c4f|1|HER2|Human Epidermal Growth Factor Receptor 2|SCHEUER FIBROSIS SCORE|[?]|[?]|mL/g/min|[?]|1|mg/m2/h|BENIGN|MONOCYTE|THAWED|METACARPAL BONE 3|BILATERAL|TIP|NUCLEAR RADIOLOGY|Y||CHILD|1|1|TREATMENT|2020-10-21|52
e|MI|02df80f9-2337-4abd-9452-41cd83dec8ba|1|CD68|CD68|BAUERMEISTER SCORE|[?]|[?]|10^6/hpf|[?]|1|10^7 TCID 50/dose|BENIGN|TISSUE|NON-HEMOLYZED|DUCTUS ARTERIOSUS|UNILATERAL|LOWER EXTENSOR SURFACE|ETDRS EYE CHART||Y|ADJUDICATION COMMITTEE|1|4|WASHOUT|2020-07-30|5
e|MI|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|KI67|Ki-67|H SCORE TOTAL SCORE|[?]|[?]|pmol/10^10 cells|[?]|1|g/cage|BENIGN|SERUM OR PLASMA|UNEXPECTED ODOR|AORTOPULMONARY WINDOW LYMPH NODE|LATERAL|ANTERIOR|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||GUARDIAN|1|2|SCREENING|2020-08-25|32
e|MI|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|CRYPARCD|Crypt Architectural Damage|ISUP GLEASON GRADE GROUP|[?]|[?]|damol/L|[?]|1|ms/mmHg|MALIGNANT|EXPIRED AIR|CALCIFIED|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|CONTRALATERAL|DORSOLATERAL|REFRACTOMETRY|||STUDY SUBJECT|1|3|WASHOUT|2020-12-03|38
e|MI|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|PMS2|PMS1 Homolog 2|METAVIR FIBROSIS SCORE|[?]|[?]|Ci/kg|[?]|1|CIGARETTE|MALIGNANT|CERVICOVAGINAL SECRETION|CALCIFIED|EAR, OUTER|BILATERAL|HIND|BRDU CELLULAR PROLIFERATION ASSAY|||FRIEND|1|1|SCREENING|2020-11-19|19
e|MI|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|MMRPINTP|Mismatch Repair Proteins Interpretation|AJCC TUMOR GRADE|[?]|[?]|pmol/g|[?]|1|MAC50|BENIGN|CERVICOVAGINAL SECRETION|CONCENTRATED|MEDIASTINUM, MIDDLE|UNILATERAL|PERIPHERAL|SANGER SEQUENCING|||CLINICAL RESEARCH COORDINATOR|1|3|TREATMENT|2020-07-28|86
e|MI|d041952e-4aa6-4b37-9cec-127adce2eabb|1|ALK|ALK Protein|PERCENT POSITIVE CELL|[?]|[?]|mL/g/min|[?]|1|mg/L FEU|MALIGNANT|SALIVA|CONCENTRATED|COCCYX|IPSILATERAL|ROSTRAL|IMPULSE OSCILLOMETRY|Y||PARENT|1|1|FOLLOW-UP|2020-12-31|93
e|MI|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|CD56|CD56|SCHEUER FIBROSIS SCORE|[?]|[?]|ppm|[?]|1|RATIO|BENIGN|ABSCESS FLUID|PARAFFIN-EMBEDDED|FASCIA|UNILATERAL|VENTROLATERAL|MAMMOGRAPHY|||CLINICAL RESEARCH ASSOCIATE|1|5|WASHOUT|2020-06-17|18
e|MI|9fc393da-4665-4be5-a869-856c45ddcf13|1|CRYPTTS|Cryptitis|TUMOR PROPORTION SCORE|[?]|[?]|mm3/mm2/year|[?]|1|kDa|MALIGNANT|SMEGMA|FROZEN|HAMATE BONE|UNILATERAL|ROSTRAL|PERIODIC ACID SCHIFF STAIN|||CLINICAL STUDY SPONSOR|1|1|TREATMENT|2020-07-29|51
e|MI|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|CHALKLEY SCORE|[?]|[?]|%/s|[?]|1|PRESSOR UNITS|MALIGNANT|ADIPOSE TISSUE|CONTAMINATED|SKIN OF THE TRUNK|LATERAL|DORSOLATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY|||CLINICAL STUDY SPONSOR|1|5|SCREENING|2021-01-12|3
e|MI|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|CD68|CD68|ALLRED STAINING INTENSITY SCORE|[?]|[?]|FFU|[?]|1|CAN|MALIGNANT|ERYTHROCYTES|LACTESCENT|COLON, HEPATIC FLEXURE|RIGHT|PROXIMAL VOLAR|LAPAROSCOPY|||VENDOR|1|6|TREATMENT|2020-12-30|14
e|MI|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|CD8|CD8|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|10^6 DNA copies/mL|[?]|1|mg/day|BENIGN|INFRANATANT, PLEURAL FLUID|REFRIGERATED|LARGE INTESTINE|BILATERAL|FORE|GRADIENT DIFFUSION|||CLINICAL RESEARCH COORDINATOR|1|4|WASHOUT|2021-01-14|40
e|MI|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|ABNCE|Abnormal Cells|KNODELL FIBROSIS SCORE|[?]|[?]|pmol/g|[?]|1|mL|MALIGNANT|URINE|THAWED|MID-CIRCUMFLEX ARTERY|UNILATERAL|PARIETO-OCCIPITAL|MULTI-SLICE SPIRAL CT|||GUARDIAN|1|1|FOLLOW-UP|2020-08-04|37
e|MI|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|CY16|Cytokeratin 16|KNODELL FIBROSIS SCORE|[?]|[?]|msec|[?]|1|/h|MALIGNANT|PERITONEAL FLUID|LACTESCENT|CEREBRAL HEMISPHERE, RIGHT|LEFT|CENTRAL|KINETIC MICROPARTICLE IMMUNOASSAY|||SIGNIFICANT OTHER|1|5|FOLLOW-UP|2020-08-02|11
e|MI|47fad45a-9a4c-47ee-a863-089d979523b5|1|MSNGMTRX|Mesangial Matrix|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|lx|[?]|1|PATCH|MALIGNANT|CERVICOVAGINAL SECRETION|LACTESCENT|T3 VERTEBRA|LEFT|SURFACE|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|Y|SIBLING|1|4|TREATMENT|2020-11-24|58
e|MI|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|ESTRCPT|Estrogen Receptor|SCHEUER FIBROSIS SCORE|[?]|[?]|F|[?]|1|10^3 organisms|BENIGN|EMOTIONAL TEAR|GELLED|SPLENIC HILAR LYMPH NODE|LATERAL|PROXIMAL VOLAR|PULSE OXIMETRY|||FAMILY MEMBER|1|4|TREATMENT|2020-05-18|5
e|MI|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|TUMCECE|Tumor Cells/Total Cells|PERCENT POSITIVE CELL|[?]|[?]|L/day|[?]|1|aMFI|BENIGN|SERUM OR PLASMA OR BLOOD|CLOTTED|LUNG, LEFT|RIGHT|LOWER FLEXOR SURFACE|HEMAGGLUTINATION INHIBITION ASSAY|||FRIEND|1|7|WASHOUT|2020-09-11|73
e|MI|e7cee930-54f6-482e-b782-01aed0f0db06|1|MMRPINTP|Mismatch Repair Proteins Interpretation|METMAB SCORE|[?]|[?]|U/dL|[?]|1|%(w/v)|BENIGN|HAIR FOLLICLE|CONTAMINATED|THIRD RIGHT POSTEROLATERAL ARTERY|RIGHT|POSTERIOR|CT SCAN WITHOUT CONTRAST|Y||CAREGIVER|1|3|SCREENING|2021-01-04|7
e|MI|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|CD56|CD56|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|kg/cm2|[?]|1|mmHg*min/L|BENIGN|ARTERIAL BLOOD|DRIED|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL|LOWER MEDIAL|PANENDOSCOPY|Y||SIGNIFICANT OTHER|1|2|TREATMENT|2021-04-18|97
e|MI|f754ae7d-0776-41c0-988c-8cf2879d85da|1|TUBATRO|Tubular Atrophy|PERCENT POSITIVE CELL|[?]|[?]|/2000 RBC|[?]|1|Gy/h|BENIGN|GASTRIC FLUID|AUTOLYZED|FACIAL BONE|LEFT|UPPER|DNA MICROARRAY||Y|CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-10-19|42
e|MI|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|CD56|CD56|H SCORE TOTAL SCORE|[?]|[?]|KIT|[?]|1|kg/mol|MALIGNANT|VENOUS PLASMA|PARAFFIN-EMBEDDED|KIDNEY, HILUM|BILATERAL|DISTAL VOLAR|TWO-COLOR MICROARRAY|||CAREGIVER|1|6|TREATMENT|2020-08-07|53
e|MI|482e40c9-2908-4269-b93c-61c311e9fde3|1|CY16|Cytokeratin 16|H SCORE TOTAL SCORE|[?]|[?]|BE/mL|[?]|1|/10^3|MALIGNANT|STOOL|ICTERIC|FEMUR|BILATERAL|INFERIOR|INDIRECT IMMUNOFLUORESCENCE|||INDEPENDENT ASSESSOR|1|1|SCREENING|2020-10-04|90
e|MI|f7cfb281-0556-4316-9373-65edf63c4b23|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|ISUP GLEASON GRADE GROUP|[?]|[?]|nmol/day|[?]|1|mL/m2/min|MALIGNANT|AMNIOTIC FLUID|ICTERIC|PECTORALIS MINOR MUSCLE|BILATERAL|FACIAL|NEPHELOMETRY||Y|CHILD|1|3|TREATMENT|2020-06-22|3
e|MI|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|CD4|CD4|SCHEUER FIBROSIS SCORE|[?]|[?]|keV|[?]|1|dpm/mg|MALIGNANT|PLATELET|CALCIFIED|PYLORIC SPHINCTER|UNILATERAL|DORSAL|MICRO BROTH DILUTION||Y|ADJUDICATION COMMITTEE|1|2|FOLLOW-UP|2021-03-12|71
e|MI|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|MIEXAM|Microscopic Examination|RECEPTOR OVERALL STATUS|[?]|[?]|fmol/g|[?]|1|pm|MALIGNANT|DISCHARGE|GELLED|BRAIN STEM|LEFT|DORSOLATERAL|PANENDOSCOPY|Y||ADJUDICATION COMMITTEE|1|7|WASHOUT|2020-09-06|14
e|MI|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|PROGESTR|Progesterone Receptor|ALLRED TOTAL SCORE|[?]|[?]|s/h|[?]|1|umol/h/mmol|MALIGNANT|SYNOVIAL FLUID|FRESH|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|SUPERIOR|LC/MS|||SIGNIFICANT OTHER|1|2|TREATMENT|2020-12-24|77
e|MI|7e56eb43-62a6-45ac-9476-1d0655595a04|1|EGFR|Epidermal Growth Factor Receptor|H SCORE TOTAL SCORE|[?]|[?]|mL/breath|[?]|1|10^9 organisms/mg|BENIGN|HAIR|CONCENTRATED|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LATERAL|PERIPHERAL|CELLULOSE TAPE||Y|INVESTIGATOR|1|1|FOLLOW-UP|2021-03-17|62
e|MI|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|MITOFIG|Mitotic Figure|GLEASON SECONDARY SCORE|[?]|[?]|Siemens|[?]|1|DRUM|MALIGNANT|NAIL|CLOTTED|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|PROXIMAL VOLAR|PET SCAN|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|2|SCREENING|2020-07-14|25
e|MI|84f74359-c79b-4f1c-8119-a4993b071973|1|GRNLMA|Granuloma|EUROPEAN CONSENSUS SCORE|[?]|[?]|PLUG|[?]|1|10^7 CFU|BENIGN|FLUID|FROZEN|MOTOR CORTEX|RIGHT|VENTROLATERAL|IMMUNOBLOT|||VENDOR|1|1|TREATMENT|2020-06-09|38
e|MI|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|ALK|ALK Protein|ALLRED STAINING INTENSITY SCORE|[?]|[?]|DRINK|[?]|1|V/sec|MALIGNANT|SYNOVIAL FLUID|DRIED|AMYGDALA|LEFT|PERIVENTRICULAR|CLINICAL EVALUATION|||INTERVIEWER|1|5|TREATMENT|2021-01-12|77
e|MI|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|CY16|Cytokeratin 16|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|umol/day|[?]|1|U.CARR|MALIGNANT|SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|LUMBAR SPINE|LEFT|SUPERIOR|ELASTOGRAPHY|||SIGNIFICANT OTHER|1|2|FOLLOW-UP|2020-09-07|8
e|MI|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|PNTHCEMP|Paneth Cell Metaplasia|STAINING INTENSITY|[?]|[?]|PUFF|[?]|1|CIGAR|BENIGN|SEBUM|FRESH|OVARIAN FOLLICLE|CONTRALATERAL|PERIVENTRICULAR|IN VITRO GENE EXPRESSION ASSAY|||CHILD|1|3|WASHOUT|2021-04-14|86
e|MI|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|NORMCECE|Normal Cells/Total Cells|H SCORE TOTAL SCORE|[?]|[?]|mN|[?]|1|HEP|BENIGN|SKELETAL MUSCLE TISSUE|THAWED|PARATRACHEAL LYMPH NODE|BILATERAL|PROXIMAL VOLAR|ULTRASONOGRAPHIC ELASTOGRAPHY|||INTERVIEWER|1|5|TREATMENT|2021-01-03|40
e|MI|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|CD56|CD56|TUMOR PROPORTION SCORE|[?]|[?]|U/m2/min|[?]|1|ELISA unit|BENIGN|CORD BLOOD|FROZEN|INCUS|RIGHT|UPPER|HEMAGGLUTINATION INHIBITION ASSAY|Y||VENDOR|1|6|TREATMENT|2020-06-14|22
e|MI|8effbbff-acda-4718-89f1-e30a418f6bae|1|TISABNUM|Number of Abnormal Tissue Samples|CHALKLEY SCORE|[?]|[?]|GPS U|[?]|1|BE/mL|MALIGNANT|EXHALED BREATH CONDENSATE|AGGLUTINATED|NUCLEUS ACCUMBENS|LATERAL|NASAL|QUANTITATIVE ULTRASOUND||Y|SIBLING|1|6|FOLLOW-UP|2020-12-10|44
e|MI|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|EGFR|Epidermal Growth Factor Receptor|TUMOR PROPORTION SCORE|[?]|[?]|g/animal|[?]|1|mg/L|BENIGN|VENOUS BLOOD|FROZEN|ANUS|LATERAL|SUBCORTICAL|LC/MS|||GUARDIAN|1|7|FOLLOW-UP|2020-09-29|52
e|MI|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|NKX2_1|NK2 Homeobox 1|ISUP GLEASON GRADE GROUP|[?]|[?]|mol/mol|[?]|1|ug/g/min|BENIGN|DERMAL TISSUE|LIPEMIC|NASAL BONE|IPSILATERAL|LOWER FLEXOR SURFACE|AGAR PROPORTION||Y|FAMILY MEMBER|1|4|TREATMENT|2020-08-09|3
e|MI|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|NORMCECE|Normal Cells/Total Cells|ISUP GLEASON GRADE GROUP|[?]|[?]|BOWL|[?]|1|VOXEL|BENIGN|CALCULUS|FRESH|LIMB|IPSILATERAL|DORSOLATERAL|TRICHROME STAIN|Y|Y|CLINICAL RESEARCH COORDINATOR|1|1|WASHOUT|2020-08-27|67
e|MI|6794dffe-333b-425b-8883-26f6e5ba0797|1|CDX2AG|CDX2 Antigen|STAINING INTENSITY|[?]|[?]|grain|[?]|1|10^7 CFU/mL|BENIGN|NAIL|NON-HEMOLYZED|COSTOCHONDRAL JOINT 7|IPSILATERAL|LATERAL|PULMONARY ANGIOGRAPHY|||PROXY|1|3|TREATMENT|2020-09-16|79
e|MI|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|ULCER|Ulceration|TUMOR PROPORTION SCORE|[?]|[?]|LOZENGE|[?]|1|Log10 ELISA unit|BENIGN|EXPIRED AIR|AUTOLYZED|COLON, LEFT|LATERAL|ANTERIOR|PANENDOSCOPY|||INVESTIGATOR|1|2|TREATMENT|2020-07-13|46
e|MI|45897452-8f5a-458d-9a43-13237460ba48|1|ULCER|Ulceration|SCHEUER FIBROSIS SCORE|[?]|[?]|U/g Hb|[?]|1|kN/cm2|BENIGN|SPUTUM|AGGLUTINATED|LUNG|LEFT|VOLAR|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-12-06|35
e|MI|16eb981f-2118-4658-a83f-93d925c410c9|1|NORMCECE|Normal Cells/Total Cells|ISUP GLEASON GRADE GROUP|[?]|[?]|ukat/10^12 RBC|[?]|1|uL|MALIGNANT|ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|SUBCUTIS|CONTRALATERAL|OUTER|SPIRAL CT|Y||ADJUDICATION COMMITTEE|1|3|TREATMENT|2021-01-30|55
e|MI|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|GLOMPATH|Glomerulopathy|ISUP GLEASON GRADE GROUP|[?]|[?]|ug/mL/h|[?]|1|cm H2O|BENIGN|STRIATED MUSCLE TISSUE|DRIED|CORPUS CALLOSUM, BODY|CONTRALATERAL|VENTROLATERAL|CELLULAR PROLIFERATION ASSAY|||HEALTH CARE PROFESSIONAL|1|7|FOLLOW-UP|2021-03-20|78
e|MI|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|CD3|CD3|ISUP GLEASON GRADE GROUP|[?]|[?]|mEq/kg|[?]|1|Ci/uL|MALIGNANT|VENOUS CORD BLOOD|CONTAMINATED|AXILLARY LYMPH NODE LEVEL I|BILATERAL|PARIETO-OCCIPITAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y||HEALTH CARE PROFESSIONAL|1|6|WASHOUT|2021-02-26|38
e|MI|874f491c-5d55-4738-86b7-b1200b16d106|1|KI67|Ki-67|CHALKLEY SCORE|[?]|[?]|ng/day|[?]|1|log EID 50/dose|MALIGNANT|CARDIAC MUSCLE TISSUE|FRESH|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|VENTRAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y||CHILD|1|7|SCREENING|2021-04-05|97
e|MI|281ccdef-794c-49ad-9616-6f6f68dd4543|1|CELLDIFF|Cellular Differentiation|METMAB SCORE|[?]|[?]|BU|[?]|1|CAN|BENIGN|BILE|SOLIDIFIED|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|CONTRALATERAL|ANTEROMEDIAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|GUARDIAN|1|3|SCREENING|2020-07-14|50
e|MI|b1179e10-e8fe-472c-a511-d6d460571857|1|MSH6|MutS Homolog 6|TUMOR PROPORTION SCORE|[?]|[?]|PRESSOR UNITS|[?]|1|EVENTS|BENIGN|FLUID|FROZEN|MALLEUS|LEFT|PROXIMAL|EIA|||PARENT|1|3|FOLLOW-UP|2020-10-19|88
e|MI|6362cf42-f286-4151-bdf7-38fcc5639eed|1|MLH1|MutL Homolog 1|GLEASON TOTAL SUM|[?]|[?]|mL/dL|[?]|1|oz|MALIGNANT|DISCHARGE|CALCIFIED|HAIR|RIGHT|PROXIMAL VOLAR|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-10-08|41
e|MI|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|KI67|Ki-67|CHALKLEY SCORE|[?]|[?]|/40 HPFs|[?]|1|Gy/min|MALIGNANT|DIALYSIS FLUID, PERITONEAL|AUTOLYZED|ESOPHAGUS, UPPER THIRD|UNILATERAL|UPPER FLEXOR SURFACE|LIGHT MICROSCOPY|||SIGNIFICANT OTHER|1|2|TREATMENT|2021-01-28|69
e|MI|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|ABNCE|Abnormal Cells|SCHEUER FIBROSIS SCORE|[?]|[?]|10^4/hpf|[?]|1|mEq/ug|BENIGN|SUPERNATANT, SERUM OR PLASMA|LIPEMIC|RETINAL PIGMENTED EPITHELIAL LAYER|UNILATERAL|POSTERIOR|PANENDOSCOPY||Y|CAREGIVER|1|5|TREATMENT|2020-06-30|13
e|MI|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|GLEASON TOTAL SUM|[?]|[?]|PIPE|[?]|1|pkat/L|BENIGN|AQUEOUS HUMOR|FROZEN|STERNOCLAVICULAR JOINT|LEFT|INFERIOR|MACRO BROTH DILUTION|Y||ADJUDICATOR|1|2|TREATMENT|2020-07-29|47
e|MI|43880587-c397-402d-886b-9b666e3fe455|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/kg/h|[?]|1|cGy|BENIGN|FLUID|SOLIDIFIED|COCCYGEAL VERTEBRA|LEFT|SUPERFICIAL|TRYPAN BLUE STAIN||Y|VENDOR|1|2|WASHOUT|2020-08-22|42
e|MI|807f83d2-9364-4ee4-855d-304f3e252555|1|CD68|CD68|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|atm|[?]|1|umol/mg/min|BENIGN|CARDIAC MUSCLE TISSUE|FRESH|FORELIMB|LATERAL|SUBCORTICAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|PROXY|1|7|FOLLOW-UP|2020-07-07|64
e|MI|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|MSNGMTRX|Mesangial Matrix|METMAB SCORE|[?]|[?]|mL/100g/min|[?]|1|TCID 50/dose|BENIGN|LEUKOCYTE|FROZEN|PAROTID GLAND|RIGHT|PROXIMAL VOLAR|NUCLEAR RADIOLOGY|||SIGNIFICANT OTHER|1|4|TREATMENT|2021-02-18|81
e|MI|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|HISTTYPC|Histologic Type of Cancer|RECEPTOR OVERALL STATUS|[?]|[?]|10^6 CFU|[?]|1|pg/cell|BENIGN|PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|FEMUR SHAFT|UNILATERAL|UPPER FLEXOR SURFACE|WESTERGREN|Y||SPOUSE|1|3|FOLLOW-UP|2020-10-03|59
e|MI|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|PROGESTR|Progesterone Receptor|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|MPL U|[?]|1|Coulomb|MALIGNANT|PLATELET POOR PLASMA|FROZEN|AORTO-ILIAC PERIPHERAL ARTERY|UNILATERAL|DISTAL VOLAR|FLUORESCEIN STAIN|Y||CLINICAL RESEARCH COORDINATOR|1|2|FOLLOW-UP|2020-07-26|4
e|MI|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|GZMB|Granzyme B|GLEASON TOTAL SUM|[?]|[?]|RFU|[?]|1|VIRTUAL PIXEL|MALIGNANT|CALCULUS|CONCENTRATED|ATRIOVENTRICULAR VALVE|CONTRALATERAL|PROXIMAL|TRANSMISSION ELECTRON MICROSCOPY|||CHILD|1|5|FOLLOW-UP|2020-10-31|70
e|MI|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|PDL1|Programmed Death Ligand 1|ALLRED TOTAL SCORE|[?]|[?]|10^3 CFU/g|[?]|1|IU/L|BENIGN|GASTRIC FLUID|CONTAMINATED|L5-S1 INTERVERTEBRAL SPACE|RIGHT|SUPERFICIAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y|CLINICAL RESEARCH COORDINATOR|1|4|WASHOUT|2021-02-06|20
e|MI|21740641-69bb-49a9-a86d-2444914f6d12|1|NKX2_1|NK2 Homeobox 1|H SCORE TOTAL SCORE|[?]|[?]|km/h|[?]|1|min/day|MALIGNANT|STOOL|CONTAMINATED|HEART, VENTRICULAR WALL|IPSILATERAL|INTERMEDIATE|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|Y|INVESTIGATOR|1|3|TREATMENT|2020-08-03|88
e|MI|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mmol/L|[?]|1|umol/L/h|BENIGN|ARTERIAL CORD BLOOD|THAWED|RIB 6|UNILATERAL|OUTER|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||ADJUDICATION COMMITTEE|1|1|WASHOUT|2020-09-08|92
e|MI|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|NKX2_1|NK2 Homeobox 1|METAVIR FIBROSIS SCORE|[?]|[?]|Hz|[?]|1|MAC50|MALIGNANT|LOCHIA|SOLIDIFIED|SCLERA|UNILATERAL|DISTAL|CONTRAST ENHANCED X-RAY|||PROXY|1|3|FOLLOW-UP|2021-03-22|70
e|MI|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|TRCETMCE|Transitional Cells/Tumor Cells|METMAB SCORE|[?]|[?]|10^9 organisms|[?]|1|deg/mm|MALIGNANT|MUCUS|REFRIGERATED|PERIFACIAL LYMPH NODE|LEFT|FORE|RAJI CELL EIA|||GUARDIAN|1|1|FOLLOW-UP|2020-08-28|45
e|MI|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|BD1|Beta-defensin 1|BAUERMEISTER SCORE|[?]|[?]|pmol/L|[?]|1|nmol/L/h|MALIGNANT|SERUM OR PLASMA OR BLOOD|SOLIDIFIED|MEDIAL FEMORAL CONDYLE|LEFT|LATERAL|HPLC/MS/MS|||INVESTIGATOR|1|1|WASHOUT|2020-11-06|50
e|MI|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|ALK|ALK Protein|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|PFU/animal|[?]|1|CAPFUL|BENIGN|MUCUS|LIPEMIC|PENIS, BODY|CONTRALATERAL|DEEP|MACRO BROTH DILUTION|||INDEPENDENT ASSESSOR|1|6|WASHOUT|2020-08-21|79
e|MI|a3b72841-3401-4dcc-9d06-75438b408d0b|1|CRYPABSC|Crypt Abscess|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^6/Ejaculate U|[?]|1|anti-Xa IU|MALIGNANT|PLATELET POOR PLASMA|CONTAMINATED|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|VOLAR|MAGNETIC RESONANCE ENTEROGRAPHY||Y|CLINICAL RESEARCH ASSOCIATE|1|6|TREATMENT|2020-11-12|17
e|MI|4393406e-bda5-42e4-a752-a8121004b7ef|1|CD8|CD8|TUMOR PROPORTION SCORE|[?]|[?]|P|[?]|1|GPL U|BENIGN|MENSTRUAL BLOOD|LIPEMIC|FOREHEAD|CONTRALATERAL|ROSTRAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||CAREGIVER|1|2|TREATMENT|2020-11-29|42
e|MI|d70f5903-3d94-422b-8f69-212f015b54c9|1|NKX2_1|NK2 Homeobox 1|PERCENT POSITIVE CELL|[?]|[?]|ft3|[?]|1|SCOOPFUL|BENIGN|PLEURAL TISSUE|NON-HEMOLYZED|BASILIC VEIN|LATERAL|VOLAR|ENZYMATIC COLORIMETRY|Y||ADJUDICATOR|1|2|SCREENING|2020-08-14|97
e|MI|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|EGFRVP|EGFR Variant Protein|GLEASON SECONDARY SCORE|[?]|[?]|mV2/Hz|[?]|1|mL/m2/h|BENIGN|BREAST MILK|UNEXPECTED ODOR|MIDDLE EAR|BILATERAL|PROXIMAL|MICROBIAL CONCENTRATION|Y|Y|CAREGIVER|1|6|TREATMENT|2021-01-24|28
e|MI|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|CELLDIFF|Cellular Differentiation|H SCORE TOTAL SCORE|[?]|[?]|Coulomb|[?]|1|uV2|MALIGNANT|EXHALED BREATH CONDENSATE|LACTESCENT|RENAL FOSSA|LEFT|VENTROLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|Y|PROXY|1|7|TREATMENT|2020-08-25|52
e|MI|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|TRCETMCE|Transitional Cells/Tumor Cells|EUROPEAN CONSENSUS SCORE|[?]|[?]|RNA copies/mL|[?]|1|ng/dL|BENIGN|ERYTHROCYTES|HEMOLYZED|RIGHT ATRIAL ENDOCARDIUM|RIGHT|PERIPHERAL|MAGNETIC RESONANCE ANGIOGRAPHY|||CLINICAL RESEARCH COORDINATOR|1|4|TREATMENT|2021-01-28|70
e|MI|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|VASINV|Vascular Invasion|STAINING INTENSITY|[?]|[?]|IU|[?]|1|mol/day|MALIGNANT|TRANSUDATE|LACTESCENT|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL|INTERMEDIATE|MICROSCOPY||Y|INVESTIGATOR|1|1|WASHOUT|2021-03-15|82
e|MI|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|FOXP3|Forkhead Box Protein 3|ALLRED TOTAL SCORE|[?]|[?]|BOTTLE|[?]|1|m|MALIGNANT|TUMOR TISSUE|ROOM TEMPERATURE|HEART, RIGHT VENTRICLE|UNILATERAL|PERIPHERAL|PERCUSSION|||INVESTIGATOR|1|7|TREATMENT|2021-02-09|34
e|MI|296f8314-5a07-47b5-8796-31afe709b379|1|HISTTYPC|Histologic Type of Cancer|RECEPTOR OVERALL STATUS|[?]|[?]|BOTTLE|[?]|1|PELLET|MALIGNANT|INTERSTITIAL FLUID|FROZEN|GENITAL TUBERCLE|CONTRALATERAL|UPPER FLEXOR SURFACE|AGAR PROPORTION|||PARENT|1|6|FOLLOW-UP|2020-07-07|9
e|MI|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|EPITHINT|Epithelial Integrity|KNODELL FIBROSIS SCORE|[?]|[?]|BAG|[?]|1|mmol/mol|MALIGNANT|ERYTHROCYTES|CONCENTRATED|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|OUTER|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||INTERVIEWER|1|1|TREATMENT|2021-02-17|76
e|MI|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|BDKRB1|Bradykinin Receptor B1|BAUERMEISTER SCORE|[?]|[?]|tsp eq|[?]|1|g/day|BENIGN|CARDIAC MUSCLE TISSUE|AUTOLYZED|SUBMENTAL LYMPH NODE|UNILATERAL|DEEP|GC/MS|||FRIEND|1|2|TREATMENT|2021-03-04|48
e|MI|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|CD8|CD8|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|ms/mmHg|[?]|1|PFU|MALIGNANT|ABSCESS FLUID|SOLIDIFIED|STRIATUM|LATERAL|ROSTRAL|ICC|Y||CAREGIVER|1|1|FOLLOW-UP|2020-11-18|21
e|MI|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|HER2|Human Epidermal Growth Factor Receptor 2|CHALKLEY SCORE|[?]|[?]|dL|[?]|1|IU/mL|MALIGNANT|BASAL TEAR|PARAFFIN-EMBEDDED|SHIN|RIGHT|INTERMEDIATE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||SPOUSE|1|1|TREATMENT|2020-07-18|15
e|MI|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|EPITHINT|Epithelial Integrity|KNODELL FIBROSIS SCORE|[?]|[?]|kN/cm2|[?]|1|DNA copies/ug|BENIGN|PERSPIRATION|SOLIDIFIED|SKIN OF THE BACK|IPSILATERAL|TEMPORAL|MUGA||Y|HEALTH CARE PROFESSIONAL|1|4|SCREENING|2021-02-10|37
e|MI|b1215705-4c22-43bd-aa65-58bd8745f081|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|GLEASON TOTAL SUM|[?]|[?]|g/cage/wk|[?]|1|cmH2O*s/mL|BENIGN|FLUID|FRESH|VASTUS MEDIALIS MUSCLE|BILATERAL|DISTAL VOLAR|MICROSCOPY|||SIGNIFICANT OTHER|1|4|WASHOUT|2020-08-20|46
e|MI|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|GRNLMA|Granuloma|STAINING INTENSITY|[?]|[?]|mg/kg/h|[?]|1|Newton|MALIGNANT|INFRANATANT, PLASMA|ROOM TEMPERATURE|SKIN OF THE EAR|IPSILATERAL|LOWER|AUDIOMETRY|||FAMILY MEMBER|1|4|TREATMENT|2021-01-07|84
e|MI|6848e438-51ca-4a7d-8f81-26c375969a64|1|CD68|CD68|KNODELL FIBROSIS SCORE|[?]|[?]|amp|[?]|1|scm|BENIGN|SERUM OR PLASMA|LIPEMIC|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|POSTERIOR|ACCELERATOR MASS SPECTROMETRY|||CLINICAL RESEARCH COORDINATOR|1|3|FOLLOW-UP|2020-11-06|4
e|MI|a6e11c33-7905-42d2-bda9-671d756d4c51|1|CD4|CD4|GLEASON TOTAL SUM|[?]|[?]|10^4 CFU/mL|[?]|1|mN|BENIGN|GASTRIC CONTENTS|AGGLUTINATED|FEMUR|LEFT|VOLAR|KINYOUN STAIN|||STUDY SUBJECT|1|5|TREATMENT|2020-10-10|75
e|MI|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|BD1|Beta-defensin 1|METMAB SCORE|[?]|[?]|Torr|[?]|1|mL/kg|MALIGNANT|SALIVA|ROOM TEMPERATURE|COLON, DESCENDING|CONTRALATERAL|CRANIAL|MULTI-SLICE SPIRAL CT|||ADJUDICATOR|1|1|SCREENING|2020-11-17|15
e|MI|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|FIBROSIS|Fibrosis|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Bq|[?]|1|CFU/mL|MALIGNANT|SERUM|CLOTTED|HEAD AND NECK|LATERAL|FRONTAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||NON-HEALTH CARE PROFESSIONAL|1|2|TREATMENT|2020-10-09|38
e|MI|cf10035c-4d44-4512-810b-c267d1c8821b|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|RECEPTOR OVERALL STATUS|[?]|[?]|mMU/mL|[?]|1|Enzyme U|MALIGNANT|STOOL|SOLIDIFIED|EYE, ANTERIOR CHAMBER|IPSILATERAL|TIP|POPULATION SEQUENCING|||ADJUDICATOR|1|7|TREATMENT|2020-07-15|59
e|MI|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|PNLINV|Perineural Invasion|RECEPTOR OVERALL STATUS|[?]|[?]|kcal/day|[?]|1|mV2/Hz|MALIGNANT|MIXED VENOUS BLOOD|ICTERIC|HIP JOINT|LATERAL|SUPERIOR|PUPILLOMETRY|||INTERVIEWER|1|5|WASHOUT|2020-10-22|92
e|MI|a1e0035a-3328-4966-8664-82e53a44eb59|1|CY16|Cytokeratin 16|BAUERMEISTER SCORE|[?]|[?]|PA|[?]|1|POUCH|MALIGNANT|HAIR|CLOTTED|ILEUM, TERMINAL|UNILATERAL|LOWER|FLUORESCENT MICROSCOPY|||CLINICAL STUDY SPONSOR|1|2|WASHOUT|2020-09-21|52
e|MI|771377fd-724f-4056-b2ea-84e1adab1f47|1|EGFRVP|EGFR Variant Protein|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mol/L|[?]|1|umol/mol|MALIGNANT|INTERSTITIAL FLUID|GELLED|GINGIVAL MUCOSA|LATERAL|HIND|STATIC PERIMETRY|||SPOUSE|1|4|WASHOUT|2021-01-21|84
e|MI|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|CRYPABSC|Crypt Abscess|EUROPEAN CONSENSUS SCORE|[?]|[?]|uCi|[?]|1|bel|MALIGNANT|TRANSUDATE|HEMOLYZED|GUT-ASSOCIATED LYMPHOID TISSUE|IPSILATERAL|DEEP|GRADIENT DIFFUSION|||CLINICAL RESEARCH ASSOCIATE|1|1|TREATMENT|2020-09-23|41
e|MI|3aea0861-8f67-4717-93ce-c1e322f151d9|1|INTMART|Intimal Arteritis|PERCENT POSITIVE CELL|[?]|[?]|mL/kg|[?]|1|C|BENIGN|GASTRIC FLUID|ROOM TEMPERATURE|INFRARENAL AORTA|LATERAL|SUBCORTICAL|ELISA|||SIBLING|1|7|FOLLOW-UP|2020-09-27|54
e|MI|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|MSH2|MutS Homolog 2|GLEASON TOTAL SUM|[?]|[?]|ft|[?]|1|CUP|BENIGN|EXUDATE|CLOTTED|TARSAL JOINT|UNILATERAL|LATERAL|HIGH RESOLUTION CT||Y|CLINICAL RESEARCH COORDINATOR|1|1|TREATMENT|2020-11-04|40
e|MI|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|HER2|Human Epidermal Growth Factor Receptor 2|ISUP GLEASON GRADE GROUP|[?]|[?]|mL/breath|[?]|1|kBq|BENIGN|REFLEX TEAR|NON-HEMOLYZED|FACET JOINT|IPSILATERAL|BASAL|ENZYMATIC COLORIMETRY|||HEALTH CARE PROFESSIONAL|1|6|FOLLOW-UP|2021-01-24|35
e|MI|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|ALK|ALK Protein|CHALKLEY SCORE|[?]|[?]|mEq/mL|[?]|1|dyn|MALIGNANT|VENOUS CORD BLOOD|CALCIFIED|ESOPHAGUS, LOWER THIRD|RIGHT|SUBCORTICAL|ANGIOGRAPHY|||INTERVIEWER|1|5|TREATMENT|2020-09-15|6
e|MI|80565a22-8cec-46a2-abd7-91daf0767035|1|EPITHINT|Epithelial Integrity|ISHAK FIBROSIS SCORE|[?]|[?]|BAU/mL|[?]|1|10^9/L|MALIGNANT|BASAL TEAR|ROOM TEMPERATURE|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|BILATERAL|LATERAL|DROPLET DIGITAL PCR||Y|FRIEND|1|1|TREATMENT|2021-04-19|91
e|MI|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|FIBROSIS|Fibrosis|METAVIR FIBROSIS SCORE|[?]|[?]|mL/breath|[?]|1|FEU|MALIGNANT|ALVEOLAR AIR|ICTERIC|HEART, ATRIUM|LEFT|FACIAL|DOUBLE IMMUNODIFFUSION||Y|ADJUDICATION COMMITTEE|1|6|WASHOUT|2020-10-31|22
e|MI|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|BD2|Beta-defensin 2|CHALKLEY SCORE|[?]|[?]|DAYS|[?]|1|pkat/L|BENIGN|SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|MESENTERIC ARTERY|CONTRALATERAL|PROXIMAL VOLAR|IMMUNODIFFUSION|||CLINICAL RESEARCH COORDINATOR|1|3|WASHOUT|2020-11-15|77
e|MI|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|NKX2_1|NK2 Homeobox 1|ALLRED TOTAL SCORE|[?]|[?]|Watt|[?]|1|GPL U/mL|BENIGN|CARDIAC MUSCLE TISSUE|LACTESCENT|L1 VERTEBRA|LATERAL|PARIETO-OCCIPITAL|THIN SMEAR|||PARENT|1|1|WASHOUT|2020-08-31|86
e|MI|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|BD2|Beta-defensin 2|SCHEUER FIBROSIS SCORE|[?]|[?]|titer|[?]|1|foz_br|BENIGN|LYSATE|CALCIFIED|ESOPHAGUS, CERVICAL|LATERAL|ANTEROPOSTERIOR|SLIT LAMP PHOTOGRAPHY|||FAMILY MEMBER|1|4|FOLLOW-UP|2020-08-15|79
e|MI|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|CD4|CD4|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|uU/L|[?]|1|HOMEOPATHIC DILUTION|MALIGNANT|BUFFY COAT|CONCENTRATED|TYMPANIC MEMBRANE|BILATERAL|CAUDAL|IMMUNOPRECIPITATION|||INDEPENDENT ASSESSOR|1|7|TREATMENT|2020-10-17|93
e|MI|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|VASINV|Vascular Invasion|SCHEUER FIBROSIS SCORE|[?]|[?]|GBq|[?]|1|L|BENIGN|GASTRIC FLUID|CALCIFIED|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|LOWER EXTENSOR SURFACE|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|Y|PROXY|1|4|FOLLOW-UP|2020-11-18|68
e|MI|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|CRYPTTS|Cryptitis|SCHEUER FIBROSIS SCORE|[?]|[?]|mol/mg|[?]|1|ugEq|MALIGNANT|VENOUS PLASMA|GELLED|LEG|BILATERAL|TIP|PHYSICAL EXAMINATION|||ADJUDICATOR|1|6|TREATMENT|2020-11-05|67
e|MI|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|PNTHCEMP|Paneth Cell Metaplasia|KNODELL FIBROSIS SCORE|[?]|[?]|SPRAY|[?]|1|mL/h|MALIGNANT|SPUTUM|NON-HEMOLYZED|KIDNEY, UPPER LOBE|LATERAL|LOWER|CLAUSS METHOD|||FAMILY MEMBER|1|7|TREATMENT|2021-04-05|86
e|MI|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|MYFIBROS|Myelofibrosis|STAINING INTENSITY|[?]|[?]|ug|[?]|1|/5x10^4 WBC|MALIGNANT|VENOUS PLASMA|THAWED|XIPHOID PROCESS|BILATERAL|NASAL|IMMUNOBLOT||Y|PROXY|1|6|SCREENING|2021-01-09|23
e|MI|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|CRYPABSC|Crypt Abscess|KNODELL FIBROSIS SCORE|[?]|[?]|mL/kg/day|[?]|1|/kg|MALIGNANT|ADIPOSE TISSUE|LIPEMIC|WRIST JOINT FLEXOR MUSCLES|CONTRALATERAL|DISTAL|PHOTOMETRY||Y|VENDOR|1|4|FOLLOW-UP|2020-08-10|32
e|MI|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|INTSFBRO|Interstitial Fibrosis|RECEPTOR OVERALL STATUS|[?]|[?]|mL/animal/day|[?]|1|dL|MALIGNANT|CERVICOVAGINAL SECRETION|ICTERIC|SYMPATHETIC GANGLIA|LATERAL|TIP|MANUAL COUNT|||VENDOR|1|2|WASHOUT|2020-07-14|5
e|MI|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ALLRED STAINING INTENSITY SCORE|[?]|[?]|VIRTUAL PIXEL|[?]|1|uV*sec|BENIGN|ISOLATE|HEMOLYZED|MITRAL VALVE|IPSILATERAL|OCCIPITAL|INDIRECT IMMUNOFLUORESCENCE|||CLINICAL RESEARCH ASSOCIATE|1|3|WASHOUT|2020-12-24|30
e|MI|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|METAVIR FIBROSIS SCORE|[?]|[?]|uOsm|[?]|1|mL/m2/h|BENIGN|LYMPH|ROOM TEMPERATURE|HAND DIGIT 5|BILATERAL|ANTEROMEDIAL|CELL BASED BIOASSAY|||ADJUDICATION COMMITTEE|1|6|TREATMENT|2020-07-28|60
e|MI|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|NKX2_1|NK2 Homeobox 1|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|MPS U|[?]|1|g/dL|BENIGN|SOFT TISSUE|GELLED|ENDOMETRIUM|RIGHT|ANTEROPOSTERIOR|SPECTROPHOTOMETRY|Y||DOMESTIC PARTNER|1|5|TREATMENT|2020-07-17|37
e|MI|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|TUMOR PROPORTION SCORE|[?]|[?]|PFU|[?]|1|kV|MALIGNANT|ERYTHROCYTES|PARAFFIN-EMBEDDED|EXTENSOR HALLUCIS BREVIS MUSCLE|LEFT|LATERAL|LANDOLT RING|||INTERVIEWER|1|1|TREATMENT|2021-01-05|68
e|MI|2a141b73-e336-4701-9067-8d51d532596b|1|LYMPHINV|Lymphatic Invasion|GLEASON PRIMARY SCORE|[?]|[?]|nmol/L/h|[?]|1|Hounsfield Unit|BENIGN|SUPERNATANT, CEREBROSPINAL FLUID|LACTESCENT|PORTACAVAL LYMPH NODE|UNILATERAL|LOWER EXTENSOR SURFACE|STRESS ECHOCARDIOGRAPHY|Y||SIBLING|1|4|SCREENING|2020-07-03|31
e|MI|4adf9a2c-3c43-4289-8156-1a109791580c|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|RECEPTOR OVERALL STATUS|[?]|[?]|uU/L|[?]|1|deg/mm|BENIGN|AMNIOTIC FLUID|LIPEMIC|ARM|UNILATERAL|CAUDAL|DIGITAL PCR ARRAY|||PROXY|1|6|WASHOUT|2020-12-21|39
e|MI|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|PNTHCEMP|Paneth Cell Metaplasia|ALLRED STAINING INTENSITY SCORE|[?]|[?]|ppth|[?]|1|uIU/dL|BENIGN|BONE|AGGLUTINATED|METATARSOPHALANGEAL JOINT 5|BILATERAL|OCCIPITAL|ELECTRONEUROGRAPHY|||GUARDIAN|1|5|WASHOUT|2020-05-18|5
e|MI|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|CANCLLTY|Cancer Cellularity|METMAB SCORE|[?]|[?]|TRACE|[?]|1|mL/animal/day|BENIGN|BASAL TEAR|SOLIDIFIED|DORSAL MOTOR NUCLEUS|UNILATERAL|SUPERFICIAL|SICKLE CELL SOLUBILITY TEST||Y|CAREGIVER|1|4|WASHOUT|2020-06-01|23
e|MI|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|GLOMLTIS|Glomerulitis|TUMOR PROPORTION SCORE|[?]|[?]|10^7 CFU|[?]|1|ug/g/day|BENIGN|EPITHELIAL CELL|PARAFFIN-EMBEDDED|ILEUM LYMPH NODE|CONTRALATERAL|VENTRAL|CELLULAR PROLIFERATION ASSAY||Y|INDEPENDENT ASSESSOR|1|4|WASHOUT|2020-07-08|53
e|MI|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|PNTHCEMP|Paneth Cell Metaplasia|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|APPLICATION|[?]|1|V/sec|MALIGNANT|EXUDATE|GELLED|CENTRAL NERVOUS SYSTEM|UNILATERAL|INNER|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||INDEPENDENT ASSESSOR|1|6|SCREENING|2020-07-08|50
e|MI|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|CRYPABSC|Crypt Abscess|AJCC TUMOR GRADE|[?]|[?]|%|[?]|1|gtt|MALIGNANT|SUPERNATANT, PLASMA|DRIED|RIB 5|UNILATERAL|PROXIMAL|CONTRAST ENHANCED MRI||Y|CLINICAL STUDY SPONSOR|1|2|WASHOUT|2020-12-20|27
e|MI|08e4310f-f868-4858-a321-f33a21a771e8|1|EGFRVP|EGFR Variant Protein|METAVIR FIBROSIS SCORE|[?]|[?]|uL/kg/day|[?]|1|BISCUIT|BENIGN|TUMOR TISSUE|CLOTTED|HEART, LEFT VENTRICLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|HPLC/MS/MS|Y||NON-HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-06-07|33
e|MI|29edf133-8b5b-46d5-bf7a-f75af4658417|1|GZMB|Granzyme B|GLEASON SECONDARY SCORE|[?]|[?]|umol/L|[?]|1|Bq/g|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|SPLEEN, HILUM|IPSILATERAL|CAUDAL|ELISPOT|Y||PROXY|1|3|TREATMENT|2020-11-19|99
e|MI|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|FIBROSIS|Fibrosis|GLEASON TOTAL SUM|[?]|[?]|umol/min|[?]|1|TCID 50/dose|MALIGNANT|EXPIRED AIR|NON-HEMOLYZED|ANTERIOR TIBIAL ARTERY|LEFT|CAUDAL|RADIAL IMMUNODIFFUSION|||ADJUDICATION COMMITTEE|1|7|SCREENING|2020-10-08|70
e|MI|7a046104-7215-4708-9d85-66683ceb8fe8|1|TUBULTIS|Tubulitis|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|Log10 ELISA unit/dose|[?]|1|ppth|MALIGNANT|EPIDERMAL TISSUE|HEMOLYZED|CAPITATE BONE|LEFT|OUTER|ETDRS EYE CHART|||STUDY SUBJECT|1|1|WASHOUT|2020-12-25|80
e|MI|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|MMRPINTP|Mismatch Repair Proteins Interpretation|ALLRED STAINING INTENSITY SCORE|[?]|[?]|EU|[?]|1|mL/kg/h|BENIGN|LOCHIA|GELLED|EYE, ANTERIOR SEGMENT|UNILATERAL|LOWER|COMPUTERIZED CORNEAL TOPOGRAPHY|Y||ADJUDICATOR|1|3|TREATMENT|2021-01-24|8
e|MI|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|Log10 ELISA unit/dose|[?]|1|AFU|BENIGN|INFRANATANT, PLASMA|REFRIGERATED|MYOMETRIUM|RIGHT|INNER|ELECTRONEUROGRAPHY|||PARENT|1|4|SCREENING|2020-06-17|33
e|MI|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|EGFR|Epidermal Growth Factor Receptor|METMAB SCORE|[?]|[?]|MBq|[?]|1|mV/sec|MALIGNANT|CELL PELLET|ICTERIC|PELVIS|LATERAL|SUBCORTICAL|AMSLER GRID|||CLINICAL STUDY SPONSOR|1|6|SCREENING|2021-02-03|24
e|MI|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|ABNCE|Abnormal Cells|GLEASON SECONDARY SCORE|[?]|[?]|MBP|[?]|1|m/sec|BENIGN|URINE|PARAFFIN-EMBEDDED|FIBULA SHAFT|BILATERAL|LOWER|ACID FAST STAIN|||STUDY SUBJECT|1|5|SCREENING|2020-11-05|93
e|MI|6ec23671-252e-4dc9-b919-88254fce68a5|1|MIEXAM|Microscopic Examination|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|DNA copies/mL|[?]|1|SACHET|BENIGN|ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|RETROPERITONEUM|UNILATERAL|LATERAL|TOLUIDINE BLUE STAIN|Y|Y|FAMILY MEMBER|1|5|WASHOUT|2020-10-13|87
e|MI|db59e5e1-ccda-480b-8955-da5157e16c4a|1|MSNGMTRX|Mesangial Matrix|STAINING INTENSITY|[?]|[?]|cd|[?]|1|Torr|MALIGNANT|CERVICOVAGINAL SECRETION|LACTESCENT|HILAR LYMPH NODE|RIGHT|LATERAL|MULTIPLE BREATH WASHOUT|Y|Y|ADJUDICATOR|1|7|TREATMENT|2020-07-14|71
e|MI|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|FIBROSIS|Fibrosis|GLEASON PRIMARY SCORE|[?]|[?]|mm3/mm2/year|[?]|1|RING|BENIGN|EMOTIONAL TEAR|ROOM TEMPERATURE|PERICARDIAL WALL|BILATERAL|POSTERIOR|SNP ARRAY|||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-10-10|38
e|MI|7449180b-e226-4e97-a059-8760f6523f77|1|LYMPHINV|Lymphatic Invasion|PERCENT POSITIVE CELL|[?]|[?]|COAT|[?]|1|mL/cm3/min|BENIGN|LAVAGE FLUID|AUTOLYZED|LIMB, LOWER|LATERAL|FORE|CELL OF ORIGIN ASSAY||Y|FAMILY MEMBER|1|6|TREATMENT|2020-08-27|64
e|MI|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|HGFR|Hepatocyte Growth Factor Receptor|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|10^7 PFU|[?]|1|10^6 U|MALIGNANT|PLASMA|REFRIGERATED|AMYGDALA|IPSILATERAL|CAUDAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||CHILD|1|1|TREATMENT|2020-08-19|82
e|MI|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|CANCLLTY|Cancer Cellularity|H SCORE TOTAL SCORE|[?]|[?]|mL/kg|[?]|1|CAPFUL|MALIGNANT|VENOUS CORD BLOOD|FRESH|SIGMOID SINUS|BILATERAL|ANTEROLATERAL|MEDIASTINOSCOPY|||FAMILY MEMBER|1|6|TREATMENT|2020-07-18|46
e|MI|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|CD68|CD68|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|MPL U|[?]|1|mg/min|MALIGNANT|CERUMEN|THAWED|SECOND RIGHT POSTEROLATERAL ARTERY|RIGHT|UPPER EXTENSOR SURFACE|SLOAN LETTER EYE CHART 1.25%|Y||PARENT|1|1|FOLLOW-UP|2021-01-16|15
e|MI|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|PAX3FKHR|PAX3-FKHR Fusion Protein|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|umol/min|[?]|1|mL/kg|BENIGN|BASAL TEAR|GELLED|INTERATRIAL SEPTUM|CONTRALATERAL|INNER|FLUORESCENT SPOT TEST|Y|Y|STUDY SUBJECT|1|4|TREATMENT|2020-10-11|29
e|MI|7b201f93-bd8c-4507-a7b7-27a02e364647|1|CORBIOMN|Number of Malignant Biopsy Cores|ALLRED TOTAL SCORE|[?]|[?]|MET|[?]|1|nL|MALIGNANT|TRANSUDATE|NON-HEMOLYZED|C6 VERTEBRA|BILATERAL|TIP|OLIGO ACGH||Y|ADJUDICATOR|1|6|TREATMENT|2021-03-20|97
e|MI|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|CANCLLTY|Cancer Cellularity|GLEASON SECONDARY SCORE|[?]|[?]|Osm|[?]|1|HOMEOPATHIC DILUTION|BENIGN|HAIR FOLLICLE|LIPEMIC|PARATRACHEAL LYMPH NODE|IPSILATERAL|VENTRAL|LINE PROBE ASSAY|||FRIEND|1|4|WASHOUT|2020-10-30|96
e|MI|3611b798-9b3d-4173-b23e-3017939847e0|1|PTBCPLTS|Peritubular Capillaritis|RECEPTOR OVERALL STATUS|[?]|[?]|10^3 organisms/g|[?]|1|log10 IU/mL|BENIGN|BASAL TEAR|CLOTTED|FLEXOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|VENTRAL|HPLC-UV|||INDEPENDENT ASSESSOR|1|5|FOLLOW-UP|2020-08-28|35
e|MI|f651799b-9723-4c2c-88d1-de2f347e9a69|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|GLEASON TOTAL SUM|[?]|[?]|cmol/L|[?]|1|cd*s/m2|MALIGNANT|ENDOTRACHEAL FLUID|HEMOLYZED|EYE, ANTERIOR CHAMBER|UNILATERAL|LOWER MEDIAL|CONTRAST ENHANCED X-RAY|Y||FRIEND|1|3|TREATMENT|2020-07-08|24
e|MI|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|CD3|CD3|ISHAK FIBROSIS SCORE|[?]|[?]|Ci|[?]|1|U/animal|MALIGNANT|MIXED VENOUS BLOOD|DRIED|GLOSSOPHARYNGEAL NERVE|CONTRALATERAL|PERIVENTRICULAR|IN SITU HYBRIDIZATION|||CLINICAL STUDY SPONSOR|1|5|SCREENING|2020-12-30|82
e|MI|29b16c31-df0e-493c-a777-46113b904879|1|EGFR|Epidermal Growth Factor Receptor|STAINING INTENSITY|[?]|[?]|Bq/L|[?]|1|pg|MALIGNANT|ARTERIAL CORD BLOOD|AUTOLYZED|CERVICAL VERTEBRA|UNILATERAL|INTERMEDIATE|PHOTOMETRIC CLOT DETECTION|||VENDOR|1|7|SCREENING|2020-07-31|64
e|MI|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|SMUSCAB|Smooth Muscle Antibody|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Gy/h|[?]|1|Ci/mL|MALIGNANT|GASTRIC CONTENTS|DRIED|EYE, VITREOUS CHAMBER|LATERAL|PERIVENTRICULAR|TOTAL BODY RADIOGRAPHY|Y|Y|FRIEND|1|5|TREATMENT|2020-08-08|18
e|MI|118914c8-9f6a-47c8-b427-296a99547756|1|TRCETMCE|Transitional Cells/Tumor Cells|EUROPEAN CONSENSUS SCORE|[?]|[?]|deg2|[?]|1|fraction of 1|BENIGN|SERUM|PARAFFIN-EMBEDDED|L5 VERTEBRA|BILATERAL|UPPER FLEXOR SURFACE|LC/MS|||ADJUDICATOR|1|2|SCREENING|2020-10-30|15
e|MI|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|PMS2|PMS1 Homolog 2|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mL/g/min|[?]|1|kcal|BENIGN|SYNOVIAL FLUID|CALCIFIED|INTESTINE|LATERAL|ANTEROMEDIAL|LINE PROBE ASSAY|||ADJUDICATION COMMITTEE|1|1|WASHOUT|2021-01-23|55
e|MI|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|BD1|Beta-defensin 1|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|10^6 DNA copies/mL|[?]|1|ug/kg/h|BENIGN|MONOCYTE|NON-HEMOLYZED|INTERPHALANGEAL JOINT OF THE HAND|UNILATERAL|ANTERIOR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y|HEALTH CARE PROFESSIONAL|1|4|FOLLOW-UP|2021-01-17|19
e|MI|7a5ae465-03b9-4006-a29e-94822ed857aa|1|ULCER|Ulceration|H SCORE TOTAL SCORE|[?]|[?]|ng|[?]|1|Tbsp|BENIGN|CELL PELLET|DRIED|PARACOLIC GUTTER|UNILATERAL|INFERIOR|INTERRUPTER TECHNIQUE|||SIGNIFICANT OTHER|1|7|TREATMENT|2020-08-11|50
e|MI|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|GRNLMA|Granuloma|H SCORE TOTAL SCORE|[?]|[?]|EU|[?]|1|deg/mm|BENIGN|PLASMA ULTRAFILTRATE|UNEXPECTED ODOR|CERVICAL SPINE|LEFT|ANTEROPOSTERIOR|KINETIC MICROPARTICLE IMMUNOASSAY|||SPOUSE|1|1|FOLLOW-UP|2020-10-30|48
e|MI|2e4cd860-734a-40b0-bde5-ca08297415a9|1|PDL1|Programmed Death Ligand 1|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|log10 IU/mL|[?]|1|/2000 RBC|BENIGN|SMEGMA|LACTESCENT|NUCLEUS OF DIAGONAL BAND|CONTRALATERAL|DORSOLATERAL|SANGER SEQUENCING|||FAMILY MEMBER|1|4|SCREENING|2020-12-11|26
e|MI|3f1854fb-d14e-4699-888b-d5042fa9327c|1|PMS2|PMS1 Homolog 2|GLEASON TOTAL SUM|[?]|[?]|DRINK|[?]|1|log10 copies/mL|MALIGNANT|ISOLATE|FRESH|PORTACAVAL LYMPH NODE|CONTRALATERAL|ANTEROTEMPORAL|LISSAMINE GREEN STAIN|||VENDOR|1|4|SCREENING|2020-09-14|51
e|MI|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|ESTRCPT|Estrogen Receptor|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|beats/min|[?]|1|kV|BENIGN|PLASMA ULTRAFILTRATE|AGGLUTINATED|NASOPHARYNX|LATERAL|VOLAR|INDIA INK STAIN|Y||ADJUDICATION COMMITTEE|1|6|FOLLOW-UP|2021-01-24|55
e|MI|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|NKX2_1|NK2 Homeobox 1|GLEASON TOTAL SUM|[?]|[?]|10^3 RNA copies/mL|[?]|1|s/h|BENIGN|KERATINOCYTE|FROZEN|KIDNEY, HILUM|CONTRALATERAL|PROXIMAL VOLAR|RADIATION DOSIMETRY|Y||SIGNIFICANT OTHER|1|7|TREATMENT|2020-10-26|97
e|MI|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|TUMCECE|Tumor Cells/Total Cells|KNODELL FIBROSIS SCORE|[?]|[?]|mol/mg|[?]|1|BLOCKS|BENIGN|SKIN TISSUE|NON-HEMOLYZED|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|BILATERAL|OUTER|RAJI CELL RIA|||INDEPENDENT ASSESSOR|1|4|WASHOUT|2020-07-27|56
e|MI|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|TMCE|Tumor Cells|BAUERMEISTER SCORE|[?]|[?]|MBq|[?]|1|g/cage|MALIGNANT|CERUMEN|HEMOLYZED|ILIOPSOAS MUSCLE|BILATERAL|CENTRAL|THERMAL IONIZATION MASS SPECTROMETRY|Y||CHILD|1|5|SCREENING|2020-07-23|38
e|MI|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|INTMART|Intimal Arteritis|KNODELL FIBROSIS SCORE|[?]|[?]|mEq/uL|[?]|1|cL|BENIGN|ENDOMETRIAL TISSUE|UNEXPECTED ODOR|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|CONTRALATERAL|OCCIPITAL|CONTRAST ENHANCED CT SCAN|Y||FRIEND|1|4|FOLLOW-UP|2020-11-23|38
e|MI|2cda4297-410a-49e4-949c-deb3dc4c6656|1|PNLINV|Perineural Invasion|METMAB SCORE|[?]|[?]|IU/g Hb|[?]|1|pmol/g|BENIGN|SUPERNATANT, PLEURAL FLUID|CONTAMINATED|VASTUS MEDIALIS MUSCLE|RIGHT|ANTEROPOSTERIOR|ELECTROCHEMILUMINESCENCE|||STUDY SUBJECT|1|4|TREATMENT|2020-07-18|38
e|MI|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|INTSFBRO|Interstitial Fibrosis|GLEASON TOTAL SUM|[?]|[?]|10^9/L|[?]|1|U/L|MALIGNANT|SERUM OR PLASMA|LACTESCENT|PORTAL VEIN|BILATERAL|SURFACE|PHYSICAL EXAMINATION|||GUARDIAN|1|3|TREATMENT|2021-01-21|2
e|MI|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|PAP|Prostatic Acid Phosphatase|RECEPTOR OVERALL STATUS|[?]|[?]|mAnson U/mL|[?]|1|DAgU|MALIGNANT|SPUTUM|THAWED|SOFT PALATE|CONTRALATERAL|DISTAL VOLAR|SXA SCAN|||CLINICAL RESEARCH COORDINATOR|1|1|SCREENING|2020-05-24|3
e|MI|4b432c61-c620-4c5e-8aad-411facc0f4db|1|ARTLRHYT|Arteriolar Hyaline Thickening|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|1/(s*kPa)|[?]|1|log10 TCID 50/mL|MALIGNANT|INFRANATANT, PLEURAL FLUID|SOLIDIFIED|HIPPOCAMPUS|UNILATERAL|SURFACE|INDIA INK STAIN|Y|Y|ADJUDICATOR|1|5|TREATMENT|2020-10-11|37
e|MI|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|ROS1|ROS1 Protein|ALLRED STAINING INTENSITY SCORE|[?]|[?]|YEARS|[?]|1|RING|BENIGN|ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|PALPEBRAL CONJUNCTIVA|IPSILATERAL|TEMPORAL|ETDRS EYE CHART|||NON-HEALTH CARE PROFESSIONAL|1|6|SCREENING|2020-12-18|2
e|MI|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|FOXP3|Forkhead Box Protein 3|EUROPEAN CONSENSUS SCORE|[?]|[?]|Tesla|[?]|1|umol/L/min|MALIGNANT|EXPIRED AIR|AUTOLYZED|MUSCLE|LATERAL|TEMPORAL|ETDRS EYE CHART||Y|INVESTIGATOR|1|3|FOLLOW-UP|2020-07-04|64
e|MI|c3b911a8-116e-4940-80a2-7128db004f4a|1|TISABNUM|Number of Abnormal Tissue Samples|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|Tesla|[?]|1|SQU/mL|BENIGN|BLOOD|THAWED|SPINOUS PROCESS|BILATERAL|POSTERIOR|SPECTROPHOTOMETRY||Y|CLINICAL RESEARCH ASSOCIATE|1|4|TREATMENT|2020-11-20|11
e|MI|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|TRCETMCE|Transitional Cells/Tumor Cells|ISHAK FIBROSIS SCORE|[?]|[?]|SPRAY|[?]|1|/min|BENIGN|TUMOR TISSUE|LIPEMIC|BRAIN VENTRICLE, LATERAL|LEFT|VOLAR|IMMUNOCHROMATOGRAPHY|||FRIEND|1|1|FOLLOW-UP|2020-07-06|35
e|MI|f8113725-4deb-48a1-876a-ba168a6d2cee|1|MITOFIG|Mitotic Figure|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|g|[?]|1|mg/cm2|BENIGN|INFRANATANT, SERUM|ROOM TEMPERATURE|PANCREATIC DUCT|CONTRALATERAL|SUPERFICIAL|MASS SPECTROMETRY|||FRIEND|1|7|TREATMENT|2021-01-23|11
e|MI|f056c174-b6da-4df6-bf95-2e31911939fb|1|MSH2|MutS Homolog 2|PERCENT POSITIVE CELL|[?]|[?]|TCID 50/dose|[?]|1|PHERESIS UNIT|MALIGNANT|DISCHARGE|AUTOLYZED|EXTERNAL ILIAC LYMPH NODE|LEFT|LOWER FLEXOR SURFACE|PALPATION|||INVESTIGATOR|1|6|FOLLOW-UP|2021-01-30|55
e|MI|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|CDX2AG|CDX2 Antigen|ALLRED STAINING INTENSITY SCORE|[?]|[?]|v/v|[?]|1|cmol/L|BENIGN|COLOSTRUM|SOLIDIFIED|CALCANEUS|BILATERAL|ROSTRAL|DIGITAL PCR|Y||VENDOR|1|7|TREATMENT|2020-11-13|68
e|MI|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|PNTHCEMP|Paneth Cell Metaplasia|PERCENT POSITIVE CELL|[?]|[?]|Bq/L|[?]|1|dL|BENIGN|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|PERIANAL REGION|CONTRALATERAL|INNER|IMPEDANCE CONDUCTIVITY|||ADJUDICATOR|1|7|SCREENING|2021-01-24|16
e|MI|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|STAINING INTENSITY|[?]|[?]|DAgU|[?]|1|m3|BENIGN|CAPILLARY BLOOD|HEMOLYZED|INTRAHEPATIC BILE DUCT|BILATERAL|LOWER MEDIAL|HIGH RESOLUTION MELT ANALYSIS||Y|CLINICAL RESEARCH ASSOCIATE|1|2|TREATMENT|2020-10-15|41
e|MI|81480f83-206f-40c0-a5a4-f75b31cda363|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ALLRED TOTAL SCORE|[?]|[?]|mol|[?]|1|10^3 copies/mL|MALIGNANT|SMOOTH MUSCLE TISSUE|CLOTTED|TEMPORAL BONE|BILATERAL|LOWER MEDIAL|SCINTIGRAPHY|||CAREGIVER|1|2|TREATMENT|2020-12-29|47
e|MI|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|CRYPTTS|Cryptitis|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|10^5/hpf|[?]|1|Ci/g|MALIGNANT|GASTRIC FLUID|AUTOLYZED|LEFT POSTERIOR DESCENDING ARTERY|IPSILATERAL|DORSOLATERAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||VENDOR|1|4|TREATMENT|2020-11-24|49
e|MI|6ed8a749-81c0-4998-817d-efc86cfaa091|1|CRYPABSC|Crypt Abscess|H SCORE TOTAL SCORE|[?]|[?]|mol/g|[?]|1|FINGERTIP UNIT|BENIGN|SWABBED MATERIAL|NON-HEMOLYZED|L3-L4 INTERVERTEBRAL SPACE|RIGHT|SUPERIOR|FUNCTIONAL MRI|||CLINICAL RESEARCH ASSOCIATE|1|2|FOLLOW-UP|2020-07-09|44
e|MI|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|LCN2|Lipocalin-2|ISUP GLEASON GRADE GROUP|[?]|[?]|MBP|[?]|1|10^3 organisms/mL|BENIGN|VENOUS PLASMA|CLOTTED|SHIN|LEFT|FORE|IMMUNORADIOMETRIC ASSAY|Y||CAREGIVER|1|5|SCREENING|2021-03-13|64
e|MI|e6162980-e240-4924-a13a-dde28b2345cd|1|BD2|Beta-defensin 2|GLEASON PRIMARY SCORE|[?]|[?]|CAPLET|[?]|1|mg/mL/day|BENIGN|STRIATED MUSCLE TISSUE|AGGLUTINATED|PARA-AORTIC LYMPH NODE|UNILATERAL|CENTRAL|MICROBIAL CULTURE, LIQUID|||INVESTIGATOR|1|5|TREATMENT|2020-10-15|75
e|MI|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|LCN2|Lipocalin-2|H SCORE TOTAL SCORE|[?]|[?]|mmol/min/kPa/L|[?]|1|mmHg/L/min|MALIGNANT|URINE|SOLIDIFIED|RAPHE|IPSILATERAL|BASAL|FARNSWORTH-MUNSELL 100 HUE TEST|||INTERVIEWER|1|3|TREATMENT|2020-09-06|95
e|MI|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|PTEN|Phosphatase and Tensin Homolog|GLEASON TOTAL SUM|[?]|[?]|FFU|[?]|1|nmol/mL/min|BENIGN|STRIATED MUSCLE TISSUE|LIPEMIC|COCCYX|IPSILATERAL|SUPERFICIAL|LIGHT SCATTERING SPECTROSCOPY|||FRIEND|1|4|WASHOUT|2021-02-05|23
e|MI|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|RECEPTOR OVERALL STATUS|[?]|[?]|ug/kg/h|[?]|1|nmol/L/h|BENIGN|AQUEOUS HUMOR|THAWED|OCCIPITAL LOBE|CONTRALATERAL|ROSTRAL|REFRACTOMETRY||Y|VENDOR|1|5|TREATMENT|2020-12-29|50
e|MI|2738b933-c71d-4239-a093-6b4aa7cc41df|1|BD2|Beta-defensin 2|H SCORE TOTAL SCORE|[?]|[?]|100 IU/mL|[?]|1|g/mol|BENIGN|DISCHARGE|UNEXPECTED ODOR|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|LOWER|INTRAVASCULAR ULTRASOUND|Y|Y|PARENT|1|5|TREATMENT|2020-06-30|43
e|MI|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|ROS1|ROS1 Protein|BAUERMEISTER SCORE|[?]|[?]|PA|[?]|1|BEAM BREAKS|BENIGN|SUPERNATANT, PLASMA|REFRIGERATED|SPLENIC LYMPH NODE|CONTRALATERAL|SURFACE|SCANNING ELECTRON MICROSCOPY||Y|FRIEND|1|3|TREATMENT|2021-02-06|39
e|MI|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|BANFRDX|Banff Diagnostic Category Renal|GLEASON SECONDARY SCORE|[?]|[?]|mL/min|[?]|1|min/day|MALIGNANT|HAIR|DRIED|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|HIND|JAFFE REACTION|||STUDY SUBJECT|1|2|SCREENING|2020-11-19|96
e|MI|6affe43d-e455-40af-8478-dc38019e89e1|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|GLEASON SECONDARY SCORE|[?]|[?]|g/U|[?]|1|GLOBULE|MALIGNANT|SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|GINGIVA|CONTRALATERAL|ROSTRAL|PLETHYSMOGRAPHY|Y||PARENT|1|4|TREATMENT|2020-07-26|49
e|MI|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|LCN2|Lipocalin-2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|uL|[?]|1|pmol|BENIGN|LYMPH|UNEXPECTED ODOR|CORONARY ARTERY, LEFT|UNILATERAL|UPPER FLEXOR SURFACE|URANYL ACETATE STAIN|Y|Y|PROXY|1|4|FOLLOW-UP|2020-08-15|79
e|MI|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|VFBINTMT|Vascular Fibrous Intimal Thickening|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|g/kg/day|[?]|1|s/h|BENIGN|ARTERIAL BLOOD|UNEXPECTED ODOR|ABDOMINAL CAVITY|IPSILATERAL|OUTER|PET/SPECT SCAN|Y||FRIEND|1|1|FOLLOW-UP|2021-02-28|73
e|MI|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|TUBULTIS|Tubulitis|TUMOR PROPORTION SCORE|[?]|[?]|mL/sec/1.73m2|[?]|1|ug/dL|MALIGNANT|MENSTRUAL BLOOD|LACTESCENT|L6 VERTEBRA|IPSILATERAL|LOWER FLEXOR SURFACE|CELL OF ORIGIN ASSAY|||CAREGIVER|1|1|TREATMENT|2021-02-19|47
e|MI|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|CANCLLTY|Cancer Cellularity|METMAB SCORE|[?]|[?]|log EID 50/dose|[?]|1|Torr|BENIGN|STOOL|LIPEMIC|T11 VERTEBRA|CONTRALATERAL|DISTAL|CENTRIFUGATION|||STUDY SUBJECT|1|1|WASHOUT|2020-06-06|36
e|MI|7176f852-7392-4636-800f-3aad48e93065|1|EGFRVP|EGFR Variant Protein|KNODELL FIBROSIS SCORE|[?]|[?]|U/cL|[?]|1|DAYS|BENIGN|PERSPIRATION|ICTERIC|GREAT SAPHENOUS VEIN|BILATERAL|SUBCORTICAL|ANTIMICROBIAL COMBINATION TESTING|Y|Y|SIBLING|1|7|FOLLOW-UP|2021-02-07|32
e|MI|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|TMCE|Tumor Cells|ALLRED TOTAL SCORE|[?]|[?]|mL/cage|[?]|1|ugEq|MALIGNANT|VENOUS BLOOD|DRIED|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|LOWER|MRI|||NON-HEALTH CARE PROFESSIONAL|1|6|FOLLOW-UP|2020-12-06|69
e|MI|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|SGMGSTAT|Surgical Margins Status|AJCC TUMOR GRADE|[?]|[?]|umol/min|[?]|1|cmH2O*s2/mL|MALIGNANT|GASTRIC FLUID|PARAFFIN-EMBEDDED|RIB 8|UNILATERAL|ROSTRAL|CENTRIFUGATION|||FAMILY MEMBER|1|3|TREATMENT|2020-12-15|58
e|MI|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|GLOMLTIS|Glomerulitis|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|PACKET|[?]|1|mg2/dL2|BENIGN|ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|INTERTROCHANTERIC REGION|UNILATERAL|VENTRAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||SIGNIFICANT OTHER|1|1|TREATMENT|2020-11-16|3
e|MI|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|TUMOR PROPORTION SCORE|[?]|[?]|YEARS|[?]|1|OI50|MALIGNANT|BONE|LACTESCENT|VASTUS LATERALIS MUSCLE|BILATERAL|LATERAL|FLOW MICROSCOPY|||CLINICAL RESEARCH COORDINATOR|1|6|FOLLOW-UP|2020-11-04|49
e|MI|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|GLOMLTIS|Glomerulitis|SCHEUER FIBROSIS SCORE|[?]|[?]|LOZENGE|[?]|1|/LPF|MALIGNANT|SEMEN|CALCIFIED|ILIUM|CONTRALATERAL|PERIVENTRICULAR|IODINE STAIN|Y||INVESTIGATOR|1|4|FOLLOW-UP|2021-03-07|75
e|MI|dd518f55-0280-445d-a29f-10f09b21fd53|1|EPITHINT|Epithelial Integrity|ISHAK FIBROSIS SCORE|[?]|[?]|hr/day|[?]|1|BOLUS|MALIGNANT|SPERMATOZOON|SOLIDIFIED|SKIN OF THE TRUNK|UNILATERAL|VENTROLATERAL|CALCULATION|||INDEPENDENT ASSESSOR|1|4|SCREENING|2020-06-21|44
e|MI|49a972da-dfad-438e-b5bc-26ee6b955a59|1|ESTRCPT|Estrogen Receptor|ALLRED STAINING INTENSITY SCORE|[?]|[?]|DISK|[?]|1|mL/min/mmHg|MALIGNANT|MIXED VENOUS BLOOD|GELLED|SHOULDER JOINT|LEFT|LATERAL|ANGIOGRAPHY|||SIGNIFICANT OTHER|1|5|TREATMENT|2020-07-17|33
e|MI|502a42a7-2ed6-46b9-9b10-728f849334b6|1|PCTISCA|Percentage of In situ Carcinoma|CHALKLEY SCORE|[?]|[?]|sec|[?]|1|cmHg|MALIGNANT|PERSPIRATION|REFRIGERATED|PANCREAS, BODY|BILATERAL|CRANIAL|LIGHT SCATTERING SPECTROSCOPY|||FAMILY MEMBER|1|7|WASHOUT|2020-11-30|19
e|MI|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|THICK|Thickness|AJCC TUMOR GRADE|[?]|[?]|copies/uL|[?]|1|ms/mmHg|MALIGNANT|SKELETAL MUSCLE TISSUE|GELLED|PITUITARY GLAND|UNILATERAL|DEEP|DIFFUSION WEIGHTED MRI|||CHILD|1|1|TREATMENT|2020-12-12|57
e|MI|40c048ea-d637-426b-8afe-2da3a6961528|1|CELLDIFF|Cellular Differentiation|RECEPTOR OVERALL STATUS|[?]|[?]|ft3|[?]|1|log10 TCID 50/uL|MALIGNANT|CALCULUS|CALCIFIED|CORPUS CALLOSUM, GENU|RIGHT|ANTERIOR|OPTICAL MAPPING|Y||CLINICAL STUDY SPONSOR|1|3|SCREENING|2020-07-07|4
e|MI|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|VFBINTMT|Vascular Fibrous Intimal Thickening|H SCORE TOTAL SCORE|[?]|[?]|mL/kg/min|[?]|1|10^6 CFU|BENIGN|PLEURAL FLUID|AUTOLYZED|DIAPHRAGM|LEFT|DEEP|MRI|||SIBLING|1|6|TREATMENT|2021-03-31|98
e|MI|35f01eda-1acb-4700-8285-c8cd4b69b524|1|TUMCECE|Tumor Cells/Total Cells|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/m2/h|[?]|1|10^9 CFU/g|BENIGN|SERUM|CONTAMINATED|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|IPSILATERAL|VENTROLATERAL|TRIPLE-PHASE SPIRAL CT SCAN|||STUDY SUBJECT|1|5|TREATMENT|2020-12-08|79
e|MI|9df97277-7d07-4020-bae0-dfa982f21c8d|1|BLDVESD|Blood Vessel Density|ISHAK FIBROSIS SCORE|[?]|[?]|mm/2h|[?]|1|v/v|MALIGNANT|SPUTUM|DRIED|ULNAR ARTERY|LEFT|PERIVENTRICULAR|CRYOSCOPY|Y||NON-HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-11-22|30
e|MI|d1b522d5-557a-4361-a9da-292aa601fbc3|1|CDX2AG|CDX2 Antigen|ISHAK FIBROSIS SCORE|[?]|[?]|STEPS|[?]|1|Tesla|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|FRESH|HEPATOBILIARY SYSTEM|UNILATERAL|ANTEROMEDIAL|MANUAL CLOT DETECTION|Y|Y|SIGNIFICANT OTHER|1|3|SCREENING|2020-12-31|93
e|MI|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|CORBIOMN|Number of Malignant Biopsy Cores|EUROPEAN CONSENSUS SCORE|[?]|[?]|cmHg|[?]|1|/h|MALIGNANT|REFLEX TEAR|CONTAMINATED|AORTIC VALVE, LEFT CORONARY CUSP|LATERAL|ANTEROTEMPORAL|INDIRECT IMMUNOFLUORESCENCE||Y|ADJUDICATION COMMITTEE|1|6|SCREENING|2020-10-23|98
e|MI|da2d0844-3608-4927-9103-cb7c52dd2c96|1|GRNLMA|Granuloma|STAINING INTENSITY|[?]|[?]|log10 PFU/mL|[?]|1|mL/dL|BENIGN|CERUMEN|AGGLUTINATED|TONGUE|IPSILATERAL|VENTROLATERAL|PANENDOSCOPY|Y||FAMILY MEMBER|1|2|FOLLOW-UP|2021-01-28|12
e|MI|30b6f8a7-4512-462d-a162-45c3dad853e5|1|PNTHCEMP|Paneth Cell Metaplasia|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|%|[?]|1|mmHg/L/min|BENIGN|SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|CHEST|LEFT|PERIPHERAL|APPLANATION TONOMETRY|||PARENT|1|3|TREATMENT|2020-12-17|25
e|MI|1a3808b9-6004-4133-8f59-49905d04655e|1|MSH6|MutS Homolog 6|STAINING INTENSITY|[?]|[?]|10^6 organisms|[?]|1|log10 TCID 50/mL|BENIGN|CAPILLARY BLOOD|GELLED|MEDIAN NERVE|RIGHT|DISTAL VOLAR|FLOCCULATION|||INDEPENDENT ASSESSOR|1|1|TREATMENT|2020-12-01|34
e|MI|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|VFBINTMT|Vascular Fibrous Intimal Thickening|TUMOR PROPORTION SCORE|[?]|[?]|IU/L|[?]|1|OD Unit|BENIGN|SUPERNATANT, PLASMA|GELLED|INFRATENTORIAL BRAIN|LATERAL|LOWER|IMMUNOASSAY|||ADJUDICATION COMMITTEE|1|7|TREATMENT|2021-04-07|88
e|MI|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|FOLH1|Folate Hydrolase 1|METAVIR FIBROSIS SCORE|[?]|[?]|uL/kg/day|[?]|1|foz_br|BENIGN|REFLEX TEAR|REFRIGERATED|SMALL SAPHENOUS VEIN|IPSILATERAL|PROXIMAL VOLAR|HPLC/MS|||INVESTIGATOR|1|5|FOLLOW-UP|2020-07-30|25
e|MI|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|ESTRCPT|Estrogen Receptor|SCHEUER FIBROSIS SCORE|[?]|[?]|BAR|[?]|1|U/L|BENIGN|SMEGMA|NON-HEMOLYZED|ANAL CANAL|UNILATERAL|BASAL|REBOUND TONOMETRY|||HEALTH CARE PROFESSIONAL|1|5|TREATMENT|2020-12-01|87
e|MI|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|ESTRCPT|Estrogen Receptor|METMAB SCORE|[?]|[?]|/40 HPFs|[?]|1|mmol/g|BENIGN|PLASMA|NON-HEMOLYZED|URETHRA, PROSTATIC|UNILATERAL|SUPERIOR|BALLPOINT PEN TECHNIQUE|||NON-HEALTH CARE PROFESSIONAL|1|6|WASHOUT|2020-09-05|97
e|MI|37610314-f803-4ffa-a584-ebfe09267a0d|1|FIBROSIS|Fibrosis|ALLRED TOTAL SCORE|[?]|[?]|mm|[?]|1|/MBP|BENIGN|SUPERNATANT, SERUM|THAWED|ANTRUM PYLORI|RIGHT|ANTEROLATERAL|MAPH|||PARENT|1|4|FOLLOW-UP|2020-07-31|41
e|MI|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|INTSFBRO|Interstitial Fibrosis|EUROPEAN CONSENSUS SCORE|[?]|[?]|mg/mol|[?]|1|kIU|MALIGNANT|ARTERIALIZED CAPILLARY BLOOD|GELLED|ANASTOMOSIS|LATERAL|PROXIMAL|GC/MS|||CLINICAL STUDY SPONSOR|1|6|TREATMENT|2020-12-07|84
e|MI|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|HGFR|Hepatocyte Growth Factor Receptor|ALLRED TOTAL SCORE|[?]|[?]|ug/mL/h|[?]|1|MPL U|MALIGNANT|ARTERIAL CORD BLOOD|CONCENTRATED|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|PARIETO-OCCIPITAL|NUCLEIC ACID BASED METHOD|||CAREGIVER|1|1|WASHOUT|2020-08-05|61
e|MI|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|NKX2_1|NK2 Homeobox 1|H SCORE TOTAL SCORE|[?]|[?]|U/m2/day|[?]|1|anti-Xa IU|MALIGNANT|VENOUS BLOOD|THAWED|LYMPH NODE HILUM|BILATERAL|INNER|AUDIOMETRY|||HEALTH CARE PROFESSIONAL|1|6|TREATMENT|2021-02-11|28
e|MI|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|PTEN|Phosphatase and Tensin Homolog|RECEPTOR OVERALL STATUS|[?]|[?]|g/U|[?]|1|pmol/10^10 cells|MALIGNANT|MUSCLE TISSUE|GELLED|GRACILIS MUSCLE|BILATERAL|LOWER MEDIAL|URANYL ACETATE STAIN||Y|INVESTIGATOR|1|3|TREATMENT|2021-02-04|93
e|MI|d7b41e15-6725-4433-8a35-72629e342b47|1|PNTHCEMP|Paneth Cell Metaplasia|ISHAK FIBROSIS SCORE|[?]|[?]|fmol|[?]|1|/2500 WBC|MALIGNANT|CALCULUS|PARAFFIN-EMBEDDED|PANCREAS, TAIL|CONTRALATERAL|INNER|CENTRIFUGATION||Y|VENDOR|1|7|TREATMENT|2020-09-28|24
e|MI|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|ULCER|Ulceration|METAVIR FIBROSIS SCORE|[?]|[?]|cm2|[?]|1|ug/mL/h|MALIGNANT|SPUTUM|ROOM TEMPERATURE|FAT PAD|LEFT|LOWER EXTENSOR SURFACE|CARDIAC THERMODILUTION|||ADJUDICATION COMMITTEE|1|7|WASHOUT|2020-11-28|54
e|MI|3effe272-6a68-4163-a4f3-bd269af6061c|1|TUBULTIS|Tubulitis|EUROPEAN CONSENSUS SCORE|[?]|[?]|log10 TCID 50/mL|[?]|1|%/min|BENIGN|INTERSTITIAL FLUID|AGGLUTINATED|ANTERIOR TIBIAL VEIN|LEFT|VOLAR|SLOAN LETTER EYE CHART 2.5%||Y|PROXY|1|4|FOLLOW-UP|2021-01-24|19
e|MI|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|HISTTYPC|Histologic Type of Cancer|SCHEUER FIBROSIS SCORE|[?]|[?]|pg|[?]|1|Bq/uL|MALIGNANT|DISCHARGE|LIPEMIC|COCCYGEAL VERTEBRA|CONTRALATERAL|ROSTRAL|TELLER ACUITY CARDS|Y||NON-HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-10-18|29
e|MI|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|MCINTINF|Mononuc Cell Interstitial Inflammation|GLEASON SECONDARY SCORE|[?]|[?]|U/g/h|[?]|1|GPL U|BENIGN|CIRCULATING TUMOR CELL|UNEXPECTED ODOR|ELBOW JOINT|CONTRALATERAL|OUTER|SNELLEN EYE CHART|||HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-11-11|22
e|MI|5c2791ff-aaf6-413f-9827-6e97e2273388|1|PMS2|PMS1 Homolog 2|ALLRED TOTAL SCORE|[?]|[?]|10^3/hpf|[?]|1|PFU/animal|MALIGNANT|SPERMATOZOON|HEMOLYZED|RIB 9|IPSILATERAL|POSTERIOR|AGAR PROPORTION|||ADJUDICATOR|1|5|FOLLOW-UP|2020-09-07|11
e|MI|b336d8c2-7bca-404e-aea3-5148d559ea99|1|FOLH1|Folate Hydrolase 1|ISHAK FIBROSIS SCORE|[?]|[?]|P|[?]|1|kHz|MALIGNANT|RETICULOCYTES|DRIED|METATARSOPHALANGEAL JOINT|LEFT|FORE|HEMATOXYLIN AND EOSIN STAIN|Y||CLINICAL RESEARCH COORDINATOR|1|5|TREATMENT|2020-11-14|66
e|MI|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|MCINTINF|Mononuc Cell Interstitial Inflammation|BAUERMEISTER SCORE|[?]|[?]|cd|[?]|1|mJoule/cm2|BENIGN|SWABBED MATERIAL|UNEXPECTED ODOR|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|CONTRALATERAL|HIND|HANSEL STAIN|||CLINICAL RESEARCH COORDINATOR|1|2|WASHOUT|2020-09-06|91
e|MI|1261eee1-f073-4419-b0b7-28abd0ec1513|1|BDKRB1|Bradykinin Receptor B1|GLEASON PRIMARY SCORE|[?]|[?]|DISK|[?]|1|Bq/L|BENIGN|RETICULOCYTES|NON-HEMOLYZED|SACRUM|BILATERAL|SUPERIOR|POLYGRAPHY|||CLINICAL STUDY SPONSOR|1|6|WASHOUT|2020-12-17|87
e|MI|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|ARTLRHYT|Arteriolar Hyaline Thickening|METAVIR FIBROSIS SCORE|[?]|[?]|Bq/ug|[?]|1|CCID 50/mL|BENIGN|PERITONEAL FLUID|GELLED|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|UNILATERAL|MEDIAL|NUCLEIC ACID SEQUENCING|||SPOUSE|1|1|FOLLOW-UP|2021-01-22|34
e|MI|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|FOLH1|Folate Hydrolase 1|EUROPEAN CONSENSUS SCORE|[?]|[?]|BOTTLE|[?]|1|/LPF|MALIGNANT|EXPIRED AIR|PARAFFIN-EMBEDDED|OPPONENS POLLICIS MUSCLE|LATERAL|CENTRAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||CAREGIVER|1|3|WASHOUT|2021-01-15|13
e|MI|898a9d2f-338b-41bf-8ac0-c4a025481349|1|MLH1|MutL Homolog 1|AJCC TUMOR GRADE|[?]|[?]|10^8/L|[?]|1|MASK|MALIGNANT|ERYTHROCYTES|DRIED|SKIN OF THE SOLE|CONTRALATERAL|INTERMEDIATE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||VENDOR|1|1|TREATMENT|2020-06-20|37
e|MI|db3824aa-375d-4e40-a14b-af0e4460914e|1|CELLDIFF|Cellular Differentiation|ISHAK FIBROSIS SCORE|[?]|[?]|10^6 IU|[?]|1|mL/cm H2O|BENIGN|INFRANATANT, SERUM|NON-HEMOLYZED|METACARPAL BONE 3|LATERAL|INNER|CELLULOSE TAPE|Y||CHILD|1|6|TREATMENT|2020-06-15|36
e|MI|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|GZMB|Granzyme B|GLEASON PRIMARY SCORE|[?]|[?]|rpm|[?]|1|cs|MALIGNANT|ABSCESS FLUID|ICTERIC|PROCERUS MUSCLE|LATERAL|OCCIPITAL|DUCTOGRAPHY|||DOMESTIC PARTNER|1|1|FOLLOW-UP|2021-02-21|34
e|MI|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|MITOFIG|Mitotic Figure|BAUERMEISTER SCORE|[?]|[?]|cm/min|[?]|1|ug/m2/day|MALIGNANT|CERUMEN|FROZEN|HAMSTRING MUSCLE|UNILATERAL|MIDLINE|CONTACT SPECULAR MICROSCOPY|||CLINICAL RESEARCH ASSOCIATE|1|2|TREATMENT|2020-08-02|51
e|MI|7f211d8a-7478-4082-8d95-4ace9ceee919|1|MSH6|MutS Homolog 6|ALLRED STAINING INTENSITY SCORE|[?]|[?]|L|[?]|1|MPL U|BENIGN|ARTERIALIZED CAPILLARY BLOOD|FROZEN|DISTAL RADIOULNAR JOINT|IPSILATERAL|CAUDAL|REVERSE TRANSCRIPTASE PCR|||SIBLING|1|4|SCREENING|2020-11-10|93
e|MI|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|BD2|Beta-defensin 2|GLEASON TOTAL SUM|[?]|[?]|MPL U|[?]|1|Gy|MALIGNANT|SOFT TISSUE|FRESH|COLON WALL|LEFT|DEEP|LISSAMINE GREEN STAIN|||CLINICAL STUDY SPONSOR|1|6|WASHOUT|2020-12-26|88
e|MI|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|EPITHINT|Epithelial Integrity|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Shock Wave|[?]|1|copies/uL|MALIGNANT|SWABBED MATERIAL|SOLIDIFIED|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|DISTAL|LIGHT MICROSCOPY|Y||INVESTIGATOR|1|6|TREATMENT|2021-02-22|73
e|MI|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|CRYPTTS|Cryptitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mEq/ug|[?]|1|pmol/10^9 cells|BENIGN|CALCULUS|CONCENTRATED|AXILLARY LYMPH NODE LEVEL II|CONTRALATERAL|DEEP|ELECTROGASTROGRAPHY||Y|SPOUSE|1|7|SCREENING|2020-07-10|66
e|MI|d394120d-7630-4fcf-a336-482599d88296|1|EPITHINT|Epithelial Integrity|KNODELL FIBROSIS SCORE|[?]|[?]|mg/cm2|[?]|1|nmol|BENIGN|PUS|AUTOLYZED|LATERAL RAMUS INTERMEDIUS ARTERY|LEFT|CRANIAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||PARENT|1|6|FOLLOW-UP|2021-04-12|90
e|MI|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|CRYPTTS|Cryptitis|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|Roentgen|BENIGN|PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED|PROFUNDA FEMORIS ARTERY|UNILATERAL|VENTRAL|EEG|Y|Y|SIBLING|1|6|TREATMENT|2020-12-14|64
e|MI|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|CRYPABSC|Crypt Abscess|BAUERMEISTER SCORE|[?]|[?]|PA|[?]|1|/h|BENIGN|MUSCLE TISSUE|CONTAMINATED|AXIAL SKELETON|LEFT|INNER|SPECULAR MICROSCOPY|||SPOUSE|1|5|TREATMENT|2020-08-25|20
e|MI|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|CD56|CD56|GLEASON SECONDARY SCORE|[?]|[?]|umol/L/h|[?]|1|DNA copies/ug|BENIGN|VENOUS CORD BLOOD|FROZEN|SKULL, BASE|CONTRALATERAL|ANTEROMEDIAL|FLOCCULATION|||INDEPENDENT ASSESSOR|1|5|TREATMENT|2021-01-31|51
e|MI|59b0fee3-2294-448e-9837-38bd6b5c794b|1|NORMCECE|Normal Cells/Total Cells|SCHEUER FIBROSIS SCORE|[?]|[?]|nmol/L/h|[?]|1|IU/mL|MALIGNANT|LYSATE|LACTESCENT|HEART, ATRIUM|RIGHT|DISTAL VOLAR|PHOROPTER|||FRIEND|1|3|WASHOUT|2021-01-17|26
e|MI|d9bdb1e3-4630-423f-be01-4873bce30422|1|ABNCE|Abnormal Cells|BAUERMEISTER SCORE|[?]|[?]|mol/L|[?]|1|MBq/uL|MALIGNANT|BASAL TEAR|AUTOLYZED|MASTOID PROCESS|BILATERAL|CENTRAL|TRYPAN BLUE STAIN|||NON-HEALTH CARE PROFESSIONAL|1|6|WASHOUT|2021-02-12|62
e|MI|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|STRMCECE|Stromal Cells/Total Cells|SCHEUER FIBROSIS SCORE|[?]|[?]|mU/g|[?]|1|gtt|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|LEFT MAIN CORONARY ARTERY BIFURCATION|RIGHT|DEEP|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||GUARDIAN|1|7|TREATMENT|2020-06-24|9
e|MI|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|ICAM1|Intercellular Adhesion Molecule 1|METMAB SCORE|[?]|[?]|kDa|[?]|1|Ci/L|MALIGNANT|LUNG SURFACTANT|GELLED|INTERNAL MAMMARY ARTERY|RIGHT|CAUDAL|FLAME PHOTOMETRY|||CAREGIVER|1|3|WASHOUT|2020-10-08|75
e|MI|933c3a61-59a0-4cfb-ae17-45bc48229323|1|IENFDEN|Intraepidermal Nerve Fiber Density|EUROPEAN CONSENSUS SCORE|[?]|[?]|psec|[?]|1|DRINK|BENIGN|EPITHELIAL CELL|CONCENTRATED|COMMON ILIAC ARTERY|IPSILATERAL|INFERIOR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||HEALTH CARE PROFESSIONAL|1|6|TREATMENT|2020-10-20|51
e|MI|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|CELLDIFF|Cellular Differentiation|GLEASON PRIMARY SCORE|[?]|[?]|mIU/L|[?]|1|cm/s|BENIGN|VITREOUS HUMOR|UNEXPECTED ODOR|ADDUCTOR LONGUS MUSCLE|LATERAL|DISTAL|COULOMETRIC TITRATION|||HEALTH CARE PROFESSIONAL|1|2|WASHOUT|2020-11-04|19
e|MI|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|MCINTINF|Mononuc Cell Interstitial Inflammation|EUROPEAN CONSENSUS SCORE|[?]|[?]|genEq/mL|[?]|1|Enzyme U/m2|BENIGN|MIXED VENOUS BLOOD|CALCIFIED|BLOOD|RIGHT|DISTAL|TRYPAN BLUE STAIN||Y|STUDY SUBJECT|1|5|TREATMENT|2020-11-08|20
e|MI|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|FOXP3|Forkhead Box Protein 3|RECEPTOR OVERALL STATUS|[?]|[?]|/VF|[?]|1|Enzyme U/L|BENIGN|SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|GASTROINTESTINAL TRACT, LOWER|RIGHT|NASAL|POLYMERASE CHAIN REACTION|||CLINICAL STUDY SPONSOR|1|4|FOLLOW-UP|2020-09-06|14
e|MI|3d59a754-10bb-4847-93ea-433b43265a2f|1|LCN2|Lipocalin-2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|ELISA unit|[?]|1|Gy/h|BENIGN|GASTRIC CONTENTS|SOLIDIFIED|METACARPOPHALANGEAL JOINT 1|IPSILATERAL|LOWER EXTENSOR SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||CLINICAL STUDY SPONSOR|1|5|WASHOUT|2020-11-04|21
e|MI|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|THICK|Thickness|METMAB SCORE|[?]|[?]|10^6 CFU/g|[?]|1|g/dL|BENIGN|GASTRIC FLUID|CONTAMINATED|HEART, RIGHT VENTRICLE|LEFT|UPPER EXTENSOR SURFACE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||SIGNIFICANT OTHER|1|4|WASHOUT|2021-01-15|5
e|MI|89209495-c485-4eb7-b858-8dc5490d2b64|1|MSNGMTRX|Mesangial Matrix|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|SFC/10^6 PBMC|[?]|1|um/s|BENIGN|HAIR FOLLICLE|GELLED|METACARPOPHALANGEAL JOINT 4|RIGHT|LATERAL|NO INFORMATION|||SPOUSE|1|3|SCREENING|2020-09-27|30
e|MI|d80522bb-f146-4270-a6e1-326fde50d9ca|1|PAP|Prostatic Acid Phosphatase|KNODELL FIBROSIS SCORE|[?]|[?]|ng|[?]|1|TRACE|MALIGNANT|BONE MARROW MONONUCLEAR CELL|DRIED|SCLERA|LEFT|MEDIAL|DROPLET DIGITAL PCR|||PARENT|1|6|SCREENING|2021-03-20|89
e|MI|3982a462-95f6-4e71-93e5-9df777770067|1|PNTHCEMP|Paneth Cell Metaplasia|EUROPEAN CONSENSUS SCORE|[?]|[?]|TROCHE|[?]|1|%/s|MALIGNANT|EMOTIONAL TEAR|LIPEMIC|PLACENTA|CONTRALATERAL|PERIVENTRICULAR|GEL ELECTROPHORESIS|Y||PARENT|1|6|TREATMENT|2021-02-20|67
e|MI|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|ROS1|ROS1 Protein|ISUP GLEASON GRADE GROUP|[?]|[?]|NEBULE|[?]|1|CIGAR|BENIGN|CAPILLARY PLASMA|CLOTTED|CEREBELLUM|LATERAL|APICAL|BETA LACTAMASE|||DOMESTIC PARTNER|1|4|FOLLOW-UP|2020-12-21|52
e|MI|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|CRYPARCD|Crypt Architectural Damage|STAINING INTENSITY|[?]|[?]|Coulomb|[?]|1|EID 50/mL|BENIGN|BONE MARROW MONONUCLEAR CELL|CONCENTRATED|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|RIGHT|MEDIAL|CRYOSCOPY|||GUARDIAN|1|2|WASHOUT|2020-06-18|33
e|MI|e19b469c-40d5-4506-8233-a86bebde880d|1|SGMGSTAT|Surgical Margins Status|CHALKLEY SCORE|[?]|[?]|kat|[?]|1|PUFF|BENIGN|PUS|ICTERIC|ELBOW FLEXOR MUSCLES|CONTRALATERAL|FACIAL|CAPILLARY ELECTROPHORESIS|||SIBLING|1|4|TREATMENT|2021-03-27|74
e|MI|f280a4a5-9826-4d77-adf1-992284cb3314|1|IENFDEN|Intraepidermal Nerve Fiber Density|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mg/day|[?]|1|genEq|MALIGNANT|STOOL|CONTAMINATED|EXTENSOR DIGITORUM BREVIS MUSCLE|UNILATERAL|LOWER MEDIAL|TARGETED GENOME SEQUENCING|||SIGNIFICANT OTHER|1|5|SCREENING|2020-12-27|18
e|MI|82840929-7800-4254-b60a-8af4786664f6|1|PAX3FKHR|PAX3-FKHR Fusion Protein|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mAmp|[?]|1|MET|MALIGNANT|VENOUS PLASMA|LIPEMIC|HYPOGLOSSAL NERVE|IPSILATERAL|ROSTRAL|MRI|||ADJUDICATION COMMITTEE|1|4|SCREENING|2020-08-28|95
e|MI|dae25bdb-38fd-4852-9a9a-7627368e9497|1|TUBULTIS|Tubulitis|EUROPEAN CONSENSUS SCORE|[?]|[?]|TRANSDUCING UNIT/mL|[?]|1|10^11/L|MALIGNANT|BASAL TEAR|PARAFFIN-EMBEDDED|HARD PALATE|UNILATERAL|FACIAL|OSCILLOMETRY|||NON-HEALTH CARE PROFESSIONAL|1|2|WASHOUT|2020-09-09|17
e|MI|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|MMRPINTP|Mismatch Repair Proteins Interpretation|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|V|[?]|1|L/s/kPa|BENIGN|PLATELET POOR PLASMA|CLOTTED|MEDULLA OBLONGATA|UNILATERAL|ANTEROMEDIAL|MICROBIAL CULTURE, LIQUID|||NON-HEALTH CARE PROFESSIONAL|1|1|SCREENING|2020-10-11|16
e|MI|e7468d01-71b3-47c4-9715-62fe143364cb|1|MSH6|MutS Homolog 6|TUMOR PROPORTION SCORE|[?]|[?]|cup eq|[?]|1|GBq|BENIGN|MUSCLE TISSUE|LACTESCENT|SENSORIMOTOR CORTEX|CONTRALATERAL|FORE|KNEMOMETRY|||SPOUSE|1|4|TREATMENT|2021-01-11|98
e|MI|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|EGFR|Epidermal Growth Factor Receptor|BAUERMEISTER SCORE|[?]|[?]|mMU/mL|[?]|1|PFU/dose|MALIGNANT|COLOSTRUM|CLOTTED|EYELASH|CONTRALATERAL|INTERMEDIATE|EPSILOMETER|||HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-06-22|45
e|MI|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|GLOMPATH|Glomerulopathy|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|usec|[?]|1|U/m2/h|BENIGN|WHITE MATTER TISSUE|THAWED|METACARPOPHALANGEAL JOINT 3|UNILATERAL|INNER|PERCUSSION|||INTERVIEWER|1|7|WASHOUT|2021-02-01|64
e|MI|2178f542-809d-4306-84e4-26d3b3b370b0|1|TRCETMCE|Transitional Cells/Tumor Cells|GLEASON SECONDARY SCORE|[?]|[?]|uIU/dL|[?]|1|%(w/w)|BENIGN|PLEURAL FLUID|UNEXPECTED ODOR|POSTERIOR POLE OF THE EYE|UNILATERAL|SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||Y|SIBLING|1|6|FOLLOW-UP|2020-11-04|8
e|MI|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|ROS1|ROS1 Protein|GLEASON PRIMARY SCORE|[?]|[?]|mOsm/L|[?]|1|mN|BENIGN|LEUKOCYTE|DRIED|KIDNEY|IPSILATERAL|PARIETO-OCCIPITAL|NO INFORMATION|||ADJUDICATION COMMITTEE|1|5|TREATMENT|2020-10-19|25
e|MI|40e4c69f-6115-4f0e-8555-45b12b222801|1|MSH2|MutS Homolog 2|METMAB SCORE|[?]|[?]|mmol/s|[?]|1|Gy/min|BENIGN|CIRCULATING TUMOR CELL|GELLED|SCAPHOID BONE|LEFT|LATERAL|SIZE EXCLUSION CHROMATOGRAPHY|||SPOUSE|1|4|WASHOUT|2021-03-11|50
e|MI|1307d7f6-acb6-4096-a907-08345548a82b|1|PROGESTR|Progesterone Receptor|RECEPTOR OVERALL STATUS|[?]|[?]|sec|[?]|1|mCi|MALIGNANT|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|HEART, RIGHT ATRIAL APPENDAGE|LEFT|LOWER MEDIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||Y|ADJUDICATOR|1|2|TREATMENT|2020-08-14|88
e|MI|bac23835-1120-43b2-9d99-694bef97f44b|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|g/animal|[?]|1|PLUG|BENIGN|SPUTUM|ICTERIC|RIB 1|CONTRALATERAL|LOWER MEDIAL|SICKLE CELL SOLUBILITY TEST|||PROXY|1|6|TREATMENT|2020-05-17|6
e|MI|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|CELLDIFF|Cellular Differentiation|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mg/m2/min|[?]|1|Mile|BENIGN|SUPERNATANT, PLASMA|UNEXPECTED ODOR|PUTAMEN|BILATERAL|BASAL|PHOTOMETRIC CLOT DETECTION|||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-12-19|96
e|MI|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|IENFDEN|Intraepidermal Nerve Fiber Density|CHALKLEY SCORE|[?]|[?]|VIAL|[?]|1|10^3 DNA copies/mL|BENIGN|ADIPOSE TISSUE|CONTAMINATED|MEDIASTINUM, MIDDLE|CONTRALATERAL|HIND|LIQUID SCINTILLATION COUNTING|||ADJUDICATION COMMITTEE|1|4|TREATMENT|2020-11-28|75
e|MI|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|NORMCECE|Normal Cells/Total Cells|ISHAK FIBROSIS SCORE|[?]|[?]|log10 TCID 50/dose|[?]|1|Gravitational Unit|MALIGNANT|URINE SEDIMENT|NON-HEMOLYZED|HYOID BONE|RIGHT|LOWER FLEXOR SURFACE|TRYPAN BLUE STAIN|||INDEPENDENT ASSESSOR|1|6|WASHOUT|2020-11-25|63
e|MI|55504c69-a659-402b-a0cb-95ab4e08c086|1|HGFR|Hepatocyte Growth Factor Receptor|ALLRED TOTAL SCORE|[?]|[?]|g/kg|[?]|1|MET|MALIGNANT|SERUM|THAWED|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|RIGHT|UPPER EXTENSOR SURFACE|QUANTITATIVE ULTRASOUND|||PARENT|1|2|SCREENING|2021-03-25|80
e|MI|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|TUBATRO|Tubular Atrophy|EUROPEAN CONSENSUS SCORE|[?]|[?]|mL/mmHg/min/L|[?]|1|cm/s|MALIGNANT|PERITONEAL FLUID|CONTAMINATED|HEART, SEPTUM|UNILATERAL|SUBCORTICAL|ULTRASOUND|||PROXY|1|1|WASHOUT|2020-12-05|15
e|MI|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|CD56|CD56|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mV/sec|[?]|1|BAU/mL|MALIGNANT|REFLEX TEAR|LIPEMIC|SUBCLAVIAN VEIN|CONTRALATERAL|UPPER FLEXOR SURFACE|GIEMSA STAIN|Y||CLINICAL STUDY SPONSOR|1|7|FOLLOW-UP|2020-12-30|29
e|MI|12c24fff-080b-4889-a455-ff55d5c0536c|1|MSNGMTRX|Mesangial Matrix|METAVIR FIBROSIS SCORE|[?]|[?]|EID 50/dose|[?]|1|deg/s|MALIGNANT|DERMAL TISSUE|CONTAMINATED|CORONARY SINUS|RIGHT|DISTAL VOLAR|ELECTRICAL IMPEDANCE MYOGRAPHY|||INDEPENDENT ASSESSOR|1|1|SCREENING|2021-03-20|62
e|MI|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|TGFB1|Transforming Growth Factor Beta 1|RECEPTOR OVERALL STATUS|[?]|[?]|g/kg|[?]|1|SACHET|BENIGN|EPITHELIAL CELL|GELLED|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|DORSOLATERAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||VENDOR|1|1|TREATMENT|2021-03-13|61
e|MI|05a142dc-a779-44cb-ab2e-f961676a3940|1|BD1|Beta-defensin 1|SCHEUER FIBROSIS SCORE|[?]|[?]|uL/dose|[?]|1|10^6 CFU|BENIGN|EPIDERMAL TISSUE|FROZEN|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|CONTRALATERAL|TEMPORAL|IRON HEMATOXYLIN STAIN|Y||SIBLING|1|6|TREATMENT|2021-01-23|76
e|MI|498524c5-08c4-41a4-af81-876ab2452f64|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|AJCC TUMOR GRADE|[?]|[?]|10^5/hpf|[?]|1|/2000 RBC|BENIGN|CEREBROSPINAL FLUID|LACTESCENT|FOOT DIGIT 3|IPSILATERAL|SUPERFICIAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||HEALTH CARE PROFESSIONAL|1|4|SCREENING|2021-01-27|59
e|MI|93490930-01cd-470e-81a3-bcd7a140ccc1|1|GLOMLTIS|Glomerulitis|TUMOR PROPORTION SCORE|[?]|[?]|DRINK|[?]|1|gpELISA unit/mL|BENIGN|INFRANATANT, PLASMA|FRESH|RIB 11|CONTRALATERAL|LATERAL|FLOCCULATION, CHARCOAL ENHANCED|Y|Y|CLINICAL STUDY SPONSOR|1|1|TREATMENT|2020-12-10|33
e|MI|fd588c97-c57f-432f-81a0-a116a017c5dd|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Weber|[?]|1|nmol/mol|BENIGN|MIXED VENOUS BLOOD|THAWED|C6 VERTEBRA|BILATERAL|SURFACE|DYNAMIC CONTRAST ENHANCED MRI|Y||INTERVIEWER|1|5|TREATMENT|2020-07-12|49
e|MI|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|CRYPARCD|Crypt Architectural Damage|ALLRED STAINING INTENSITY SCORE|[?]|[?]|Gauss|[?]|1|Gy/h|MALIGNANT|ARTERIAL BLOOD|THAWED|MUCOSA OF THE LIP|BILATERAL|LOWER EXTENSOR SURFACE|CELL OF ORIGIN ASSAY|||CLINICAL RESEARCH COORDINATOR|1|4|TREATMENT|2021-01-18|37
e|MI|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|IENFDEN|Intraepidermal Nerve Fiber Density|ISHAK FIBROSIS SCORE|[?]|[?]|TRACE|[?]|1|APL U/mL|MALIGNANT|PLASMA|NON-HEMOLYZED|PREPUTIAL GLAND|IPSILATERAL|ANTEROMEDIAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||GUARDIAN|1|5|SCREENING|2020-05-29|4
e|MI|08fccce4-64bf-431e-81b0-a96566e77df6|1|CELLDIFF|Cellular Differentiation|AJCC TUMOR GRADE|[?]|[?]|/500 WBC|[?]|1|10^6 U|BENIGN|ADIPOSE TISSUE|THAWED|VERTEBRAL ARTERY|UNILATERAL|SUPERIOR|LANDOLT RING||Y|PROXY|1|7|TREATMENT|2021-03-19|68
e|MI|0354fab5-5636-4504-8345-af060ad4c90c|1|SGMGSTAT|Surgical Margins Status|ISUP GLEASON GRADE GROUP|[?]|[?]|AgU/mL|[?]|1|/month|BENIGN|BILE|ICTERIC|ASCENDING AORTA|UNILATERAL|UPPER FLEXOR SURFACE|DNA MICROARRAY|||ADJUDICATION COMMITTEE|1|3|FOLLOW-UP|2021-03-01|47
e|MI|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|NKX2_1|NK2 Homeobox 1|METAVIR FIBROSIS SCORE|[?]|[?]|mL/s/m2|[?]|1|SACHET|MALIGNANT|HAIR FOLLICLE|LIPEMIC|MEDIASTINUM, MIDDLE|BILATERAL|TIP|MODIFIED ACID FAST STAIN|Y||ADJUDICATION COMMITTEE|1|3|SCREENING|2021-01-24|25
e|MI|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|GZMB|Granzyme B|RECEPTOR OVERALL STATUS|[?]|[?]|s*kPa|[?]|1|10^5/hpf|BENIGN|CIRCULATING TUMOR CELL|NON-HEMOLYZED|PROSTATE GLAND, LATERAL LOBE|BILATERAL|OCCIPITAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||CHILD|1|2|TREATMENT|2020-12-29|99
e|MI|679423a4-92cf-4a93-8277-282f9b43f2ed|1|TUMCECE|Tumor Cells/Total Cells|BAUERMEISTER SCORE|[?]|[?]|BAG|[?]|1|/100 WBC|BENIGN|VENOUS PLASMA|LACTESCENT|POSTERIOR SUPERIOR ILIAC SPINE|BILATERAL|SUBCORTICAL|MICROPARTICLE ENZYME IMMUNOASSAY||Y|ADJUDICATION COMMITTEE|1|4|TREATMENT|2020-10-13|81
e|MI|fb686cda-337b-46aa-b67b-790414201d9a|1|TUMCECE|Tumor Cells/Total Cells|EUROPEAN CONSENSUS SCORE|[?]|[?]|kcal|[?]|1|ug|MALIGNANT|VENOUS BLOOD|DRIED|AORTA|LATERAL|PERIVENTRICULAR|AUDIOMETRY||Y|INVESTIGATOR|1|5|TREATMENT|2020-08-03|79
e|MI|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|CRYPTTS|Cryptitis|GLEASON TOTAL SUM|[?]|[?]|mL/dose|[?]|1|10^4/L|BENIGN|EXHALED BREATH CONDENSATE|DRIED|BRACHIOCEPHALIC ARTERY|RIGHT|DEEP|ICP-MS|||STUDY SUBJECT|1|2|TREATMENT|2020-11-09|45
e|MI|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|LFA1|Lymphocyte Function-Associated Antigen 1|GLEASON TOTAL SUM|[?]|[?]|HOURS|[?]|1|mL/s/m2|MALIGNANT|INFRANATANT, PLEURAL FLUID|HEMOLYZED|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|VENTROLATERAL|PELLI-ROBSON EYE CHART|||FRIEND|1|6|WASHOUT|2021-02-19|85
e|MI|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|PNLINV|Perineural Invasion|CHALKLEY SCORE|[?]|[?]|log10 CFU/g|[?]|1|ug/L/h|MALIGNANT|PROSTATIC FLUID|DRIED|LARGE INTESTINE|UNILATERAL|INTERMEDIATE|SPECT SCAN||Y|ADJUDICATOR|1|2|TREATMENT|2020-12-30|84
e|MI|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|MSH6|MutS Homolog 6|GLEASON PRIMARY SCORE|[?]|[?]|breaths/min|[?]|1|1/(s*kPa)|MALIGNANT|ENDOMETRIAL TISSUE|GELLED|INTESTINE|CONTRALATERAL|DEEP|CELLULOSE TAPE|||CLINICAL RESEARCH ASSOCIATE|1|5|TREATMENT|2020-11-20|9
e|MI|4a195822-d646-4b22-a3b9-f6642442474d|1|CANCLLTY|Cancer Cellularity|GLEASON SECONDARY SCORE|[?]|[?]|mL/mmHg/min/L|[?]|1|DRINK|MALIGNANT|HAIR FOLLICLE|GELLED|HEART, LEFT ATRIUM|LEFT|LOWER|GC/MS-CI|Y|Y|INDEPENDENT ASSESSOR|1|5|TREATMENT|2020-10-07|84
e|MI|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|THICK|Thickness|ALLRED TOTAL SCORE|[?]|[?]|kPa/L/sec|[?]|1|g/L|BENIGN|INFRANATANT, PLEURAL FLUID|AGGLUTINATED|SUBMENTAL LYMPH NODE|BILATERAL|ANTERIOR|PELLI-ROBSON EYE CHART||Y|ADJUDICATION COMMITTEE|1|3|TREATMENT|2020-10-24|57
e|MI|18461665-388d-403b-90e4-2b42fcb4a01a|1|ICAM1|Intercellular Adhesion Molecule 1|ISHAK FIBROSIS SCORE|[?]|[?]|U/m2/day|[?]|1|g/U|BENIGN|VENOUS BLOOD|UNEXPECTED ODOR|ILEUM, TERMINAL|CONTRALATERAL|SUBCORTICAL|PERIPHERAL ANGIOGRAPHY|||CAREGIVER|1|3|TREATMENT|2020-12-17|85
e|MI|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|ULCER|Ulceration|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|10^3 organisms/g|[?]|1|L|MALIGNANT|CERUMEN|HEMOLYZED|URETHRA, PROSTATIC|UNILATERAL|DORSOLATERAL|LEAD CITRATE STAIN|||SIBLING|1|4|TREATMENT|2020-10-15|72
e|MI|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|EGFR|Epidermal Growth Factor Receptor|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|U/g/min|[?]|1|IU/mL|BENIGN|SYNOVIAL FLUID|CALCIFIED|ABDOMINAL WALL|BILATERAL|UPPER EXTENSOR SURFACE|PYROSEQUENCING|Y||CHILD|1|3|SCREENING|2020-10-26|85
e|MI|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|NORMCECE|Normal Cells/Total Cells|GLEASON TOTAL SUM|[?]|[?]|mEq/kg|[?]|1|cmH2O*s/mL|BENIGN|MIXED VENOUS BLOOD|NON-HEMOLYZED|PECTORALIS MINOR MUSCLE|CONTRALATERAL|OUTER|LAPAROSCOPY|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|4|TREATMENT|2021-01-09|41
e|MI|fccf5c5d-deb6-4f13-a485-afcda3556578|1|MSH6|MutS Homolog 6|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mol/g|[?]|1|RATIO|MALIGNANT|COLOSTRUM|FROZEN|CILIARY BODY|RIGHT|INNER|MICROSCOPY||Y|INTERVIEWER|1|5|TREATMENT|2020-09-21|58
e|MI|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|PTEN|Phosphatase and Tensin Homolog|ISUP GLEASON GRADE GROUP|[?]|[?]|LB|[?]|1|uV*sec|BENIGN|INFRANATANT, PLASMA|HEMOLYZED|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|ROSTRAL|IMMUNORADIOMETRIC ASSAY|||CLINICAL STUDY SPONSOR|1|3|FOLLOW-UP|2020-09-06|43
e|MI|9c3b6912-19be-435c-87fc-781a08efb847|1|CRYPARCD|Crypt Architectural Damage|RECEPTOR OVERALL STATUS|[?]|[?]|ELISA unit/mL|[?]|1|%(w/v)|BENIGN|CERUMEN|SOLIDIFIED|INTRAHEPATIC LARGE BILE DUCT|RIGHT|TEMPORAL|ANALYTICAL ULTRACENTRIFUGATION||Y|FAMILY MEMBER|1|7|TREATMENT|2021-01-31|19
e|MI|171a6d85-ba2e-45da-b31b-01651b26e890|1|SGMGSTAT|Surgical Margins Status|KNODELL FIBROSIS SCORE|[?]|[?]|10^4/L|[?]|1|ug/L|BENIGN|SALIVA|AUTOLYZED|ANTRUM PYLORI|IPSILATERAL|PERIPHERAL|CENTRIFUGATION|Y||ADJUDICATION COMMITTEE|1|7|TREATMENT|2020-08-09|17
e|MI|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|FOXP3|Forkhead Box Protein 3|RECEPTOR OVERALL STATUS|[?]|[?]|nkat/L|[?]|1|GBq|BENIGN|EXUDATE|AGGLUTINATED|GASTROCNEMIUS MUSCLE, LATERAL HEAD|UNILATERAL|LATERAL|CONGO RED STAIN|||STUDY SUBJECT|1|3|TREATMENT|2021-02-05|67
e|MI|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|METAVIR FIBROSIS SCORE|[?]|[?]|g/L|[?]|1|nmol/kg/day|BENIGN|AMNIOTIC FLUID|LIPEMIC|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|UNILATERAL|ANTEROPOSTERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||GUARDIAN|1|6|FOLLOW-UP|2020-08-09|63
e|MI|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|GRNLMA|Granuloma|AJCC TUMOR GRADE|[?]|[?]|kg/cm|[?]|1|GBq/g|MALIGNANT|GASTRIC CONTENTS|CALCIFIED|ADDUCTOR POLLICIS MUSCLE|CONTRALATERAL|OUTER|DIRECT SEQUENCING|||PROXY|1|2|SCREENING|2021-02-03|50
e|MI|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|THICK|Thickness|ALLRED STAINING INTENSITY SCORE|[?]|[?]|TRACE|[?]|1|10^6 organisms|MALIGNANT|SYNOVIAL FLUID|GELLED|WRIST JOINT FLEXOR MUSCLES|UNILATERAL|UPPER FLEXOR SURFACE|POPULATION SEQUENCING|||INDEPENDENT ASSESSOR|1|6|WASHOUT|2020-09-21|48
e|MI|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|BD2|Beta-defensin 2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|POUCH|[?]|1|MAC50|BENIGN|PLATELET RICH PLASMA|ICTERIC|INGUINAL REGION|IPSILATERAL|FORE|TONOMETRY||Y|CLINICAL STUDY SPONSOR|1|3|TREATMENT|2021-02-18|50
e|MI|87998e13-813a-464d-935c-d5513cd0db5e|1|PNTHCEMP|Paneth Cell Metaplasia|H SCORE TOTAL SCORE|[?]|[?]|Bq/L|[?]|1|Gravitational Unit|MALIGNANT|PLASMA ULTRAFILTRATE|THAWED|BICEPS FEMORIS MUSCLE|LEFT|BASAL|ULTRASONOGRAPHIC ELASTOGRAPHY|||ADJUDICATION COMMITTEE|1|3|TREATMENT|2020-10-22|62
e|MI|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|CRYPABSC|Crypt Abscess|SCHEUER FIBROSIS SCORE|[?]|[?]|g/g/day|[?]|1|EU|BENIGN|ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|BILATERAL|FACIAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||CLINICAL RESEARCH COORDINATOR|1|1|FOLLOW-UP|2021-01-26|9
e|MI|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|MSH2|MutS Homolog 2|CHALKLEY SCORE|[?]|[?]|hPa|[?]|1|ugEq|MALIGNANT|MUSCLE TISSUE|CALCIFIED|DISTAL PHALANX 3 OF THE HAND|CONTRALATERAL|MEDIAL|NON-INVASIVE DIELECTRIC SENSING|Y||PROXY|1|7|TREATMENT|2020-11-19|21
e|MI|e8da815a-b53c-46f4-a546-e8553152719f|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|METAVIR FIBROSIS SCORE|[?]|[?]|ug/m2/day|[?]|1|WEEKS|MALIGNANT|STRIATED MUSCLE TISSUE|REFRIGERATED|ANTERIOR CINGULATE GYRUS|UNILATERAL|DORSOLATERAL|NEURAMINIDASE INHIBITION ASSAY|||STUDY SUBJECT|1|3|SCREENING|2021-02-02|47
e|MI|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|S100A7|S100 Calcium Binding Protein A7|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Gravitational Unit|[?]|1|U/m2/h|MALIGNANT|HAIR FOLLICLE|PARAFFIN-EMBEDDED|AORTIC VALVE, RIGHT CORONARY CUSP|LATERAL|TEMPORAL|COULOMETRIC TITRATION|||FRIEND|1|2|SCREENING|2021-01-22|3
e|MI|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|PDL1|Programmed Death Ligand 1|KNODELL FIBROSIS SCORE|[?]|[?]|10^4/hpf|[?]|1|kPa/L/sec|BENIGN|MONOCYTE|LACTESCENT|SKIN AROUND THE MOUTH|IPSILATERAL|DISTAL|ORCHIDOMETERY|Y||INDEPENDENT ASSESSOR|1|2|FOLLOW-UP|2021-03-10|85
e|MI|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|CORBIOMN|Number of Malignant Biopsy Cores|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|nCi|[?]|1|K|BENIGN|MIXED VENOUS BLOOD|DRIED|GREAT VESSELS|UNILATERAL|PERIVENTRICULAR|ICP-MS|Y||INDEPENDENT ASSESSOR|1|5|WASHOUT|2020-08-03|3
e|MI|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|GLOMLTIS|Glomerulitis|METMAB SCORE|[?]|[?]|genEq|[?]|1|foz_us|MALIGNANT|PERSPIRATION|REFRIGERATED|LIVER|UNILATERAL|MEDIAL|FARNSWORTH-MUNSELL 100 HUE TEST||Y|SIGNIFICANT OTHER|1|3|WASHOUT|2021-02-25|64
e|MI|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|PNTHCEMP|Paneth Cell Metaplasia|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|g/m2/day|[?]|1|umol/mg/min|MALIGNANT|SEMEN|AUTOLYZED|INTERNAL MAMMARY ARTERY|LEFT|ANTEROTEMPORAL|HEMAGGLUTINATION INHIBITION ASSAY|||ADJUDICATION COMMITTEE|1|1|WASHOUT|2021-01-26|68
e|MI|2661da18-b539-49d8-ac80-9da03c127d21|1|EPITHINT|Epithelial Integrity|GLEASON TOTAL SUM|[?]|[?]|ng/L|[?]|1|WEEKS|BENIGN|LAVAGE FLUID|DRIED|PHARYNGEAL TONSIL|CONTRALATERAL|UPPER|NO INFORMATION|||FAMILY MEMBER|1|2|SCREENING|2020-09-25|71
e|MI|f1835786-c567-4235-9bd1-f7ffcec12741|1|SGMGSTAT|Surgical Margins Status|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|CARTRIDGE|[?]|1|cmol/L|BENIGN|VITREOUS HUMOR|FRESH|BRONCHUS|IPSILATERAL|OUTER|IMMUNOCHROMATOGRAPHY|||FRIEND|1|1|TREATMENT|2020-10-18|83
e|MI|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|CDX2AG|CDX2 Antigen|METAVIR FIBROSIS SCORE|[?]|[?]|m/sec2|[?]|1|ug/kg/h|BENIGN|ALVEOLAR AIR|REFRIGERATED|DUCTUS ARTERIOSUS|LATERAL|PARIETO-OCCIPITAL|GC/MS-EI|||SPOUSE|1|7|WASHOUT|2020-08-16|47
e|MI|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|CORBIOMN|Number of Malignant Biopsy Cores|GLEASON SECONDARY SCORE|[?]|[?]|ms/mmHg|[?]|1|U/g Hb|BENIGN|WHITE MATTER TISSUE|FRESH|TRICUSPID VALVE ANNULUS|LATERAL|FORE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y||INTERVIEWER|1|2|SCREENING|2020-09-08|57
e|MI|65c439f8-9658-4ac5-9eae-0837182a90fd|1|GLOMLTIS|Glomerulitis|TUMOR PROPORTION SCORE|[?]|[?]|%(v/v)|[?]|1|mol|MALIGNANT|ADIPOSE TISSUE|FROZEN|TRUNK|BILATERAL|INNER|MEDIASTINOSCOPY||Y|CLINICAL RESEARCH ASSOCIATE|1|2|TREATMENT|2020-08-16|83
e|MI|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|IENFDEN|Intraepidermal Nerve Fiber Density|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|RFU|[?]|1|/day|BENIGN|SKELETAL MUSCLE TISSUE|CONCENTRATED|MITRAL VALVE, ANTERIOR CUSP|LEFT|LOWER FLEXOR SURFACE|PHASE CONTRAST MICROSCOPY|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|3|FOLLOW-UP|2020-06-28|26
e|MI|16dcaefa-701c-4863-b010-8ac640aeb55a|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|ISHAK FIBROSIS SCORE|[?]|[?]|gMFI|[?]|1|TUBE|MALIGNANT|SUPERNATANT, PLEURAL FLUID|REFRIGERATED|CORNEAL STROMA|CONTRALATERAL|VENTROLATERAL|AUTOMATED COUNT|||PROXY|1|5|SCREENING|2020-08-04|58
e|MI|4c19e870-9195-41d8-9c8a-8a54bb428732|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|METAVIR FIBROSIS SCORE|[?]|[?]|GPL U/mL|[?]|1|fraction of 1|MALIGNANT|CERUMEN|CONTAMINATED|LOCUS CERULEUS|LATERAL|PROXIMAL|BRDU CELLULAR PROLIFERATION ASSAY|Y|Y|SIGNIFICANT OTHER|1|5|TREATMENT|2020-09-23|61
e|MI|7682184f-0801-4315-9c5f-116f7321a2b0|1|FIBROSIS|Fibrosis|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|U/kg|[?]|1|log10 IU/mL|MALIGNANT|SMEGMA|SOLIDIFIED|EXTRAOCULAR MUSCLE|IPSILATERAL|PARIETO-OCCIPITAL|LISSAMINE GREEN STAIN|||INTERVIEWER|1|3|SCREENING|2021-01-17|36
e|MI|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|PERCENT POSITIVE CELL|[?]|[?]|deg/s|[?]|1|pmol/L|BENIGN|ABSCESS FLUID|GELLED|MALE REPRODUCTIVE SYSTEM|LATERAL|INNER|MAGNETIC RESONANCE ANGIOGRAPHY|||CLINICAL RESEARCH COORDINATOR|1|6|SCREENING|2020-12-20|18
e|MI|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|GLEASON PRIMARY SCORE|[?]|[?]|ug/dL|[?]|1|mEq/kg|BENIGN|ABSCESS FLUID|LIPEMIC|FLANK|RIGHT|INTERMEDIATE|LIGHT MICROSCOPY||Y|CHILD|1|2|FOLLOW-UP|2020-11-22|84
e|MI|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|PAP|Prostatic Acid Phosphatase|AJCC TUMOR GRADE|[?]|[?]|F|[?]|1|ug/dose|BENIGN|PERSPIRATION|LIPEMIC|CARPOMETACARPAL JOINT|LATERAL|PROXIMAL|IN SITU HYBRIDIZATION|Y||SPOUSE|1|4|TREATMENT|2021-01-05|69
e|MI|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|GZMB|Granzyme B|BAUERMEISTER SCORE|[?]|[?]|10^3 organisms/g|[?]|1|grain|MALIGNANT|MECONIUM|ROOM TEMPERATURE|COMMON FEMORAL ARTERY|CONTRALATERAL|OUTER|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|||SIGNIFICANT OTHER|1|2|SCREENING|2020-08-30|18
e|MI|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|CD56|CD56|ALLRED TOTAL SCORE|[?]|[?]|10^9 CFU|[?]|1|deg/s|MALIGNANT|CELL PELLET|ROOM TEMPERATURE|POPLITEAL LYMPH NODE|LATERAL|ANTEROLATERAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y||PARENT|1|5|TREATMENT|2021-02-21|42
e|MI|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|FOXP3|Forkhead Box Protein 3|H SCORE TOTAL SCORE|[?]|[?]|TRANSDUCING UNIT/mL|[?]|1|cd|MALIGNANT|DIALYSIS FLUID|UNEXPECTED ODOR|PECTORALIS MINOR MUSCLE|IPSILATERAL|LOWER EXTENSOR SURFACE|MS/MS|||INDEPENDENT ASSESSOR|1|7|SCREENING|2020-10-07|62
e|MI|440119fb-ad46-4348-b236-8e2979c7bf2e|1|PNTHCEMP|Paneth Cell Metaplasia|METMAB SCORE|[?]|[?]|10^6/L|[?]|1|dpm/mL|BENIGN|AMNIOTIC FLUID|FRESH|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|LOWER FLEXOR SURFACE|MACRO BROTH DILUTION|Y||INDEPENDENT ASSESSOR|1|1|FOLLOW-UP|2021-03-07|91
e|MI|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|ULCER|Ulceration|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|mJoule/cm2|[?]|1|Bq/L|MALIGNANT|SEMEN|GELLED|GASTROCNEMIUS MUSCLE|CONTRALATERAL|LOWER|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y||ADJUDICATION COMMITTEE|1|5|TREATMENT|2020-08-11|67
e|MI|23306866-3fcb-418d-861b-de3bd779260d|1|BANFRDX|Banff Diagnostic Category Renal|BAUERMEISTER SCORE|[?]|[?]|Linear ft*LB|[?]|1|pmol/10^10 cells|MALIGNANT|CIRCULATING TUMOR CELL|SOLIDIFIED|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LATERAL|OUTER|SNELLEN EYE CHART|||SIBLING|1|5|FOLLOW-UP|2020-08-12|28
e|MI|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|PROGESTR|Progesterone Receptor|ALLRED TOTAL SCORE|[?]|[?]|mmol2/L2|[?]|1|10^5/hpf|MALIGNANT|BONE MARROW MONONUCLEAR CELL|ICTERIC|PINEAL GLAND|UNILATERAL|BASAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y|FRIEND|1|7|SCREENING|2020-09-16|53
e|MI|92855d33-eee6-449f-a9e6-c06a1532571f|1|CD4|CD4|EUROPEAN CONSENSUS SCORE|[?]|[?]|/100 WBC|[?]|1|cmol/L|BENIGN|AQUEOUS HUMOR|UNEXPECTED ODOR|MEDIAN NERVE|UNILATERAL|SUPERFICIAL|PERCUSSION|Y||NON-HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-12-12|23
e|MI|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|PERCENT POSITIVE CELL|[?]|[?]|ng/mol|[?]|1|BOX|BENIGN|REFLEX TEAR|PARAFFIN-EMBEDDED|RADIUS|BILATERAL|OUTER|RIA||Y|SIBLING|1|7|WASHOUT|2021-01-24|5
e|MI|40cb9bc3-abec-4158-bdee-becdeceba727|1|SMUSCAB|Smooth Muscle Antibody|GLEASON PRIMARY SCORE|[?]|[?]|IU/mmol|[?]|1|DPM|BENIGN|SUPERNATANT, PLASMA|FRESH|RIB 3|IPSILATERAL|DORSOLATERAL|IN SITU HYBRIDIZATION|||PROXY|1|4|TREATMENT|2020-12-19|71
e|MI|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|CDX2AG|CDX2 Antigen|RECEPTOR OVERALL STATUS|[?]|[?]|mmAL|[?]|1|10^9 organisms|BENIGN|PLATELET RICH PLASMA|CONTAMINATED|RIB 3|BILATERAL|VENTROLATERAL|MICROARRAY|||ADJUDICATOR|1|7|TREATMENT|2020-12-18|72
e|MI|616b284a-3fed-4009-bafe-7da10acd537e|1|TUBATRO|Tubular Atrophy|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mm|[?]|1|ug/min|MALIGNANT|KERATINOCYTE|FRESH|TIBIOTARSAL JOINT|IPSILATERAL|PERIPHERAL|HIGH RESOLUTION MELT ANALYSIS|||FAMILY MEMBER|1|7|TREATMENT|2020-09-25|32
e|MI|d39b53da-187f-4da6-9614-2bd301e9ad05|1|TUBULTIS|Tubulitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|POUCH|[?]|1|GBq/g|BENIGN|SEBUM|DRIED|PULMONARY VALVE, ANTERIOR CUSP|LEFT|LOWER MEDIAL|JAFFE REACTION|Y||HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-10-12|20
e|MI|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|MSH2|MutS Homolog 2|H SCORE TOTAL SCORE|[?]|[?]|/h|[?]|1|MHz|BENIGN|BASAL TEAR|LIPEMIC|RIB|IPSILATERAL|CRANIAL|NUCLEIC ACID HYBRIDIZATION||Y|VENDOR|1|5|TREATMENT|2021-02-02|70
e|MI|e51cf168-af89-44d9-9e56-14785071f6b0|1|VASINV|Vascular Invasion|ALLRED TOTAL SCORE|[?]|[?]|mg/kg/h|[?]|1|MET*h|BENIGN|SPERMATOZOON|ICTERIC|DISTANT LYMPH NODE|CONTRALATERAL|PERIPHERAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||Y|INVESTIGATOR|1|7|SCREENING|2021-02-17|92
e|MI|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|ABNCE|Abnormal Cells|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mL/kg|[?]|1|CCID 50/mL|BENIGN|LOCHIA|NON-HEMOLYZED|TRIGEMINAL NERVE|RIGHT|LATERAL|SLIT LAMP PHOTOGRAPHY|Y|Y|INDEPENDENT ASSESSOR|1|2|TREATMENT|2020-09-04|93
e|MI|a110e924-90a1-4e84-b47a-410f800fa201|1|ULCER|Ulceration|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|U/g/h|[?]|1|PFU|MALIGNANT|ERYTHROCYTES|UNEXPECTED ODOR|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|UNILATERAL|PROXIMAL|CARDIAC THERMODILUTION|||FAMILY MEMBER|1|5|TREATMENT|2021-01-02|75
e|MI|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|MCINTINF|Mononuc Cell Interstitial Inflammation|METAVIR FIBROSIS SCORE|[?]|[?]|ng/mol|[?]|1|fraction of 1|BENIGN|DIALYSIS FLUID|GELLED|CAPITATE-LUNATE JOINT|LATERAL|ANTEROTEMPORAL|URANYL ACETATE STAIN|||PROXY|1|7|SCREENING|2020-08-25|27
e|MI|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mL/mmHg|[?]|1|ng/day|MALIGNANT|VENOUS PLASMA|HEMOLYZED|DIAPHRAGMATIC LYMPH NODE|LATERAL|PARIETO-OCCIPITAL|KINETIC CHROMOGENIC ASSAY|Y||PARENT|1|4|WASHOUT|2020-12-20|13
e|MI|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|LFA1|Lymphocyte Function-Associated Antigen 1|METMAB SCORE|[?]|[?]|mg/cm2|[?]|1|GPL U|MALIGNANT|TUMOR TISSUE|UNEXPECTED ODOR|SHIN|LEFT|OUTER|KINETIC MICROPARTICLE IMMUNOASSAY|||INTERVIEWER|1|4|FOLLOW-UP|2020-11-08|69
e|MI|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|ROS1|ROS1 Protein|METAVIR FIBROSIS SCORE|[?]|[?]|nU/cL|[?]|1|%(w/w)|BENIGN|SUPERNATANT, SERUM|LACTESCENT|WRIST JOINT|LEFT|LATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||Y|CLINICAL STUDY SPONSOR|1|5|TREATMENT|2020-08-18|47
e|MI|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|MSNGMTRX|Mesangial Matrix|H SCORE TOTAL SCORE|[?]|[?]|ug/L DDU|[?]|1|LENS|BENIGN|VITREOUS HUMOR|AUTOLYZED|CORONARY ARTERY|UNILATERAL|DISTAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y||VENDOR|1|4|TREATMENT|2020-07-29|70
e|MI|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|BD2|Beta-defensin 2|ALLRED TOTAL SCORE|[?]|[?]|PELLET|[?]|1|10^9/dose|BENIGN|SKIN TISSUE|REFRIGERATED|FLEXOR CARPI ULNARIS MUSCLE|CONTRALATERAL|ANTEROTEMPORAL|PET/SPECT SCAN|||NON-HEALTH CARE PROFESSIONAL|1|1|FOLLOW-UP|2020-06-30|16
e|MI|84d68bcc-dc7a-4366-9630-40ce8885351d|1|INTSFBRO|Interstitial Fibrosis|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|PIPE|[?]|1|HEP|BENIGN|DIALYSIS FLUID, PERITONEAL|HEMOLYZED|TIBIA|RIGHT|TEMPORAL|WRIGHT STAIN|||SPOUSE|1|4|TREATMENT|2020-07-31|55
e|MI|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|CY16|Cytokeratin 16|PERCENT POSITIVE CELL|[?]|[?]|/VF|[?]|1|BOLUS|BENIGN|LOCHIA|ROOM TEMPERATURE|MANDIBLE|LEFT|LOWER|INDIRECT IMMUNOFLUORESCENCE|Y||INVESTIGATOR|1|3|FOLLOW-UP|2021-01-21|23
e|MI|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|CELLDIFF|Cellular Differentiation|RECEPTOR OVERALL STATUS|[?]|[?]|mmol/mol|[?]|1|mkat|BENIGN|LUNG SURFACTANT|ROOM TEMPERATURE|ILEUM, TERMINAL|RIGHT|INFERIOR|PAP STAIN|Y||CLINICAL STUDY SPONSOR|1|3|SCREENING|2021-02-12|63
e|MI|98737dfa-0058-4420-a515-38526f01f90d|1|CRYPABSC|Crypt Abscess|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|ug/m2/min|[?]|1|mm/h|MALIGNANT|BONE MARROW MONONUCLEAR CELL|CONTAMINATED|CERVIX UTERI|UNILATERAL|OCCIPITAL|NEPHELOMETRY|||NON-HEALTH CARE PROFESSIONAL|1|6|TREATMENT|2020-11-12|74
e|MI|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|TUMCECE|Tumor Cells/Total Cells|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|IU/day|[?]|1|dL|MALIGNANT|SUPERNATANT, PLASMA|ROOM TEMPERATURE|LUNG, RIGHT LOWER LOBE|UNILATERAL|UPPER|PYROSEQUENCING|||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-12-14|82
e|MI|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|GLOMLTIS|Glomerulitis|KNODELL FIBROSIS SCORE|[?]|[?]|SQU/mL|[?]|1|%(w/w)|MALIGNANT|CORD BLOOD|GELLED|MESENTERIC VEIN|LATERAL|ANTEROTEMPORAL|HANSEL STAIN|||NON-HEALTH CARE PROFESSIONAL|1|2|TREATMENT|2020-10-21|41
e|MI|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|CD8|CD8|ISUP GLEASON GRADE GROUP|[?]|[?]|mg/kg|[?]|1|/mm2|MALIGNANT|BASAL TEAR|CLOTTED|SOLE|UNILATERAL|DORSAL|GRADIENT DIFFUSION|||CAREGIVER|1|4|TREATMENT|2021-01-09|29
e|MI|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|AJCC TUMOR GRADE|[?]|[?]|mU/L|[?]|1|mm/2h|MALIGNANT|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|FLEXOR DIGITORUM BREVIS MUSCLE|LEFT|SUPERFICIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y|GUARDIAN|1|2|TREATMENT|2020-07-17|48
e|MI|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|MCINTINF|Mononuc Cell Interstitial Inflammation|GLEASON TOTAL SUM|[?]|[?]|Osm|[?]|1|MET*h|BENIGN|EXHALED BREATH CONDENSATE|AGGLUTINATED|FIBULA SHAFT|BILATERAL|LOWER EXTENSOR SURFACE|FLOCCULATION|Y|Y|ADJUDICATION COMMITTEE|1|3|WASHOUT|2020-06-24|37
e|MI|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|CD3|CD3|ALLRED TOTAL SCORE|[?]|[?]|10^3 organisms|[?]|1|CAPSULE|BENIGN|EMESIS|FRESH|STRIATUM|LEFT|DORSOLATERAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|6|SCREENING|2021-01-18|81
e|MI|7e9f4283-f90b-4f74-939c-b42648e8373c|1|CD68|CD68|METMAB SCORE|[?]|[?]|ft3|[?]|1|in2|MALIGNANT|BASAL TEAR|REFRIGERATED|RIB 4|CONTRALATERAL|DORSAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y|INTERVIEWER|1|5|WASHOUT|2021-02-21|78
e|MI|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|MMRPINTP|Mismatch Repair Proteins Interpretation|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|titer|[?]|1|pmol|BENIGN|SERUM OR PLASMA|NON-HEMOLYZED|SCAPHOID-CAPITATE JOINT|IPSILATERAL|SUPERFICIAL|SPECT/CT SCAN|||SIBLING|1|2|WASHOUT|2020-12-04|44
e|MI|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|EGFRVP|EGFR Variant Protein|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|ELISA unit/mL|[?]|1|umol/L/h|BENIGN|LEUKOCYTE|PARAFFIN-EMBEDDED|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|IODINE STAIN|||PARENT|1|6|TREATMENT|2020-05-30|24
e|MI|595aa95c-4378-47c1-96e9-5512d08fb653|1|HGFR|Hepatocyte Growth Factor Receptor|METAVIR FIBROSIS SCORE|[?]|[?]|ug/kg|[?]|1|Bq/mL|MALIGNANT|TISSUE|CONTAMINATED|PARACAVAL LYMPH NODE|LEFT|DEEP|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|||FRIEND|1|1|TREATMENT|2020-08-25|12
e|MI|b528dc24-e791-41b1-95b3-fc0be18da47f|1|NKX2_1|NK2 Homeobox 1|ALLRED TOTAL SCORE|[?]|[?]|GBq/mg|[?]|1|PELLET|MALIGNANT|PERITONEAL FLUID|CALCIFIED|CRANIAL CAVITY|BILATERAL|CRANIAL|PUPILLOMETRY|||VENDOR|1|2|WASHOUT|2021-03-19|92
e|MI|7a43c892-0e7f-4f33-9130-e175e475531f|1|TUBULTIS|Tubulitis|ISHAK FIBROSIS SCORE|[?]|[?]|log10 CFU/mL|[?]|1|mMU/mL|BENIGN|ALVEOLAR AIR|SOLIDIFIED|HYPOGLOSSAL NERVE|UNILATERAL|APICAL|AMSLER GRID||Y|ADJUDICATOR|1|1|FOLLOW-UP|2020-07-21|75
e|MI|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|TMCE|Tumor Cells|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mL/breath|[?]|1|mol/g|MALIGNANT|EXHALED BREATH CONDENSATE|CLOTTED|COLON, RECTOSIGMOID|UNILATERAL|CAUDAL|CARDIAC THERMODILUTION|||STUDY SUBJECT|1|3|TREATMENT|2021-02-07|69
e|MI|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|MLH1|MutL Homolog 1|SCHEUER FIBROSIS SCORE|[?]|[?]|DAgU/mL|[?]|1|L/min|BENIGN|SYNOVIAL FLUID|HEMOLYZED|TALUS|LATERAL|DORSAL|HPLC-UV|||GUARDIAN|1|1|TREATMENT|2020-09-23|37
e|MI|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|CORBIOMN|Number of Malignant Biopsy Cores|GLEASON TOTAL SUM|[?]|[?]|PFU/mL|[?]|1|L/L|MALIGNANT|BUFFY COAT|LACTESCENT|PROXIMAL PHALANX 4 OF THE HAND|LEFT|HIND|CONTACT SPECULAR MICROSCOPY||Y|PROXY|1|7|TREATMENT|2020-09-21|95
e|MI|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|HISTTYPC|Histologic Type of Cancer|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mEq|[?]|1|MET*h|MALIGNANT|URINE SEDIMENT|SOLIDIFIED|SUPRAPUBIC REGION|UNILATERAL|ROSTRAL|ELISPOT|||STUDY SUBJECT|1|2|TREATMENT|2020-10-05|49
e|MI|0cac2007-ca12-45ba-9b1c-70f753232f05|1|LYMPHINV|Lymphatic Invasion|ISHAK FIBROSIS SCORE|[?]|[?]|DAgU/mL|[?]|1|BAU/mL|MALIGNANT|PERITONEAL FLUID|LIPEMIC|PULMONARY VALVE, ANTERIOR CUSP|RIGHT|LATERAL|CELL BASED BIOASSAY|Y||CLINICAL RESEARCH COORDINATOR|1|3|SCREENING|2020-11-25|4
e|MI|2339e91a-b93e-426f-9b60-3d3b6969268d|1|MSH2|MutS Homolog 2|PERCENT POSITIVE CELL|[?]|[?]|g/cage|[?]|1|g/animal|MALIGNANT|HAIR|FRESH|COLON, RIGHT|IPSILATERAL|UPPER FLEXOR SURFACE|REBOUND TONOMETRY|||DOMESTIC PARTNER|1|1|WASHOUT|2020-07-01|4
e|MI|0d09e35b-e864-4492-a341-21c71d92b551|1|MYFIBROS|Myelofibrosis|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|BAG|[?]|1|/cmH2O|MALIGNANT|INFRANATANT, PLEURAL FLUID|CLOTTED|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|ANTEROTEMPORAL|MICROSCOPY|Y|Y|NON-HEALTH CARE PROFESSIONAL|1|5|SCREENING|2021-01-26|98
e|MI|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|PNLINV|Perineural Invasion|H SCORE TOTAL SCORE|[?]|[?]|mL/breath|[?]|1|10^7 PFU|BENIGN|PUS|REFRIGERATED|FUNDUS OF THE EYE|RIGHT|LOWER MEDIAL|BIOIMPEDANCE SPECTROSCOPY||Y|SPOUSE|1|7|SCREENING|2020-06-08|13
e|MI|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|KI67|Ki-67|METMAB SCORE|[?]|[?]|nkat/g Hb|[?]|1|log10 TCID 50/mL|MALIGNANT|SMEGMA|CONTAMINATED|FINGER FLEXOR TENDONS|RIGHT|TEMPORAL|CALCOFLUOR WHITE STAIN|||CHILD|1|6|SCREENING|2021-03-19|86
e|MI|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|EUROPEAN CONSENSUS SCORE|[?]|[?]|/h|[?]|1|umol/h/mmol|MALIGNANT|SPERMATOZOON|SOLIDIFIED|DISTAL EXTRAHEPATIC BILE DUCT REGION|IPSILATERAL|LOWER MEDIAL|IN SITU HYBRIDIZATION|||CLINICAL RESEARCH ASSOCIATE|1|4|TREATMENT|2020-10-24|34
e|MI|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|ALK|ALK Protein|ISUP GLEASON GRADE GROUP|[?]|[?]|RFU|[?]|1|ug/dose|BENIGN|EXUDATE|CALCIFIED|SEMITENDINOSUS MUSCLE|UNILATERAL|SUPERFICIAL|MACRO BROTH DILUTION|||ADJUDICATOR|1|5|WASHOUT|2020-12-07|35
e|MI|e7262592-01e8-4cb3-b967-ec1037505e81|1|CORBIOMN|Number of Malignant Biopsy Cores|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|log10 copies/mL|[?]|1|PNU/mL|MALIGNANT|CAPILLARY BLOOD|NON-HEMOLYZED|ESOPHAGUS, THORACIC|IPSILATERAL|OCCIPITAL|IMMUNO-PET SCAN|Y||VENDOR|1|6|FOLLOW-UP|2020-10-25|53
e|MI|bf150829-1b25-418a-9bc6-61716984387c|1|CRYPABSC|Crypt Abscess|H SCORE TOTAL SCORE|[?]|[?]|10^9 CFU/mL|[?]|1|SQU/mL|BENIGN|ARTERIALIZED CAPILLARY BLOOD|CLOTTED|TOE|RIGHT|SUPERFICIAL|BALLPOINT PEN TECHNIQUE|||VENDOR|1|1|FOLLOW-UP|2020-08-23|79
e|MI|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|MYFIBROS|Myelofibrosis|CHALKLEY SCORE|[?]|[?]|nkat/L|[?]|1|MPL U|BENIGN|PLEURAL FLUID|LIPEMIC|INTERPHALANGEAL JOINT OF THE HAND|IPSILATERAL|UPPER FLEXOR SURFACE|SCINTIGRAPHY||Y|PROXY|1|2|TREATMENT|2020-10-15|49
e|MI|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|CRYPABSC|Crypt Abscess|ISUP GLEASON GRADE GROUP|[?]|[?]|/10^5|[?]|1|L/s|BENIGN|BREAST MILK|ICTERIC|LENS|LEFT|VENTROLATERAL|FLOCCULATION, CHARCOAL ENHANCED|||SIGNIFICANT OTHER|1|3|TREATMENT|2020-07-11|2
e|MI|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|MMRPINTP|Mismatch Repair Proteins Interpretation|CHALKLEY SCORE|[?]|[?]|g/cage/day|[?]|1|U.CARR|MALIGNANT|VITREOUS HUMOR|THAWED|T12 VERTEBRA|UNILATERAL|PROXIMAL VOLAR|ELECTRONEUROGRAPHY||Y|VENDOR|1|4|FOLLOW-UP|2020-12-17|81
e|MI|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|IENFDEN|Intraepidermal Nerve Fiber Density|BAUERMEISTER SCORE|[?]|[?]|10^3/hpf|[?]|1|ft|BENIGN|PLATELET|GELLED|CALCANEUS|CONTRALATERAL|INNER|PET/CT SCAN|||ADJUDICATOR|1|2|FOLLOW-UP|2020-06-07|33
e|MI|09238251-feaf-45a9-b295-dfed9a75fbb2|1|LYMPHINV|Lymphatic Invasion|PERCENT POSITIVE CELL|[?]|[?]|mL/s|[?]|1|mEq/ug|BENIGN|ENDOTRACHEAL FLUID|DRIED|SKIN OF THE HAND|LATERAL|INFERIOR|POLYGRAPHY|Y|Y|SPOUSE|1|6|TREATMENT|2020-08-13|58
e|MI|3e896568-85dc-4a14-ba41-eb3575940a9d|1|KI67|Ki-67|ISUP GLEASON GRADE GROUP|[?]|[?]|K|[?]|1|MET*min|BENIGN|EMESIS|FRESH|THROAT|RIGHT|MIDLINE|LYMPHANGIOGRAPHY|Y||DOMESTIC PARTNER|1|3|TREATMENT|2021-04-24|98
e|MI|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|ISUP GLEASON GRADE GROUP|[?]|[?]|ka_u/dL|[?]|1|mm/h|MALIGNANT|ENDOMETRIAL TISSUE|CONCENTRATED|OCCIPITAL LOBE|UNILATERAL|NASAL|INDIRECT IMMUNOFLUORESCENCE|||INTERVIEWER|1|5|FOLLOW-UP|2020-11-13|32
e|MI|725c5a91-72b0-4b2c-a51a-d1006303373e|1|BDKRB1|Bradykinin Receptor B1|STAINING INTENSITY|[?]|[?]|mL/kg|[?]|1|deg/mm|BENIGN|SEMINAL FLUID|CALCIFIED|EYELASH|UNILATERAL|SURFACE|GC/FID|||CHILD|1|7|TREATMENT|2021-01-27|75
e|MI|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|PMS2|PMS1 Homolog 2|METMAB SCORE|[?]|[?]|breaths/min|[?]|1|ppth|MALIGNANT|ARTERIAL BLOOD|REFRIGERATED|COLON LYMPH NODE|CONTRALATERAL|FORE|PAP STAIN|||DOMESTIC PARTNER|1|3|FOLLOW-UP|2021-03-25|93
e|MI|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|PAX3FKHR|PAX3-FKHR Fusion Protein|PERCENT POSITIVE CELL|[?]|[?]|/10^3|[?]|1|V/sec|BENIGN|SALIVA|UNEXPECTED ODOR|SCIATIC NERVE|BILATERAL|DISTAL VOLAR|CALCOFLUOR WHITE STAIN|||SPOUSE|1|5|TREATMENT|2020-05-31|15
e|MI|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|PNLINV|Perineural Invasion|AJCC TUMOR GRADE|[?]|[?]|/h|[?]|1|PATCH|BENIGN|INFRANATANT, PLEURAL FLUID|LIPEMIC|PARAVERTEBRAL GANGLIA|LEFT|ANTEROLATERAL|RADIATION DOSIMETRY|Y||FRIEND|1|3|TREATMENT|2020-11-04|31
e|MI|f8878ffd-67af-414c-b346-596dbec640cf|1|MITOFIG|Mitotic Figure|RECEPTOR OVERALL STATUS|[?]|[?]|kDa|[?]|1|%(w/v)|MALIGNANT|SUPERNATANT, PLEURAL FLUID|CONCENTRATED|RIB 11|RIGHT|TIP|OLIGO ACGH|||NON-HEALTH CARE PROFESSIONAL|1|1|WASHOUT|2021-03-06|71
e|MI|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|MYFIBROS|Myelofibrosis|METAVIR FIBROSIS SCORE|[?]|[?]|IU/L|[?]|1|SFC/10^6 PBMC|MALIGNANT|CALCULUS|NON-HEMOLYZED|KIDNEY, HILUM|RIGHT|CRANIAL|LANDOLT RING||Y|ADJUDICATION COMMITTEE|1|1|TREATMENT|2020-08-05|96
e|MI|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|EGFRVP|EGFR Variant Protein|PERCENT POSITIVE CELL|[?]|[?]|L/h|[?]|1|um/s|BENIGN|DERMAL TISSUE|SOLIDIFIED|SKIN OF THE FACE|UNILATERAL|UPPER FLEXOR SURFACE|ERGOSPIROMETRY|||SIGNIFICANT OTHER|1|2|WASHOUT|2020-07-05|13
e|MI|b832144e-88c4-4ad6-b173-abac7802a36c|1|IENFDEN|Intraepidermal Nerve Fiber Density|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|10^3/hpf|[?]|1|vp/dose|MALIGNANT|ABSCESS FLUID|LACTESCENT|NASAL SEPTUM|LEFT|PROXIMAL VOLAR|SLIT LAMP|Y|Y|INDEPENDENT ASSESSOR|1|3|TREATMENT|2021-04-02|88
e|MI|6acacd87-c487-401c-8888-76ccf97b640d|1|THICK|Thickness|EUROPEAN CONSENSUS SCORE|[?]|[?]|uL/mL|[?]|1|Bq/kg|BENIGN|AMNIOTIC FLUID|LACTESCENT|LIMB|LATERAL|CAUDAL|QUANTITATIVE ULTRASOUND|||INTERVIEWER|1|4|TREATMENT|2020-06-29|45
e|MI|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|INTMART|Intimal Arteritis|EUROPEAN CONSENSUS SCORE|[?]|[?]|PFU/mL|[?]|1|10^3 DNA copies/mL|MALIGNANT|PLEURAL FLUID|LIPEMIC|GENITALIA|LEFT|PROXIMAL VOLAR|ROMANOWSKY STAIN|Y||ADJUDICATOR|1|5|SCREENING|2020-08-29|54
e|MI|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|MMRPINTP|Mismatch Repair Proteins Interpretation|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|Siemens|[?]|1|min*mg/mL|MALIGNANT|LYMPH|FROZEN|ABDOMINAL LYMPH NODE|BILATERAL|TIP|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|||PARENT|1|3|FOLLOW-UP|2021-03-24|90
e|MI|0670f6a3-18c9-4027-91c1-56f5555589a8|1|KI67|Ki-67|ALLRED STAINING INTENSITY SCORE|[?]|[?]|breaths/min|[?]|1|mEq/uL|BENIGN|LYMPH|CONTAMINATED|PERIURETHRAL REGION|LATERAL|DORSAL|SLOAN LETTER EYE CHART 2.5%|||CAREGIVER|1|3|TREATMENT|2020-07-28|86
e|MI|59179734-8784-4a88-aa6b-51b6082ffc1b|1|CELLDIFF|Cellular Differentiation|ALLRED STAINING INTENSITY SCORE|[?]|[?]|scm|[?]|1|V|BENIGN|DERMAL TISSUE|AUTOLYZED|BODY OF STOMACH|LEFT|DISTAL VOLAR|SINGLE-MOLECULE ARRAY|||SIBLING|1|7|TREATMENT|2020-08-04|3
e|MI|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|FOXP3|Forkhead Box Protein 3|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mEq/kg|[?]|1|BAU|BENIGN|TUMOR TISSUE|CLOTTED|PRELARYNGEAL LYMPH NODE|LEFT|LOWER EXTENSOR SURFACE|PALM METHOD|||NON-HEALTH CARE PROFESSIONAL|1|7|TREATMENT|2020-09-18|37
e|MI|01c642f8-48ef-4375-aa2b-d0940b74e580|1|MSH6|MutS Homolog 6|METAVIR FIBROSIS SCORE|[?]|[?]|deg|[?]|1|APL U|MALIGNANT|SMOOTH MUSCLE TISSUE|FROZEN|PANCREAS, HEAD|IPSILATERAL|NASAL|TRICHROME STAIN|||SPOUSE|1|6|TREATMENT|2020-11-23|75
e|MI|c0e7028c-6f5c-410a-afde-e56af2177983|1|TUBULTIS|Tubulitis|AJCC TUMOR GRADE|[?]|[?]|km|[?]|1|deg|MALIGNANT|BONE|CONCENTRATED|FUNDUS UTERI|RIGHT|SUBCORTICAL|SLIT LAMP||Y|NON-HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-08-01|36
e|MI|eba928ed-9434-4e75-b49d-169298f966e1|1|GRNLMA|Granuloma|RECEPTOR OVERALL STATUS|[?]|[?]|copies/uL|[?]|1|mm/min|BENIGN|SERUM|LACTESCENT|L1 VERTEBRA|BILATERAL|PROXIMAL VOLAR|OBSERVATION|Y||STUDY SUBJECT|1|1|WASHOUT|2020-10-30|89
e|MI|4772aa80-2097-4867-a549-b6f9b140f141|1|CRYPTTS|Cryptitis|ISHAK FIBROSIS SCORE|[?]|[?]|nmol/g|[?]|1|nmol/L|MALIGNANT|DIALYSIS FLUID, PERITONEAL|FRESH|INTERPHALANGEAL JOINT 3|LATERAL|VENTROLATERAL|TOLUIDINE BLUE STAIN|||SIBLING|1|2|TREATMENT|2020-08-24|53
e|MI|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|MMRPINTP|Mismatch Repair Proteins Interpretation|ALLRED STAINING INTENSITY SCORE|[?]|[?]|10^4/hpf|[?]|1|dL|MALIGNANT|INFRANATANT, SERUM|ROOM TEMPERATURE|INTERNAL MAMMARY LYMPH NODE|CONTRALATERAL|LOWER FLEXOR SURFACE|MICROARRAY|||INDEPENDENT ASSESSOR|1|6|SCREENING|2020-08-11|75
e|MI|4d8dd0d0-407d-4374-8345-c11f30603273|1|LFA1|Lymphocyte Function-Associated Antigen 1|ALLRED STAINING INTENSITY SCORE|[?]|[?]|g/animal/day|[?]|1|SFC/10^6 PBMC|BENIGN|HAIR FOLLICLE|THAWED|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|UNILATERAL|TIP|SLOAN LETTER EYE CHART 1.25%||Y|SIBLING|1|6|TREATMENT|2021-03-20|88
e|MI|6996077b-556a-47b9-bbff-20c1b4df35ea|1|HGFR|Hepatocyte Growth Factor Receptor|GLEASON SECONDARY SCORE|[?]|[?]|mg/m2/min|[?]|1|dpm/100mg|BENIGN|DERMAL TISSUE|REFRIGERATED|MID-CIRCUMFLEX ARTERY|IPSILATERAL|ROSTRAL|RADIAL IMMUNODIFFUSION|Y|Y|GUARDIAN|1|2|TREATMENT|2020-08-19|82
e|MI|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|MSNGMTRX|Mesangial Matrix|ALLRED STAINING INTENSITY SCORE|[?]|[?]|10^6 CFU/mL|[?]|1|mL/kg|MALIGNANT|LEUKOCYTE|CONTAMINATED|LEG SKIN|LATERAL|FRONTAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||Y|GUARDIAN|1|7|FOLLOW-UP|2021-01-08|87
e|MI|738d539e-a810-4207-8904-fc6a5d055424|1|THICK|Thickness|GLEASON TOTAL SUM|[?]|[?]|10^7 CFU/mL|[?]|1|nmol/kg/day|BENIGN|BUFFY COAT|LACTESCENT|RETINAL NERVE FIBER LAYER|BILATERAL|ANTEROLATERAL|CALIPER MEASUREMENT METHOD|||INVESTIGATOR|1|4|TREATMENT|2021-02-28|61
e|MI|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|MSH6|MutS Homolog 6|EUROPEAN CONSENSUS SCORE|[?]|[?]|APL U|[?]|1|IMPLANT|MALIGNANT|EPITHELIAL CELL|ROOM TEMPERATURE|EPIGASTRIC REGION|LEFT|INNER|GIEMSA STAIN|||NON-HEALTH CARE PROFESSIONAL|1|6|TREATMENT|2020-08-21|20
e|MI|20841d37-0444-4d1d-b934-1e805cdacdaf|1|PAP|Prostatic Acid Phosphatase|STAINING INTENSITY|[?]|[?]|EIA unit|[?]|1|F|MALIGNANT|VENOUS BLOOD|AUTOLYZED|LOWER JUGULAR LYMPH NODE|LEFT|ANTEROMEDIAL|DARK FIELD MICROSCOPY||Y|DOMESTIC PARTNER|1|2|FOLLOW-UP|2020-11-19|7
e|MI|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|MSH2|MutS Homolog 2|KNODELL FIBROSIS SCORE|[?]|[?]|10^6/L|[?]|1|U/g/day|BENIGN|SMOOTH MUSCLE TISSUE|GELLED|LIP, UPPER|LATERAL|ANTEROMEDIAL|INFRARED SPECTROMETRY|||NON-HEALTH CARE PROFESSIONAL|1|1|WASHOUT|2020-12-15|54
e|MI|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|CY16|Cytokeratin 16|GLEASON SECONDARY SCORE|[?]|[?]|DAYS|[?]|1|um2|MALIGNANT|LUNG SURFACTANT|GELLED|ULNA SHAFT|UNILATERAL|TEMPORAL|MRI|||INDEPENDENT ASSESSOR|1|6|TREATMENT|2020-09-22|55
e|MI|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|CRYPABSC|Crypt Abscess|STAINING INTENSITY|[?]|[?]|MBP|[?]|1|SBE/mL|BENIGN|LUNG SURFACTANT|FROZEN|THORACIC ARTERY|RIGHT|DEEP|ANTIBIOTIC AGAR SCREEN|||NON-HEALTH CARE PROFESSIONAL|1|5|TREATMENT|2020-12-23|26
e|MI|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|S100A7|S100 Calcium Binding Protein A7|GLEASON PRIMARY SCORE|[?]|[?]|C|[?]|1|cycle/min|MALIGNANT|COLOSTRUM|PARAFFIN-EMBEDDED|SUPERIOR VENA CAVA|RIGHT|ANTEROMEDIAL|DIRECT SEQUENCING|||CAREGIVER|1|4|TREATMENT|2020-07-01|9
e|MI|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|MCINTINF|Mononuc Cell Interstitial Inflammation|METMAB SCORE|[?]|[?]|PIXELS/cm|[?]|1|MBq/uL|MALIGNANT|COLOSTRUM|CONCENTRATED|NOSTRIL|LEFT|FRONTAL|MICROSCOPY|||INTERVIEWER|1|7|SCREENING|2021-01-09|63
e|MI|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|THICK|Thickness|PERCENT POSITIVE CELL|[?]|[?]|mL/m2|[?]|1|ug/day|BENIGN|HAIR FOLLICLE|CONCENTRATED|ELBOW EXTENSOR MUSCLES|IPSILATERAL|DORSAL|CELLULOSE TAPE|Y||GUARDIAN|1|7|TREATMENT|2021-01-16|91
e|MI|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|PNTHCEMP|Paneth Cell Metaplasia|SCHEUER FIBROSIS SCORE|[?]|[?]|mEq/day|[?]|1|mL/kg/min|BENIGN|CORD BLOOD|AUTOLYZED|CORPUS CALLOSUM, BODY|UNILATERAL|INTERMEDIATE|CELL BASED BIOASSAY|||SIBLING|1|5|TREATMENT|2021-01-14|31
e|MI|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|MSNGMTRX|Mesangial Matrix|GLEASON TOTAL SUM|[?]|[?]|10^6 organisms|[?]|1|ug/g/h|BENIGN|PLATELET POOR PLASMA|LACTESCENT|RIB 2|RIGHT|SURFACE|PET/SPECT SCAN|||ADJUDICATION COMMITTEE|1|5|TREATMENT|2020-06-10|35
e|MI|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|CORBIOMN|Number of Malignant Biopsy Cores|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|CAPSULE|[?]|1|10^6 CFU/mL|MALIGNANT|BUFFY COAT|GELLED|INTERPHALANGEAL THUMB JOINT|UNILATERAL|PROXIMAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y||SIBLING|1|2|TREATMENT|2021-01-14|56
e|MI|1e1de453-920a-4132-b2f7-6335ee81ec83|1|SMUSCAB|Smooth Muscle Antibody|GLEASON PRIMARY SCORE|[?]|[?]|pg/dL|[?]|1|fmol/g|BENIGN|ARTERIAL BLOOD|FROZEN|FACE|IPSILATERAL|DEEP|CONGO RED STAIN|||CHILD|1|2|TREATMENT|2021-01-18|98
e|MI|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|MITOFIG|Mitotic Figure|METMAB SCORE|[?]|[?]|mEq/g|[?]|1|mg/kg|BENIGN|INFRANATANT, SERUM|PARAFFIN-EMBEDDED|SUPERFICIAL FEMORAL ARTERY|IPSILATERAL|VENTROLATERAL|INDIRECT IMMUNOFLUORESCENCE|||ADJUDICATION COMMITTEE|1|7|FOLLOW-UP|2020-08-05|47
e|MI|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|SGMGSTAT|Surgical Margins Status|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|GBq/ug|[?]|1|L/kg|BENIGN|HAIR FOLLICLE|ROOM TEMPERATURE|HYMENAL RING|RIGHT|MIDLINE|LIGHT SCATTERING SPECTROSCOPY|||CLINICAL STUDY SPONSOR|1|4|WASHOUT|2020-12-13|7
e|MI|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|EGFRVP|EGFR Variant Protein|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|MONTHS|[?]|1|DROP|BENIGN|ENDOTRACHEAL FLUID|LIPEMIC|BLADDER, DOME|UNILATERAL|POSTERIOR|ZIEHL NEELSEN ACID FAST STAIN|||ADJUDICATOR|1|6|TREATMENT|2020-09-01|94
e|MI|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|ICAM1|Intercellular Adhesion Molecule 1|METMAB SCORE|[?]|[?]|mU/g|[?]|1|DDU|BENIGN|SMOOTH MUSCLE TISSUE|FRESH|ILIAC VEIN|RIGHT|LOWER EXTENSOR SURFACE|SINGLE-SLICE SPIRAL CT|||ADJUDICATION COMMITTEE|1|6|TREATMENT|2020-12-26|68
e|MI|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|ROS1|ROS1 Protein|SCHEUER FIBROSIS SCORE|[?]|[?]|10^6/g|[?]|1|10^9/L|MALIGNANT|PERSPIRATION|ICTERIC|INTESTINE|IPSILATERAL|BASAL|DNA MICROARRAY||Y|DOMESTIC PARTNER|1|3|WASHOUT|2021-02-11|59
e|MI|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|CRYPTTS|Cryptitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|MBP|[?]|1|PA|BENIGN|EXHALED BREATH CONDENSATE|DRIED|FEMORAL CONDYLE|RIGHT|DORSOLATERAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y|CLINICAL RESEARCH ASSOCIATE|1|3|WASHOUT|2020-10-26|19
e|MI|a1d203ef-7ee1-4373-988a-370532bae2b1|1|PMS2|PMS1 Homolog 2|STAINING INTENSITY|[?]|[?]|umol/min|[?]|1|IU/mL|BENIGN|ENDOTRACHEAL FLUID|ROOM TEMPERATURE|POPLITEAL LYMPH NODE|BILATERAL|MIDLINE|IMMUNODIFFUSION|Y||HEALTH CARE PROFESSIONAL|1|4|WASHOUT|2021-02-22|35
e|MI|4389d158-cb51-4779-b19a-f38dbef0806a|1|THICK|Thickness|GLEASON PRIMARY SCORE|[?]|[?]|ug/kg/day|[?]|1|umol/min|BENIGN|CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|THROAT|IPSILATERAL|FACIAL|MIGET|||NON-HEALTH CARE PROFESSIONAL|1|7|TREATMENT|2020-07-22|40
e|MI|3a973b7a-3583-4383-b59e-3dab51b511bd|1|CD68|CD68|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|nmol BCE/L|[?]|1|nmol/day|BENIGN|CORD BLOOD|NON-HEMOLYZED|CORNEAL STROMA|IPSILATERAL|PROXIMAL|ELECTROMYOGRAPHY||Y|INDEPENDENT ASSESSOR|1|2|FOLLOW-UP|2021-04-03|84
e|MI|d283591c-2085-459e-94f2-d3eb6b81aea7|1|TISABNUM|Number of Abnormal Tissue Samples|ALLRED STAINING INTENSITY SCORE|[?]|[?]|BE/mL|[?]|1|VIAL|BENIGN|DERMAL TISSUE|REFRIGERATED|PUBIC BONE|BILATERAL|OCCIPITAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||PARENT|1|1|SCREENING|2020-11-30|73
e|MI|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|MLH1|MutL Homolog 1|EUROPEAN CONSENSUS SCORE|[?]|[?]|ug/m2|[?]|1|ft3|MALIGNANT|BREAST MILK|AGGLUTINATED|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LATERAL|LATERAL|LASER CAPTURE MICRODISSECTION|||INDEPENDENT ASSESSOR|1|6|TREATMENT|2020-11-09|49
e|MI|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|TRCETMCE|Transitional Cells/Tumor Cells|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|PUFF|[?]|1|DAYS|BENIGN|ENDOTRACHEAL FLUID|CONTAMINATED|AXILLARY LYMPH NODE LEVEL II|LEFT|SUPERIOR|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||SIBLING|1|4|FOLLOW-UP|2021-03-03|76
e|MI|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ISHAK FIBROSIS SCORE|[?]|[?]|ft2|[?]|1|mg/m2/h|MALIGNANT|INFRANATANT, SERUM|THAWED|PRIMARY VISUAL CORTEX|UNILATERAL|OCCIPITAL|PEAK FLOWMETRY||Y|CLINICAL STUDY SPONSOR|1|7|FOLLOW-UP|2020-07-05|53
e|MI|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|PNLINV|Perineural Invasion|GLEASON SECONDARY SCORE|[?]|[?]|um/s|[?]|1|Tesla|BENIGN|SERUM OR PLASMA OR BLOOD|FRESH|PERIUMBILICAL REGION|CONTRALATERAL|DORSAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|||CLINICAL RESEARCH ASSOCIATE|1|6|FOLLOW-UP|2020-10-19|81
e|MI|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|BD1|Beta-defensin 1|BAUERMEISTER SCORE|[?]|[?]|yd|[?]|1|mol/L|BENIGN|GASTRIC CONTENTS|HEMOLYZED|LIVER, RIGHT LOBE|BILATERAL|FRONTAL|DOUBLE IMMUNODIFFUSION|||STUDY SUBJECT|1|1|SCREENING|2020-09-02|76
e|MI|9bdf9856-3b2a-43db-b369-3e13868ef413|1|BD1|Beta-defensin 1|GLEASON TOTAL SUM|[?]|[?]|HOMEOPATHIC DILUTION|[?]|1|kN/cm2|BENIGN|SEMINAL FLUID|AUTOLYZED|MYOMETRIUM|LATERAL|TEMPORAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||ADJUDICATION COMMITTEE|1|4|TREATMENT|2021-03-21|67
e|MI|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|HISTTYPC|Histologic Type of Cancer|METAVIR FIBROSIS SCORE|[?]|[?]|mMU/mL|[?]|1|Ci/g|BENIGN|AMNIOTIC FLUID|HEMOLYZED|T12 VERTEBRA|BILATERAL|VENTROLATERAL|CONGO RED STAIN|||ADJUDICATION COMMITTEE|1|4|WASHOUT|2021-03-09|81
e|MI|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|STRMCECE|Stromal Cells/Total Cells|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|uU/dL|[?]|1|mEq|BENIGN|BILE|CLOTTED|ANTERIOR TIBIAL VEIN|UNILATERAL|LOWER EXTENSOR SURFACE|PANENDOSCOPY|||ADJUDICATOR|1|5|TREATMENT|2021-01-14|26
e|MI|066281d3-27b8-439f-8340-f59115f646ef|1|MLH1|MutL Homolog 1|ISHAK FIBROSIS SCORE|[?]|[?]|EU|[?]|1|Bq/mL|MALIGNANT|SMOOTH MUSCLE TISSUE|ICTERIC|LENS|LEFT|VENTROLATERAL|MULTIPLE BREATH WASHOUT|||INVESTIGATOR|1|3|SCREENING|2020-12-29|79
e|MI|d23cc47e-da96-4042-a69f-60097beaef0e|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|RECEPTOR OVERALL STATUS|[?]|[?]|ELISA unit|[?]|1|APS U|MALIGNANT|SEBUM|CONCENTRATED|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL|UPPER FLEXOR SURFACE|MAGNETIC RESONANCE ELASTOGRAPHY|||CLINICAL STUDY SPONSOR|1|2|WASHOUT|2021-03-19|67
e|MI|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|PNLINV|Perineural Invasion|KNODELL FIBROSIS SCORE|[?]|[?]|BEAM BREAKS|[?]|1|cd/m2|MALIGNANT|CORD BLOOD|HEMOLYZED|C5 VERTEBRA|LEFT|CRANIAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||NON-HEALTH CARE PROFESSIONAL|1|2|WASHOUT|2021-01-28|36
e|MI|6d0ec221-6eb6-4fed-806e-2bc700968333|1|HISTTYPC|Histologic Type of Cancer|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^10/L|[?]|1|Arbitrary U|BENIGN|RETICULOCYTES|CONTAMINATED|OLFACTORY NERVE|LEFT|UPPER EXTENSOR SURFACE|ENZYMATIC COLORIMETRY|Y|Y|FAMILY MEMBER|1|5|SCREENING|2020-09-20|65
e|MI|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|SMUSCAB|Smooth Muscle Antibody|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|ug/dose|[?]|1|mL/animal/day|BENIGN|VENOUS BLOOD|FROZEN|SOLE|LEFT|DORSAL|CELLULAR PROLIFERATION ASSAY|||SIGNIFICANT OTHER|1|2|TREATMENT|2020-11-12|50
e|MI|15e5e7ca-b832-450c-a20c-b21585086328|1|MMRPINTP|Mismatch Repair Proteins Interpretation|SCHEUER FIBROSIS SCORE|[?]|[?]|Bq/g|[?]|1|pmol/dL|BENIGN|STOOL|DRIED|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LEFT|CAUDAL|WRIGHT STAIN|||FRIEND|1|2|FOLLOW-UP|2021-01-12|17
e|MI|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|HISTTYPC|Histologic Type of Cancer|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|IU/mmol|[?]|1|pmol|BENIGN|EXUDATE|DRIED|TRIANGULAR-HAMATE JOINT|UNILATERAL|DORSAL|LISSAMINE GREEN STAIN|||CLINICAL RESEARCH COORDINATOR|1|3|TREATMENT|2020-11-24|52
e|MI|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|FOXP3|Forkhead Box Protein 3|EUROPEAN CONSENSUS SCORE|[?]|[?]|10^9/L|[?]|1|mL/mmHg/min/L|MALIGNANT|ENDOTRACHEAL FLUID|CONTAMINATED|PANCREAS, HEAD|UNILATERAL|INNER|ZIEHL NEELSEN ACID FAST STAIN|Y|Y|INVESTIGATOR|1|3|TREATMENT|2021-02-16|82
e|MI|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|ARTLRHYT|Arteriolar Hyaline Thickening|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/kg/min|[?]|1|Enzyme U/g Hb|BENIGN|STOOL|FRESH|POPLITEAL FOSSA|LEFT|SUBCORTICAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||FAMILY MEMBER|1|4|WASHOUT|2020-11-28|63
e|MI|944a2627-13f1-4ecf-9545-8819a1327138|1|ROS1|ROS1 Protein|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mg/dL|[?]|1|/wk|BENIGN|CERUMEN|LIPEMIC|SUPRAGLOTTIS|CONTRALATERAL|DISTAL VOLAR|DYNAMOMETRY|||INVESTIGATOR|1|3|SCREENING|2021-04-10|93
e|MI|7902955a-6336-45e5-a15d-7c368a28ac4f|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|KNODELL FIBROSIS SCORE|[?]|[?]|pmol/dL|[?]|1|mL/h|MALIGNANT|EXHALED BREATH CONDENSATE|LIPEMIC|MID-JUGULAR LYMPH NODE|LATERAL|MEDIAL|KINYOUN STAIN|||ADJUDICATION COMMITTEE|1|4|SCREENING|2020-08-15|85
e|MI|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|KI67|Ki-67|H SCORE TOTAL SCORE|[?]|[?]|in2|[?]|1|mCi/L|BENIGN|MONOCYTE|CLOTTED|ILIAC CREST|LATERAL|SUPERFICIAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||SPOUSE|1|2|TREATMENT|2021-03-19|99
e|MI|6071d81f-2f38-414f-90ca-4ad80c971054|1|VFBINTMT|Vascular Fibrous Intimal Thickening|KNODELL FIBROSIS SCORE|[?]|[?]|nkat/L|[?]|1|BOTTLE|MALIGNANT|EPIDERMAL TISSUE|CONCENTRATED|APPENDICULAR SKELETON|UNILATERAL|OUTER|POTENTIOMETRY|||SPOUSE|1|1|WASHOUT|2020-10-27|60
e|MI|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|ICAM1|Intercellular Adhesion Molecule 1|ISHAK FIBROSIS SCORE|[?]|[?]|YEARS|[?]|1|U/mmol|BENIGN|ALVEOLAR AIR|PARAFFIN-EMBEDDED|BUCCAL MUCOSA|BILATERAL|LATERAL|GC/MS-EI|||PARENT|1|7|WASHOUT|2020-12-07|80
e|MI|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|NORMCECE|Normal Cells/Total Cells|AJCC TUMOR GRADE|[?]|[?]|mL/kg/h|[?]|1|cm H2O|BENIGN|URINE SEDIMENT|DRIED|BRAIN, THIRD VENTRICLE|RIGHT|VOLAR|TRICHROME STAIN|||CAREGIVER|1|3|SCREENING|2020-09-03|43
e|MI|8b60e1b0-2cd9-419d-b345-9006af042932|1|TISABNUM|Number of Abnormal Tissue Samples|TUMOR PROPORTION SCORE|[?]|[?]|IU/mg|[?]|1|oz eq|MALIGNANT|CALCULUS|GELLED|CHOROID PLEXUS|BILATERAL|PERIPHERAL|TOTAL BODY IRRADIATION|||STUDY SUBJECT|1|6|SCREENING|2021-02-01|57
e|MI|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|CD8|CD8|TUMOR PROPORTION SCORE|[?]|[?]|10^3 DNA copies/mL|[?]|1|oz|BENIGN|VITREOUS HUMOR|ICTERIC|TRICUSPID VALVE ANNULUS|UNILATERAL|BASAL|FLUORESCENT ENZYME IMMUNOASSAY|Y||VENDOR|1|1|FOLLOW-UP|2021-03-15|60
e|MI|92c0183d-5704-45ad-9aec-e24bc5777b80|1|TISABNUM|Number of Abnormal Tissue Samples|ALLRED TOTAL SCORE|[?]|[?]|MBq|[?]|1|U/mL|BENIGN|LYSATE|CLOTTED|JEJUNUM|BILATERAL|DORSAL|ACRIDINE ORANGE STAIN|||CLINICAL STUDY SPONSOR|1|4|TREATMENT|2021-04-18|98
e|MI|52ce3b1f-9500-4323-861d-73c8b96f59de|1|CANCLLTY|Cancer Cellularity|CHALKLEY SCORE|[?]|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|mmAL|MALIGNANT|BONE MARROW MONONUCLEAR CELL|REFRIGERATED|SCLERA|IPSILATERAL|PERIPHERAL|MANUAL COUNT|||FAMILY MEMBER|1|7|SCREENING|2020-11-24|39
e|MI|3655d198-2e7e-419e-8337-d7eea7d795ca|1|PCTISCA|Percentage of In situ Carcinoma|GLEASON TOTAL SUM|[?]|[?]|POUCH|[?]|1|pm|BENIGN|SERUM OR PLASMA OR BLOOD|LACTESCENT|PYRAMIDAL TRACTS, BRAINSTEM|BILATERAL|LOWER EXTENSOR SURFACE|SCINTIGRAPHY|||CLINICAL STUDY SPONSOR|1|6|SCREENING|2021-02-18|97
e|MI|d47da6bf-8abf-4b62-8bb8-797155981158|1|CORBIOMN|Number of Malignant Biopsy Cores|GLEASON SECONDARY SCORE|[?]|[?]|cm/min|[?]|1|Hounsfield Unit|BENIGN|AQUEOUS HUMOR|HEMOLYZED|URETHRA, PENILE|LEFT|INNER|AMSLER GRID|||GUARDIAN|1|7|SCREENING|2020-11-13|74
e|MI|25e81c81-8c23-4c9e-be79-35247384dd1f|1|INTSFBRO|Interstitial Fibrosis|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|RATIO|[?]|1|BAU/mL|MALIGNANT|BREAST MILK|NON-HEMOLYZED|COLON|IPSILATERAL|ANTERIOR|NUCLEIC ACID BASED METHOD|||ADJUDICATOR|1|5|TREATMENT|2020-09-17|50
e|MI|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|TRCETMCE|Transitional Cells/Tumor Cells|TUMOR PROPORTION SCORE|[?]|[?]|kg/cm2|[?]|1|10^3 CFU/g|BENIGN|PLATELET|FRESH|RIB|LATERAL|OUTER|BRDU CELLULAR PROLIFERATION ASSAY||Y|CAREGIVER|1|1|FOLLOW-UP|2020-10-23|98
e|MI|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|HISTTYPC|Histologic Type of Cancer|CHALKLEY SCORE|[?]|[?]|MnFI|[?]|1|EP U|BENIGN|TRANSUDATE|ICTERIC|BLADDER, NECK|CONTRALATERAL|OCCIPITAL|TARGETED GENOME SEQUENCING|||CLINICAL RESEARCH ASSOCIATE|1|6|TREATMENT|2021-01-29|88
e|MI|5ba70148-c29b-47af-9280-10d1a942380a|1|MSH6|MutS Homolog 6|METAVIR FIBROSIS SCORE|[?]|[?]|10^9 organisms/g|[?]|1|mL/cage/wk|BENIGN|GASTRIC CONTENTS|GELLED|INTERTROCHANTERIC REGION|UNILATERAL|MEDIAL|REBOUND TONOMETRY||Y|FRIEND|1|6|WASHOUT|2020-11-23|5
e|MI|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|MIEXAM|Microscopic Examination|METMAB SCORE|[?]|[?]|anti-Xa IU|[?]|1|TAMPON|MALIGNANT|ERYTHROCYTES|THAWED|PARALARYNGEAL LYMPH NODE|LATERAL|SURFACE|ALCIAN BLUE STAIN|||GUARDIAN|1|3|WASHOUT|2020-06-13|27
e|MI|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|LFA1|Lymphocyte Function-Associated Antigen 1|ISHAK FIBROSIS SCORE|[?]|[?]|PACKET|[?]|1|mg/L FEU|BENIGN|EMOTIONAL TEAR|FROZEN|UMBILICAL CORD|CONTRALATERAL|VENTRAL|FLUORESCENCE ANGIOGRAPHY|||CLINICAL RESEARCH COORDINATOR|1|2|TREATMENT|2020-06-14|5
e|MI|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|BLDVESD|Blood Vessel Density|AJCC TUMOR GRADE|[?]|[?]|genEq|[?]|1|mg/L FEU|MALIGNANT|REFLEX TEAR|CONCENTRATED|ANUS|RIGHT|SUPERFICIAL|DOPPLER ULTRASOUND|Y||SPOUSE|1|4|SCREENING|2020-10-16|67
e|MI|a73142e4-e34b-4144-b95f-7a5562574c1b|1|ICAM1|Intercellular Adhesion Molecule 1|GLEASON SECONDARY SCORE|[?]|[?]|SACHET|[?]|1|DRINK|MALIGNANT|CAPILLARY BLOOD|AUTOLYZED|SUPRARENAL AORTA|RIGHT|FRONTAL|PET/CT SCAN WITHOUT CONTRAST|||CLINICAL RESEARCH ASSOCIATE|1|2|SCREENING|2020-08-31|33
e|MI|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|STRMCECE|Stromal Cells/Total Cells|ALLRED TOTAL SCORE|[?]|[?]|mm|[?]|1|10^9/g|BENIGN|PLATELET RICH PLASMA|FROZEN|PATELLA|CONTRALATERAL|SUPERFICIAL|PET SCAN|||FAMILY MEMBER|1|7|WASHOUT|2020-07-09|46
e|MI|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|GZMB|Granzyme B|GLEASON PRIMARY SCORE|[?]|[?]|ug/min|[?]|1|g|MALIGNANT|SWABBED MATERIAL|FROZEN|LATERAL RAMUS INTERMEDIUS ARTERY|CONTRALATERAL|POSTERIOR|ORCHIDOMETERY|||INDEPENDENT ASSESSOR|1|1|TREATMENT|2020-08-20|93
e|MI|1d8aba56-f62e-4116-b447-899dedd3d4df|1|EGFR|Epidermal Growth Factor Receptor|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|U/mg|[?]|1|log10 TCID 50/dose|BENIGN|ALVEOLAR AIR|AGGLUTINATED|BRAIN|LEFT|UPPER|MODIFIED ACID FAST STAIN|||FRIEND|1|6|WASHOUT|2020-10-18|29
e|MI|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|ROS1|ROS1 Protein|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mmol/kg|[?]|1|mV*min|BENIGN|BREAST MILK|FROZEN|ETHMOID SINUS|IPSILATERAL|INNER|GC/MS|Y||GUARDIAN|1|4|SCREENING|2020-09-28|55
e|MI|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|BD1|Beta-defensin 1|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mg/m2/day|[?]|1|FIU|BENIGN|SUPERNATANT, PLASMA|UNEXPECTED ODOR|LUNG LOBE|BILATERAL|PARIETO-OCCIPITAL|INDIA INK STAIN|||CLINICAL STUDY SPONSOR|1|1|TREATMENT|2020-06-06|9
e|MI|b4f81b74-fee9-4544-9404-206d931ed8e5|1|ALK|ALK Protein|AJCC TUMOR GRADE|[?]|[?]|10^6/L|[?]|1|g/cm2|BENIGN|SUPERNATANT, SERUM|CALCIFIED|PROXIMAL LAD ARTERY|UNILATERAL|LOWER|ACRIDINE ORANGE STAIN|||CHILD|1|7|TREATMENT|2020-11-28|51
e|MI|9e69b457-20db-45e5-a535-0cd8ac102fea|1|PMS2|PMS1 Homolog 2|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|umol/h/mmol|[?]|1|10^9 organisms/g|MALIGNANT|BILE|PARAFFIN-EMBEDDED|FUNDUS UTERI|CONTRALATERAL|LOWER MEDIAL|TRANSVAGINAL ULTRASOUND|||CLINICAL RESEARCH ASSOCIATE|1|3|SCREENING|2020-08-30|94
e|MI|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mmol/L|[?]|1|/2500 WBC|MALIGNANT|BLOOD|CONTAMINATED|SUBMANDIBULAR GLAND|LATERAL|INFERIOR|ENDPOINT DILUTION ASSAY|||INDEPENDENT ASSESSOR|1|1|WASHOUT|2020-10-09|23
e|MI|63f3194e-9b88-491a-9a68-19109ed86e2b|1|CD56|CD56|ISHAK FIBROSIS SCORE|[?]|[?]|10^6 CFU|[?]|1|BAR|BENIGN|BONE|ROOM TEMPERATURE|MIDDLE PHALANX 2 OF THE HAND|LEFT|ROSTRAL|ERGOSPIROMETRY|||FAMILY MEMBER|1|3|TREATMENT|2020-07-15|45
e|MI|b6208258-d7c2-4dde-addf-4677946ab165|1|HER2|Human Epidermal Growth Factor Receptor 2|BAUERMEISTER SCORE|[?]|[?]|gMFI|[?]|1|10^3 organisms|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED|FASCIA|IPSILATERAL|LOWER|KNEMOMETRY|Y||NON-HEALTH CARE PROFESSIONAL|1|4|TREATMENT|2020-11-19|70
e|MI|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|CDX2AG|CDX2 Antigen|BAUERMEISTER SCORE|[?]|[?]|%(w/v)|[?]|1|DAYS|MALIGNANT|ARTERIAL BLOOD|HEMOLYZED|CORNEAL STROMA|LATERAL|SUBCORTICAL|SIZE EXCLUSION CHROMATOGRAPHY|Y||PROXY|1|1|WASHOUT|2021-04-03|77
e|MI|e148c13d-ee41-4503-a7e5-397dd6155f04|1|CRYPTTS|Cryptitis|GLEASON TOTAL SUM|[?]|[?]|mL/s|[?]|1|dpm/mg|BENIGN|SEMEN|PARAFFIN-EMBEDDED|ESOPHAGUS, CERVICAL|CONTRALATERAL|APICAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||Y|FAMILY MEMBER|1|6|TREATMENT|2020-09-29|83
e|MI|815de94a-f259-41ee-8951-8df150184a25|1|SGMGSTAT|Surgical Margins Status|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|TABLET|[?]|1|umol/L/min|BENIGN|PLATELET|CONCENTRATED|OVARY|IPSILATERAL|VENTRAL|CINEANGIOGRAPHY||Y|CLINICAL RESEARCH COORDINATOR|1|1|WASHOUT|2020-09-10|75
e|MI|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|BLDVESD|Blood Vessel Density|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|nL|[?]|1|IMPLANT|MALIGNANT|EXHALED BREATH CONDENSATE|SOLIDIFIED|SUPRASPINATUS MUSCLE|IPSILATERAL|DISTAL VOLAR|HIGH RESOLUTION MELT ANALYSIS|Y|Y|FAMILY MEMBER|1|4|SCREENING|2020-06-02|27
e|MI|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|KNODELL FIBROSIS SCORE|[?]|[?]|mg/kg/day|[?]|1|/cmH2O|BENIGN|MECONIUM|LIPEMIC|PERIPANCREATIC LYMPH NODE|CONTRALATERAL|UPPER EXTENSOR SURFACE|POLYGRAPHY|||CLINICAL RESEARCH ASSOCIATE|1|5|TREATMENT|2021-04-03|78
e|MI|a616ef00-05d6-459a-8474-06ab3eb493b1|1|NKX2_1|NK2 Homeobox 1|ALLRED TOTAL SCORE|[?]|[?]|JAR|[?]|1|Hz|BENIGN|SEMEN|NON-HEMOLYZED|EXTRAOCULAR MUSCLE|RIGHT|LOWER|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|||INVESTIGATOR|1|7|TREATMENT|2020-11-22|68
e|MI|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|TUBATRO|Tubular Atrophy|GLEASON SECONDARY SCORE|[?]|[?]|/2000 RBC|[?]|1|CAN|MALIGNANT|EPITHELIAL CELL|CALCIFIED|BLADDER, NECK|LEFT|PROXIMAL|HEMOCYTOMETRY|||PARENT|1|3|TREATMENT|2020-09-03|24
e|MI|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|ICAM1|Intercellular Adhesion Molecule 1|RECEPTOR OVERALL STATUS|[?]|[?]|g/day|[?]|1|MdFI|MALIGNANT|CEREBROSPINAL FLUID|AGGLUTINATED|PANCREATIC DUCT|RIGHT|BASAL|MICRODENSITOMETRY|||PARENT|1|4|TREATMENT|2021-01-03|84
e|MI|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|MLH1|MutL Homolog 1|BAUERMEISTER SCORE|[?]|[?]|%|[?]|1|log10 TCID 50/uL|MALIGNANT|HAIR FOLLICLE|SOLIDIFIED|COMMON FEMORAL VEIN|UNILATERAL|ANTEROMEDIAL|QUANTITATIVE ULTRASOUND|||GUARDIAN|1|1|TREATMENT|2020-09-15|83
e|MI|2014bcd0-1430-4096-87f5-650a01dae626|1|GRNLMA|Granuloma|PERCENT POSITIVE CELL|[?]|[?]|ELISA unit|[?]|1|kBq|MALIGNANT|VENOUS CORD BLOOD|FROZEN|MEDIAN NERVE|IPSILATERAL|LATERAL|PHOTOGRAPHY|||FAMILY MEMBER|1|4|TREATMENT|2020-08-13|84
e|MI|e043f1b3-6b65-45c0-bdae-eb783406c263|1|NKX2_1|NK2 Homeobox 1|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|10^3 CFU/mL|[?]|1|kg/mol|MALIGNANT|CORD SERUM|LIPEMIC|ANTERIOR TIBIAL ARTERY|LATERAL|HIND|TRANSVAGINAL ULTRASOUND|||STUDY SUBJECT|1|2|TREATMENT|2020-12-12|41
e|MI|45623c39-86de-4b2f-bf2d-998d0e941e92|1|MCINTINF|Mononuc Cell Interstitial Inflammation|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|CARTRIDGE|[?]|1|IU/dL|BENIGN|BILE|LACTESCENT|T10 VERTEBRA|LATERAL|ROSTRAL|WHOLE GENOME SEQUENCING|Y||SIGNIFICANT OTHER|1|7|FOLLOW-UP|2020-09-11|61
e|MI|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|METMAB SCORE|[?]|[?]|APL U/mL|[?]|1|Bq/L|MALIGNANT|CARDIAC MUSCLE TISSUE|HEMOLYZED|CORPUS STRIATUM|LATERAL|LOWER FLEXOR SURFACE|SPECT/CT SCAN||Y|STUDY SUBJECT|1|6|TREATMENT|2021-01-02|86
e|MI|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|LCN2|Lipocalin-2|AJCC TUMOR GRADE|[?]|[?]|mCi/L|[?]|1|U/mg|MALIGNANT|MUSCLE TISSUE|REFRIGERATED|PROXIMAL LAD ARTERY|LEFT|PARIETO-OCCIPITAL|DUCTOGRAPHY||Y|CLINICAL RESEARCH COORDINATOR|1|1|TREATMENT|2020-10-18|55
e|MI|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|ESTRCPT|Estrogen Receptor|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mg/g/h|[?]|1|VOXEL|BENIGN|BONE MARROW|FRESH|THORACIC SPINE|IPSILATERAL|FORE|IN VITRO GENE EXPRESSION ASSAY|||INDEPENDENT ASSESSOR|1|2|SCREENING|2021-03-09|64
e|MI|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|ROS1|ROS1 Protein|BAUERMEISTER SCORE|[?]|[?]|copies/uL|[?]|1|nL|BENIGN|PLATELET RICH PLASMA|ICTERIC|NUCLEUS OF DIAGONAL BAND|LEFT|CAUDAL|SINGLE-MOLECULE ARRAY|||PROXY|1|5|TREATMENT|2020-09-23|3
e|MI|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|PAX3FKHR|PAX3-FKHR Fusion Protein|PERCENT POSITIVE CELL|[?]|[?]|ug/m2/min|[?]|1|g/kg|BENIGN|MUCUS|NON-HEMOLYZED|HEAD AND NECK|LATERAL|SUBCORTICAL|X-RAY FLUORESCENCE SPECTROMETRY|Y||DOMESTIC PARTNER|1|7|SCREENING|2020-11-03|99
e|MI|c40fc52b-2668-4fab-b051-5b258da72f2c|1|SGMGSTAT|Surgical Margins Status|SCHEUER FIBROSIS SCORE|[?]|[?]|TRACE|[?]|1|uU/L|MALIGNANT|SUPERNATANT, SERUM|ICTERIC|NUCLEUS ACCUMBENS|BILATERAL|MIDLINE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y||VENDOR|1|1|FOLLOW-UP|2020-12-29|89
e|MI|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|HGFR|Hepatocyte Growth Factor Receptor|RECEPTOR OVERALL STATUS|[?]|[?]|10^12 IU/L|[?]|1|ug/cm2|MALIGNANT|PLATELET|ROOM TEMPERATURE|RIB 1|LEFT|UPPER FLEXOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|||INTERVIEWER|1|6|TREATMENT|2020-08-09|22
e|MI|f7773659-f207-4b29-8389-3aa766a6337a|1|PCTISCA|Percentage of In situ Carcinoma|ISHAK FIBROSIS SCORE|[?]|[?]|genEq/mL|[?]|1|U/mmol|MALIGNANT|MUCUS|THAWED|PERIPANCREATIC LYMPH NODE|LEFT|UPPER EXTENSOR SURFACE|CYSTOMETRY|||SPOUSE|1|1|SCREENING|2020-11-20|42
e|MI|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|HGFR|Hepatocyte Growth Factor Receptor|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|%(v/v)|[?]|1|umol/min|MALIGNANT|FLUID|REFRIGERATED|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LEFT|LOWER EXTENSOR SURFACE|PET/CT SCAN||Y|ADJUDICATOR|1|6|TREATMENT|2021-01-18|21
e|MI|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|SGMGSTAT|Surgical Margins Status|BAUERMEISTER SCORE|[?]|[?]|g/g|[?]|1|POUCH|MALIGNANT|KERATINOCYTE|DRIED|GREAT SAPHENOUS VEIN|LEFT|TIP|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y|CLINICAL RESEARCH ASSOCIATE|1|6|TREATMENT|2021-04-15|89
e|MI|700049a2-ef66-466b-b1d8-f0800bcfde43|1|MSNGMTRX|Mesangial Matrix|GLEASON TOTAL SUM|[?]|[?]|g/cage/wk|[?]|1|oz eq|MALIGNANT|VENOUS PLASMA|LIPEMIC|SUBCLAVIAN ARTERY|IPSILATERAL|ANTERIOR|ANTIBIOTIC AGAR SCREEN|||INDEPENDENT ASSESSOR|1|3|TREATMENT|2020-07-03|16
e|MI|00d906a6-2d14-4199-aff9-524388c5117f|1|PTBCPLTS|Peritubular Capillaritis|CHALKLEY SCORE|[?]|[?]|vp/mL|[?]|1|mIU/L|BENIGN|SALIVA|FRESH|SKIN OF THE CHIN|LEFT|OUTER|ELISPOT|||CLINICAL STUDY SPONSOR|1|1|TREATMENT|2020-12-20|36
e|MI|2fcc5910-bce0-4510-b17e-3925850d6d32|1|CD8|CD8|STAINING INTENSITY|[?]|[?]|cy/cm|[?]|1|ms/mmHg|MALIGNANT|INTERSTITIAL FLUID|FROZEN|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|SUPERIOR|MICRODENSITOMETRY|Y||FAMILY MEMBER|1|2|TREATMENT|2020-12-21|15
e|MI|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|MCINTINF|Mononuc Cell Interstitial Inflammation|RECEPTOR OVERALL STATUS|[?]|[?]|%|[?]|1|Tbsp|MALIGNANT|PERSPIRATION|NON-HEMOLYZED|TRAPEZOID BONE|LATERAL|ROSTRAL|DIFFUSION TENSOR MRI|Y||SPOUSE|1|1|TREATMENT|2020-10-06|46
e|MI|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|THICK|Thickness|RECEPTOR OVERALL STATUS|[?]|[?]|g/animal/day|[?]|1|Absorbance U/mL|BENIGN|ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|LATERAL SECOND DIAGONAL BRANCH ARTERY|BILATERAL|LOWER|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||Y|PARENT|1|4|TREATMENT|2020-07-28|12
e|MI|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|PTBCPLTS|Peritubular Capillaritis|ALLRED TOTAL SCORE|[?]|[?]|%(w/w)|[?]|1|%/min|BENIGN|SALIVA|ROOM TEMPERATURE|ORBICULARIS OCULI MUSCLE|CONTRALATERAL|LOWER EXTENSOR SURFACE|SPIRAL CT|||INDEPENDENT ASSESSOR|1|6|TREATMENT|2020-10-31|13
e|MI|ff163542-abec-4260-b257-f15a11e580ee|1|CRYPARCD|Crypt Architectural Damage|GLEASON SECONDARY SCORE|[?]|[?]|cm2|[?]|1|mL/dL|BENIGN|INTERSTITIAL FLUID|ICTERIC|RIB 11|RIGHT|PROXIMAL VOLAR|NUCLEIC ACID AMPLIFICATION TEST||Y|DOMESTIC PARTNER|1|7|WASHOUT|2020-10-16|71
e|MI|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|GZMB|Granzyme B|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|PIXELS/in|[?]|1|10^6 organisms/mL|BENIGN|CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|SINUS|UNILATERAL|TIP|PET/CT SCAN|||PARENT|1|2|WASHOUT|2020-08-22|27
e|MI|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|GRNLMA|Granuloma|ALLRED STAINING INTENSITY SCORE|[?]|[?]|g/dL|[?]|1|mV2/Hz|BENIGN|TRANSUDATE|LACTESCENT|THROAT|BILATERAL|PROXIMAL VOLAR|TWO-COLOR MICROARRAY|||INDEPENDENT ASSESSOR|1|1|FOLLOW-UP|2020-10-07|88
e|MI|8e056558-ffd2-4c43-bbfa-40914b38af34|1|ROS1|ROS1 Protein|TUMOR PROPORTION SCORE|[?]|[?]|ug/kg|[?]|1|SUPPOSITORY|BENIGN|CAPILLARY BLOOD|LIPEMIC|PROXIMAL INTERPHALANGEAL JOINT 5|LATERAL|PARIETO-OCCIPITAL|AGAR PROPORTION||Y|SIBLING|1|1|FOLLOW-UP|2021-04-12|83
e|MI|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|S100A7|S100 Calcium Binding Protein A7|GLEASON PRIMARY SCORE|[?]|[?]|FIU|[?]|1|cy/cm|BENIGN|FLUID|FRESH|ETHMOID BONE|BILATERAL|PERIPHERAL|SIZE EXCLUSION CHROMATOGRAPHY|||GUARDIAN|1|6|SCREENING|2020-07-01|43
e|MI|624c1353-347a-417d-9aab-7f1e7077ba7f|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|CHALKLEY SCORE|[?]|[?]|U/animal|[?]|1|SPRAY|BENIGN|MONOCYTE|THAWED|THROAT|LEFT|DORSOLATERAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|Y|PROXY|1|2|TREATMENT|2020-10-05|48
e|MI|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|PMS2|PMS1 Homolog 2|GLEASON SECONDARY SCORE|[?]|[?]|PIPE|[?]|1|DISK|MALIGNANT|STRIATED MUSCLE TISSUE|FRESH|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|LEFT|SUBCORTICAL|MULTI-SLICE SPIRAL CT|Y||VENDOR|1|2|TREATMENT|2020-09-23|62
e|MI|da6294b5-de91-4bf7-b160-55d22fefcb07|1|BLDVESD|Blood Vessel Density|ISHAK FIBROSIS SCORE|[?]|[?]|kPa/L/sec|[?]|1|GPS U|MALIGNANT|VITREOUS HUMOR|CONCENTRATED|MAIN BRONCHUS, RIGHT|IPSILATERAL|LATERAL|ZIEHL NEELSEN ACID FAST STAIN|||SPOUSE|1|1|TREATMENT|2020-07-19|31
e|MI|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|THICK|Thickness|ISUP GLEASON GRADE GROUP|[?]|[?]|P|[?]|1|10^7 CFU/mL|BENIGN|DISCHARGE|REFRIGERATED|HEART, LEFT VENTRICLE|RIGHT|INNER|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|||INTERVIEWER|1|7|TREATMENT|2020-11-11|43
e|MI|6036407d-5ac8-400d-91f7-afd63f3cab88|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|ALLRED TOTAL SCORE|[?]|[?]|m2|[?]|1|100 IU/mL|MALIGNANT|ABSCESS FLUID|ICTERIC|FOOT PHALANX|UNILATERAL|TEMPORAL|FLOCCULATION|||SIGNIFICANT OTHER|1|6|TREATMENT|2020-07-12|30
e|MI|69cf0c4b-13f6-4955-8046-72a333059d6e|1|GLOMLTIS|Glomerulitis|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|Shock Wave|[?]|1|mL/kg/h|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|CHIN|CONTRALATERAL|PERIVENTRICULAR|BAC ACGH||Y|CHILD|1|1|TREATMENT|2020-12-29|23
e|MI|19829028-595c-4811-90e3-0ca696a04ba3|1|TGFB1|Transforming Growth Factor Beta 1|ALLRED TOTAL SCORE|[?]|[?]|mOsm/L|[?]|1|SQU/mL|MALIGNANT|INFRANATANT, PLASMA|AUTOLYZED|CHIN|UNILATERAL|PROXIMAL|PANENDOSCOPY||Y|INDEPENDENT ASSESSOR|1|5|WASHOUT|2020-08-15|41
e|MI|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|MSH2|MutS Homolog 2|PERCENT POSITIVE CELL|[?]|[?]|oz|[?]|1|aMFI|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|FROZEN|ABDOMINAL SKIN|LEFT|PROXIMAL VOLAR|IRON HEMATOXYLIN STAIN|||GUARDIAN|1|4|TREATMENT|2020-11-18|84
e|MI|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|FIBROSIS|Fibrosis|GLEASON TOTAL SUM|[?]|[?]|dpm/100mg|[?]|1|10^3/hpf|MALIGNANT|KERATINOCYTE|HEMOLYZED|COMMON ILIAC LYMPH NODE|IPSILATERAL|ANTERIOR|GC/MS/MS|||SIBLING|1|2|TREATMENT|2021-01-20|11
e|MI|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|MYFIBROS|Myelofibrosis|METAVIR FIBROSIS SCORE|[?]|[?]|ng/dL|[?]|1|cm/min|BENIGN|SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|CERVICAL SPINE|IPSILATERAL|INNER|ELECTROPHORESIS|||FRIEND|1|4|WASHOUT|2020-08-22|84
e|MI|396295ba-9f4c-4689-88c2-f80cb28b567a|1|MITOFIG|Mitotic Figure|KNODELL FIBROSIS SCORE|[?]|[?]|mL/animal|[?]|1|Bq|MALIGNANT|SEMEN|UNEXPECTED ODOR|XIPHOID PROCESS|LEFT|DISTAL VOLAR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y||CLINICAL RESEARCH ASSOCIATE|1|7|TREATMENT|2021-03-07|76
e|MI|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|MIEXAM|Microscopic Examination|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|pmol/10^10 cells|[?]|1|U/10^12 RBC|MALIGNANT|SPERMATOZOON|LIPEMIC|TRIANGULAR-LUNATE JOINT|UNILATERAL|POSTERIOR|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||CHILD|1|3|TREATMENT|2020-09-06|21
e|MI|55b23180-01f2-498e-a0af-cb9cd7d81750|1|TISABNUM|Number of Abnormal Tissue Samples|STAINING INTENSITY|[?]|[?]|STEPS|[?]|1|mU/g|BENIGN|PLATELET RICH PLASMA|CONCENTRATED|ANASTOMOSIS|UNILATERAL|ROSTRAL|WRIGHT-GIEMSA STAIN||Y|SIGNIFICANT OTHER|1|5|SCREENING|2020-09-02|73
e|MI|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|MSH2|MutS Homolog 2|ALLRED STAINING INTENSITY SCORE|[?]|[?]|/wk|[?]|1|BAG|MALIGNANT|DIALYSIS FLUID, PERITONEAL|LIPEMIC|LIVER, QUADRATE LOBE|CONTRALATERAL|INTERMEDIATE|ORCHIDOMETERY|||PARENT|1|4|WASHOUT|2020-11-11|12
e|MI|940e4aef-5648-46b3-9c3e-7c40f7930030|1|PMS2|PMS1 Homolog 2|STAINING INTENSITY|[?]|[?]|Log10 ELISA unit/dose|[?]|1|umol/mol|BENIGN|PROSTATIC FLUID|REFRIGERATED|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|UNILATERAL|ANTEROMEDIAL|MRI WITHOUT CONTRAST|Y|Y|SIBLING|1|6|TREATMENT|2020-12-13|38
e|MI|e4bece1e-6672-4b55-824f-56aa923e60f9|1|EPITHINT|Epithelial Integrity|METAVIR FIBROSIS SCORE|[?]|[?]|CAPLET|[?]|1|ms2|MALIGNANT|LEUKOCYTE|CALCIFIED|STERNOCLAVICULAR JOINT|UNILATERAL|CAUDAL|MALDI|||SPOUSE|1|5|TREATMENT|2020-09-09|89
e|MI|12e607da-f53c-4078-9742-23a111db6f54|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|H SCORE TOTAL SCORE|[?]|[?]|cd*s/m2|[?]|1|/2000 RBC|MALIGNANT|LYSATE|SOLIDIFIED|AORTOCAVAL LYMPH NODE|BILATERAL|NASAL|WHOLE EXOME SEQUENCING|Y|Y|ADJUDICATION COMMITTEE|1|6|SCREENING|2020-12-30|98
e|MI|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|STAINING INTENSITY|[?]|[?]|ag|[?]|1|g/g/day|MALIGNANT|BILE|GELLED|SKIN OF THE UPPER LIMB|CONTRALATERAL|VENTROLATERAL|NUCLEAR RADIOLOGY||Y|CHILD|1|5|TREATMENT|2021-01-20|4
e|MI|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|THICK|Thickness|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|copies/uL|[?]|1|cmH2O/mL|BENIGN|DIALYSIS FLUID|GELLED|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LATERAL|DORSOLATERAL|PERIPHERAL ANGIOGRAPHY||Y|FAMILY MEMBER|1|3|SCREENING|2020-07-14|8
e|MI|3260122d-3bf4-45ff-a026-2379158721d0|1|CORBIOMN|Number of Malignant Biopsy Cores|H SCORE TOTAL SCORE|[?]|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|PFU/dose|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|LIVER LOBE|LATERAL|INNER|CONTRAST ENHANCED SPIRAL CT SCAN||Y|STUDY SUBJECT|1|7|SCREENING|2020-08-27|94
e|MI|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|VFBINTMT|Vascular Fibrous Intimal Thickening|CHALKLEY SCORE|[?]|[?]|PACKAGE|[?]|1|kat|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|FROZEN|MESENTERIC LYMPH NODE|LEFT|CENTRAL|CHROMATOGRAPHY|Y||DOMESTIC PARTNER|1|5|TREATMENT|2020-11-06|11
e|MI|c8390c70-766d-4252-9356-39591651bcdf|1|TISABNUM|Number of Abnormal Tissue Samples|ALLRED STAINING INTENSITY SCORE|[?]|[?]|/500 WBC|[?]|1|mEq/uL|BENIGN|DISCHARGE|CALCIFIED|METACARPOPHALANGEAL JOINT 1|IPSILATERAL|UPPER EXTENSOR SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||SIBLING|1|5|TREATMENT|2020-10-29|89
e|MI|a40bf877-c070-40b3-89df-d566b942246e|1|LYMPHINV|Lymphatic Invasion|GLEASON SECONDARY SCORE|[?]|[?]|mL|[?]|1|10^3 CFU|MALIGNANT|HAIR FOLLICLE|DRIED|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|RIGHT|BASAL|RADIOGRAPHY|||SIBLING|1|2|SCREENING|2020-08-28|83
e|MI|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|PNTHCEMP|Paneth Cell Metaplasia|RECEPTOR OVERALL STATUS|[?]|[?]|MPL U|[?]|1|gtt|BENIGN|LUNG SURFACTANT|CLOTTED|AXILLARY LYMPH NODE LEVEL I|UNILATERAL|UPPER FLEXOR SURFACE|MAMMOGRAPHY|Y||SIBLING|1|4|TREATMENT|2021-03-14|67
e|MI|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|CORBIOMN|Number of Malignant Biopsy Cores|METAVIR FIBROSIS SCORE|[?]|[?]|QUANTITY SUFFICIENT|[?]|1|dB|BENIGN|LYSATE|AUTOLYZED|RIGHT VENTRICULAR BRANCH|LATERAL|TEMPORAL|ACRIDINE ORANGE STAIN|||NON-HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-06-25|27
e|MI|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|BD2|Beta-defensin 2|EUROPEAN CONSENSUS SCORE|[?]|[?]|DDU|[?]|1|psi|MALIGNANT|MONOCYTE|HEMOLYZED|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|ANTEROTEMPORAL|SMEAR|||PARENT|1|3|TREATMENT|2020-10-08|94
e|MI|63f43990-e56e-440c-a445-76e7d114cf26|1|VFBINTMT|Vascular Fibrous Intimal Thickening|METMAB SCORE|[?]|[?]|m2|[?]|1|tuberculin unit|MALIGNANT|CERVICOVAGINAL SECRETION|CALCIFIED|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|DISTAL|OLIGO ACGH|Y||CLINICAL RESEARCH COORDINATOR|1|3|TREATMENT|2020-11-08|47
e|MI|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|PTBCPLTS|Peritubular Capillaritis|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|/10^3|[?]|1|mAmp|BENIGN|VENOUS BLOOD|NON-HEMOLYZED|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|UNILATERAL|UPPER FLEXOR SURFACE|MICROBIAL CULTURE, LIQUID|Y||INDEPENDENT ASSESSOR|1|3|TREATMENT|2020-12-30|79
e|MI|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|KI67|Ki-67|STAINING INTENSITY|[?]|[?]|mg/mol|[?]|1|10^6 organisms/mL|BENIGN|URINE|CALCIFIED|TARSAL JOINT|IPSILATERAL|PERIVENTRICULAR|SINGLE-MOLECULE ARRAY|||GUARDIAN|1|3|FOLLOW-UP|2020-12-11|16
e|MI|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|SMUSCAB|Smooth Muscle Antibody|RECEPTOR OVERALL STATUS|[?]|[?]|ELISA unit/dose|[?]|1|Enzyme U/m2|MALIGNANT|VENOUS BLOOD|SOLIDIFIED|COCCYX|LEFT|PERIVENTRICULAR|OPHTHALMOSCOPY|Y||ADJUDICATOR|1|5|WASHOUT|2020-07-14|71
e|MI|a201c78a-e826-4f42-a997-7c6a019e2c91|1|ROS1|ROS1 Protein|METMAB SCORE|[?]|[?]|uEq/L|[?]|1|10^5/L|BENIGN|VITREOUS HUMOR|AGGLUTINATED|TRIANGULAR-HAMATE JOINT|LEFT|VENTRAL|CELL BASED BIOASSAY|Y||PARENT|1|6|TREATMENT|2020-08-28|35
e|MI|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|GLEASON PRIMARY SCORE|[?]|[?]|10^12/L|[?]|1|ug/m2/day|MALIGNANT|PLATELET|ROOM TEMPERATURE|PERICARDIAL LYMPH NODE|UNILATERAL|DEEP|COLORIMETRY|Y||CLINICAL RESEARCH COORDINATOR|1|4|TREATMENT|2020-11-25|85
e|MI|7de60015-fa9d-4a39-bd19-51c718a624e6|1|INTMART|Intimal Arteritis|SCHEUER FIBROSIS SCORE|[?]|[?]|ug/kg/day|[?]|1|FINGERTIP UNIT|BENIGN|VITREOUS HUMOR|LIPEMIC|SCAPHOID-LUNATE JOINT|CONTRALATERAL|CENTRAL|THERMAL IONIZATION MASS SPECTROMETRY|Y|Y|SPOUSE|1|2|SCREENING|2020-12-21|68
e|MI|34d03f58-155a-4908-bba3-aa979be84610|1|MITOFIG|Mitotic Figure|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|uIU/dL|[?]|1|mU|MALIGNANT|ADIPOSE TISSUE|THAWED|FAT PAD|LATERAL|PROXIMAL|MAPH|||CLINICAL STUDY SPONSOR|1|7|WASHOUT|2020-07-17|28
e|MI|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|MCINTINF|Mononuc Cell Interstitial Inflammation|KNODELL FIBROSIS SCORE|[?]|[?]|mg/dL|[?]|1|IU/kg|BENIGN|CAPILLARY PLASMA|LIPEMIC|LUMBAR VERTEBRA|BILATERAL|CRANIAL|SLIT LAMP PHOTOGRAPHY|||CAREGIVER|1|1|TREATMENT|2020-08-29|16
e|MI|4191788e-b2dc-4885-87d8-da9feb6deea5|1|LCN2|Lipocalin-2|GLEASON TOTAL SUM|[?]|[?]|Pa|[?]|1|Ci/uL|MALIGNANT|ABSCESS FLUID|AGGLUTINATED|THORACIC SPINE|LEFT|UPPER EXTENSOR SURFACE|TEST STRIP|||CLINICAL RESEARCH COORDINATOR|1|6|FOLLOW-UP|2020-11-10|70
e|MI|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|PAP|Prostatic Acid Phosphatase|ALLRED TOTAL SCORE|[?]|[?]|/h|[?]|1|10^5/L|BENIGN|SERUM|REFRIGERATED|COLON WALL|LATERAL|MIDLINE|CONTRAST ENHANCED MRI|||HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2021-01-03|20
e|MI|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|EGFRVP|EGFR Variant Protein|H SCORE TOTAL SCORE|[?]|[?]|cm2|[?]|1|IU/g|BENIGN|SMOOTH MUSCLE TISSUE|FROZEN|EPICARDIUM|LEFT|SUPERIOR|CLIP|Y||CLINICAL RESEARCH ASSOCIATE|1|2|WASHOUT|2020-12-03|17
e|MI|3eceae61-a4a0-49fd-964b-9f142e0da067|1|PTEN|Phosphatase and Tensin Homolog|ISUP GLEASON GRADE GROUP|[?]|[?]|kg/cm|[?]|1|POUCH|BENIGN|ARTERIAL BLOOD|FROZEN|PHARYNX|BILATERAL|APICAL|FLOCCULATION, CHARCOAL ENHANCED|||CLINICAL RESEARCH ASSOCIATE|1|6|TREATMENT|2020-08-25|7
e|MI|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|TUBULTIS|Tubulitis|GLEASON PRIMARY SCORE|[?]|[?]|lx|[?]|1|U/cL|BENIGN|TRANSUDATE|CONCENTRATED|METACARPAL BONE 2|BILATERAL|LATERAL|TELLER ACUITY CARDS|||ADJUDICATION COMMITTEE|1|7|TREATMENT|2020-07-04|54
e|MI|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|NKX2_1|NK2 Homeobox 1|CHALKLEY SCORE|[?]|[?]|Gy|[?]|1|mg/kg/dose|BENIGN|VITREOUS HUMOR|PARAFFIN-EMBEDDED|HYPOGLOSSAL NERVE|IPSILATERAL|DISTAL|MICRONEUTRALIZATION ASSAY|Y|Y|PROXY|1|3|TREATMENT|2020-07-01|5
e|MI|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|ICAM1|Intercellular Adhesion Molecule 1|STAINING INTENSITY|[?]|[?]|mg/mL/day|[?]|1|Newton|MALIGNANT|INFRANATANT, PLEURAL FLUID|AUTOLYZED|VULVA|CONTRALATERAL|MEDIAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||SPOUSE|1|5|TREATMENT|2021-03-22|62
e|MI|1409edea-a372-4938-889b-df6ee93b8543|1|ESTRCPT|Estrogen Receptor|BAUERMEISTER SCORE|[?]|[?]|/5x10^4 WBC|[?]|1|mEq/mL|MALIGNANT|CIRCULATING TUMOR CELL|GELLED|THYROID GLAND, RIGHT LOBE|LATERAL|DORSAL|HPLC/IEX|||ADJUDICATOR|1|1|TREATMENT|2020-10-10|54
e|MI|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|PTEN|Phosphatase and Tensin Homolog|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|g/cm2|[?]|1|PA|BENIGN|INFRANATANT, PLASMA|FROZEN|BRACHIALIS MUSCLE|LEFT|LOWER|HEMAGGLUTINATION ASSAY|Y||FRIEND|1|7|WASHOUT|2020-09-13|19
e|MI|7c244128-0508-422f-88ba-ecce68cec054|1|ULCER|Ulceration|CHALKLEY SCORE|[?]|[?]|cycle/min|[?]|1|min|MALIGNANT|BONE MARROW|CLOTTED|FIRST RIGHT POSTEROLATERAL ARTERY|LATERAL|PARIETO-OCCIPITAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y|ADJUDICATOR|1|5|TREATMENT|2020-10-04|70
e|MI|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|HGFR|Hepatocyte Growth Factor Receptor|STAINING INTENSITY|[?]|[?]|mg/kg/min|[?]|1|kHz|BENIGN|BONE MARROW MONONUCLEAR CELL|CONTAMINATED|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|RIGHT|LATERAL|PERIPHERAL ANGIOGRAPHY|||CLINICAL STUDY SPONSOR|1|3|FOLLOW-UP|2021-01-10|35
e|MI|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|MMRPINTP|Mismatch Repair Proteins Interpretation|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mL/sec/1.73m2|[?]|1|uL/mL|BENIGN|HAIR FOLLICLE|HEMOLYZED|BICEPS FEMORIS MUSCLE|RIGHT|INNER|FLOW MICROSCOPY|||DOMESTIC PARTNER|1|7|TREATMENT|2020-11-06|96
e|MI|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|HGFR|Hepatocyte Growth Factor Receptor|ISHAK FIBROSIS SCORE|[?]|[?]|mEq/kg|[?]|1|amol|BENIGN|SERUM|CONCENTRATED|MITRAL VALVE, ANTERIOR CUSP|UNILATERAL|FACIAL|LYMPHANGIOGRAPHY|Y||CLINICAL STUDY SPONSOR|1|5|TREATMENT|2020-08-05|31
e|MI|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|CANCLLTY|Cancer Cellularity|EUROPEAN CONSENSUS SCORE|[?]|[?]|10^6/hpf|[?]|1|ug/dL|BENIGN|VENOUS PLASMA|CALCIFIED|STERNOCLAVICULAR JOINT|CONTRALATERAL|PROXIMAL|MALDI-TOF|||CAREGIVER|1|7|TREATMENT|2020-11-30|25
e|MI|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|MCINTINF|Mononuc Cell Interstitial Inflammation|GLEASON PRIMARY SCORE|[?]|[?]|EID 50/dose|[?]|1|ug/g/h|BENIGN|EPITHELIAL CELL|DRIED|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|RIGHT|LOWER MEDIAL|COULOMETRIC TITRATION|||ADJUDICATION COMMITTEE|1|6|FOLLOW-UP|2020-08-08|22
e|MI|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|ULCER|Ulceration|CHALKLEY SCORE|[?]|[?]|pmol|[?]|1|10^9 CFU/mL|BENIGN|BONE MARROW|DRIED|VAGINA|UNILATERAL|BASAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|Y|STUDY SUBJECT|1|4|SCREENING|2020-11-19|26
e|MI|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|MLH1|MutL Homolog 1|METMAB SCORE|[?]|[?]|AgU/mL|[?]|1|GPL U|MALIGNANT|AMNIOTIC FLUID|NON-HEMOLYZED|DUCTUS ARTERIOSUS|LEFT|MIDLINE|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||CAREGIVER|1|4|SCREENING|2020-07-25|72
e|MI|6edb7414-d8f4-44da-8483-504b93a7e705|1|ARTLRHYT|Arteriolar Hyaline Thickening|GLEASON PRIMARY SCORE|[?]|[?]|% INHIBITION|[?]|1|Tbsp|BENIGN|SERUM OR PLASMA OR BLOOD|AGGLUTINATED|AXILLARY LYMPH NODE LEVEL I|BILATERAL|INNER|COMPLEMENT FIXATION|Y||CHILD|1|2|FOLLOW-UP|2020-08-16|80
e|MI|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|EGFRVP|EGFR Variant Protein|GLEASON PRIMARY SCORE|[?]|[?]|g/mol|[?]|1|V/sec|BENIGN|SUPERNATANT, SERUM OR PLASMA|FRESH|SECOND OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|FORE|CLIP SEQUENCING||Y|SPOUSE|1|6|FOLLOW-UP|2020-07-23|78
e|MI|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|PTBCPLTS|Peritubular Capillaritis|PERCENT POSITIVE CELL|[?]|[?]|mL/min|[?]|1|log10 CFU/mL|BENIGN|PERSPIRATION|FRESH|FUNDUS UTERI|LATERAL|TIP|AMSLER GRID||Y|NON-HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2020-08-05|89
e|MI|47d55e87-e559-424d-a6ad-d533a0d77f39|1|PNLINV|Perineural Invasion|GLEASON SECONDARY SCORE|[?]|[?]|10^8/L|[?]|1|DPM|MALIGNANT|URINE SEDIMENT|DRIED|SCAPHOID-RADIUS JOINT|RIGHT|VENTROLATERAL|ISHIHARA COLOR PLATES|||INVESTIGATOR|1|2|TREATMENT|2021-02-07|36
e|MI|f89c08df-2e24-4c97-a451-1980cecebf14|1|CDX2AG|CDX2 Antigen|METMAB SCORE|[?]|[?]|tsp eq|[?]|1|CUP|MALIGNANT|WHITE MATTER TISSUE|CALCIFIED|MIDBRAIN|BILATERAL|LOWER MEDIAL|MICRODENSITOMETRY|||INDEPENDENT ASSESSOR|1|4|TREATMENT|2021-01-18|41
e|MI|dbb225ed-e322-4946-a60a-0fafd7e22953|1|GZMB|Granzyme B|SCHEUER FIBROSIS SCORE|[?]|[?]|OI50|[?]|1|SYRINGE|BENIGN|BLOOD|ICTERIC|SOLEUS MUSCLE|IPSILATERAL|FACIAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|Y|PROXY|1|6|TREATMENT|2021-04-23|99
e|MI|95e61698-43f7-4cc5-aafa-06dac7870743|1|SMUSCAB|Smooth Muscle Antibody|TUMOR PROPORTION SCORE|[?]|[?]|/day|[?]|1|ECL unit|BENIGN|CAPILLARY PLASMA|REFRIGERATED|OLFACTORY MUCOSA|LEFT|VENTROLATERAL|INCISION-INDUCED BLEEDING METHOD|||PARENT|1|7|SCREENING|2021-02-08|55
e|MI|151308c7-03aa-4a0b-b13f-9838edb218ef|1|PTEN|Phosphatase and Tensin Homolog|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|VIRTUAL PIXEL|[?]|1|POINT|MALIGNANT|PROSTATIC FLUID|AGGLUTINATED|HEPATIC VEIN|BILATERAL|LOWER EXTENSOR SURFACE|GIEMSA STAIN|Y||GUARDIAN|1|2|WASHOUT|2020-10-10|37
e|MI|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|BDKRB1|Bradykinin Receptor B1|BAUERMEISTER SCORE|[?]|[?]|mmAL|[?]|1|g/mol|BENIGN|VENOUS PLASMA|REFRIGERATED|SUPRATENTORIAL BRAIN|BILATERAL|LOWER|POLYSOMNOGRAPHY|||DOMESTIC PARTNER|1|5|FOLLOW-UP|2020-07-26|51
e|MI|23605586-1b30-4f05-bb15-417dd3a79994|1|TUMCECE|Tumor Cells/Total Cells|H SCORE TOTAL SCORE|[?]|[?]|10^7 CFU/mL|[?]|1|mg/animal|BENIGN|TISSUE|ICTERIC|PYRAMIDAL TRACTS, BRAINSTEM|IPSILATERAL|BASAL|FLUOROSCOPY|||ADJUDICATOR|1|3|TREATMENT|2020-10-27|6
e|MI|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ISHAK FIBROSIS SCORE|[?]|[?]|vg/dose|[?]|1|mEq/L|BENIGN|FLUID|REFRIGERATED|SHOULDER|LATERAL|SUPERFICIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y|CLINICAL RESEARCH ASSOCIATE|1|7|WASHOUT|2020-09-07|20
e|MI|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|BLDVESD|Blood Vessel Density|STAINING INTENSITY|[?]|[?]|10^6 organisms/mL|[?]|1|cd/m2|MALIGNANT|SOFT TISSUE|SOLIDIFIED|BASILIC VEIN|UNILATERAL|ANTEROMEDIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||INVESTIGATOR|1|7|FOLLOW-UP|2020-09-16|45
e|MI|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|LCN2|Lipocalin-2|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^3 CFU/g|[?]|1|mAmp|MALIGNANT|ABSCESS FLUID|UNEXPECTED ODOR|HEART, RIGHT ATRIAL APPENDAGE|CONTRALATERAL|PROXIMAL VOLAR|TELLER ACUITY CARDS|||ADJUDICATOR|1|3|TREATMENT|2020-10-17|57
e|MI|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|MCINTINF|Mononuc Cell Interstitial Inflammation|H SCORE TOTAL SCORE|[?]|[?]|g/m2/day|[?]|1|kV|MALIGNANT|STRIATED MUSCLE TISSUE|DRIED|SUPERFICIAL FEMORAL ARTERY|LATERAL|ANTEROMEDIAL|KINETIC CHROMOGENIC ASSAY|Y|Y|STUDY SUBJECT|1|3|TREATMENT|2020-12-27|13
e|MI|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|EGFRVP|EGFR Variant Protein|CHALKLEY SCORE|[?]|[?]|PFU/animal|[?]|1|cmol/L|BENIGN|FLUID|ROOM TEMPERATURE|C7 VERTEBRA|IPSILATERAL|VENTROLATERAL|TOTAL BODY IRRADIATION|Y||FAMILY MEMBER|1|1|TREATMENT|2020-07-04|12
e|MI|81f62132-123e-4888-abbe-8e289599e965|1|IENFDEN|Intraepidermal Nerve Fiber Density|PERCENT POSITIVE CELL|[?]|[?]|hPa|[?]|1|10^7 CFU/mL|MALIGNANT|WHITE MATTER TISSUE|GELLED|AXIAL SKELETON|IPSILATERAL|ANTERIOR|ETDRS EYE CHART||Y|DOMESTIC PARTNER|1|7|SCREENING|2021-01-20|57
e|MI|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|BDKRB1|Bradykinin Receptor B1|TUMOR PROPORTION SCORE|[?]|[?]|/200 HPFs|[?]|1|mmol/L|BENIGN|EXPIRED AIR|GELLED|POSTERIOR POLE OF THE EYE|CONTRALATERAL|APICAL|NEXT GENERATION TARGETED SEQUENCING|||INDEPENDENT ASSESSOR|1|4|WASHOUT|2020-06-27|52
e|MI|49282406-97ec-4108-adf9-e01c18ce59c6|1|SGMGSTAT|Surgical Margins Status|ALLRED STAINING INTENSITY SCORE|[?]|[?]|Tbsp|[?]|1|mmHg|BENIGN|LOCHIA|REFRIGERATED|EXTERNAL ILIAC ARTERY|IPSILATERAL|PROXIMAL VOLAR|MULTIPLE BREATH WASHOUT|||INDEPENDENT ASSESSOR|1|3|WASHOUT|2020-05-10|3
e|MI|310936c8-7d24-4eea-9892-1cd8bb675421|1|CDX2AG|CDX2 Antigen|GLEASON PRIMARY SCORE|[?]|[?]|%(w/w)|[?]|1|mg/m2/h|BENIGN|SUPERNATANT, PLASMA|CALCIFIED|SUBCARINAL LYMPH NODE|UNILATERAL|FORE|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||HEALTH CARE PROFESSIONAL|1|3|WASHOUT|2020-08-30|65
e|MI|034e303b-5675-4188-bcea-fc2e53b155d6|1|PTBCPLTS|Peritubular Capillaritis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mU/L|[?]|1|PUFF|MALIGNANT|CERVICOVAGINAL SECRETION|LACTESCENT|HEAD AND NECK|LATERAL|FRONTAL|LANDOLT RING|||SIBLING|1|2|TREATMENT|2020-06-11|20
e|MI|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|ESTRCPT|Estrogen Receptor|METMAB SCORE|[?]|[?]|/cmH2O|[?]|1|Pack Year|BENIGN|HAIR FOLLICLE|FROZEN|HEART, LEFT ATRIAL APPENDAGE|IPSILATERAL|FORE|ECHOCARDIOGRAPHY|||SPOUSE|1|5|FOLLOW-UP|2020-07-11|14
e|MI|c912affb-cbc2-4919-81b4-ecaa03908261|1|TISABNUM|Number of Abnormal Tissue Samples|AJCC TUMOR GRADE|[?]|[?]|dram|[?]|1|cpm|BENIGN|REFLEX TEAR|THAWED|DISTAL EXTRAHEPATIC BILE DUCT REGION|LEFT|DORSAL|HPLC/MS/MS|||DOMESTIC PARTNER|1|3|FOLLOW-UP|2020-07-11|9
e|MI|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|HGFR|Hepatocyte Growth Factor Receptor|BAUERMEISTER SCORE|[?]|[?]|mL/s/m2|[?]|1|copies/uL|MALIGNANT|VENOUS BLOOD|CALCIFIED|INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|SUBCORTICAL|CONTRAST ENHANCED SPIRAL CT SCAN|||GUARDIAN|1|4|TREATMENT|2020-08-18|53
e|MI|dcefd656-a59a-4b71-9260-efcbcecd2132|1|KI67|Ki-67|GLEASON TOTAL SUM|[?]|[?]|cs|[?]|1|mN|MALIGNANT|MUSCLE TISSUE|ROOM TEMPERATURE|PALPEBRAL CONJUNCTIVA|RIGHT|TIP|FLUORESCENT SPOT TEST||Y|NON-HEALTH CARE PROFESSIONAL|1|3|SCREENING|2020-08-28|95
e|MI|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|CANCLLTY|Cancer Cellularity|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|pt_br|[?]|1|min/day|MALIGNANT|HAIR|ROOM TEMPERATURE|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|OCCIPITAL|HPLC-FL|||ADJUDICATOR|1|6|TREATMENT|2021-01-26|45
e|MI|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|ROS1|ROS1 Protein|METMAB SCORE|[?]|[?]|Log10 ELISA unit|[?]|1|mg/h|MALIGNANT|CEREBROSPINAL FLUID|FRESH|SACROILIAC JOINT|RIGHT|POSTERIOR|HEMATOXYLIN AND EOSIN STAIN|Y||CHILD|1|6|TREATMENT|2020-10-20|36
e|MI|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|S100A7|S100 Calcium Binding Protein A7|CHALKLEY SCORE|[?]|[?]|PACK|[?]|1|mg/kg/day|MALIGNANT|PLEURAL TISSUE|GELLED|PARASPINAL REGION|RIGHT|PROXIMAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||HEALTH CARE PROFESSIONAL|1|7|FOLLOW-UP|2021-01-22|93
e|MI|46304edd-0b05-4819-8fcb-35cf9c02764d|1|TMCE|Tumor Cells|GLEASON SECONDARY SCORE|[?]|[?]|FINGERTIP UNIT|[?]|1|nmol BCE/L|BENIGN|CALCULUS|UNEXPECTED ODOR|AORTO-ILIAC PERIPHERAL ARTERY|IPSILATERAL|LOWER FLEXOR SURFACE|CINEANGIOGRAPHY||Y|PARENT|1|6|FOLLOW-UP|2021-01-31|69
e|MI|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|MITOFIG|Mitotic Figure|RECEPTOR OVERALL STATUS|[?]|[?]|PLUG|[?]|1|log10 CFU/mL|MALIGNANT|REFLEX TEAR|CLOTTED|VULVA|RIGHT|MEDIAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y||STUDY SUBJECT|1|4|WASHOUT|2020-05-19|3
e|MI|daa3b89e-637a-43de-86c1-d0db93f00430|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|SCHEUER FIBROSIS SCORE|[?]|[?]|U/kg/day|[?]|1|cP|BENIGN|BREAST MILK|PARAFFIN-EMBEDDED|CAUDAL VERTEBRA|LEFT|LOWER MEDIAL|CLIP SEQUENCING|||CHILD|1|6|FOLLOW-UP|2020-11-25|55
e|MI|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|TUBATRO|Tubular Atrophy|ISHAK FIBROSIS SCORE|[?]|[?]|GBq|[?]|1|deg2|BENIGN|NAIL|UNEXPECTED ODOR|SMALL INTESTINE|LEFT|LOWER EXTENSOR SURFACE|QUANTITATIVE ULTRASOUND|||FRIEND|1|4|WASHOUT|2020-09-19|87
e|MI|c22014f2-2d7b-4897-8ad5-e46785e51837|1|STRMCECE|Stromal Cells/Total Cells|ALLRED STAINING INTENSITY SCORE|[?]|[?]|dram|[?]|1|/10^3|BENIGN|CORD BLOOD|CALCIFIED|POSTERIOR CINGULATE CORTEX|CONTRALATERAL|OCCIPITAL|PH METER MEASUREMENT METHOD|||INTERVIEWER|1|6|FOLLOW-UP|2020-08-25|22
e|MI|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|KI67|Ki-67|METMAB SCORE|[?]|[?]|gtt|[?]|1|PACK|BENIGN|ARTERIAL CORD BLOOD|ROOM TEMPERATURE|T2 VERTEBRA|BILATERAL|MIDLINE|MECHANICAL CLOT DETECTION||Y|SPOUSE|1|6|FOLLOW-UP|2020-10-29|28
e|MI|24ce0c77-1921-4b87-91da-3627e2afd399|1|MSNGMTRX|Mesangial Matrix|ISHAK FIBROSIS SCORE|[?]|[?]|uV2|[?]|1|ug/m2/min|BENIGN|SKELETAL MUSCLE TISSUE|DRIED|METACARPAL BONE 3|LEFT|DORSOLATERAL|FISH|||FRIEND|1|3|TREATMENT|2021-04-06|77
e|MI|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|PNLINV|Perineural Invasion|ALLRED TOTAL SCORE|[?]|[?]|mL/100g/min|[?]|1|% INHIBITION|BENIGN|SPUTUM|PARAFFIN-EMBEDDED|NASAL BONE|RIGHT|VOLAR|IMMUNODIFFUSION|||CLINICAL STUDY SPONSOR|1|5|FOLLOW-UP|2020-09-18|39
e|MI|f4b83a72-7cde-4e02-8883-05e789c617a8|1|MIEXAM|Microscopic Examination|RECEPTOR OVERALL STATUS|[?]|[?]|mL/cm|[?]|1|Gy/min|BENIGN|DISCHARGE|AGGLUTINATED|VAGINAL WALL|LEFT|HIND|CALCULATION||Y|INVESTIGATOR|1|5|WASHOUT|2021-03-14|89
e|MI|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|MMRPINTP|Mismatch Repair Proteins Interpretation|AJCC TUMOR GRADE|[?]|[?]|nkat|[?]|1|TRACE|MALIGNANT|GASTRIC CONTENTS|CONCENTRATED|COLON, DESCENDING|RIGHT|PROXIMAL|CORONARY ANGIOGRAPHY|||CHILD|1|4|FOLLOW-UP|2021-03-25|85
e|MI|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|VASINV|Vascular Invasion|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|g/animal/day|[?]|1|ug/cm2|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|PERONEAL ARTERY|IPSILATERAL|TIP|CONGO RED STAIN|Y||SPOUSE|1|5|FOLLOW-UP|2020-11-23|27
e|MI|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|HISTTYPC|Histologic Type of Cancer|TUMOR PROPORTION SCORE|[?]|[?]|anti-Xa IU/mL|[?]|1|mEq/uL|BENIGN|CAPILLARY BLOOD|CLOTTED|KIDNEY, CORTEX|BILATERAL|NASAL|REFRACTOMETRY|Y|Y|INDEPENDENT ASSESSOR|1|3|TREATMENT|2020-09-04|34
e|MI|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|SMUSCAB|Smooth Muscle Antibody|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Torr|[?]|1|lm|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|ENDOCARDIUM|UNILATERAL|FORE|GEL ELECTROPHORESIS|Y||VENDOR|1|4|WASHOUT|2021-01-04|95
e|MI|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|CY16|Cytokeratin 16|AJCC TUMOR GRADE|[?]|[?]|Pa|[?]|1|scm|BENIGN|CELL PELLET|CONCENTRATED|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|CAUDAL|DIGITAL PCR ARRAY|||CLINICAL STUDY SPONSOR|1|5|WASHOUT|2020-07-14|20
e|MI|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|INTSFBRO|Interstitial Fibrosis|GLEASON PRIMARY SCORE|[?]|[?]|msec|[?]|1|log EID 50/dose|BENIGN|BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|PERIUMBILICAL REGION|CONTRALATERAL|SUPERIOR|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y|ADJUDICATION COMMITTEE|1|6|TREATMENT|2020-11-08|56
e|MI|f845101e-c057-4f84-94b3-6043afb42ac7|1|FIBROSIS|Fibrosis|STAINING INTENSITY|[?]|[?]|gMFI|[?]|1|pg/L|BENIGN|LYSATE|CLOTTED|EPIDURAL SPACE|LEFT|APICAL|ENZYMATIC SPECTROPHOTOMETRY|||SPOUSE|1|3|TREATMENT|2020-12-04|48
e|MI|4ddb2076-6837-4028-81bc-3e8057475977|1|ABNCE|Abnormal Cells|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|pg/L|[?]|1|g/g|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|SKIN OF THE NECK|LEFT|VOLAR|IMMUNOBLOT||Y|INDEPENDENT ASSESSOR|1|3|FOLLOW-UP|2021-02-15|60
e|MI|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|CD8|CD8|METAVIR FIBROSIS SCORE|[?]|[?]|Ci|[?]|1|dpm/mg|BENIGN|ATHEROSCLEROTIC PLAQUE|ICTERIC|COLON, SIGMOID|IPSILATERAL|CAUDAL|IMMUNOBLOT|||CLINICAL STUDY SPONSOR|1|3|TREATMENT|2021-03-16|84
e|MI|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|TUBATRO|Tubular Atrophy|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|mL/min|[?]|1|Absorbance U/mL|MALIGNANT|PLEURAL FLUID|CLOTTED|EYELID|RIGHT|MIDLINE|CINEANGIOGRAPHY||Y|NON-HEALTH CARE PROFESSIONAL|1|3|WASHOUT|2021-03-04|75
e|MI|024a9f6d-4ff1-4673-8617-3790f831fce7|1|EPITHINT|Epithelial Integrity|PERCENT POSITIVE CELL|[?]|[?]|PHERESIS UNIT|[?]|1|/500 WBC|MALIGNANT|PLEURAL FLUID|NON-HEMOLYZED|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|PERIPHERAL|INTERRUPTER TECHNIQUE|Y||INDEPENDENT ASSESSOR|1|4|SCREENING|2020-09-10|99
e|MI|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|TRCETMCE|Transitional Cells/Tumor Cells|AJCC TUMOR GRADE|[?]|[?]|cGy|[?]|1|PATCH|BENIGN|CARDIAC MUSCLE TISSUE|CLOTTED|DORSAL MOTOR NUCLEUS|IPSILATERAL|ANTEROPOSTERIOR|FLUORESCENT MICROSCOPY|Y|Y|CHILD|1|5|TREATMENT|2020-12-16|38
e|MI|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|CD3|CD3|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|log10 IU/mL|[?]|1|/10^5|MALIGNANT|URINE|LIPEMIC|HAND DIGIT 5|LATERAL|BASAL|CAPILLARY ELECTROPHORESIS|||PROXY|1|4|TREATMENT|2021-02-08|99
e|MI|95c4465b-162a-433d-83c9-6d67dd729c9e|1|PCTISCA|Percentage of In situ Carcinoma|TUMOR PROPORTION SCORE|[?]|[?]|Watt|[?]|1|uCi/kg|BENIGN|ARTERIAL BLOOD|SOLIDIFIED|RENAL FOSSA|RIGHT|VOLAR|ELECTROMYOGRAPHY|||CLINICAL RESEARCH COORDINATOR|1|6|FOLLOW-UP|2020-10-22|10
e|MI|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|SGMGSTAT|Surgical Margins Status|ISHAK FIBROSIS SCORE|[?]|[?]|fmol|[?]|1|GBq/ug|BENIGN|SMOOTH MUSCLE TISSUE|NON-HEMOLYZED|INTERPHALANGEAL JOINT 2 OF THE HAND|RIGHT|LOWER EXTENSOR SURFACE|SCINTIGRAPHY|Y||FRIEND|1|2|TREATMENT|2020-07-09|22
e|MI|beb6b1ab-1264-456a-bf2b-81e28493301d|1|PCTISCA|Percentage of In situ Carcinoma|TUMOR PROPORTION SCORE|[?]|[?]|GPL U/mL|[?]|1|anti-Xa IU|MALIGNANT|BREAST MILK|NON-HEMOLYZED|FACE|CONTRALATERAL|HIND|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y|FRIEND|1|7|FOLLOW-UP|2020-08-01|62
e|MI|4292c06d-044e-4dff-aea0-830178a6e220|1|GZMB|Granzyme B|METMAB SCORE|[?]|[?]|/7.5 mL|[?]|1|mPa|MALIGNANT|EMESIS|LACTESCENT|CORPUS LUTEUM|CONTRALATERAL|CRANIAL|HANSEL STAIN||Y|CLINICAL STUDY SPONSOR|1|6|WASHOUT|2020-12-29|37
e|MI|050c12d2-cf9f-402b-9332-d6a9771ed115|1|BDKRB1|Bradykinin Receptor B1|ISHAK FIBROSIS SCORE|[?]|[?]|ug/day|[?]|1|cm/min|BENIGN|SERUM OR PLASMA|PARAFFIN-EMBEDDED|PULMONARY ARTERY BRANCH|IPSILATERAL|DISTAL VOLAR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|VENDOR|1|2|TREATMENT|2020-09-24|47
e|MI|2f1073e4-607f-423f-a5de-f531b828e2d3|1|SMUSCAB|Smooth Muscle Antibody|BAUERMEISTER SCORE|[?]|[?]|U/m2/min|[?]|1|EU|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|VOLAR|TRIPLE-PHASE MRI SCAN|||STUDY SUBJECT|1|6|SCREENING|2020-12-20|76
e|MI|df466903-3212-4e73-bff0-a183447c7408|1|LCN2|Lipocalin-2|RECEPTOR OVERALL STATUS|[?]|[?]|pmol/g|[?]|1|mL/sec/1.73m2|MALIGNANT|BILE|ICTERIC|HIP ADDUCTORS|BILATERAL|DISTAL VOLAR|CONTRAST ENHANCED MRI|||ADJUDICATION COMMITTEE|1|2|TREATMENT|2020-12-28|67
e|MI|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|TMCE|Tumor Cells|ISUP GLEASON GRADE GROUP|[?]|[?]|mL/sec/1.73m2|[?]|1|mL/mmHg|BENIGN|BILE|AUTOLYZED|NAIL BED|UNILATERAL|ANTERIOR|PHOROPTER|Y||DOMESTIC PARTNER|1|7|SCREENING|2020-09-24|83
e|MI|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|PTBCPLTS|Peritubular Capillaritis|ISHAK FIBROSIS SCORE|[?]|[?]|cP|[?]|1|PIXELS/in|MALIGNANT|PLASMA ULTRAFILTRATE|FRESH|BODY OF STOMACH|IPSILATERAL|SUPERIOR|AURAMINE STAIN|||FAMILY MEMBER|1|5|TREATMENT|2020-08-21|30
e|MI|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|ALK|ALK Protein|METMAB SCORE|[?]|[?]|h*%|[?]|1|APPLICATION|BENIGN|PROSTATIC FLUID|HEMOLYZED|FIBULAR VEIN|LATERAL|ANTEROLATERAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y||GUARDIAN|1|3|TREATMENT|2020-06-07|35
e|MI|cec9e0ce-4d09-470c-9c26-df661d316a69|1|PTEN|Phosphatase and Tensin Homolog|METMAB SCORE|[?]|[?]|PIXEL|[?]|1|mL*cmH2O|MALIGNANT|EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|CEREBELLUM|LATERAL|TEMPORAL|ERGOSPIROMETRY|||SPOUSE|1|7|SCREENING|2021-03-29|93
e|MI|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|KNODELL FIBROSIS SCORE|[?]|[?]|mg/kg/week|[?]|1|Ci/uL|MALIGNANT|PLASMA ULTRAFILTRATE|CONTAMINATED|LOWER RESPIRATORY SYSTEM|RIGHT|DORSAL|HPLC/MS||Y|CHILD|1|1|WASHOUT|2021-02-28|52
e|MI|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|PERCENT POSITIVE CELL|[?]|[?]|Newton|[?]|1|min*mg/mL|BENIGN|SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|LEFT POSTERIOR DESCENDING ARTERY|LEFT|PROXIMAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|||CHILD|1|4|TREATMENT|2020-08-31|65
e|MI|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|GLOMPATH|Glomerulopathy|RECEPTOR OVERALL STATUS|[?]|[?]|PFU/mL|[?]|1|Log10 ELISA unit/dose|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|BODY|CONTRALATERAL|ANTEROMEDIAL|STATIC PERIMETRY|||STUDY SUBJECT|1|2|WASHOUT|2020-09-19|79
e|MI|7ff27a70-0472-4cc1-b057-6b161ab29568|1|CD4|CD4|EUROPEAN CONSENSUS SCORE|[?]|[?]|vp/mL|[?]|1|scm|MALIGNANT|ADIPOSE TISSUE|REFRIGERATED|HEART, LEFT VENTRICULAR WALL|UNILATERAL|LOWER|SEQUENCING|||CLINICAL RESEARCH ASSOCIATE|1|3|TREATMENT|2021-01-14|66
e|MI|40529b01-9a80-4ada-a8df-96eec0e65043|1|FOXP3|Forkhead Box Protein 3|RECEPTOR OVERALL STATUS|[?]|[?]|MBq|[?]|1|mL/kg/h|BENIGN|MUSCLE TISSUE|CONCENTRATED|VULVA|CONTRALATERAL|MEDIAL|NUCLEIC ACID HYBRIDIZATION|||ADJUDICATOR|1|6|FOLLOW-UP|2020-08-20|74
e|MI|f3e22efc-0948-4c6e-9173-8e284d342d33|1|TUBATRO|Tubular Atrophy|METAVIR FIBROSIS SCORE|[?]|[?]|ft3|[?]|1|FEU|MALIGNANT|BONE|THAWED|INFRATENTORIAL BRAIN|LEFT|PROXIMAL VOLAR|MICROBIAL CULTURE, SOLID|||SPOUSE|1|2|FOLLOW-UP|2021-01-05|40
e|MI|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|ALLRED STAINING INTENSITY SCORE|[?]|[?]|Pa|[?]|1|DISK|MALIGNANT|LUNG SURFACTANT|ROOM TEMPERATURE|EPICARDIUM|LATERAL|LOWER EXTENSOR SURFACE|NO INFORMATION|Y||CHILD|1|4|TREATMENT|2020-10-14|23
e|MI|f918d6e0-6fc2-4303-b323-521c5d531773|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|ECL unit|[?]|1|10^7 CFU|MALIGNANT|ARTERIAL BLOOD|THAWED|INFERIOR VENA CAVA|RIGHT|ANTEROPOSTERIOR|MANUAL COUNT|Y||VENDOR|1|2|TREATMENT|2020-09-04|45
e|MI|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|NKX2_1|NK2 Homeobox 1|H SCORE TOTAL SCORE|[?]|[?]|uIU/L|[?]|1|mL/mmHg|MALIGNANT|PLASMA ULTRAFILTRATE|SOLIDIFIED|SKIN OF THE CHIN|BILATERAL|UPPER FLEXOR SURFACE|FLOW CYTOMETRY|Y||STUDY SUBJECT|1|2|TREATMENT|2020-12-09|25
e|MI|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|CANCLLTY|Cancer Cellularity|AJCC TUMOR GRADE|[?]|[?]|10^5/hpf|[?]|1|U/m2|MALIGNANT|ARTERIAL CORD BLOOD|LIPEMIC|FLEXOR CARPI RADIALIS MUSCLE|LATERAL|SUPERIOR|MASS SPECTROMETRY|||GUARDIAN|1|2|TREATMENT|2020-08-20|70
e|MI|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|PAX3FKHR|PAX3-FKHR Fusion Protein|METAVIR FIBROSIS SCORE|[?]|[?]|10^9/dose|[?]|1|/sec|MALIGNANT|PLEURAL TISSUE|SOLIDIFIED|WRIST JOINT EXTENSOR MUSCLES|BILATERAL|CAUDAL|INTRAVASCULAR ULTRASOUND|||STUDY SUBJECT|1|6|SCREENING|2020-10-01|84
e|MI|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|TMCE|Tumor Cells|GLEASON PRIMARY SCORE|[?]|[?]|uV|[?]|1|IU/mL|BENIGN|SEMEN|THAWED|PREAURICULAR LYMPH NODE|BILATERAL|NASAL|VENTILATION PERFUSION LUNG SCAN||Y|STUDY SUBJECT|1|7|TREATMENT|2021-01-02|46
e|MI|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|BLDVESD|Blood Vessel Density|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/L|[?]|1|mmol/min/kPa/L|MALIGNANT|REFLEX TEAR|CONTAMINATED|URETHRAL SPHINCTER|BILATERAL|BASAL|INTRAVASCULAR ULTRASOUND|||PARENT|1|4|WASHOUT|2020-12-17|18
e|MI|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|PNLINV|Perineural Invasion|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Bq/ug|[?]|1|/500 WBC|MALIGNANT|BILE|LACTESCENT|SCROTUM|IPSILATERAL|BASAL|POLYMERASE CHAIN REACTION||Y|CLINICAL STUDY SPONSOR|1|3|SCREENING|2020-09-17|83
e|MI|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|CD8|CD8|CHALKLEY SCORE|[?]|[?]|Gauss|[?]|1|mg/kg/min|MALIGNANT|LUNG SURFACTANT|ROOM TEMPERATURE|C6 VERTEBRA|UNILATERAL|POSTERIOR|HIGH RESOLUTION MELT ANALYSIS|||DOMESTIC PARTNER|1|3|TREATMENT|2021-02-26|85
e|MI|324a2c67-4802-4806-aff2-04fb9c7394d4|1|CD8|CD8|TUMOR PROPORTION SCORE|[?]|[?]|pmol/L|[?]|1|Watt|BENIGN|MECONIUM|ICTERIC|FACE|LEFT|ANTERIOR|INTERRUPTER TECHNIQUE||Y|ADJUDICATION COMMITTEE|1|7|TREATMENT|2020-08-16|91
e|MI|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|ESTRCPT|Estrogen Receptor|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|pm|[?]|1|CFU/g|MALIGNANT|CIRCULATING TUMOR CELL|REFRIGERATED|COLON|IPSILATERAL|PERIPHERAL|PYROSEQUENCING|||DOMESTIC PARTNER|1|7|WASHOUT|2021-02-03|56
e|MI|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|CY16|Cytokeratin 16|GLEASON TOTAL SUM|[?]|[?]|VIAL|[?]|1|oz|MALIGNANT|VENOUS BLOOD|ROOM TEMPERATURE|URETERIC ORIFICE|LATERAL|SUBCORTICAL|FLOW MICROSCOPY|||STUDY SUBJECT|1|1|SCREENING|2020-09-03|20
e|MI|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|PROGESTR|Progesterone Receptor|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|TABLET|[?]|1|g/L|BENIGN|SEMEN|LIPEMIC|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|FORE|SPIRAL CT|||CHILD|1|2|SCREENING|2021-02-10|81
e|MI|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|EGFR|Epidermal Growth Factor Receptor|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|/100 WBC|[?]|1|/wk|BENIGN|DIALYSIS FLUID, PERITONEAL|THAWED|OLECRANON|IPSILATERAL|LOWER EXTENSOR SURFACE|ELECTRONEUROGRAPHY|Y||PROXY|1|5|TREATMENT|2021-02-11|88
e|MI|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|CY16|Cytokeratin 16|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|RNA copies/mL|[?]|1|mg/cm2|BENIGN|DIALYSIS FLUID|SOLIDIFIED|FINGER FLEXOR MUSCLES|CONTRALATERAL|DEEP|PET/MRI SCAN|||CLINICAL RESEARCH COORDINATOR|1|5|TREATMENT|2020-10-04|60
e|MI|7eb97152-173c-4923-8604-5dad3140cc25|1|CD3|CD3|KNODELL FIBROSIS SCORE|[?]|[?]|BAR|[?]|1|ECL unit|BENIGN|SUPERNATANT, PLASMA|FROZEN|TRICUSPID VALVE ANNULUS|LEFT|PROXIMAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||Y|SPOUSE|1|6|WASHOUT|2020-10-19|54
e|MI|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|BD2|Beta-defensin 2|GLEASON PRIMARY SCORE|[?]|[?]|ug/m2/day|[?]|1|CFU/g|BENIGN|INFRANATANT, PLASMA|FRESH|TRIGEMINAL NERVE|UNILATERAL|FRONTAL|DOUBLE IMMUNODIFFUSION|||INDEPENDENT ASSESSOR|1|7|WASHOUT|2020-09-01|34
e|MI|96f68979-6869-403b-a8bd-78c8f965f98a|1|TRCETMCE|Transitional Cells/Tumor Cells|TUMOR PROPORTION SCORE|[?]|[?]|cGy|[?]|1|IU/g Hb|MALIGNANT|VENOUS BLOOD|ICTERIC|ANTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|SUPERIOR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||ADJUDICATOR|1|5|SCREENING|2020-07-07|52
e|MI|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|ABNCE|Abnormal Cells|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Tbsp|[?]|1|/mm2|MALIGNANT|INFRANATANT, SERUM|ICTERIC|MIDDLE EAR|LEFT|SUPERIOR|LIGHT MICROSCOPY|Y|Y|DOMESTIC PARTNER|1|7|TREATMENT|2020-12-30|85
e|MI|d62dc655-8865-4592-af0b-744524d9a24c|1|CRYPARCD|Crypt Architectural Damage|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|DRINK|[?]|1|10^3 copies/mL|MALIGNANT|CARDIAC MUSCLE TISSUE|GELLED|THYROID GLAND, RIGHT LOBE|LATERAL|VENTRAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||NON-HEALTH CARE PROFESSIONAL|1|7|WASHOUT|2020-10-27|38
e|MI|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|PNLINV|Perineural Invasion|CHALKLEY SCORE|[?]|[?]|cup eq|[?]|1|mOsm/kg|BENIGN|ALVEOLAR AIR|ICTERIC|BICEPS BRACHII MUSCLE|CONTRALATERAL|ANTEROMEDIAL|MAGNETIC RESONANCE ELASTOGRAPHY|||FRIEND|1|6|TREATMENT|2021-03-30|91
e|MI|8005bd56-3bd6-477a-a466-b9a3bd189770|1|CRYPARCD|Crypt Architectural Damage|H SCORE TOTAL SCORE|[?]|[?]|rpm|[?]|1|cL|BENIGN|RETICULOCYTES|REFRIGERATED|AMYGDALA|LEFT|DORSAL|THICK SMEAR||Y|ADJUDICATION COMMITTEE|1|2|TREATMENT|2021-02-10|59
e|MI|078ea33d-4114-4320-9116-740b8385a94e|1|MSH2|MutS Homolog 2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mU|[?]|1|ug/kg/min|MALIGNANT|CORD SERUM|DRIED|SOFT PALATE|LATERAL|ANTEROTEMPORAL|SEQUENCING|||FAMILY MEMBER|1|3|WASHOUT|2020-10-14|90
e|MI|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|CORBIOMN|Number of Malignant Biopsy Cores|ALLRED STAINING INTENSITY SCORE|[?]|[?]|U/10^12 RBC|[?]|1|IU/dL|MALIGNANT|SERUM|CALCIFIED|NERVE|BILATERAL|UPPER FLEXOR SURFACE|SEQUENCING||Y|SIBLING|1|7|SCREENING|2020-08-11|79
e|MI|c5f292ad-1729-402b-820f-83ecd29ba00d|1|PNLINV|Perineural Invasion|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mL/h|[?]|1|uIU/dL|MALIGNANT|INFRANATANT, PLEURAL FLUID|CLOTTED|NASOPHARYNX|CONTRALATERAL|MIDLINE|BIOPSY||Y|CLINICAL STUDY SPONSOR|1|7|WASHOUT|2020-07-16|48
e|MI|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|CRYPARCD|Crypt Architectural Damage|ISHAK FIBROSIS SCORE|[?]|[?]|/200 HPFs|[?]|1|mmol/s|BENIGN|LEUKOCYTE|ICTERIC|PATELLA|IPSILATERAL|PERIPHERAL|FORCED OSCILLATION TECHNIQUE|Y|Y|CLINICAL STUDY SPONSOR|1|2|TREATMENT|2020-08-27|71
e|MI|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|NORMCECE|Normal Cells/Total Cells|TUMOR PROPORTION SCORE|[?]|[?]|/kg|[?]|1|WAFER|MALIGNANT|REFLEX TEAR|CLOTTED|LIVER LOBE|UNILATERAL|UPPER|DOUBLE IMMUNODIFFUSION|||INVESTIGATOR|1|7|WASHOUT|2020-11-11|57
e|MI|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|PAP|Prostatic Acid Phosphatase|METAVIR FIBROSIS SCORE|[?]|[?]|/HPF|[?]|1|%/s|BENIGN|PROSTATIC FLUID|PARAFFIN-EMBEDDED|HYPOGLOSSAL NERVE|LATERAL|LOWER|PALPATION|||INTERVIEWER|1|7|TREATMENT|2020-11-25|63
e|MI|e27e0325-5fbe-46c0-8264-982d83124203|1|CD8|CD8|ALLRED TOTAL SCORE|[?]|[?]|/2500 WBC|[?]|1|IMPLANT|BENIGN|CALCULUS|PARAFFIN-EMBEDDED|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|UNILATERAL|DISTAL|CONTRAST ENHANCED PET SCAN||Y|FAMILY MEMBER|1|4|SCREENING|2020-08-17|51
e|MI|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|IENFDEN|Intraepidermal Nerve Fiber Density|PERCENT POSITIVE CELL|[?]|[?]|ms/mmHg|[?]|1|Sv|BENIGN|SKELETAL MUSCLE TISSUE|HEMOLYZED|COSTOCHONDRAL JOINT 1|BILATERAL|LATERAL|SPECT/CT SCAN|Y||HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-12-15|6
e|MI|29e08650-9eae-461f-981e-f2a20d8d4492|1|LCN2|Lipocalin-2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mg/kg/day|[?]|1|Coulomb|MALIGNANT|BLOOD|PARAFFIN-EMBEDDED|THORACIC AORTA|CONTRALATERAL|INFERIOR|TRANSMISSION ELECTRON MICROSCOPY|||VENDOR|1|5|SCREENING|2021-01-12|66
e|MI|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|CD56|CD56|CHALKLEY SCORE|[?]|[?]|GPL U|[?]|1|SQU/mL|MALIGNANT|ENDOTRACHEAL FLUID|LIPEMIC|BRAIN VENTRICLE, LATERAL|UNILATERAL|FRONTAL|EPSILOMETER|||PARENT|1|5|FOLLOW-UP|2020-11-02|72
e|MI|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|CD56|CD56|ISUP GLEASON GRADE GROUP|[?]|[?]|U/kg/day|[?]|1|dpm/0.5 mL|BENIGN|DIALYSIS FLUID, PERITONEAL|LACTESCENT|OLECRANON|RIGHT|SUPERIOR|REBOUND TONOMETRY|||FRIEND|1|7|SCREENING|2020-11-12|74
e|MI|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|EGFR|Epidermal Growth Factor Receptor|STAINING INTENSITY|[?]|[?]|DRINK|[?]|1|cmH2O*s2/mL|MALIGNANT|CORD BLOOD|LACTESCENT|HAND DIGIT 4|BILATERAL|UPPER|ERGOSPIROMETRY||Y|VENDOR|1|2|TREATMENT|2021-01-29|88
e|MI|1fce031b-680b-414f-9b74-d6383e10091d|1|ESTRCPT|Estrogen Receptor|EUROPEAN CONSENSUS SCORE|[?]|[?]|pmol/g|[?]|1|aMFI|BENIGN|ENDOMETRIAL TISSUE|AGGLUTINATED|FOOT DIGIT 4|LATERAL|LOWER FLEXOR SURFACE|MRI WITHOUT CONTRAST|||CLINICAL RESEARCH ASSOCIATE|1|3|WASHOUT|2020-08-05|76
e|MI|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|ALLRED TOTAL SCORE|[?]|[?]|mEq|[?]|1|g/day|BENIGN|EPIDERMAL TISSUE|HEMOLYZED|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|VENTROLATERAL|STRESS ECHOCARDIOGRAPHY|||NON-HEALTH CARE PROFESSIONAL|1|1|FOLLOW-UP|2021-03-27|99
e|MI|91e83d7a-186a-4fed-8750-af796d77d356|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|CHALKLEY SCORE|[?]|[?]|IU/L|[?]|1|PACKET|BENIGN|INTERSTITIAL FLUID|LIPEMIC|CARPOMETACARPAL JOINT 1|IPSILATERAL|VENTRAL|MRS|||CLINICAL STUDY SPONSOR|1|6|TREATMENT|2020-06-14|22
e|MI|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|PCTISCA|Percentage of In situ Carcinoma|RECEPTOR OVERALL STATUS|[?]|[?]|g/cage|[?]|1|tuberculin unit|BENIGN|REFLEX TEAR|HEMOLYZED|MYOMETRIUM|IPSILATERAL|VOLAR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||VENDOR|1|5|FOLLOW-UP|2020-07-16|74
e|MI|0145dfac-a107-4368-b358-bcd136e1ecb3|1|TUBULTIS|Tubulitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|FFU|[?]|1|MASK|MALIGNANT|PROSTATIC FLUID|GELLED|ANTECUBITAL FOSSA|LEFT|UPPER EXTENSOR SURFACE|PLETHYSMOGRAPHY||Y|PROXY|1|1|WASHOUT|2021-02-14|47
e|MI|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|CD4|CD4|GLEASON SECONDARY SCORE|[?]|[?]|10^6 organisms/mL|[?]|1|/40 HPFs|BENIGN|TISSUE|GELLED|INTESTINE|LATERAL|LOWER EXTENSOR SURFACE|FREEZING POINT DEPRESSION|||GUARDIAN|1|7|FOLLOW-UP|2021-02-02|45
e|MI|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|HISTTYPC|Histologic Type of Cancer|RECEPTOR OVERALL STATUS|[?]|[?]|L/min/m2|[?]|1|bel|BENIGN|PERITONEAL FLUID|LACTESCENT|COLON, RIGHT|IPSILATERAL|INFERIOR|ENZYMATIC ULTRACENTRIFUGATION|||NON-HEALTH CARE PROFESSIONAL|1|2|WASHOUT|2021-01-11|65
e|MI|a329c350-49e2-415d-ba3c-e1ee929aec86|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/m2/day|[?]|1|APL U/mL|MALIGNANT|EMESIS|CONCENTRATED|T1 VERTEBRA|IPSILATERAL|DORSOLATERAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y||STUDY SUBJECT|1|1|TREATMENT|2020-10-12|68
e|MI|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|KI67|Ki-67|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|GPL U/mL|[?]|1|Bq/ug|MALIGNANT|ARTERIAL CORD BLOOD|UNEXPECTED ODOR|OMENTUM|LEFT|OUTER|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||Y|ADJUDICATOR|1|3|TREATMENT|2020-10-23|32
e|MI|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|CRYPARCD|Crypt Architectural Damage|EUROPEAN CONSENSUS SCORE|[?]|[?]|mg/m2|[?]|1|scm|BENIGN|EXUDATE|CLOTTED|THIRD RIGHT POSTEROLATERAL ARTERY|LATERAL|LOWER MEDIAL|CELL BASED BIOASSAY|Y||DOMESTIC PARTNER|1|3|TREATMENT|2021-02-06|36
e|MI|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|g/mol|[?]|1|L/L|BENIGN|STOOL|FROZEN|ANTERIOR HORN OF THE LATERAL VENTRICLE|LEFT|ANTEROMEDIAL|PHASE CONTRAST MICROSCOPY||Y|INDEPENDENT ASSESSOR|1|4|FOLLOW-UP|2020-06-22|15
e|MI|b7caaa04-bcc7-4350-ad98-85670a19778f|1|ESTRCPT|Estrogen Receptor|GLEASON PRIMARY SCORE|[?]|[?]|ug|[?]|1|TRANSDUCING UNIT/mL|MALIGNANT|EXUDATE|CONCENTRATED|BACK|RIGHT|INFERIOR|PHYSICAL EXAMINATION|||PROXY|1|7|TREATMENT|2020-10-01|97
e|MI|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|TISABNUM|Number of Abnormal Tissue Samples|ISUP GLEASON GRADE GROUP|[?]|[?]|atm|[?]|1|GPL U|MALIGNANT|BONE|SOLIDIFIED|THIRD POSTEROLATERAL DESCENDING ARTERY|IPSILATERAL|ANTEROTEMPORAL|INDIRECT IMMUNOFLUORESCENCE|||GUARDIAN|1|7|FOLLOW-UP|2021-01-30|54
e|MI|60b23345-43f6-42eb-9225-5a674456c9b9|1|IENFDEN|Intraepidermal Nerve Fiber Density|ALLRED TOTAL SCORE|[?]|[?]|ug/mol|[?]|1|mL/m2/min|MALIGNANT|EPITHELIAL CELL|AGGLUTINATED|OPTIC NERVE|IPSILATERAL|DORSAL|SNP ARRAY|||HEALTH CARE PROFESSIONAL|1|7|SCREENING|2021-02-04|30
e|MI|7979239e-2a6b-48e3-9d11-41c97b33d229|1|CRYPABSC|Crypt Abscess|METMAB SCORE|[?]|[?]|BAR|[?]|1|mOsm|BENIGN|PLEURAL TISSUE|CLOTTED|BILE DUCT|IPSILATERAL|TEMPORAL|SCANNING ELECTRON MICROSCOPY|Y|Y|ADJUDICATOR|1|3|SCREENING|2021-01-26|21
e|MI|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|CRYPABSC|Crypt Abscess|SCHEUER FIBROSIS SCORE|[?]|[?]|OI50|[?]|1|dpm/mg|MALIGNANT|BONE MARROW|FRESH|BRAIN VENTRICLE, LATERAL|UNILATERAL|VENTROLATERAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|||SIBLING|1|1|TREATMENT|2020-10-25|90
e|MI|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|IENFDEN|Intraepidermal Nerve Fiber Density|METMAB SCORE|[?]|[?]|ng|[?]|1|log10 TCID 50/mL|MALIGNANT|BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|KIDNEY, CORTEX|LATERAL|DORSAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||INVESTIGATOR|1|4|SCREENING|2021-02-23|59
e|MI|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|BD1|Beta-defensin 1|BAUERMEISTER SCORE|[?]|[?]|V/sec|[?]|1|mm2|MALIGNANT|NAIL|HEMOLYZED|BASAL GANGLIA|LEFT|VENTRAL|CAPILLARY ELECTROPHORESIS|||SPOUSE|1|3|WASHOUT|2020-08-17|36
e|MI|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|CY16|Cytokeratin 16|AJCC TUMOR GRADE|[?]|[?]|HEP|[?]|1|ug/animal|MALIGNANT|PLATELET POOR PLASMA|GELLED|AORTIC VALVE, LEFT CORONARY CUSP|LEFT|SUBCORTICAL|FLAME PHOTOMETRY|Y||ADJUDICATOR|1|2|SCREENING|2020-10-05|72
e|MI|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|BDKRB1|Bradykinin Receptor B1|METMAB SCORE|[?]|[?]|eq|[?]|1|vp/mL|MALIGNANT|ISOLATE|UNEXPECTED ODOR|ANTERIOR CINGULATE CORTEX|UNILATERAL|CENTRAL|FLUORESCENT MICROSCOPY|||NON-HEALTH CARE PROFESSIONAL|1|6|FOLLOW-UP|2021-02-01|59
e|MI|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|MMRPINTP|Mismatch Repair Proteins Interpretation|CHALKLEY SCORE|[?]|[?]|mL/beat|[?]|1|Hounsfield Unit|BENIGN|PLEURAL FLUID|ROOM TEMPERATURE|OVARY|LATERAL|SUPERFICIAL|MICROSCOPY|||SIGNIFICANT OTHER|1|2|TREATMENT|2020-08-04|66
e|MI|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|CD8|CD8|EUROPEAN CONSENSUS SCORE|[?]|[?]|CAPFUL|[?]|1|kHz|MALIGNANT|DISCHARGE|CALCIFIED|SOLE|LATERAL|PERIVENTRICULAR|GC/FID|||FRIEND|1|3|WASHOUT|2020-07-25|72
e|MI|136d59c6-9645-447a-a047-68d33dbb708e|1|PAP|Prostatic Acid Phosphatase|SCHEUER FIBROSIS SCORE|[?]|[?]|ppb|[?]|1|uV|BENIGN|ARTERIAL CORD BLOOD|GELLED|CARPOMETACARPAL JOINT 3|CONTRALATERAL|DORSAL|ELASTOGRAPHY|Y||NON-HEALTH CARE PROFESSIONAL|1|5|TREATMENT|2020-11-04|51
e|MI|2e393b90-213c-4661-ad55-cabb2008bf14|1|VFBINTMT|Vascular Fibrous Intimal Thickening|ISUP GLEASON GRADE GROUP|[?]|[?]|fraction of 1|[?]|1|ug/L|BENIGN|URINE SEDIMENT|UNEXPECTED ODOR|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|RIGHT|MIDLINE|FLOCCULATION, CHARCOAL ENHANCED|||GUARDIAN|1|5|SCREENING|2020-09-04|80
e|MI|f72002d8-262b-49da-84a4-42e6011286f0|1|PCTISCA|Percentage of In situ Carcinoma|EUROPEAN CONSENSUS SCORE|[?]|[?]|BOX|[?]|1|GBq/ug|BENIGN|BONE|THAWED|TARSUS BONE|LATERAL|LOWER FLEXOR SURFACE|HPLC/MS/MS|Y||DOMESTIC PARTNER|1|4|SCREENING|2020-12-25|82
e|MI|68869dda-531d-4218-b2b0-4f5f46825569|1|ULCER|Ulceration|BAUERMEISTER SCORE|[?]|[?]|Hounsfield Unit|[?]|1|Watt|BENIGN|PROSTATIC FLUID|CONTAMINATED|MAXILLARY SINUS|UNILATERAL|APICAL|ZIEHL NEELSEN ACID FAST STAIN|Y||CHILD|1|5|TREATMENT|2021-02-03|67
e|MI|68888445-1819-4f4c-bd0c-a445906476fb|1|THICK|Thickness|KNODELL FIBROSIS SCORE|[?]|[?]|Ci|[?]|1|Antibody Unit|BENIGN|ISOLATE|PARAFFIN-EMBEDDED|BULBAR CONJUNCTIVA|LATERAL|UPPER EXTENSOR SURFACE|CALCOFLUOR WHITE STAIN||Y|CLINICAL STUDY SPONSOR|1|1|TREATMENT|2021-01-13|9
e|MI|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|CRYPABSC|Crypt Abscess|STAINING INTENSITY|[?]|[?]|log10 CFU/g|[?]|1|mg/animal|BENIGN|SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|L1 VERTEBRA|CONTRALATERAL|BASAL|HILLMEN COLOR CHART|||NON-HEALTH CARE PROFESSIONAL|1|2|TREATMENT|2020-06-19|5
e|MI|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|CRYPABSC|Crypt Abscess|ISHAK FIBROSIS SCORE|[?]|[?]|dpm/mL|[?]|1|cd|MALIGNANT|BONE MARROW|CONCENTRATED|PUTAMEN|CONTRALATERAL|DISTAL|NEXT GENERATION TARGETED SEQUENCING|||SPOUSE|1|4|SCREENING|2020-12-15|81
e|MI|645a9247-efcb-4641-9514-58d6e28560e0|1|PMS2|PMS1 Homolog 2|ISUP GLEASON GRADE GROUP|[?]|[?]|gpELISA unit/mL|[?]|1|uEq/L|MALIGNANT|BONE MARROW|AGGLUTINATED|CORNEAL STROMA|LEFT|SUPERIOR|LIQUID SCINTILLATION COUNTING|||CLINICAL RESEARCH ASSOCIATE|1|4|TREATMENT|2021-01-07|27
e|MI|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|LFA1|Lymphocyte Function-Associated Antigen 1|RECEPTOR OVERALL STATUS|[?]|[?]|nmol/g|[?]|1|s^-1(%O2)^-1|BENIGN|EXHALED BREATH CONDENSATE|AGGLUTINATED|POPLITEAL VEIN|BILATERAL|SUPERIOR|ENZYMATIC COLORIMETRY|Y||FAMILY MEMBER|1|1|WASHOUT|2020-12-09|95
e|MI|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|MSH2|MutS Homolog 2|CHALKLEY SCORE|[?]|[?]|ug/m2/h|[?]|1|10^5/hpf|BENIGN|DIALYSIS FLUID|CONCENTRATED|INFRARENAL AORTA|BILATERAL|INNER|MAPH|||PARENT|1|3|FOLLOW-UP|2020-08-17|30
e|MI|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|CDX2AG|CDX2 Antigen|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|U/mmol|[?]|1|PACKAGE|MALIGNANT|BASAL TEAR|HEMOLYZED|VOCAL CORD|LATERAL|LOWER EXTENSOR SURFACE|CELL OF ORIGIN ASSAY||Y|FRIEND|1|7|SCREENING|2021-01-15|94
e|MI|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|BLDVESD|Blood Vessel Density|GLEASON TOTAL SUM|[?]|[?]|ug/mol|[?]|1|log EID 50/dose|BENIGN|INFRANATANT, PLASMA|ROOM TEMPERATURE|CLITORIS|LEFT|DORSAL|REVERSE TRANSCRIPTASE PCR|Y|Y|FAMILY MEMBER|1|4|SCREENING|2020-08-27|6
e|MI|51a49847-6405-4842-b549-0e2ab99f61b2|1|PCTISCA|Percentage of In situ Carcinoma|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|%/min|[?]|1|mL/day|MALIGNANT|INTERSTITIAL FLUID|AGGLUTINATED|THYMUS GLAND|LATERAL|HIND|FISH|||SIGNIFICANT OTHER|1|2|WASHOUT|2021-03-20|73
e|MI|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|CD4|CD4|SCHEUER FIBROSIS SCORE|[?]|[?]|U|[?]|1|10^6/g|BENIGN|SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED|BUTTOCK|CONTRALATERAL|DISTAL VOLAR|PET/CT SCAN WITHOUT CONTRAST|||VENDOR|1|7|FOLLOW-UP|2020-06-11|31
e|MI|98166d74-caa7-4693-a817-b2cbae947ff8|1|CORBIOMN|Number of Malignant Biopsy Cores|METAVIR FIBROSIS SCORE|[?]|[?]|in2|[?]|1|kN/cm2|BENIGN|ENDOTRACHEAL FLUID|FROZEN|JAW|LATERAL|OUTER|TARGETED TRANSCRIPTOME SEQUENCING||Y|INVESTIGATOR|1|7|TREATMENT|2021-02-08|38
e|MI|cb07675a-2042-44da-a1f9-8b7783347e88|1|EGFRVP|EGFR Variant Protein|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|/7.5 mL|[?]|1|/kg|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|CLOTTED|PRESACRAL SPACE|LATERAL|OCCIPITAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||PROXY|1|3|TREATMENT|2020-12-31|36
e|MI|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|CRYPABSC|Crypt Abscess|METAVIR FIBROSIS SCORE|[?]|[?]|F|[?]|1|g/g/day|BENIGN|BONE|LACTESCENT|COCCYGEAL VERTEBRA|RIGHT|UPPER EXTENSOR SURFACE|THERMAL IONIZATION MASS SPECTROMETRY|Y||CLINICAL RESEARCH COORDINATOR|1|2|TREATMENT|2020-07-03|12
e|MI|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|BLDVESD|Blood Vessel Density|ALLRED TOTAL SCORE|[?]|[?]|yd|[?]|1|/10^3|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|SUBMENTAL LYMPH NODE|BILATERAL|DISTAL VOLAR|IMMUNOCHROMATOGRAPHY|||CHILD|1|7|FOLLOW-UP|2020-08-16|83
e|MI|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|NKX2_1|NK2 Homeobox 1|GLEASON PRIMARY SCORE|[?]|[?]|nsec|[?]|1|BAR|MALIGNANT|STRIATED MUSCLE TISSUE|CONCENTRATED|THIGH|BILATERAL|ANTEROLATERAL|TOTAL BODY IRRADIATION|Y||GUARDIAN|1|4|SCREENING|2020-09-30|39
e|MI|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|CDX2AG|CDX2 Antigen|ISUP GLEASON GRADE GROUP|[?]|[?]|GBq/g|[?]|1|lm|MALIGNANT|SOFT TISSUE|ICTERIC|SEBACEOUS GLAND|RIGHT|POSTERIOR|FLUOROSCOPY||Y|INVESTIGATOR|1|4|FOLLOW-UP|2021-04-02|91
e|MI|84d7ff44-cbe2-446f-b667-5bc539de519b|1|ABNCE|Abnormal Cells|GLEASON TOTAL SUM|[?]|[?]|Torr|[?]|1|MET*min|BENIGN|FLUID|FROZEN|OBTURATOR INTERNUS MUSCLE|CONTRALATERAL|INNER|CONFOCAL MICROSCOPY|||NON-HEALTH CARE PROFESSIONAL|1|7|FOLLOW-UP|2020-09-25|91
e|MI|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|MYFIBROS|Myelofibrosis|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^10/L|[?]|1|mm2|BENIGN|MUCUS|LACTESCENT|CORNEAL STROMA|UNILATERAL|SUPERFICIAL|APPLANATION TONOMETRY||Y|CLINICAL RESEARCH ASSOCIATE|1|7|FOLLOW-UP|2020-11-24|71
e|MI|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|ESTRCPT|Estrogen Receptor|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|/200 HPFs|[?]|1|U/g/day|BENIGN|ABSCESS FLUID|FROZEN|STOMACH|UNILATERAL|LOWER FLEXOR SURFACE|X-RAY|||ADJUDICATION COMMITTEE|1|4|TREATMENT|2021-02-25|83
e|MI|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|MLH1|MutL Homolog 1|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|g/dL|[?]|1|DIP|BENIGN|SERUM|REFRIGERATED|TRIANGULAR BONE|BILATERAL|ANTEROMEDIAL|POLYSOMNOGRAPHY||Y|NON-HEALTH CARE PROFESSIONAL|1|7|TREATMENT|2021-01-05|98
e|MI|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|EGFR|Epidermal Growth Factor Receptor|GLEASON SECONDARY SCORE|[?]|[?]|mol|[?]|1|mol/mL|BENIGN|LYSATE|DRIED|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|UNILATERAL|ANTEROTEMPORAL|MALDI-TOF|||HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-08-19|58
e|MI|f9432d72-f7d7-4cdf-a173-2e2029258474|1|EGFRVP|EGFR Variant Protein|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|ug/m2/day|[?]|1|BAR|MALIGNANT|BONE MARROW|CONTAMINATED|WRIST JOINT EXTENSOR TENDONS|RIGHT|SUPERFICIAL|MANUAL CLOT DETECTION|||PROXY|1|6|TREATMENT|2020-12-18|38
e|MI|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|VFBINTMT|Vascular Fibrous Intimal Thickening|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mV/sec|[?]|1|mL/kg/h|MALIGNANT|SEMINAL FLUID|UNEXPECTED ODOR|COLON, RECTOSIGMOID|IPSILATERAL|ANTEROTEMPORAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||PROXY|1|4|SCREENING|2021-02-06|59
e|MI|0fc0650f-ed95-422d-b407-dcee93178780|1|CD56|CD56|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|nmol/day|[?]|1|m/sec2|BENIGN|INFRANATANT, PLEURAL FLUID|NON-HEMOLYZED|AORTIC VALVE, NON-CORONARY CUSP|LATERAL|DORSOLATERAL|SINGLE-SLICE SPIRAL CT|||SIBLING|1|2|WASHOUT|2020-10-08|56
e|MI|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|CD4|CD4|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|g/cage/wk|[?]|1|U/m2/h|MALIGNANT|GASTRIC FLUID|HEMOLYZED|RETROCRURAL LYMPH NODE|RIGHT|DEEP|CHROMATOGRAPHY|Y||INTERVIEWER|1|3|TREATMENT|2020-06-06|13
e|MI|a6f48290-787a-46ad-bee1-ae263ad3c121|1|KI67|Ki-67|GLEASON PRIMARY SCORE|[?]|[?]|mol/day|[?]|1|CAPLET|MALIGNANT|MECONIUM|UNEXPECTED ODOR|DORSALIS PEDIS ARTERY|UNILATERAL|OCCIPITAL|CELL OF ORIGIN ASSAY|||CLINICAL STUDY SPONSOR|1|6|FOLLOW-UP|2021-03-03|53
e|MI|565e5c83-9c67-4718-bd54-af34be936427|1|MIEXAM|Microscopic Examination|SCHEUER FIBROSIS SCORE|[?]|[?]|log10 TCID 50/dose|[?]|1|mg/m2/day|MALIGNANT|NAIL|NON-HEMOLYZED|SIGMOID SINUS|LATERAL|SUPERIOR|DARK FIELD MICROSCOPY|Y||CLINICAL RESEARCH ASSOCIATE|1|2|TREATMENT|2020-07-16|47
e|MI|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|EUROPEAN CONSENSUS SCORE|[?]|[?]|log10 IU/mL|[?]|1|uL|BENIGN|SUPERNATANT, PLEURAL FLUID|SOLIDIFIED|MITRAL VALVE, POSTERIOR CUSP|RIGHT|ANTEROLATERAL|TONOMETRY|||PARENT|1|2|TREATMENT|2021-01-31|34
e|MI|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|CORBIOMN|Number of Malignant Biopsy Cores|ALLRED STAINING INTENSITY SCORE|[?]|[?]|/10^4|[?]|1|mmol/L|BENIGN|PLEURAL TISSUE|AUTOLYZED|SUPRASPINATUS MUSCLE|LATERAL|POSTERIOR|CLINICAL EVALUATION||Y|HEALTH CARE PROFESSIONAL|1|5|WASHOUT|2020-11-21|69
e|MI|2cdb5053-2108-4f50-8906-8afabc855a36|1|BANFRDX|Banff Diagnostic Category Renal|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Antibody Unit|[?]|1|mL/sec/1.73m2|BENIGN|SERUM|UNEXPECTED ODOR|ORBIT|LATERAL|LOWER EXTENSOR SURFACE|GEL ELECTROPHORESIS|Y||ADJUDICATION COMMITTEE|1|3|WASHOUT|2020-09-23|36
e|MI|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|ARTLRHYT|Arteriolar Hyaline Thickening|GLEASON PRIMARY SCORE|[?]|[?]|ug/dose|[?]|1|CCID 50/mL|MALIGNANT|STRIATED MUSCLE TISSUE|AGGLUTINATED|PORTAL VEIN|CONTRALATERAL|TEMPORAL|MOUSE PROTECTION ASSAY|||CHILD|1|4|TREATMENT|2020-08-15|19
e|MI|c8aad550-11a1-4473-8b35-79b7dfb08122|1|LYMPHINV|Lymphatic Invasion|METAVIR FIBROSIS SCORE|[?]|[?]|mL/s/m2|[?]|1|P|BENIGN|SUPERNATANT, SERUM OR PLASMA|LIPEMIC|SCAPHOID-CAPITATE JOINT|BILATERAL|DORSAL|HIGH RESOLUTION MELT ANALYSIS|||DOMESTIC PARTNER|1|1|SCREENING|2020-06-15|16
e|MI|f1967c6e-c520-4482-be7e-01ada4380d87|1|EGFRVP|EGFR Variant Protein|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|sec|[?]|1|TRANSDUCING UNIT|BENIGN|PUS|CONTAMINATED|AORTOCAVAL LYMPH NODE|LEFT|HIND|NEPHELOMETRY|||FRIEND|1|3|WASHOUT|2020-12-30|4
e|MI|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|HISTTYPC|Histologic Type of Cancer|AJCC TUMOR GRADE|[?]|[?]|psec|[?]|1|nCi|BENIGN|ERYTHROCYTES|CONTAMINATED|SUBMENTAL LYMPH NODE|RIGHT|LOWER|KNEMOMETRY|||CLINICAL STUDY SPONSOR|1|4|FOLLOW-UP|2021-03-16|84
e|MI|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|KI67|Ki-67|SCHEUER FIBROSIS SCORE|[?]|[?]|mmol/kg|[?]|1|CCID 50/dose|BENIGN|EMESIS|THAWED|EPIDURAL SPACE|UNILATERAL|SUPERFICIAL|SNP ARRAY|Y|Y|CHILD|1|3|FOLLOW-UP|2020-08-25|67
e|MI|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|THICK|Thickness|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|10^7 CFU/mL|[?]|1|kcal/day|MALIGNANT|CORD SERUM|CLOTTED|L3-L4 INTERVERTEBRAL SPACE|IPSILATERAL|ROSTRAL|TOLUIDINE BLUE STAIN|Y||NON-HEALTH CARE PROFESSIONAL|1|5|FOLLOW-UP|2021-01-06|36
e|MI|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|LYMPHINV|Lymphatic Invasion|ISHAK FIBROSIS SCORE|[?]|[?]|dpm/100mg|[?]|1|Bq/mL|BENIGN|HAIR FOLLICLE|GELLED|TRAPEZOID BONE|UNILATERAL|LATERAL|LIGHT SCATTERING SPECTROSCOPY|||SPOUSE|1|6|WASHOUT|2020-07-09|36
e|MI|4be1ea69-9baf-45b4-873b-13a879544d9c|1|INTMART|Intimal Arteritis|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|10^9 CFU/mL|[?]|1|TUBE|MALIGNANT|TUMOR TISSUE|ROOM TEMPERATURE|GENITALIA|LEFT|ANTEROPOSTERIOR|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|Y|SIGNIFICANT OTHER|1|2|WASHOUT|2021-03-04|47
e|MI|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|MSNGMTRX|Mesangial Matrix|H SCORE TOTAL SCORE|[?]|[?]|PRESSOR UNITS|[?]|1|1/(s*kPa)|BENIGN|LYMPH|PARAFFIN-EMBEDDED|FOOT DIGIT 2|LATERAL|TEMPORAL|HPLC/MS/MS|Y|Y|INVESTIGATOR|1|5|TREATMENT|2020-11-05|17
e|MI|16720f71-55b5-478f-b041-00b61ae19ac9|1|LYMPHINV|Lymphatic Invasion|METMAB SCORE|[?]|[?]|h*%|[?]|1|pptr|MALIGNANT|ISOLATE|CONTAMINATED|FEMORAL ARTERY|IPSILATERAL|LOWER MEDIAL|COULOMETRIC TITRATION|||ADJUDICATION COMMITTEE|1|7|TREATMENT|2021-04-06|96
e|MI|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|STRMCECE|Stromal Cells/Total Cells|ALLRED TOTAL SCORE|[?]|[?]|pmol/L|[?]|1|ug/g/min|BENIGN|CAPILLARY BLOOD|SOLIDIFIED|LUNG, LEFT UPPER LOBE|LATERAL|LOWER|HPLC/MS|||STUDY SUBJECT|1|5|SCREENING|2021-02-11|41
e|MI|32e36ec1-6895-42ff-bf33-52977e72b338|1|VFBINTMT|Vascular Fibrous Intimal Thickening|ALLRED TOTAL SCORE|[?]|[?]|BAG|[?]|1|/day|BENIGN|AMNIOTIC FLUID|CALCIFIED|LIVER LOBE|RIGHT|LOWER|DOUBLE IMMUNODIFFUSION||Y|ADJUDICATION COMMITTEE|1|4|FOLLOW-UP|2020-08-31|5
e|MI|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|CORBIOMN|Number of Malignant Biopsy Cores|EUROPEAN CONSENSUS SCORE|[?]|[?]|mEq/day|[?]|1|umol/mol|MALIGNANT|PERITONEAL FLUID|LIPEMIC|STOMACH|CONTRALATERAL|UPPER|THIN SMEAR|Y|Y|FRIEND|1|7|TREATMENT|2020-11-25|41
e|MI|0329de16-fc7a-4941-900c-b390dac637aa|1|GLOMPATH|Glomerulopathy|PERCENT POSITIVE CELL|[?]|[?]|Torr|[?]|1|Bq/mL|BENIGN|SEMEN|AUTOLYZED|COLON, LEFT|CONTRALATERAL|CAUDAL|LC/MS||Y|CAREGIVER|1|1|TREATMENT|2020-12-06|80
e|MI|89d364c9-1338-472b-af0b-19280e45508b|1|EGFR|Epidermal Growth Factor Receptor|SCHEUER FIBROSIS SCORE|[?]|[?]|LB|[?]|1|uL/kg/day|MALIGNANT|EMESIS|LIPEMIC|INTERPHALANGEAL JOINT 3|IPSILATERAL|PERIPHERAL|LIQUID SCINTILLATION COUNTING||Y|FAMILY MEMBER|1|1|SCREENING|2021-01-12|99
e|MI|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|BLDVESD|Blood Vessel Density|SCHEUER FIBROSIS SCORE|[?]|[?]|EU|[?]|1|Bq/ug|MALIGNANT|BASAL TEAR|DRIED|LATERAL THIRD DIAGONAL BRANCH ARTERY|LEFT|MIDLINE|STATIC PERIMETRY|||CLINICAL RESEARCH COORDINATOR|1|7|SCREENING|2020-07-19|63
e|MI|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|PTBCPLTS|Peritubular Capillaritis|PERCENT POSITIVE CELL|[?]|[?]|Linear ft*LB|[?]|1|log EID 50/dose|BENIGN|CARDIAC MUSCLE TISSUE|HEMOLYZED|BREAST|IPSILATERAL|SUBCORTICAL|NUCLEIC ACID HYBRIDIZATION|||INTERVIEWER|1|7|TREATMENT|2020-10-28|26
e|MI|0c103005-efae-48ed-91e3-35d38fa1d359|1|SMUSCAB|Smooth Muscle Antibody|ALLRED TOTAL SCORE|[?]|[?]|mgEq|[?]|1|kcal/day|MALIGNANT|URINE|NON-HEMOLYZED|SPHENOID SINUS|CONTRALATERAL|SUBCORTICAL|DIFFUSION WEIGHTED MRI|Y||CAREGIVER|1|4|FOLLOW-UP|2020-07-08|51
e|MI|c9808184-3432-448c-a5e5-50176715effa|1|PMS2|PMS1 Homolog 2|ISHAK FIBROSIS SCORE|[?]|[?]|mL/min/mmHg|[?]|1|nmol/L/h|BENIGN|PERITONEAL FLUID|CLOTTED|TRICEPS BRACHII MUSCLE|CONTRALATERAL|UPPER|ZIEHL NEELSEN ACID FAST STAIN|||CAREGIVER|1|3|TREATMENT|2021-01-29|41
e|MI|c3d7d293-975f-44de-bd35-0168eec40ac9|1|SGMGSTAT|Surgical Margins Status|ISUP GLEASON GRADE GROUP|[?]|[?]|m3|[?]|1|g/L|MALIGNANT|INTERSTITIAL FLUID|THAWED|INFERIOR PUBIC RAMUS|LEFT|MIDLINE|WHOLE TRANSCRIPTOME SEQUENCING||Y|STUDY SUBJECT|1|3|TREATMENT|2020-12-27|2
e|MI|2db1f07d-a7db-4cc3-8943-536e24378f08|1|CRYPABSC|Crypt Abscess|GLEASON PRIMARY SCORE|[?]|[?]|fmol/g|[?]|1|mL/kg/h|BENIGN|EPIDERMAL TISSUE|CONCENTRATED|EYELID|UNILATERAL|HIND|IMPEDANCE CONDUCTIVITY|Y||SIGNIFICANT OTHER|1|6|WASHOUT|2020-08-28|87
e|MI|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|BANFRDX|Banff Diagnostic Category Renal|PERCENT POSITIVE CELL|[?]|[?]|anti-Xa IU/mL|[?]|1|log10 copies/mL|MALIGNANT|INFRANATANT, PLASMA|CLOTTED|LIGAMENT|RIGHT|ANTEROTEMPORAL|X-RAY|||GUARDIAN|1|4|WASHOUT|2021-01-13|39
e|MI|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|FOLH1|Folate Hydrolase 1|BAUERMEISTER SCORE|[?]|[?]|U/m2/min|[?]|1|Torr|MALIGNANT|BONE MARROW|PARAFFIN-EMBEDDED|PUBIC BONE|LATERAL|SUPERFICIAL|ISHIHARA COLOR PLATES|||ADJUDICATOR|1|5|TREATMENT|2021-01-04|41
e|MI|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|ALK|ALK Protein|METMAB SCORE|[?]|[?]|ug|[?]|1|mL/100g/min|MALIGNANT|VENOUS BLOOD|UNEXPECTED ODOR|PROXIMAL INTERPHALANGEAL JOINT 5|RIGHT|VENTRAL|GC/FID|||ADJUDICATOR|1|1|WASHOUT|2020-10-14|93
e|MI|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|TMCE|Tumor Cells|CHALKLEY SCORE|[?]|[?]|BAR|[?]|1|MONTHS|BENIGN|CIRCULATING TUMOR CELL|AUTOLYZED|FIBULAR VEIN|IPSILATERAL|DORSAL|JAFFE REACTION||Y|SIGNIFICANT OTHER|1|1|TREATMENT|2021-03-23|66
e|MI|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|TGFB1|Transforming Growth Factor Beta 1|GLEASON SECONDARY SCORE|[?]|[?]|/LPF|[?]|1|mEq/ug|BENIGN|MIXED VENOUS BLOOD|PARAFFIN-EMBEDDED|ANTECUBITAL FOSSA|UNILATERAL|FACIAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|||ADJUDICATOR|1|7|WASHOUT|2021-01-24|26
e|MI|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|HGFR|Hepatocyte Growth Factor Receptor|METMAB SCORE|[?]|[?]|mL/s/m2|[?]|1|10^7 PFU|MALIGNANT|SUPERNATANT, CEREBROSPINAL FLUID|LIPEMIC|LEFT VENTRICULAR MID ANTERIOR SEGMENT|RIGHT|LATERAL|FLUORESCENT IMMUNOASSAY|Y||INDEPENDENT ASSESSOR|1|6|FOLLOW-UP|2020-09-18|62
e|MI|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|HISTTYPC|Histologic Type of Cancer|METAVIR FIBROSIS SCORE|[?]|[?]|mmol/min/kPa|[?]|1|mL/dL|MALIGNANT|CIRCULATING TUMOR CELL|NON-HEMOLYZED|ISCHIAL TUBEROSITY|BILATERAL|LOWER|RADIAL IMMUNODIFFUSION|Y||CLINICAL RESEARCH ASSOCIATE|1|1|FOLLOW-UP|2020-08-23|83
e|MI|f50537d2-e098-4dae-8f91-16f2357d709c|1|CELLDIFF|Cellular Differentiation|GLEASON SECONDARY SCORE|[?]|[?]|MdFI|[?]|1|10^6/g|BENIGN|FLUID|UNEXPECTED ODOR|JEJUNUM|IPSILATERAL|APICAL|NUCLEIC ACID SEQUENCING|||SIBLING|1|3|SCREENING|2021-01-08|42
e|MI|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|CDX2AG|CDX2 Antigen|GLEASON TOTAL SUM|[?]|[?]|mL/sec/1.73m2|[?]|1|10^9 CFU|MALIGNANT|SMEGMA|LACTESCENT|OSTIOMEATAL COMPLEX|LEFT|UPPER EXTENSOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|||CAREGIVER|1|6|WASHOUT|2020-09-01|54
e|MI|489870ed-9da5-4df6-a5ef-17821c449c84|1|TUBULTIS|Tubulitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|Newton|[?]|1|mg/L FEU|MALIGNANT|SKELETAL MUSCLE TISSUE|FROZEN|SALIVARY GLAND|CONTRALATERAL|SUPERFICIAL|NUCLEAR RADIOLOGY|||CHILD|1|4|TREATMENT|2020-08-30|41
e|MI|90fe992f-5a11-4829-b3b0-1c8314f53012|1|CDX2AG|CDX2 Antigen|H SCORE TOTAL SCORE|[?]|[?]|g/day|[?]|1|mmHg/sec|MALIGNANT|SERUM OR PLASMA OR BLOOD|ICTERIC|MESENTERIC LYMPH NODE|RIGHT|FRONTAL|LAPAROSCOPY|Y|Y|SIBLING|1|1|TREATMENT|2020-11-11|59
e|MI|74be8de0-3307-4cc3-9044-05068b60f7e0|1|CRYPARCD|Crypt Architectural Damage|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|10^3 copies/mL|[?]|1|mg/day|BENIGN|CORD BLOOD|CONCENTRATED|FINGER EXTENSOR TENDONS|RIGHT|LATERAL|TURBIDIMETRY|Y||PROXY|1|1|TREATMENT|2021-01-06|88
e|MI|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|KI67|Ki-67|GLEASON PRIMARY SCORE|[?]|[?]|ug/cm2|[?]|1|tuberculin unit|MALIGNANT|REFLEX TEAR|UNEXPECTED ODOR|CEREBRAL HEMISPHERE, RIGHT|UNILATERAL|SUPERIOR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||CLINICAL RESEARCH ASSOCIATE|1|1|WASHOUT|2020-07-17|46
e|MI|8825b806-fa76-49d7-b281-d36fc42fee1e|1|ARTLRHYT|Arteriolar Hyaline Thickening|STAINING INTENSITY|[?]|[?]|uCi|[?]|1|ka_u/dL|MALIGNANT|EPITHELIAL CELL|CALCIFIED|SPHENOID SINUS|CONTRALATERAL|PERIPHERAL|MIGET|||DOMESTIC PARTNER|1|1|WASHOUT|2020-08-29|10
e|MI|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|ROS1|ROS1 Protein|AJCC TUMOR GRADE|[?]|[?]|10^6 organisms|[?]|1|in2|MALIGNANT|PLEURAL FLUID|ICTERIC|COLON LYMPH NODE|CONTRALATERAL|CRANIAL|SPECT/CT SCAN||Y|ADJUDICATION COMMITTEE|1|2|TREATMENT|2020-05-15|6
e|MI|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|PROGESTR|Progesterone Receptor|ALLRED TOTAL SCORE|[?]|[?]|RNA copies/mL|[?]|1|U/g Hb|BENIGN|TUMOR TISSUE|GELLED|KIDNEY, LOWER LOBE|UNILATERAL|ANTEROMEDIAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y|SIBLING|1|5|TREATMENT|2021-01-31|27
e|MI|b36220d8-c129-48bf-8c41-542a954b819a|1|BLDVESD|Blood Vessel Density|GLEASON SECONDARY SCORE|[?]|[?]|DIOPTER|[?]|1|mg/m2/day|BENIGN|INFRANATANT, PLEURAL FLUID|REFRIGERATED|HAMSTRING MUSCLE|LEFT|FORE|OPHTHALMOSCOPY|||PROXY|1|1|TREATMENT|2020-05-26|12
e|MI|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|INTSFBRO|Interstitial Fibrosis|SCHEUER FIBROSIS SCORE|[?]|[?]|nkat/L|[?]|1|umol/kg/min|BENIGN|LYMPH|LACTESCENT|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|ANTEROLATERAL|CLAUSS METHOD|||VENDOR|1|4|TREATMENT|2020-10-11|68
e|MI|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|NKX2_1|NK2 Homeobox 1|ALLRED TOTAL SCORE|[?]|[?]|MHz|[?]|1|nsec|MALIGNANT|SMEGMA|CONCENTRATED|SKIN OF THE AXILLA|LATERAL|CRANIAL|INFRARED SPECTROMETRY||Y|SIBLING|1|4|FOLLOW-UP|2021-03-09|93
e|MI|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|EGFR|Epidermal Growth Factor Receptor|BAUERMEISTER SCORE|[?]|[?]|BOX|[?]|1|mL/m2/day|MALIGNANT|CAPILLARY PLASMA|HEMOLYZED|AXILLARY VEIN|IPSILATERAL|LOWER MEDIAL|IMPEDANCE CONDUCTIVITY|||CHILD|1|7|TREATMENT|2020-11-15|95
e|MI|3f75a463-1348-4c7f-8b29-7472d29628c8|1|STRMCECE|Stromal Cells/Total Cells|METAVIR FIBROSIS SCORE|[?]|[?]|10^3 CFU/g|[?]|1|pmol/g|MALIGNANT|MUCUS|LACTESCENT|ELBOW FLEXOR MUSCLES|IPSILATERAL|PARIETO-OCCIPITAL|ETDRS EYE CHART|Y|Y|DOMESTIC PARTNER|1|4|WASHOUT|2020-07-06|4
e|MI|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|NORMCECE|Normal Cells/Total Cells|H SCORE TOTAL SCORE|[?]|[?]|mmol/kg|[?]|1|m/sec|BENIGN|SUPERNATANT, SERUM|THAWED|PORTACAVAL LYMPH NODE|RIGHT|LOWER|CALIPER MEASUREMENT METHOD||Y|GUARDIAN|1|4|TREATMENT|2021-04-20|90
e|MI|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|TUMCECE|Tumor Cells/Total Cells|METMAB SCORE|[?]|[?]|fmol|[?]|1|mg2/dL2|MALIGNANT|EPIDERMAL TISSUE|THAWED|INCISOR|BILATERAL|INTERMEDIATE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y||CHILD|1|1|FOLLOW-UP|2020-10-01|80
e|MI|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|MYFIBROS|Myelofibrosis|SCHEUER FIBROSIS SCORE|[?]|[?]|10^6 organisms/g|[?]|1|Bq/mL|MALIGNANT|ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|RECTUS FEMORIS MUSCLE|LEFT|PROXIMAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||VENDOR|1|7|TREATMENT|2020-09-27|7
e|MI|9171362e-0166-46f2-ab2d-2748d8c291d5|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|DRUM|[?]|1|ug/h|MALIGNANT|NAIL|REFRIGERATED|SACRAL TUBEROSITY|LEFT|FRONTAL|BALLPOINT PEN TECHNIQUE|||SIBLING|1|4|TREATMENT|2021-02-26|55
e|MI|9b150e38-dc85-4a28-aad3-43f7620be460|1|MIEXAM|Microscopic Examination|PERCENT POSITIVE CELL|[?]|[?]|g/m2|[?]|1|DAgU/mL|BENIGN|VENOUS PLASMA|NON-HEMOLYZED|PERIUMBILICAL REGION|IPSILATERAL|VOLAR|COULOMETRIC TITRATION|||SPOUSE|1|2|TREATMENT|2020-07-26|14
e|MI|2a595fc0-7621-4ec9-bd77-74444886052e|1|MIEXAM|Microscopic Examination|EUROPEAN CONSENSUS SCORE|[?]|[?]|/500 WBC|[?]|1|U/m2|MALIGNANT|COLOSTRUM|REFRIGERATED|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|IPSILATERAL|TIP|MULTIPLEXED BEAD BASED IMMUNOASSAY|||CLINICAL RESEARCH COORDINATOR|1|4|TREATMENT|2020-10-27|12
e|MI|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|HER2|Human Epidermal Growth Factor Receptor 2|GLEASON SECONDARY SCORE|[?]|[?]|uV2|[?]|1|uU/L|BENIGN|ARTERIAL BLOOD|LACTESCENT|T3 VERTEBRA|BILATERAL|VOLAR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||DOMESTIC PARTNER|1|4|FOLLOW-UP|2021-01-24|45
e|MI|84edaa9d-ce48-4866-ab43-af91bee126ae|1|EPITHINT|Epithelial Integrity|BAUERMEISTER SCORE|[?]|[?]|TRACE|[?]|1|10^3/L|BENIGN|LYMPH|PARAFFIN-EMBEDDED|CORNEAL ENDOTHELIUM|CONTRALATERAL|VENTROLATERAL|ELLA|||ADJUDICATOR|1|2|TREATMENT|2020-07-01|61
e|MI|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|MIEXAM|Microscopic Examination|GLEASON PRIMARY SCORE|[?]|[?]|ELISA unit/mL|[?]|1|10^6 U|MALIGNANT|VENOUS BLOOD|DRIED|SKIN OF THE FOOT|CONTRALATERAL|CENTRAL|MAPH|||CLINICAL RESEARCH ASSOCIATE|1|4|TREATMENT|2020-10-23|91
e|MI|9734ec2a-d06b-43e1-82a5-37764af17890|1|CELLDIFF|Cellular Differentiation|ALLRED STAINING INTENSITY SCORE|[?]|[?]|ELISA unit/mL|[?]|1|mL/animal/wk|MALIGNANT|CORD BLOOD|UNEXPECTED ODOR|ESOPHAGUS|LATERAL|LOWER|FARNSWORTH-MUNSELL 100 HUE TEST|||SIGNIFICANT OTHER|1|5|TREATMENT|2020-11-30|72
e|MI|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|THICK|Thickness|PERCENT POSITIVE CELL|[?]|[?]|MPL U|[?]|1|atm|BENIGN|DERMAL TISSUE|DRIED|SKIN OF THE CHEST|UNILATERAL|MIDLINE|NEXT GENERATION TARGETED SEQUENCING|Y||HEALTH CARE PROFESSIONAL|1|7|SCREENING|2021-01-30|73
e|MI|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|HISTTYPC|Histologic Type of Cancer|ALLRED STAINING INTENSITY SCORE|[?]|[?]|10^9/L|[?]|1|LENS|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|CORONARY ARTERY, RIGHT|CONTRALATERAL|CENTRAL|CYSTOSCOPY|||ADJUDICATION COMMITTEE|1|3|FOLLOW-UP|2020-09-15|72
e|MI|4ba88073-0003-461a-a950-4504ef7680e7|1|GLOMPATH|Glomerulopathy|ALLRED STAINING INTENSITY SCORE|[?]|[?]|in2|[?]|1|cal|MALIGNANT|WHITE MATTER TISSUE|FROZEN|LIVER|LATERAL|DISTAL|AUSCULTATION|||NON-HEALTH CARE PROFESSIONAL|1|2|TREATMENT|2020-09-08|16
e|MI|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|MLH1|MutL Homolog 1|AJCC TUMOR GRADE|[?]|[?]|steps/min|[?]|1|/2500 WBC|MALIGNANT|TUMOR TISSUE|ICTERIC|UPPER RESPIRATORY SYSTEM|LATERAL|ANTEROPOSTERIOR|GEL ELECTROPHORESIS||Y|FRIEND|1|1|WASHOUT|2020-09-07|16
e|MI|f552fa78-d78f-44c5-9590-30a737e6652d|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|GLEASON PRIMARY SCORE|[?]|[?]|mCi|[?]|1|10^6 RNA copies/mL|BENIGN|ERYTHROCYTES|ROOM TEMPERATURE|BILIARY TRACT|LEFT|LOWER|SLOAN LETTER EYE CHART 2.5%||Y|HEALTH CARE PROFESSIONAL|1|6|SCREENING|2020-10-28|33
e|MI|38d83f86-d8ce-461a-a288-95aebe498d22|1|HER2|Human Epidermal Growth Factor Receptor 2|STAINING INTENSITY|[?]|[?]|g/g|[?]|1|CFU/mL|BENIGN|SPUTUM|PARAFFIN-EMBEDDED|CHOROID PLEXUS|CONTRALATERAL|APICAL|ISHIHARA COLOR PLATES|||GUARDIAN|1|7|WASHOUT|2020-09-23|39
e|MI|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|EPITHINT|Epithelial Integrity|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|COAT|[?]|1|Ejaculate U|MALIGNANT|REFLEX TEAR|HEMOLYZED|PATELLA|BILATERAL|DEEP|FLUORIMETRY|||ADJUDICATOR|1|4|SCREENING|2020-09-03|31
e|MI|cf39d5bd-7682-4546-8495-5bcf48600a69|1|PCTISCA|Percentage of In situ Carcinoma|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Absorbance U/mL|[?]|1|ft|BENIGN|SEMEN|ICTERIC|AZYGOS VEIN|LEFT|ANTEROTEMPORAL|NON-CONTACT SPECULAR MICROSCOPY|Y||CHILD|1|4|SCREENING|2021-01-19|9
e|MI|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|MYFIBROS|Myelofibrosis|TUMOR PROPORTION SCORE|[?]|[?]|PHERESIS UNIT|[?]|1|g/kg/day|BENIGN|CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|CEREBRUM|LATERAL|PARIETO-OCCIPITAL|REFRACTOMETRY|||VENDOR|1|6|FOLLOW-UP|2021-02-07|85
e|MI|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|PAP|Prostatic Acid Phosphatase|AJCC TUMOR GRADE|[?]|[?]|g/U|[?]|1|U/kg|MALIGNANT|CAPILLARY PLASMA|ICTERIC|EPIGASTRIC LYMPH NODE|CONTRALATERAL|ANTERIOR|BAC ACGH|||GUARDIAN|1|6|TREATMENT|2021-03-12|54
e|MI|2b25e1f9-929c-4bdc-8758-79f33b832026|1|THICK|Thickness|ISHAK FIBROSIS SCORE|[?]|[?]|pg/dL|[?]|1|LENS|BENIGN|VENOUS CORD BLOOD|REFRIGERATED|MIDDLE PHALANX 5 OF THE HAND|LEFT|VOLAR|IMMUNOPRECIPITATION||Y|CLINICAL RESEARCH ASSOCIATE|1|2|TREATMENT|2020-10-21|12
e|MI|d02c7553-17f5-44ec-8c24-469234d080e8|1|PAX3FKHR|PAX3-FKHR Fusion Protein|STAINING INTENSITY|[?]|[?]|mL/animal|[?]|1|DIOPTER|BENIGN|AMNIOTIC FLUID|REFRIGERATED|AORTOPULMONARY WINDOW LYMPH NODE|CONTRALATERAL|DISTAL VOLAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||HEALTH CARE PROFESSIONAL|1|7|FOLLOW-UP|2021-03-03|46
e|MI|e819939e-548d-4e05-83e3-7976790de7e1|1|ABNCE|Abnormal Cells|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|mmol/s|[?]|1|mCi|BENIGN|SERUM OR PLASMA|LACTESCENT|HUMERAL EPICONDYLE|UNILATERAL|LOWER MEDIAL|MEDIASTINOSCOPY|Y||HEALTH CARE PROFESSIONAL|1|2|SCREENING|2020-11-08|72
e|MI|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|ROS1|ROS1 Protein|KNODELL FIBROSIS SCORE|[?]|[?]|umol/L/h|[?]|1|g/m2/day|BENIGN|SPERMATOZOON|DRIED|EPITROCHLEAR LYMPH NODE|BILATERAL|DISTAL VOLAR|STRESS ECHOCARDIOGRAPHY|||PROXY|1|6|TREATMENT|2020-10-26|79
e|MI|ea5229ad-6469-4147-be40-546d27c04c4c|1|BANFRDX|Banff Diagnostic Category Renal|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mg/kg/week|[?]|1|umol/min|MALIGNANT|SKIN TISSUE|CONCENTRATED|PARALARYNGEAL LYMPH NODE|UNILATERAL|LOWER FLEXOR SURFACE|TEMPLATE INCISION METHOD|Y||PARENT|1|2|SCREENING|2020-06-07|8
e|MI|0a566742-0f71-4603-85f0-875e2c3395e7|1|MCINTINF|Mononuc Cell Interstitial Inflammation|PERCENT POSITIVE CELL|[?]|[?]|mg/L FEU|[?]|1|dmol|BENIGN|INFRANATANT, PLEURAL FLUID|LIPEMIC|LUMBAR SPINE|LEFT|DORSOLATERAL|BIOPSY||Y|GUARDIAN|1|2|TREATMENT|2021-04-02|94
e|MI|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|MCINTINF|Mononuc Cell Interstitial Inflammation|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|foz_br|[?]|1|MET*min|MALIGNANT|ABSCESS FLUID|CONCENTRATED|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LEFT|VOLAR|IMPEDANCE CONDUCTIVITY|||SIBLING|1|3|WASHOUT|2020-07-26|83
e|MI|48103500-0f3d-4108-9167-6afee1098773|1|MIEXAM|Microscopic Examination|PERCENT POSITIVE CELL|[?]|[?]|mJoule/cm2|[?]|1|pmol|MALIGNANT|HAIR FOLLICLE|ICTERIC|HEART, VENTRICLE|RIGHT|PERIPHERAL|SPECULAR MICROSCOPY||Y|FAMILY MEMBER|1|2|FOLLOW-UP|2020-07-17|73
e|MI|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|CORBIOMN|Number of Malignant Biopsy Cores|GLEASON SECONDARY SCORE|[?]|[?]|g/cage/day|[?]|1|uV|MALIGNANT|GASTRIC FLUID|SOLIDIFIED|HEART, VENTRICULAR WALL|IPSILATERAL|SURFACE|RADIATION DOSIMETRY||Y|CLINICAL STUDY SPONSOR|1|1|FOLLOW-UP|2020-10-11|88
e|MI|ceab42b0-3a7e-4aad-b599-5da311398148|1|CD8|CD8|CHALKLEY SCORE|[?]|[?]|ug/g/h|[?]|1|mg/mL/day|BENIGN|LAVAGE FLUID|AUTOLYZED|COLON, LEFT|LATERAL|UPPER|DIGITAL PCR||Y|ADJUDICATOR|1|6|SCREENING|2020-09-09|90
e|MI|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|CELLDIFF|Cellular Differentiation|GLEASON TOTAL SUM|[?]|[?]|oz|[?]|1|mL/min/mmHg|BENIGN|AQUEOUS HUMOR|REFRIGERATED|FINGER|IPSILATERAL|DISTAL VOLAR|SLIT LAMP|Y||INVESTIGATOR|1|6|SCREENING|2020-09-07|70
e|MI|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|EUROPEAN CONSENSUS SCORE|[?]|[?]|mL/m2|[?]|1|vg/dose|MALIGNANT|ALVEOLAR AIR|LIPEMIC|MEDIAL FEMORAL CONDYLE|RIGHT|ANTERIOR|SIZE EXCLUSION CHROMATOGRAPHY||Y|FAMILY MEMBER|1|4|TREATMENT|2020-09-10|72
e|MI|36a54b72-6368-460e-ab4c-952923e0fd14|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|EUROPEAN CONSENSUS SCORE|[?]|[?]|mg/g/h|[?]|1|CIGARETTE|MALIGNANT|SUPERNATANT, PLASMA|CALCIFIED|SPINAL ACCESSORY NERVE|IPSILATERAL|PERIPHERAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y|SIGNIFICANT OTHER|1|6|TREATMENT|2020-05-10|5
e|MI|84e56692-9a33-472a-9ddc-545d3342da34|1|HISTTYPC|Histologic Type of Cancer|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|PRESSOR UNITS|[?]|1|mm2|BENIGN|VENOUS BLOOD|CONCENTRATED|ABDUCTOR POLLICIS BREVIS MUSCLE|IPSILATERAL|ANTEROLATERAL|REFLECTANCE SPECTROSCOPY|||SPOUSE|1|5|WASHOUT|2021-02-10|63
e|MI|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|ABNCE|Abnormal Cells|EUROPEAN CONSENSUS SCORE|[?]|[?]|FIU|[?]|1|mmol/g|BENIGN|CARDIAC MUSCLE TISSUE|ICTERIC|FEMORAL VEIN|BILATERAL|UPPER|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y|PARENT|1|6|FOLLOW-UP|2020-06-05|15
e|MI|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|BDKRB1|Bradykinin Receptor B1|ISHAK FIBROSIS SCORE|[?]|[?]|/200 HPFs|[?]|1|mL/cm|MALIGNANT|WHITE MATTER TISSUE|HEMOLYZED|METACARPOPHALANGEAL JOINT 4|CONTRALATERAL|LOWER FLEXOR SURFACE|AUTOREFRACTION|||STUDY SUBJECT|1|4|WASHOUT|2020-07-02|32
e|MI|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|STRMCECE|Stromal Cells/Total Cells|ISHAK FIBROSIS SCORE|[?]|[?]|cmH2O*s/mL|[?]|1|MdFI|BENIGN|CEREBROSPINAL FLUID|NON-HEMOLYZED|HEART, RIGHT VENTRICULAR WALL|UNILATERAL|NASAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||CLINICAL STUDY SPONSOR|1|4|SCREENING|2021-02-09|38
e|MI|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|PECAM1|Platelet Endo Cell Adhesion Molecule 1|ALLRED TOTAL SCORE|[?]|[?]|CYLINDER|[?]|1|GBq|BENIGN|MENSTRUAL BLOOD|FROZEN|CECUM|CONTRALATERAL|SUPERFICIAL|FLUORIMETRY|||SIBLING|1|6|TREATMENT|2021-02-15|40
e|MI|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|ICAM1|Intercellular Adhesion Molecule 1|TUMOR PROPORTION SCORE|[?]|[?]|U/m2/min|[?]|1|dpm/0.5 mL|BENIGN|EPIDERMAL TISSUE|THAWED|WRIST JOINT FLEXOR MUSCLES|IPSILATERAL|MEDIAL|ANTIMICROBIAL COMBINATION TESTING||Y|ADJUDICATOR|1|6|WASHOUT|2021-02-03|50
e|MI|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|VASINV|Vascular Invasion|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|PA|[?]|1|CUP|BENIGN|CEREBROSPINAL FLUID|CALCIFIED|FLEXOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|LOWER FLEXOR SURFACE|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||INVESTIGATOR|1|4|TREATMENT|2020-08-09|39
e|MI|187b2279-526f-4978-89d4-d2da56cc2257|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|METMAB SCORE|[?]|[?]|kg/L|[?]|1|PELLET|MALIGNANT|EPITHELIAL CELL|DRIED|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|ANTEROTEMPORAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|||CLINICAL RESEARCH ASSOCIATE|1|7|TREATMENT|2020-06-15|4
e|MI|53506a04-dedb-495b-8e35-0576cdf1b323|1|IENFDEN|Intraepidermal Nerve Fiber Density|ISUP GLEASON GRADE GROUP|[?]|[?]|ug/L/h|[?]|1|Ci/g|MALIGNANT|SPUTUM|HEMOLYZED|THORACIC ARTERY|BILATERAL|PERIVENTRICULAR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y|GUARDIAN|1|7|SCREENING|2020-11-28|31
e|MI|defa600c-4205-476e-a40c-690cb16769b3|1|EGFR|Epidermal Growth Factor Receptor|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|mm/h|[?]|1|10^4 CFU|MALIGNANT|SPUTUM|HEMOLYZED|VENA CAVA|BILATERAL|VENTROLATERAL|GC/FID||Y|INDEPENDENT ASSESSOR|1|3|TREATMENT|2021-03-09|54
e|MI|e5092583-4259-40ba-a6a2-eeef6607263b|1|FOXP3|Forkhead Box Protein 3|METAVIR FIBROSIS SCORE|[?]|[?]|Gauss|[?]|1|CFU/g|BENIGN|TRANSUDATE|UNEXPECTED ODOR|WRIST JOINT EXTENSOR TENDONS|UNILATERAL|OUTER|MS/MS|Y||SIGNIFICANT OTHER|1|7|SCREENING|2020-11-18|73
e|MI|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|LFA1|Lymphocyte Function-Associated Antigen 1|RECEPTOR OVERALL STATUS|[?]|[?]|L/day|[?]|1|g|BENIGN|EMESIS|CALCIFIED|PANCREATIC DUCT|CONTRALATERAL|DISTAL VOLAR|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y||VENDOR|1|6|TREATMENT|2021-01-30|88
e|MI|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|PMS2|PMS1 Homolog 2|RECEPTOR OVERALL STATUS|[?]|[?]|mg2/dL2|[?]|1|ug/g/day|MALIGNANT|PLASMA ULTRAFILTRATE|GELLED|MEDULLA OBLONGATA|LEFT|ANTEROPOSTERIOR|CYSTOSCOPY|Y|Y|CLINICAL STUDY SPONSOR|1|2|FOLLOW-UP|2021-03-07|98
e|MI|57971bdc-14df-4d9e-a59a-2665703c12ab|1|VFBINTMT|Vascular Fibrous Intimal Thickening|RECEPTOR OVERALL STATUS|[?]|[?]|10^4/L|[?]|1|CAPSULE|BENIGN|PLATELET|SOLIDIFIED|GLOSSOPHARYNGEAL NERVE|UNILATERAL|DORSAL|CARDIAC THERMODILUTION|||PARENT|1|6|WASHOUT|2020-06-05|16
e|MI|dacea2da-9101-41e9-97aa-1cb8445b1320|1|VASINV|Vascular Invasion|ISUP GLEASON GRADE GROUP|[?]|[?]|QUANTITY SUFFICIENT|[?]|1|APPLICATION|MALIGNANT|TISSUE|ROOM TEMPERATURE|FIBULA|UNILATERAL|FACIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||SPOUSE|1|3|SCREENING|2020-10-23|24
e|MI|cbf5d05e-e934-4946-b991-5fef63a01888|1|PTEN|Phosphatase and Tensin Homolog|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|10^6/L|[?]|1|EIA unit|BENIGN|PLEURAL TISSUE|ICTERIC|CAROTID ARTERY|BILATERAL|SURFACE|REBOUND TONOMETRY|Y|Y|DOMESTIC PARTNER|1|1|SCREENING|2020-11-11|15
e|MI|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|SGMGSTAT|Surgical Margins Status|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|cm/min|[?]|1|dpm/mg|BENIGN|SEMEN|CONCENTRATED|PARATRACHEAL LYMPH NODE|BILATERAL|ANTEROTEMPORAL|SPECULAR MICROSCOPY|Y||INDEPENDENT ASSESSOR|1|7|TREATMENT|2020-11-21|44
e|MI|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|RECEPTOR OVERALL STATUS|[?]|[?]|nmol|[?]|1|pm|MALIGNANT|RETICULOCYTES|DRIED|SCAPHOID-LUNATE-CAPITATE JOINT|BILATERAL|ANTERIOR|EPSILOMETER|Y||CLINICAL RESEARCH COORDINATOR|1|4|TREATMENT|2020-06-07|36
e|MI|903199e2-56e1-41e4-8904-d33cc6846ee3|1|EPITHINT|Epithelial Integrity|METMAB SCORE|[?]|[?]|cpm|[?]|1|cm|BENIGN|EXPIRED AIR|NON-HEMOLYZED|SCROTUM|CONTRALATERAL|OUTER|FLOCCULATION|||SPOUSE|1|3|TREATMENT|2021-02-20|43
e|MI|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|MSH2|MutS Homolog 2|EUROPEAN CONSENSUS SCORE|[?]|[?]|umol/mol|[?]|1|g/day|MALIGNANT|STRIATED MUSCLE TISSUE|SOLIDIFIED|CECUM|IPSILATERAL|DORSAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|Y|SPOUSE|1|2|TREATMENT|2020-12-02|40
e|MI|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|FIBROSIS|Fibrosis|PERCENT POSITIVE CELL|[?]|[?]|10^3/L|[?]|1|mL/animal/day|MALIGNANT|HAIR FOLLICLE|SOLIDIFIED|RIB 9|IPSILATERAL|DISTAL VOLAR|CONTRAST ENHANCED X-RAY|||INDEPENDENT ASSESSOR|1|6|FOLLOW-UP|2021-02-08|99
e|MI|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|PNLINV|Perineural Invasion|METAVIR FIBROSIS SCORE|[?]|[?]|U/g|[?]|1|10^3 CFU|BENIGN|BASAL TEAR|AGGLUTINATED|CALCANEUS|LATERAL|NASAL|AMSLER GRID|||GUARDIAN|1|1|FOLLOW-UP|2020-08-20|52
e|MI|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|NKX2_1|NK2 Homeobox 1|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mL/cm|[?]|1|mg2/dL2|BENIGN|NAIL|AUTOLYZED|ILIAC FOSSA|BILATERAL|VOLAR|SCANNING ELECTRON MICROSCOPY|Y|Y|CAREGIVER|1|7|TREATMENT|2020-09-10|50
e|MI|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|GLOMLTIS|Glomerulitis|ALLRED TOTAL SCORE|[?]|[?]|MET|[?]|1|pmol/day|MALIGNANT|PLEURAL TISSUE|ICTERIC|TRAPEZOID BONE|RIGHT|LOWER EXTENSOR SURFACE|PET/CT SCAN|||CAREGIVER|1|4|TREATMENT|2020-06-03|12
e|MI|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|STRMCECE|Stromal Cells/Total Cells|GLEASON SECONDARY SCORE|[?]|[?]|mL/min/1.73m2|[?]|1|cm/s|BENIGN|VITREOUS HUMOR|ICTERIC|INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|DEEP|ENDPOINT DILUTION ASSAY|||STUDY SUBJECT|1|7|FOLLOW-UP|2020-09-10|78
e|MI|a69c6182-9c35-4365-b732-b238e0584ba7|1|CD68|CD68|EUROPEAN CONSENSUS SCORE|[?]|[?]|L/kg|[?]|1|cd*s/m2|MALIGNANT|TISSUE|CALCIFIED|SKIN OF THE UPPER LIMB|UNILATERAL|MIDLINE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||STUDY SUBJECT|1|4|WASHOUT|2020-10-30|94
e|MI|1b9896cf-160e-4a56-8737-9759cd83e784|1|TGFB1|Transforming Growth Factor Beta 1|ISUP GLEASON GRADE GROUP|[?]|[?]|cycle/min|[?]|1|g/kg/day|BENIGN|SERUM OR PLASMA OR BLOOD|CONCENTRATED|CORRUGATOR SUPERCILII MUSCLE|RIGHT|NASAL|MAGNETIC RESONANCE ENTEROGRAPHY|||STUDY SUBJECT|1|1|SCREENING|2021-01-07|37
e|MI|ea87b553-e331-40cf-bd86-d2bd22694476|1|PAX3FKHR|PAX3-FKHR Fusion Protein|BAUERMEISTER SCORE|[?]|[?]|pmol/L|[?]|1|10^3 CFU/g|MALIGNANT|CAPILLARY PLASMA|CONCENTRATED|VASTUS INTERMEDIUS MUSCLE|RIGHT|FACIAL|SINGLE-SLICE SPIRAL CT|||CHILD|1|7|SCREENING|2020-09-05|41
e|MI|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|ULCER|Ulceration|TUMOR PROPORTION SCORE|[?]|[?]|Gy|[?]|1|mL/dose|BENIGN|MIXED VENOUS BLOOD|FROZEN|T2 VERTEBRA|LEFT|PARIETO-OCCIPITAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|Y|INVESTIGATOR|1|1|TREATMENT|2020-09-12|54
e|MI|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|ARTLRHYT|Arteriolar Hyaline Thickening|ISHAK FIBROSIS SCORE|[?]|[?]|10^9 CFU/g|[?]|1|CAPLET|MALIGNANT|DISCHARGE|THAWED|ILIAC FOSSA|UNILATERAL|DISTAL VOLAR|KLEIHAUER-BETKE||Y|INDEPENDENT ASSESSOR|1|4|TREATMENT|2020-08-01|34
e|MI|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|CORBIOMN|Number of Malignant Biopsy Cores|METAVIR FIBROSIS SCORE|[?]|[?]|kUSP|[?]|1|nL|MALIGNANT|MIXED VENOUS BLOOD|NON-HEMOLYZED|SUPERIOR PUBIC RAMUS|LEFT|LOWER EXTENSOR SURFACE|TRIPLE-PHASE MRI SCAN|||SIGNIFICANT OTHER|1|3|SCREENING|2020-06-08|15
e|MI|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|KI67|Ki-67|CHALKLEY SCORE|[?]|[?]|MASK|[?]|1|PNU/mL|MALIGNANT|EPITHELIAL CELL|PARAFFIN-EMBEDDED|FASCIA|UNILATERAL|POSTERIOR|IHC|||SPOUSE|1|7|TREATMENT|2020-10-14|52
e|MI|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|CD68|CD68|PERCENT POSITIVE CELL|[?]|[?]|pL|[?]|1|MET|MALIGNANT|CELL PELLET|LIPEMIC|NOSTRIL|LATERAL|INNER|FORCED OSCILLATION TECHNIQUE|||SPOUSE|1|3|SCREENING|2021-02-28|49
e|MI|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|PNLINV|Perineural Invasion|PERCENT POSITIVE CELL|[?]|[?]|mU|[?]|1|mL/cage/wk|MALIGNANT|GASTRIC CONTENTS|REFRIGERATED|CORPUS UTERI|UNILATERAL|DEEP|FREEZING POINT DEPRESSION|||INTERVIEWER|1|4|TREATMENT|2020-08-08|56
e|MI|835594ab-e93c-402b-8129-6af659be5ae1|1|ICAM1|Intercellular Adhesion Molecule 1|SCHEUER FIBROSIS SCORE|[?]|[?]|PNU/mL|[?]|1|U/m2/day|BENIGN|HAIR|UNEXPECTED ODOR|SOLEUS MUSCLE|IPSILATERAL|LATERAL|PATHOLOGICAL EVALUATION||Y|SPOUSE|1|2|TREATMENT|2021-01-19|89
e|MI|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|GZMB|Granzyme B|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mgEq|[?]|1|10^4 CFU|MALIGNANT|HAIR FOLLICLE|CLOTTED|RIB 5|RIGHT|ANTEROPOSTERIOR|URANYL ACETATE STAIN|Y||NON-HEALTH CARE PROFESSIONAL|1|7|TREATMENT|2020-11-03|37
e|MI|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|BRCA1|Breast Cancer Type 1 Susceptibility Prot|SCHEUER FIBROSIS SCORE|[?]|[?]|mEq/mL|[?]|1|L/kg|BENIGN|LYSATE|REFRIGERATED|BODY|LATERAL|ANTEROLATERAL|DXA SCAN||Y|ADJUDICATOR|1|3|TREATMENT|2020-11-29|24
e|MI|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|CD4|CD4|ALLRED STAINING INTENSITY SCORE|[?]|[?]|kBq/uL|[?]|1|nmol/day|MALIGNANT|SPUTUM|DRIED|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|ANTEROPOSTERIOR|CELL OF ORIGIN ASSAY|Y||ADJUDICATION COMMITTEE|1|7|FOLLOW-UP|2020-07-09|25
e|MI|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|TISABNUM|Number of Abnormal Tissue Samples|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|cmol|[?]|1|km/h|MALIGNANT|SEMEN|CALCIFIED|POSTERIOR TIBIAL ARTERY|IPSILATERAL|SUPERIOR|DC SHEATH FLOW|||ADJUDICATION COMMITTEE|1|4|SCREENING|2020-11-07|96
e|MI|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|PNLINV|Perineural Invasion|TUMOR PROPORTION SCORE|[?]|[?]|Bq/uL|[?]|1|PACKAGE|MALIGNANT|PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|URETHRAL SPHINCTER|IPSILATERAL|NASAL|AGAR PROPORTION|||INVESTIGATOR|1|7|WASHOUT|2020-12-29|85
e|MI|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|MITOFIG|Mitotic Figure|RECEPTOR OVERALL STATUS|[?]|[?]|mg/kg/week|[?]|1|fmol/L/sec|BENIGN|BREAST MILK|LIPEMIC|QUADRICEPS MUSCLE|RIGHT|LOWER FLEXOR SURFACE|ECHOCARDIOGRAPHY|||CLINICAL STUDY SPONSOR|1|6|TREATMENT|2020-08-14|84
e|MI|11b2b359-d4a1-411d-a676-075b26e1453c|1|GRNLMA|Granuloma|TUMOR PROPORTION SCORE|[?]|[?]|SCOOPFUL|[?]|1|CUP|MALIGNANT|INFRANATANT, SERUM|ICTERIC|ANTERIOR CINGULATE CORTEX|IPSILATERAL|LOWER EXTENSOR SURFACE|LANDOLT RING|||CHILD|1|5|WASHOUT|2020-10-06|26
e|MI|293f673d-af6a-473e-8bce-118bb85bbd9e|1|CD4|CD4|SCHEUER FIBROSIS SCORE|[?]|[?]|mL/breath|[?]|1|K|MALIGNANT|INFRANATANT, PLASMA|ICTERIC|CORNEA|RIGHT|FACIAL|TOTAL BODY RADIOGRAPHY|||SPOUSE|1|7|TREATMENT|2021-01-05|88
e|MI|0f60ab31-ee13-4846-93d2-6bcac139006f|1|SMUSCAB|Smooth Muscle Antibody|ALLRED STAINING INTENSITY SCORE|[?]|[?]|atm|[?]|1|ECL unit|MALIGNANT|INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE|SECOND RIGHT POSTEROLATERAL ARTERY|RIGHT|MEDIAL|WESTERN BLOT|||FRIEND|1|3|WASHOUT|2020-08-15|54
e|MI|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|BANFRDX|Banff Diagnostic Category Renal|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|umol/day|[?]|1|in2|MALIGNANT|CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|TEMPORAL BONE|LEFT|PERIVENTRICULAR|GC/MS/MS||Y|PROXY|1|5|TREATMENT|2020-09-24|34
e|MI|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|TUBATRO|Tubular Atrophy|ALLRED TOTAL SCORE|[?]|[?]|vp/mL|[?]|1|YEARS|BENIGN|DERMAL TISSUE|LIPEMIC|MITRAL VALVE|LEFT|MEDIAL|PEAK FLOWMETRY|||CAREGIVER|1|3|WASHOUT|2020-07-01|5
e|MI|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|BD2|Beta-defensin 2|RECEPTOR OVERALL STATUS|[?]|[?]|days/wk|[?]|1|deg/mm|BENIGN|LEUKOCYTE|CLOTTED|PINEAL GLAND|CONTRALATERAL|CENTRAL|VIRUS PLAQUE ASSAY||Y|FRIEND|1|5|FOLLOW-UP|2021-02-17|95
e|MI|78778706-6b5b-4ad8-90af-f56d602863ae|1|MSNGMTRX|Mesangial Matrix|AJCC TUMOR GRADE|[?]|[?]|Torr|[?]|1|U/mL|MALIGNANT|INFRANATANT, PLEURAL FLUID|CONCENTRATED|INGUINAL REGION|UNILATERAL|FRONTAL|SICKLE CELL SOLUBILITY TEST|Y||HEALTH CARE PROFESSIONAL|1|6|WASHOUT|2020-06-02|30
e|MI|a6954aa1-4860-412a-b988-7f708aca2ab2|1|S100A7|S100 Calcium Binding Protein A7|ALLRED STAINING INTENSITY SCORE|[?]|[?]|lx|[?]|1|Bq/ug|BENIGN|SERUM OR PLASMA|THAWED|CHEST WALL|CONTRALATERAL|ANTEROLATERAL|CELLULOSE TAPE|||DOMESTIC PARTNER|1|6|SCREENING|2020-11-30|84
e|MI|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|CY16|Cytokeratin 16|ALLRED TOTAL SCORE|[?]|[?]|g/mol|[?]|1|ECL unit|BENIGN|TUMOR TISSUE|PARAFFIN-EMBEDDED|CONJUNCTIVA|BILATERAL|LOWER EXTENSOR SURFACE|COLORIMETRY|Y|Y|FRIEND|1|2|FOLLOW-UP|2020-07-20|77
e|MI|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|PDL1|Programmed Death Ligand 1|GLEASON PRIMARY SCORE|[?]|[?]|/2000 RBC|[?]|1|ft2|MALIGNANT|SERUM OR PLASMA|DRIED|MANDIBLE|LATERAL|ANTEROMEDIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||STUDY SUBJECT|1|3|WASHOUT|2021-03-03|46
e|MI|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|TUBULTIS|Tubulitis|EUROPEAN CONSENSUS SCORE|[?]|[?]|U|[?]|1|um|MALIGNANT|DISCHARGE|REFRIGERATED|THYMUS GLAND|RIGHT|ANTEROTEMPORAL|SLIT LAMP PHOTOGRAPHY|||CAREGIVER|1|5|TREATMENT|2020-11-08|86
e|MI|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|THICK|Thickness|PERCENT POSITIVE CELL|[?]|[?]|CAPFUL|[?]|1|EID 50/mL|BENIGN|FLUID|AGGLUTINATED|GASTROINTESTINAL SYSTEM|IPSILATERAL|LATERAL|SLOAN LETTER EYE CHART 100%|||SIGNIFICANT OTHER|1|2|WASHOUT|2020-05-25|20
e|MI|fa11534a-92f9-4887-828b-25b7637b8f57|1|NORMCECE|Normal Cells/Total Cells|GLEASON TOTAL SUM|[?]|[?]|Bq/L|[?]|1|kg/cm|MALIGNANT|BASAL TEAR|DRIED|DISTAL FEMUR R1|LEFT|ANTEROMEDIAL|MICROPARTICLE ENZYME IMMUNOASSAY|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|1|TREATMENT|2021-03-05|92
e|MI|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|GLOMLTIS|Glomerulitis|AJCC TUMOR GRADE|[?]|[?]|mL/m2/day|[?]|1|Gy|BENIGN|ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|LUNG, RIGHT MIDDLE LOBE|BILATERAL|POSTERIOR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||SPOUSE|1|6|WASHOUT|2020-11-08|45
e|MI|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|GZMB|Granzyme B|GLEASON SECONDARY SCORE|[?]|[?]|10^3 CFU/g|[?]|1|Ci/mg|MALIGNANT|ISOLATE|LIPEMIC|PROXIMAL PHALANX 2 OF THE HAND|IPSILATERAL|MIDLINE|NON-CONTACT SPECULAR MICROSCOPY|||NON-HEALTH CARE PROFESSIONAL|1|1|TREATMENT|2020-08-13|77
e|MI|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|EGFR|Epidermal Growth Factor Receptor|EUROPEAN CONSENSUS SCORE|[?]|[?]|ug/dose|[?]|1|mmol/L|MALIGNANT|CAPILLARY BLOOD|AUTOLYZED|METACARPAL BONE 4|UNILATERAL|VENTRAL|CLINICAL EVALUATION|Y||CLINICAL RESEARCH ASSOCIATE|1|1|FOLLOW-UP|2020-08-07|9
e|MI|5d25ac6d-428d-41eb-9549-c23df035a54e|1|THICK|Thickness|SCHEUER FIBROSIS SCORE|[?]|[?]|cy/cm|[?]|1|cy/cm|BENIGN|SPERMATOZOON|CLOTTED|AORTA|CONTRALATERAL|TIP|IMMUNOBLOT|||SIGNIFICANT OTHER|1|3|WASHOUT|2020-05-15|12
e|MI|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|MITOFIG|Mitotic Figure|ALLRED STAINING INTENSITY SCORE|[?]|[?]|mL/animal|[?]|1|/mm2|MALIGNANT|PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|MEDULLA OBLONGATA|BILATERAL|ANTEROLATERAL|MS/MS|Y||CLINICAL RESEARCH COORDINATOR|1|6|WASHOUT|2020-11-14|25
e|MI|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|GZMB|Granzyme B|ALLRED TOTAL SCORE|[?]|[?]|ng|[?]|1|%/min|MALIGNANT|ADIPOSE TISSUE|PARAFFIN-EMBEDDED|OLFACTORY NERVE|LATERAL|SURFACE|U-HPLC/MS/MS|||FAMILY MEMBER|1|4|TREATMENT|2020-12-02|60
e|MI|45d1adb8-9b3b-4f06-87cb-740205448680|1|MSH2|MutS Homolog 2|H SCORE TOTAL SCORE|[?]|[?]|mmol/mol|[?]|1|ppth|MALIGNANT|CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|MUCOSA OF THE LIP|BILATERAL|INFERIOR|SINGLE-MOLECULE ARRAY|||ADJUDICATION COMMITTEE|1|1|TREATMENT|2020-09-24|79
e|MI|7403ad67-7ed5-4716-a874-c360429845bc|1|CELLDIFF|Cellular Differentiation|METMAB SCORE|[?]|[?]|/month|[?]|1|log EID 50/dose|MALIGNANT|ENDOTRACHEAL FLUID|SOLIDIFIED|T1 VERTEBRA|LATERAL|SUPERFICIAL|IVY INCISION METHOD|||CLINICAL RESEARCH ASSOCIATE|1|7|WASHOUT|2020-07-06|47
e|MI|8be919ce-34da-4e49-ac7a-3679c7af632d|1|GLOMLTIS|Glomerulitis|RECEPTOR OVERALL STATUS|[?]|[?]|10^10/L|[?]|1|GPS U|MALIGNANT|MENSTRUAL BLOOD|NON-HEMOLYZED|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|TIP|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|||HEALTH CARE PROFESSIONAL|1|3|TREATMENT|2021-01-11|8
e|MI|9c44967b-914e-43d5-be1e-6829804e04ab|1|GLOMLTIS|Glomerulitis|TUMOR PROPORTION SCORE|[?]|[?]|ug/kg/min|[?]|1|umol|MALIGNANT|LYMPH|HEMOLYZED|CINGULATE CORTEX|LATERAL|UPPER|FARR ASSAY|||CHILD|1|6|TREATMENT|2021-03-01|46
e|MI|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|ICAM1|Intercellular Adhesion Molecule 1|ALLRED TOTAL SCORE|[?]|[?]|umol/L|[?]|1|dpm/0.5 mL|BENIGN|SERUM|CONTAMINATED|THIRD RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|DEEP|TARGETED GENOME SEQUENCING|||CHILD|1|7|SCREENING|2020-10-16|87
e|MI|cad8c553-739f-4046-a898-d939eb286dba|1|S100A7|S100 Calcium Binding Protein A7|GLEASON SECONDARY SCORE|[?]|[?]|MdFI|[?]|1|MET|MALIGNANT|CIRCULATING TUMOR CELL|FROZEN|EXTRAOCULAR MUSCLE|RIGHT|ANTERIOR|IODINE STAIN|||SIGNIFICANT OTHER|1|5|FOLLOW-UP|2020-06-20|44
e|MI|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|CORBIOMN|Number of Malignant Biopsy Cores|GLEASON PRIMARY SCORE|[?]|[?]|TCID 50/dose|[?]|1|10^9 organisms|MALIGNANT|PLATELET RICH PLASMA|UNEXPECTED ODOR|CHIN|UNILATERAL|FACIAL|CELLULOSE TAPE|Y|Y|CLINICAL STUDY SPONSOR|1|7|TREATMENT|2020-10-11|40
e|MI|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|EGFR|Epidermal Growth Factor Receptor|GLEASON TOTAL SUM|[?]|[?]|10^7 CFU|[?]|1|10^3 RNA copies/mL|BENIGN|SEBUM|CONTAMINATED|SUBLINGUAL REGION|RIGHT|SUPERIOR|CINEANGIOGRAPHY|||ADJUDICATOR|1|3|TREATMENT|2021-04-04|80
e|MI|5713cabe-4d79-4f77-8ddc-daad1242a837|1|TUMCECE|Tumor Cells/Total Cells|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Bq/mg|[?]|1|mg|MALIGNANT|BILE|CALCIFIED|HEEL OF THE HAND|BILATERAL|PROXIMAL|SLOAN LETTER EYE CHART 2.5%|||ADJUDICATION COMMITTEE|1|6|TREATMENT|2020-11-27|89
e|MI|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|BD1|Beta-defensin 1|STAINING INTENSITY|[?]|[?]|cy/cm|[?]|1|10^7/L|MALIGNANT|BASAL TEAR|CLOTTED|SKIN FOLD|UNILATERAL|PARIETO-OCCIPITAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|||CAREGIVER|1|7|TREATMENT|2020-09-26|88
e|MI|21e16094-23bd-4d20-b5f8-10d45858160e|1|MIEXAM|Microscopic Examination|BAUERMEISTER SCORE|[?]|[?]|Gy/h|[?]|1|10^7 CFU|MALIGNANT|MIXED VENOUS BLOOD|THAWED|SMALL INTESTINE|LEFT|UPPER EXTENSOR SURFACE|KNEMOMETRY||Y|INDEPENDENT ASSESSOR|1|5|SCREENING|2020-11-06|60
e|MI|2346613e-6734-476a-a414-511606c2d753|1|PROGESTR|Progesterone Receptor|BAUERMEISTER SCORE|[?]|[?]|10^9/g|[?]|1|Enzyme U|BENIGN|CAPILLARY PLASMA|PARAFFIN-EMBEDDED|BILE DUCT|CONTRALATERAL|DEEP|MICROBIAL CULTURE, LIQUID|Y||NON-HEALTH CARE PROFESSIONAL|1|5|WASHOUT|2020-09-14|2
e|MI|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|NKX2_1|NK2 Homeobox 1|METMAB SCORE|[?]|[?]|kcal|[?]|1|Hz/s|MALIGNANT|TRANSUDATE|AUTOLYZED|PROXIMAL URETHRA|RIGHT|INNER|NUCLEIC ACID BASED METHOD|||INTERVIEWER|1|3|TREATMENT|2020-12-26|40
e|MI|748ef401-3def-4674-8d5e-4a198709d672|1|CELLDIFF|Cellular Differentiation|RECEPTOR OVERALL STATUS|[?]|[?]|pt_us|[?]|1|mg/m2|MALIGNANT|SMEGMA|DRIED|DORSALIS PEDIS ARTERY|CONTRALATERAL|BASAL|DXA SCAN|||PROXY|1|1|TREATMENT|2020-06-24|26
e|MI|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|LYMPHINV|Lymphatic Invasion|ALLRED STAINING INTENSITY SCORE|[?]|[?]|cL|[?]|1|CYLINDER|MALIGNANT|ABSCESS FLUID|NON-HEMOLYZED|RADIUS|CONTRALATERAL|INNER|ETDRS EYE CHART||Y|PROXY|1|4|FOLLOW-UP|2020-08-14|40
e|MI|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|FOLH1|Folate Hydrolase 1|AJCC TUMOR GRADE|[?]|[?]|pmol/L/h|[?]|1|MASK|MALIGNANT|SEBUM|AUTOLYZED|RIGHT ATRIAL ENDOCARDIUM|UNILATERAL|SUPERIOR|MULTIPLE BREATH WASHOUT|||INTERVIEWER|1|2|TREATMENT|2020-11-16|13
e|MI|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|NORMCECE|Normal Cells/Total Cells|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Ci/ug|[?]|1|CYLINDER|MALIGNANT|PLEURAL FLUID|FRESH|PENIS, BODY|CONTRALATERAL|ANTEROPOSTERIOR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y||DOMESTIC PARTNER|1|3|TREATMENT|2021-01-14|57
e|MI|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|CD56|CD56|AJCC TUMOR GRADE|[?]|[?]|DROP|[?]|1|tsp|BENIGN|BONE MARROW|CONCENTRATED|ACROMIOCLAVICULAR JOINT|UNILATERAL|PROXIMAL|MULTIPLE BREATH WASHOUT||Y|CLINICAL STUDY SPONSOR|1|3|TREATMENT|2020-07-31|41
e|MI|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|INTSFBRO|Interstitial Fibrosis|METAVIR FIBROSIS SCORE|[?]|[?]|mg/mL/day|[?]|1|grain|MALIGNANT|ERYTHROCYTES|GELLED|KNEE JOINT TENDONS|CONTRALATERAL|BASAL|ELISPOT|Y|Y|CLINICAL STUDY SPONSOR|1|5|WASHOUT|2020-12-19|20
e|MI|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|SCHEUER FIBROSIS SCORE|[?]|[?]|mm2|[?]|1|GBq/mg|BENIGN|AMNIOTIC FLUID|ICTERIC|SOFT TISSUE|IPSILATERAL|PROXIMAL|ENZYMATIC COLORIMETRY||Y|INVESTIGATOR|1|1|FOLLOW-UP|2020-12-10|31
e|MI|bc71ddfa-c71c-447b-9684-005e4c112172|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|METAVIR FIBROSIS SCORE|[?]|[?]|%(v/v)|[?]|1|PFU/animal|BENIGN|PERITONEAL FLUID|SOLIDIFIED|HEART, RIGHT VENTRICLE|IPSILATERAL|INFERIOR|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y|INVESTIGATOR|1|6|SCREENING|2020-09-29|90
e|MI|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|MSH6|MutS Homolog 6|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|10^3 organisms|[?]|1|MPL U/mL|BENIGN|PERSPIRATION|UNEXPECTED ODOR|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LEFT|DISTAL|X-RAY FLUORESCENCE SPECTROMETRY||Y|SPOUSE|1|6|TREATMENT|2020-12-16|17
e|MI|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|CD68|CD68|H SCORE TOTAL SCORE|[?]|[?]|bel|[?]|1|cg|BENIGN|EPITHELIAL CELL|FRESH|THYROID GLAND|IPSILATERAL|LOWER EXTENSOR SURFACE|X-RAY|||CHILD|1|2|TREATMENT|2020-09-30|34
e|MI|b1b3e113-8c73-4446-8095-3341f8912bd7|1|GLOMPATH|Glomerulopathy|ISHAK FIBROSIS SCORE|[?]|[?]|pmol/L|[?]|1|U/dL|MALIGNANT|AMNIOTIC FLUID|HEMOLYZED|HYOID BONE|LEFT|PERIVENTRICULAR|CENTRIFUGATION|||CLINICAL RESEARCH ASSOCIATE|1|4|TREATMENT|2021-03-21|63
e|MI|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|GLOMLTIS|Glomerulitis|CHALKLEY SCORE|[?]|[?]|RFU|[?]|1|Bq/mg|BENIGN|DIALYSIS FLUID|LIPEMIC|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LEFT|SUPERIOR|NEPHELOMETRY|Y|Y|CAREGIVER|1|4|TREATMENT|2021-02-06|86
e|MI|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|FIBROSIS|Fibrosis|ALLRED TOTAL SCORE|[?]|[?]|kcal|[?]|1|10^6 copies/mL|MALIGNANT|CORD SERUM|ROOM TEMPERATURE|NASAL BONE|LEFT|DEEP|FLOCCULATION, CHARCOAL ENHANCED|||GUARDIAN|1|1|SCREENING|2020-08-18|22
e|MI|3b83c7a0-e22b-45b1-b065-71971f014039|1|TUMCECE|Tumor Cells/Total Cells|ALLRED STAINING INTENSITY SCORE|[?]|[?]|kHz|[?]|1|ug/kg/day|BENIGN|PUS|ICTERIC|TOENAIL|CONTRALATERAL|PROXIMAL VOLAR|INCISION-INDUCED BLEEDING METHOD|||HEALTH CARE PROFESSIONAL|1|3|FOLLOW-UP|2020-11-18|88
e|MI|92c849ce-12b8-4c38-baab-f91c44a007b9|1|PNLINV|Perineural Invasion|METAVIR FIBROSIS SCORE|[?]|[?]|in2|[?]|1|mg/g/min|BENIGN|EMESIS|LIPEMIC|BODY OF STOMACH|BILATERAL|VOLAR|OPTICAL COHERENCE TOMOGRAPHY|Y||CLINICAL STUDY SPONSOR|1|1|TREATMENT|2020-11-29|27
e|MI|f2101018-c983-435e-a453-148f182388f7|1|ICAM1|Intercellular Adhesion Molecule 1|AJCC TUMOR GRADE|[?]|[?]|10^5/hpf|[?]|1|BP|MALIGNANT|SUPERNATANT, PLASMA|HEMOLYZED|PELVIC BONE|BILATERAL|ANTEROLATERAL|TONOMETRY|||SIGNIFICANT OTHER|1|4|TREATMENT|2020-09-19|28
e|MI|613284eb-edbe-446b-b4fe-f96f1510e626|1|PROGESTR|Progesterone Receptor|RECEPTOR OVERALL STATUS|[?]|[?]|mg/mol|[?]|1|/40 HPFs|BENIGN|ABSCESS FLUID|FRESH|AZYGOS VEIN|LEFT|SUPERFICIAL|CELLULAR PROLIFERATION ASSAY|||SIBLING|1|3|FOLLOW-UP|2021-01-27|91
e|MI|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|BD1|Beta-defensin 1|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|Gy|[?]|1|10^9 organisms|BENIGN|DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|SKIN OF THE AXILLA|UNILATERAL|ANTEROPOSTERIOR|THICK SMEAR|||GUARDIAN|1|5|SCREENING|2020-08-30|56
e|MI|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|EGFRVP|EGFR Variant Protein|METMAB SCORE|[?]|[?]|mL/mmHg|[?]|1|ugEq|MALIGNANT|DERMAL TISSUE|HEMOLYZED|PAROTID GLAND LYMPH NODE|BILATERAL|DISTAL VOLAR|AUTOMATED COUNT|Y|Y|CLINICAL STUDY SPONSOR|1|3|TREATMENT|2020-08-19|8
e|MI|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|ABNCE|Abnormal Cells|H SCORE TOTAL SCORE|[?]|[?]|cy/cm|[?]|1|cmHg|BENIGN|INTERSTITIAL FLUID|FROZEN|MUCOSA|LEFT|CRANIAL|SIZE EXCLUSION CHROMATOGRAPHY|||FAMILY MEMBER|1|6|FOLLOW-UP|2020-12-27|51
e|MI|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|EPITHINT|Epithelial Integrity|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|FIU|[?]|1|pmol/g|BENIGN|BILE|LACTESCENT|AORTIC ARCH|BILATERAL|LOWER MEDIAL|FREEZING POINT DEPRESSION|||CLINICAL RESEARCH ASSOCIATE|1|4|FOLLOW-UP|2020-09-04|17
e|MI|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|DCLAMP|Dendritic Cell-Lysosomal-Assoc Memb Prot|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|kPa/L/sec|[?]|1|umol/h/mmol|MALIGNANT|BUFFY COAT|AUTOLYZED|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|DISTAL|ROMANOWSKY STAIN|Y||DOMESTIC PARTNER|1|2|WASHOUT|2020-06-25|40
e|MI|1497a00d-55b1-4e02-a957-cf15e3d15512|1|CD3|CD3|EUROPEAN CONSENSUS SCORE|[?]|[?]|%/s|[?]|1|mg/dose|BENIGN|INTERSTITIAL FLUID|ICTERIC|PANCREAS, TAIL|UNILATERAL|LOWER FLEXOR SURFACE|AUTOMATED COUNT|Y||ADJUDICATION COMMITTEE|1|7|FOLLOW-UP|2021-04-17|92
e|MI|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|EGFR|Epidermal Growth Factor Receptor|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|mol/g|[?]|1|Log10 ELISA unit|MALIGNANT|MENSTRUAL BLOOD|CONCENTRATED|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|UPPER FLEXOR SURFACE|IRON HEMATOXYLIN STAIN|||SPOUSE|1|1|TREATMENT|2020-09-14|65
e|MI|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|STRMCECE|Stromal Cells/Total Cells|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|%(v/v)|[?]|1|mL/cage|BENIGN|CARDIAC MUSCLE TISSUE|REFRIGERATED|SEBACEOUS GLAND|LATERAL|LOWER EXTENSOR SURFACE|HPLC/MS/MS|||FRIEND|1|2|TREATMENT|2021-02-20|83
e|MI|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|GLOMLTIS|Glomerulitis|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|mCi/L|[?]|1|pg/cell|BENIGN|WHITE MATTER TISSUE|SOLIDIFIED|HIP ADDUCTORS|UNILATERAL|UPPER EXTENSOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY|||CLINICAL RESEARCH ASSOCIATE|1|6|TREATMENT|2020-10-28|2
e|MI|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|INTMART|Intimal Arteritis|CHALKLEY SCORE|[?]|[?]|vp/dose|[?]|1|mmAL|MALIGNANT|LYSATE|CONTAMINATED|MUCOSA|UNILATERAL|BASAL|FLOCCULATION|||INVESTIGATOR|1|6|TREATMENT|2020-07-02|46
e|MI|2216086b-197e-4780-8e10-28123eb090c5|1|NKX2_1|NK2 Homeobox 1|BAUERMEISTER SCORE|[?]|[?]|MONTHS|[?]|1|mAmp|BENIGN|SEBUM|UNEXPECTED ODOR|CORPUS UTERI|LATERAL|TEMPORAL|MODIFIED ACID FAST STAIN|Y||CLINICAL STUDY SPONSOR|1|2|TREATMENT|2021-02-19|79
e|MI|7280f69c-a0f4-48b5-b714-1e272193168c|1|PNLINV|Perineural Invasion|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|PFU|[?]|1|U.CARR|BENIGN|FLUID|SOLIDIFIED|NIPPLE|RIGHT|INNER|FLUORESCENT IMMUNOASSAY||Y|FAMILY MEMBER|1|1|TREATMENT|2020-09-16|38
e|MI|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|BD1|Beta-defensin 1|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|MAC50|[?]|1|mg/m2/h|MALIGNANT|MONOCYTE|UNEXPECTED ODOR|DISTAL PHALANX 2 OF THE HAND|IPSILATERAL|LOWER FLEXOR SURFACE|BRDU CELLULAR PROLIFERATION ASSAY|Y||CLINICAL RESEARCH COORDINATOR|1|5|TREATMENT|2020-08-30|39
e|MI|25c6812b-9200-4dc4-a954-6879183a2c54|1|CORBIOMN|Number of Malignant Biopsy Cores|H SCORE TOTAL SCORE|[?]|[?]|PLUG|[?]|1|mg/kg|BENIGN|CIRCULATING TUMOR CELL|CLOTTED|BILE DUCT|LATERAL|LOWER EXTENSOR SURFACE|KLEIHAUER-BETKE|||FRIEND|1|1|TREATMENT|2021-02-27|75
e|MI|10dca475-f364-42f3-9192-faf762832adf|1|GLOMLTIS|Glomerulitis|ALLRED STAINING INTENSITY SCORE|[?]|[?]|vg/dose|[?]|1|dram|BENIGN|ABSCESS FLUID|GELLED|ILIOPSOAS MUSCLE|LEFT|DEEP|CONTRAST ENHANCED SPIRAL CT SCAN|||ADJUDICATION COMMITTEE|1|4|TREATMENT|2020-11-24|70
e|MI|caf54095-56c3-428f-8342-ce45c6c9a287|1|KI67|Ki-67|SCHEUER FIBROSIS SCORE|[?]|[?]|cmH2O*s/mL|[?]|1|mg/kg|MALIGNANT|GASTRIC CONTENTS|FRESH|OPTIC NERVE|RIGHT|DEEP|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y||ADJUDICATION COMMITTEE|1|3|TREATMENT|2021-01-12|33
e|MI|f833ca56-d426-420b-a6d3-fedeabc02734|1|PNTHCEMP|Paneth Cell Metaplasia|ALLRED TOTAL SCORE|[?]|[?]|U/g|[?]|1|L/h|MALIGNANT|INFRANATANT, PLEURAL FLUID|CONCENTRATED|PRONATOR TERES MUSCLE|RIGHT|LOWER|BIOIMPEDANCE SPECTROSCOPY||Y|VENDOR|1|4|SCREENING|2020-07-17|37
e|MI|03c8e2c7-b70d-4d46-8064-c99370eab232|1|ABNCE|Abnormal Cells|RECEPTOR OVERALL STATUS|[?]|[?]|CYLINDER|[?]|1|dmol|MALIGNANT|SUPERNATANT, SERUM|DRIED|MALE GENITALIA|CONTRALATERAL|MIDLINE|RAJI CELL EIA|||SIBLING|1|4|SCREENING|2020-12-25|36
e|MI|944617c7-c5e6-4e06-b114-499c3020dbbd|1|PROGESTR|Progesterone Receptor|BANFF QUANTITATIVE CRITERIA SCORE RENAL|[?]|[?]|EVENTS|[?]|1|PIXELS/cm|BENIGN|BLOOD|PARAFFIN-EMBEDDED|AXILLARY LYMPH NODE LEVEL II|UNILATERAL|CENTRAL|CYSTOSCOPY|||SIBLING|1|2|SCREENING|2020-11-19|38
e|MI|e4878c66-1e2b-49bb-838e-85139d160dd4|1|CD56|CD56|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|eq|[?]|1|RFU|BENIGN|PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|TRANSVERSE TARSAL JOINT|LEFT|NASAL|CONTRAST ENHANCED PET SCAN||Y|FAMILY MEMBER|1|6|TREATMENT|2020-10-25|14
e|MI|6873e227-baef-4d6e-8600-0bb61d60fe49|1|PNLINV|Perineural Invasion|EUROPEAN CONSENSUS SCORE|[?]|[?]|log10 PFU|[?]|1|CIGAR|BENIGN|LEUKOCYTE|FROZEN|SCAPHOID BONE|LEFT|LOWER|GEL ELECTROPHORESIS|Y||INTERVIEWER|1|2|TREATMENT|2020-06-03|7
e|MI|bad01879-9b97-4d9c-9eec-58871168bd57|1|HGFR|Hepatocyte Growth Factor Receptor|CHALKLEY SCORE|[?]|[?]|mmHg*min/L|[?]|1|PFU/dose|BENIGN|BASAL TEAR|FRESH|ARM|LEFT|PROXIMAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y||FRIEND|1|7|TREATMENT|2020-12-19|75
e|MI|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|CRYPARCD|Crypt Architectural Damage|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|DROP|[?]|1|mEq/g|MALIGNANT|LAVAGE FLUID|THAWED|FLEXOR HALLUCIS LONGUS MUSCLE|RIGHT|UPPER EXTENSOR SURFACE|TONOMETRY|||PROXY|1|3|SCREENING|2021-01-17|83
e|MI|0df77775-6e65-4f77-9f8f-7faaa1471141|1|CELLDIFF|Cellular Differentiation|BAUERMEISTER SCORE|[?]|[?]|mEq/dL|[?]|1|10^3 organisms|MALIGNANT|ADIPOSE TISSUE|AUTOLYZED|PALATE|IPSILATERAL|ANTEROTEMPORAL|CALIPER MEASUREMENT METHOD|||HEALTH CARE PROFESSIONAL|1|6|FOLLOW-UP|2020-10-14|61
e|MI|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|CD68|CD68|ISHAK FIBROSIS SCORE|[?]|[?]|MET*min|[?]|1|cP|MALIGNANT|SKELETAL MUSCLE TISSUE|CLOTTED|INTERVENTRICULAR SEPTUM|LATERAL|HIND|MALDI-TOF|||INVESTIGATOR|1|2|WASHOUT|2020-10-19|68
e|MI|cd68296c-95d4-489e-8b64-b2404f16316c|1|LYMPHINV|Lymphatic Invasion|ISUP GLEASON GRADE GROUP|[?]|[?]|dmol|[?]|1|cup eq|MALIGNANT|BREAST MILK|PARAFFIN-EMBEDDED|CERVIX UTERI|IPSILATERAL|INTERMEDIATE|ETDRS EYE CHART|||ADJUDICATOR|1|3|TREATMENT|2021-01-22|43
e|MI|fe137506-d1ce-4b08-a043-9366d86c421e|1|BDKRB1|Bradykinin Receptor B1|CHALKLEY SCORE|[?]|[?]|psec|[?]|1|pmol/dL|MALIGNANT|FLUID|REFRIGERATED|LEFT ATRIOVENTRICULAR ARTERY|LATERAL|ANTEROMEDIAL|BRDU CELLULAR PROLIFERATION ASSAY||Y|INVESTIGATOR|1|2|TREATMENT|2020-07-28|35
e|MI|b112c524-42c8-4e9e-8699-209e739972a7|1|PTEN|Phosphatase and Tensin Homolog|STAINING INTENSITY|[?]|[?]|nmol/mol|[?]|1|10^12/L|BENIGN|SUPERNATANT, SERUM|FRESH|SKIN OF THE KNEE|IPSILATERAL|BASAL|ENZYMATIC ULTRACENTRIFUGATION|||INTERVIEWER|1|2|TREATMENT|2021-01-22|29
e|MI|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|CRYPTTS|Cryptitis|H SCORE TOTAL SCORE|[?]|[?]|cmH2O*s/mL|[?]|1|K|BENIGN|SERUM OR PLASMA OR BLOOD|DRIED|CALCARINE SULCUS|IPSILATERAL|SURFACE|IN SITU HYBRIDIZATION|||ADJUDICATION COMMITTEE|1|4|TREATMENT|2020-10-25|63
e|MI|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|BLDVESD|Blood Vessel Density|KNODELL FIBROSIS SCORE|[?]|[?]|log10 CFU/mL|[?]|1|kHz|MALIGNANT|SYNOVIAL FLUID|FRESH|GASTROINTESTINAL SYSTEM|RIGHT|DORSOLATERAL|PERCUSSION|||CAREGIVER|1|4|TREATMENT|2020-09-27|19
e|MI|5002de57-45df-4525-a6b7-b6cc33c22229|1|GZMB|Granzyme B|ISUP GLEASON GRADE GROUP|[?]|[?]|Gy/min|[?]|1|10^3 DNA copies/mL|BENIGN|REFLEX TEAR|CALCIFIED|MEDIASTINAL LYMPH NODE|LEFT|PERIPHERAL|BAC ACGH|||DOMESTIC PARTNER|1|6|TREATMENT|2021-01-05|3
e|MI|298f2081-bb11-4856-9e88-4be3b9b2250d|1|TUMCECE|Tumor Cells/Total Cells|SCHEUER FIBROSIS SCORE|[?]|[?]|mJoule/cm2|[?]|1|TRANSDUCING UNIT/mL|BENIGN|STRIATED MUSCLE TISSUE|ICTERIC|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|CONTRALATERAL|SUPERIOR|ELECTRICAL IMPEDANCE MYOGRAPHY|||HEALTH CARE PROFESSIONAL|1|5|FOLLOW-UP|2020-12-04|70
e|MI|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|PAP|Prostatic Acid Phosphatase|RECEPTOR OVERALL STATUS|[?]|[?]|CYLINDER|[?]|1|g/mol|MALIGNANT|INFRANATANT, SERUM|ICTERIC|OCCIPITAL SCALP|RIGHT|DISTAL VOLAR|SICKLE CELL SOLUBILITY TEST|||CAREGIVER|1|7|TREATMENT|2021-01-16|28
e|MI|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|PAP|Prostatic Acid Phosphatase|GLEASON TOTAL SUM|[?]|[?]|kg|[?]|1|%(v/v)|BENIGN|LOCHIA|CONTAMINATED|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|IPSILATERAL|LOWER FLEXOR SURFACE|GC/MS||Y|PARENT|1|4|TREATMENT|2020-05-22|20
e|MI|18c21176-db5e-4650-a1af-beb2042c31d8|1|BLDVESD|Blood Vessel Density|SCHEUER FIBROSIS SCORE|[?]|[?]|fmol/g|[?]|1|BAU|BENIGN|GASTRIC CONTENTS|REFRIGERATED|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|IPSILATERAL|TIP|OPHTHALMOSCOPY|||SPOUSE|1|7|TREATMENT|2020-10-09|50
e|MI|7808abd1-7d6f-4090-aa08-916a804c95f5|1|NKX2_1|NK2 Homeobox 1|ALLRED STAINING INTENSITY SCORE|[?]|[?]|PIPE|[?]|1|MHz|BENIGN|LYSATE|CLOTTED|LUNG|RIGHT|ANTEROTEMPORAL|TEMPLATE INCISION METHOD||Y|CAREGIVER|1|7|TREATMENT|2020-09-02|84
e|MI|57553b78-e761-4577-aae2-5c693a2dc303|1|BD2|Beta-defensin 2|METMAB SCORE|[?]|[?]|vg/dose|[?]|1|ug/kg|MALIGNANT|MECONIUM|CONTAMINATED|HEEL OF THE FOOT|CONTRALATERAL|UPPER FLEXOR SURFACE|ELECTROPHORESIS|Y||INVESTIGATOR|1|1|WASHOUT|2021-02-21|61
e|MI|40883550-4627-4f92-974a-7eeb5bde74c5|1|MYFIBROS|Myelofibrosis|TUMOR PROPORTION SCORE|[?]|[?]|mmHg/L/min|[?]|1|10^6/hpf|BENIGN|LYSATE|THAWED|PLACENTA|BILATERAL|DORSAL|FLUOROSCOPY||Y|SIBLING|1|2|SCREENING|2020-12-16|74
e|MI|4199b549-d021-4bfd-97e6-95630d407183|1|PTEN|Phosphatase and Tensin Homolog|GLEASON SECONDARY SCORE|[?]|[?]|Sv|[?]|1|pm|MALIGNANT|REFLEX TEAR|ROOM TEMPERATURE|CEREBRAL HEMISPHERE, LEFT|UNILATERAL|TEMPORAL|FLUOROSCOPY|Y||ADJUDICATION COMMITTEE|1|7|WASHOUT|2020-12-05|13
e|MI|6366647f-62fa-48dc-9d77-1677fce62fc7|1|CANCLLTY|Cancer Cellularity|GLEASON PRIMARY SCORE|[?]|[?]|DRUM|[?]|1|mm/sec|BENIGN|SWABBED MATERIAL|CONTAMINATED|SPLENIC VEIN|LEFT|SURFACE|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y||NON-HEALTH CARE PROFESSIONAL|1|4|SCREENING|2020-09-26|84
e|MI|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|CRYPABSC|Crypt Abscess|PERCENT POSITIVE CELL|[?]|[?]|MET*h|[?]|1|nmol/g|MALIGNANT|ENDOTRACHEAL FLUID|CALCIFIED|HEART, RIGHT VENTRICULAR FREE WALL|BILATERAL|UPPER FLEXOR SURFACE|SPECT SCAN||Y|DOMESTIC PARTNER|1|4|TREATMENT|2020-06-29|57
e|MI|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|HISTTYPC|Histologic Type of Cancer|GLEASON PRIMARY SCORE|[?]|[?]|mL/g/day|[?]|1|L/h/m2|MALIGNANT|CERVICOVAGINAL SECRETION|FRESH|LEG|CONTRALATERAL|ANTEROTEMPORAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||CHILD|1|4|FOLLOW-UP|2020-07-23|60
e|MI|696cd04a-cde7-4481-b5e2-fad1877ec284|1|BLDVESD|Blood Vessel Density|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|ug/min|[?]|1|mmHg/sec|BENIGN|INFRANATANT, PLEURAL FLUID|AUTOLYZED|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LEFT|CENTRAL|PYROSEQUENCING|||HEALTH CARE PROFESSIONAL|1|2|WASHOUT|2020-10-08|48
e|MI|ce4699cb-66f1-4c13-8428-84064255b765|1|TMCE|Tumor Cells|STAINING INTENSITY|[?]|[?]|10^6 IU/mL|[?]|1|g/U|MALIGNANT|ERYTHROCYTES|DRIED|CRANIAL NERVE|UNILATERAL|LOWER MEDIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|Y|CLINICAL RESEARCH ASSOCIATE|1|6|FOLLOW-UP|2020-12-28|36
e|MI|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|FOLH1|Folate Hydrolase 1|BAUERMEISTER SCORE|[?]|[?]|tuberculin unit|[?]|1|h/wk|BENIGN|PUS|CONTAMINATED|ORAL CAVITY|RIGHT|ANTEROTEMPORAL|HILLMEN COLOR CHART|||CAREGIVER|1|1|TREATMENT|2021-01-31|73
e|MI|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|PMS2|PMS1 Homolog 2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|Ci/kg|[?]|1|m3|MALIGNANT|SUPERNATANT, SERUM|REFRIGERATED|CHEST|LATERAL|ANTEROPOSTERIOR|ELECTRONEUROGRAPHY|||PROXY|1|5|TREATMENT|2020-07-08|41
e|MI|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|MLH1|MutL Homolog 1|SCHEUER FIBROSIS SCORE|[?]|[?]|um|[?]|1|uCi|BENIGN|CELL PELLET|CLOTTED|MYOMETRIUM|IPSILATERAL|BASAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||HEALTH CARE PROFESSIONAL|1|6|TREATMENT|2020-09-21|42
e|MI|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|HGFR|Hepatocyte Growth Factor Receptor|ALLRED STAINING INTENSITY SCORE|[?]|[?]|10^7 CFU/mL|[?]|1|/HPF|BENIGN|SERUM OR PLASMA OR BLOOD|AGGLUTINATED|PERIANAL REGION|CONTRALATERAL|DISTAL|TRYPAN BLUE STAIN|||VENDOR|1|2|TREATMENT|2020-10-05|89
e|MI|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|AMACR|Alpha-Methylacyl Coenzyme A Racemase|ALLRED PROPORTION POSITIVE SCORE|[?]|[?]|Tbsp|[?]|1|ka_u/dL|MALIGNANT|STRIATED MUSCLE TISSUE|FROZEN|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|CONTRALATERAL|PERIVENTRICULAR|TRIPLE-PHASE MRI SCAN|Y||INDEPENDENT ASSESSOR|1|7|SCREENING|2020-08-21|94
e|MI|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|LCN2|Lipocalin-2|STAINING INTENSITY|[?]|[?]|MONTHS|[?]|1|APS U|BENIGN|ERYTHROCYTES|PARAFFIN-EMBEDDED|FIBULA SHAFT|UNILATERAL|NASAL|MICRONEUTRALIZATION ASSAY|||FRIEND|1|1|SCREENING|2020-07-19|40
e|MI|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|KI67|Ki-67|RECEPTOR OVERALL STATUS|[?]|[?]|mCi/L|[?]|1|in2|BENIGN|EXUDATE|ROOM TEMPERATURE|EPITROCHLEAR LYMPH NODE|UNILATERAL|SUBCORTICAL|OPTICAL MAPPING|||INTERVIEWER|1|4|SCREENING|2020-12-09|66
e|MI|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|MITOFIG|Mitotic Figure|SCHEUER FIBROSIS SCORE|[?]|[?]|uCi/kg|[?]|1|cs|BENIGN|EXPIRED AIR|UNEXPECTED ODOR|FOOT|LATERAL|FACIAL|FORCED OSCILLATION TECHNIQUE|||HEALTH CARE PROFESSIONAL|1|1|SCREENING|2020-11-26|35
e|MI|9eb6e591-d266-4e05-85b6-230e8a02d494|1|NORMCECE|Normal Cells/Total Cells|CHALKLEY SCORE|[?]|[?]|Tesla|[?]|1|10^9 organisms|MALIGNANT|PLATELET RICH PLASMA|FROZEN|ANTERIOR TIBIAL ARTERY|BILATERAL|PROXIMAL|HPLC-UV||Y|PROXY|1|7|SCREENING|2020-09-23|97
e|MI|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|GLOMPATH|Glomerulopathy|SCHEUER FIBROSIS SCORE|[?]|[?]|uCi|[?]|1|CYLINDER|BENIGN|SMOOTH MUSCLE TISSUE|FRESH|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|LOWER FLEXOR SURFACE|PERIODIC ACID SCHIFF STAIN||Y|HEALTH CARE PROFESSIONAL|1|7|TREATMENT|2020-07-03|13
e|MI|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|CD3|CD3|EUROPEAN CONSENSUS SCORE|[?]|[?]|dpm/mL|[?]|1|/day|BENIGN|EXHALED BREATH CONDENSATE|GELLED|BODY OF STOMACH|LATERAL|LOWER MEDIAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||PARENT|1|1|FOLLOW-UP|2020-09-24|48
e|MI|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|CD8|CD8|SCHEUER FIBROSIS SCORE|[?]|[?]|HOURS|[?]|1|PIPE|BENIGN|LEUKOCYTE|ICTERIC|DISTAL RADIOULNAR JOINT|LATERAL|TEMPORAL|GRAM STAIN||Y|INTERVIEWER|1|7|WASHOUT|2021-03-26|76
e|MI|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|FOXP3|Forkhead Box Protein 3|METAVIR FIBROSIS SCORE|[?]|[?]|DRINK|[?]|1|mg/kg/day|MALIGNANT|SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|RIB 9|RIGHT|OUTER|COLORIMETRY|||CLINICAL RESEARCH ASSOCIATE|1|4|WASHOUT|2020-06-07|36
e|MI|ba99022a-d398-4c60-828c-876f119459e1|1|CD68|CD68|ALLRED STAINING INTENSITY SCORE|[?]|[?]|10^7 PFU|[?]|1|umol/h/mmol|MALIGNANT|SOFT TISSUE|GELLED|LIMB, UPPER|CONTRALATERAL|SURFACE|SLIT LAMP|||CAREGIVER|1|6|TREATMENT|2020-12-15|24
e|MI|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|MCINTINF|Mononuc Cell Interstitial Inflammation|ALLRED STAINING INTENSITY SCORE|[?]|[?]|LOZENGE|[?]|1|kHz|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|URETERIC ORIFICE|LEFT|LOWER EXTENSOR SURFACE|EEG|Y|Y|PARENT|1|2|TREATMENT|2020-07-25|59
e|MI|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|ESTRCPT|Estrogen Receptor|ENHANCED LIVER FIBROSIS SCORE|[?]|[?]|s^-1(%O2)^-1|[?]|1|AMPULE|MALIGNANT|VENOUS CORD BLOOD|DRIED|CINGULATE CORTEX|BILATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE ULTRASOUND|Y||INDEPENDENT ASSESSOR|1|4|WASHOUT|2020-09-24|85
e|MI|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|EGFRVP|EGFR Variant Protein|BAUERMEISTER SCORE|[?]|[?]|/month|[?]|1|IMPLANT|MALIGNANT|EPIDERMAL TISSUE|LIPEMIC|NUCLEUS ACCUMBENS|BILATERAL|DORSAL|WHOLE TRANSCRIPTOME SEQUENCING|Y||INDEPENDENT ASSESSOR|1|5|SCREENING|2021-03-17|85
e|MI|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|INTSFBRO|Interstitial Fibrosis|ALLRED TOTAL SCORE|[?]|[?]|ag|[?]|1|mL/cage/day|BENIGN|SALIVA|REFRIGERATED|RENAL PELVIS|UNILATERAL|ANTEROMEDIAL|PERCUSSION|||ADJUDICATION COMMITTEE|1|3|WASHOUT|2020-07-01|19
e|MI|8a2147b1-2deb-410e-a298-d028a5efc555|1|TRCETMCE|Transitional Cells/Tumor Cells|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|/cmH2O|[?]|1|mL/cage/wk|MALIGNANT|SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|CORNEA|UNILATERAL|DEEP|COMPUTERIZED CORNEAL TOPOGRAPHY|Y||SIBLING|1|3|TREATMENT|2021-01-07|79
e|MI|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|EGFRVP|EGFR Variant Protein|RECEPTOR OVERALL STATUS|[?]|[?]|Ci/mL|[?]|1|g/cm2|MALIGNANT|AMNIOTIC FLUID|FRESH|TIBIOTARSAL JOINT|CONTRALATERAL|DISTAL|KNEMOMETRY|Y||INVESTIGATOR|1|6|TREATMENT|2020-09-30|97
e|MI|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|FOXP3|Forkhead Box Protein 3|TUMOR PROPORTION SCORE|[?]|[?]|cmH2O*s/mL|[?]|1|m3|MALIGNANT|LYSATE|LACTESCENT|BACK|LEFT|LOWER|PHASE-CONTRAST MRI|||NON-HEALTH CARE PROFESSIONAL|1|7|WASHOUT|2020-09-04|87
e|MI|8dd493b7-a892-4cab-8f69-701471c51d99|1|TGFB1|Transforming Growth Factor Beta 1|PERCENT POSITIVE CELL|[?]|[?]|Roentgen|[?]|1|mEq/g|MALIGNANT|SUPERNATANT, SERUM|THAWED|SPLENIC VEIN|LATERAL|INFERIOR|ELECTROCHEMILUMINESCENCE|||SIBLING|1|1|TREATMENT|2021-01-08|6
e|MI|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|SMUSCAB|Smooth Muscle Antibody|RECEPTOR OVERALL STATUS|[?]|[?]|BOLUS|[?]|1|pg/L|MALIGNANT|ENDOMETRIAL TISSUE|THAWED|ADDUCTOR MAGNUS MUSCLE|BILATERAL|INTERMEDIATE|PERIPHERAL ANGIOGRAPHY|||DOMESTIC PARTNER|1|3|SCREENING|2020-11-22|25
e|MI|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|BLDVESD|Blood Vessel Density|AJCC TUMOR GRADE|[?]|[?]|mJoule/cm2|[?]|1|Enzyme U/m2|BENIGN|INFRANATANT, PLEURAL FLUID|ICTERIC|PERIURETERAL REGION|CONTRALATERAL|HIND|IODINE STAIN||Y|SIGNIFICANT OTHER|1|4|FOLLOW-UP|2020-10-04|40
e|MI|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|ABNCE|Abnormal Cells|RECEPTOR OVERALL STATUS|[?]|[?]|dpm/0.5 mL|[?]|1|umol/dL|MALIGNANT|GASTRIC FLUID|UNEXPECTED ODOR|MITRAL VALVE|LEFT|LOWER FLEXOR SURFACE|DOUBLE IMMUNODIFFUSION|||PARENT|1|1|TREATMENT|2021-01-24|75
e|MI|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|MIEXAM|Microscopic Examination|GLEASON SECONDARY SCORE|[?]|[?]|STRIP|[?]|1|BE/mL|BENIGN|INTERSTITIAL FLUID|DRIED|DISTAL FEMUR R1|RIGHT|ANTEROPOSTERIOR|FLUORIMETRY|||PROXY|1|2|TREATMENT|2021-02-23|59
e|MI|df041193-ee4e-4835-8db9-5be9b832ded0|1|TUBATRO|Tubular Atrophy|GLEASON TOTAL SUM|[?]|[?]|umol/day|[?]|1|ft|MALIGNANT|CAPILLARY BLOOD|CALCIFIED|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|IPSILATERAL|ANTEROPOSTERIOR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||INDEPENDENT ASSESSOR|1|6|TREATMENT|2021-02-06|83
e|MI|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|S100A7|S100 Calcium Binding Protein A7|ALLRED STAINING INTENSITY SCORE|[?]|[?]|tsp|[?]|1|days/wk|MALIGNANT|SERUM|FRESH|SEMITENDINOSUS MUSCLE|CONTRALATERAL|FORE|VIRUS PLAQUE ASSAY|||SIGNIFICANT OTHER|1|6|WASHOUT|2021-01-09|6
e|MI|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|LCN2|Lipocalin-2|BATTS-LUDWIG FIBROSIS SCORE|[?]|[?]|nCi|[?]|1|cmol|MALIGNANT|PLATELET POOR PLASMA|HEMOLYZED|T12 VERTEBRA|CONTRALATERAL|FACIAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||PROXY|1|3|TREATMENT|2021-01-10|5
e|MI|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|KI67|Ki-67|AJCC TUMOR GRADE|[?]|[?]|BAR|[?]|1|10^4 CFU/mL|BENIGN|EMOTIONAL TEAR|CALCIFIED|CAPITATE-HAMATE JOINT|IPSILATERAL|LOWER EXTENSOR SURFACE|IMMUNO-PET SCAN|||FRIEND|1|2|SCREENING|2020-12-09|7
e|MI|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|LFA1|Lymphocyte Function-Associated Antigen 1|STAINING INTENSITY|[?]|[?]|MASK|[?]|1|10^8 PFU|BENIGN|PUS|HEMOLYZED|SUBMANDIBULAR LYMPH NODE|UNILATERAL|SUBCORTICAL|INTERRUPTER TECHNIQUE|||CLINICAL RESEARCH ASSOCIATE|1|3|WASHOUT|2021-03-15|59
e|MI|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|GZMB|Granzyme B|BAUERMEISTER SCORE|[?]|[?]|U.CARR|[?]|1|uSiemens|MALIGNANT|LAVAGE FLUID|THAWED|RIGHT CORONARY ARTERY OSTIUM|UNILATERAL|DORSAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y|PARENT|1|6|SCREENING|2020-08-17|99
e|MI|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|ESTRCPT|Estrogen Receptor|RECEPTOR OVERALL STATUS|[?]|[?]|nmol BCE/mmol|[?]|1|mol/mg|BENIGN|ATHEROSCLEROTIC PLAQUE|DRIED|URETHRA, ANTERIOR|RIGHT|TEMPORAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y|HEALTH CARE PROFESSIONAL|1|3|WASHOUT|2020-09-30|37
e|MI|e515b916-5d28-4236-8835-2ff43b498ab3|1|MIEXAM|Microscopic Examination|KNODELL FIBROSIS SCORE|[?]|[?]|kPa/L/sec|[?]|1|CAPFUL|MALIGNANT|EPITHELIAL CELL|PARAFFIN-EMBEDDED|SKIN OF THE ELBOW|LEFT|UPPER|PANENDOSCOPY|Y||ADJUDICATION COMMITTEE|1|2|WASHOUT|2020-05-28|15
e|MI|158af2a8-d447-45e5-8c58-3b950f1bd889|1|ERLIERLT|Epi RBM Lngth, Intact/Epi RBM Lngth, Tot|ALLRED TOTAL SCORE|[?]|[?]|/LSQN|[?]|1|Frames/s|MALIGNANT|REFLEX TEAR|HEMOLYZED|RIB 6|CONTRALATERAL|DISTAL|HANSEL STAIN|||INDEPENDENT ASSESSOR|1|1|TREATMENT|2020-08-16|88
e|MI|e9a930d5-ca57-4069-8251-c164273df082|1|CORBIOMN|Number of Malignant Biopsy Cores|KNODELL FIBROSIS SCORE|[?]|[?]|pt_us|[?]|1|10^3 RNA copies/mL|BENIGN|NAIL|THAWED|STOMACH|CONTRALATERAL|FORE|PET/CT SCAN WITHOUT CONTRAST|||CHILD|1|7|WASHOUT|2020-05-25|14
e|MI|e654e37e-1c95-4f25-83b1-9233186626c6|1|BD2|Beta-defensin 2|ALLRED TOTAL SCORE|[?]|[?]|ks|[?]|1|%(w/v)|MALIGNANT|SKELETAL MUSCLE TISSUE|ICTERIC|MUSCLE|CONTRALATERAL|SURFACE|IMMUNOTURBIDIMETRY|||PROXY|1|5|TREATMENT|2020-10-13|80
e|MI|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|GZMB|Granzyme B|RECEPTOR OVERALL STATUS|[?]|[?]|nkat|[?]|1|PNU/mL|BENIGN|SOFT TISSUE|CLOTTED|ARM|IPSILATERAL|OCCIPITAL|ATOMIC ABSORPTION SPECTROMETRY||Y|CLINICAL RESEARCH ASSOCIATE|1|1|TREATMENT|2020-07-22|43
